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ABSTRACT 
Background 
Stroke is a major cause of death and disability in the UK. Few treatments exist and 
those that do, such as thrombolysis (‘clot-busting’ treatment) must be given urgently 
and are not risk-free. Large scale randomised controlled trials are crucial for the 
development of safe, effective, acute interventions, but progress has been limited, 
ostensibly due to ethical and regulatory difficulties. Theoretical work in this area has 
focussed primarily upon the requirement for prospective informed consent, but has also 
considered potential conflicts of interests inherent in the dual role of clinician-
researchers, and the notion that research and clinical practice are, can be, and should be 
conducted separately. Empirical evidence on this topic is lacking. By providing such 
evidence, this study examines claims made in the literature regarding the difficulties 
encountered or perceived in conducting emergency research. It also explores whether, 
how, and to what effect, the distinction between research and clinical activity advocated 
in the bioethical literature is maintained. 
Methods 
Ethnographic methods were employed, including participant observation, semi-
structured interviews, and audio-recording of research consent interactions in an acute 
stroke unit. Data were analysed drawing upon constant comparative and framework 
methods.   
Results and conclusion 
Whilst providing empirical evidence supporting some of the theoretical and conceptual 
literature, the data also furnish a detailed account of pragmatic issues encountered and 
managed daily by healthcare professionals in the acute stroke environment. Whilst 
attempts were made at the study site to separate, at least in part, clinical and research 
activity, it was observed that absolute separation of clinical activities is neither 
attainable, sustainable, nor desirable. Placement of research nurses within the clinical 
environment may promote transparency and greater understanding of their role, whilst 
simultaneously demystifying research concepts. Ultimately this may promote closer 
working relationships, contributing to enhanced recruitment, retention and management 
of research participants. 
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Chapter 1. Introduction  
 
 
 
 
 
 
 
 
 
 
1.1 The Case For Emergency Research In Stroke Management 
Stroke is the third largest cause of death in the UK and is the biggest cause of 
disability (National Audit Office, 2010). Ischaemic stroke is caused by a sudden 
blockage of blood flow to or within the brain and may result in varying degrees of 
paralysis of the limbs, speech and/or visual disturbances, cognitive deficits and 
fluctuating or diminished level of consciousness. Many survivors remain disabled and 
require the support of carers. In our increasingly ageing population, it is predicted that 
the incidence of vascular events, including stroke, will increase by 33% by 2020 
(Hankey, 2005). Few treatments are available, and those that are, such as thrombolysis, 
(‘clot-busting’ treatment) must be given urgently and are not without their own major 
risks (Hacke et al., 2004). Until relatively recently, possibly until the advent of 
thrombolysis, there has been a somewhat nihilistic view of stroke. The National Audit 
Office (2005) noted that ‘an emergency response to stroke with efficient and effective 
acute care is generally lacking’ ((National Audit Office, 2005; p.7).  Nevertheless, 
reducing disability from stroke is recognised as a key priority in the Draft Regional 
Health Strategy for the North East (Singleton, 2007).  
Large scale randomised controlled trials are crucial for the development of safe 
and effective acute interventions for stroke but data from the 2008 National Stroke 
Audit indicated that only 6% of patients included in the audit were enrolled in research 
protocols (not all of which were acute interventions) (Intercollegiate Stroke Working 
Party, 2009). Further research is urgently required but little progress has been made in 
This thesis describes the findings from an ethnographic study exploring the 
way in which randomised controlled trials of acute and hyperacute stroke 
interventions are conducted in an acute stroke unit. It seeks to determine whether the 
barriers identified in the literature are indeed those experienced in day to day 
practice, as well as reviewing whether, how, and to what effect, the distinction 
between research and clinical activity advocated in the bioethical literature is 
maintained. Chapter 1 introduces the topic and research design, and provides an 
outline of the thesis structure. 
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recent years. Of 75 therapeutic strategies tested in acute stroke trials during the 
twentieth century, only 2 (3%) are considered to be of proven benefit (Kidwell et al., 
2001). This lack of progress is attributed not least to the perceived difficulties in 
conducting research in the emergency situation in general, and in acute stroke care more 
specifically.  
1.2 Structure Of The Thesis 
1.2.1 Literature review and background 
The medical and bioethical literature, reviewed in Chapter 2, suggests that the 
difficulties facing acute and hyperacute stroke research (and other emergency situations) 
are, for the most part, related to ethical and regulatory issues, often focussing primarily 
on the requirement to obtain prospective informed consent. Questions are also raised 
about the dual role of clinician-researchers, the attendant conflicts of interests, and the 
notion that research and clinical care are, can be and should be conducted quite 
separately. These issues shaped my research and the context in which this work was 
conducted. 
This study aims to provide empirical evidence to situate claims made in the 
literature regarding the difficulties encountered or perceived in conducting emergency 
research. It explores whether, how, and to what effect the distinction between research 
and clinical practice was maintained in daily practice in an acute stroke care 
environment.  
In order to contextualise my fieldwork, in Chapter 3, I provide data regarding the 
study site, personnel, admission processes and the current position of pharmaceutical 
research within the field.  
1.2.2 Study design 
 In Chapter 4, I outline the ethnographic approach I used. Having secured a 
favourable ethical opinion (See Appendix A, Letter of Confirmation, application not 
included as this would compromise anonymity of the site and certain individuals), data 
collection was undertaken over an 18 month period from June 2006 to November 2007.  
Participant observation, and audio-recording in the case of consent interactions, 
provided a detailed account of how acute and hyperacute research was conducted in the 
acute stroke unit. Informal discussions and semi-structured interviews with clinical 
researchers and other non-research healthcare professionals facilitated the development 
of a more subjective record of their experiences, behaviours, involvement in, and more 
3 
 
 
general views about, conducting research in the clinical environment. When combined, 
these different sources of evidence, alongside the literature, furnish a more detailed 
understanding of day-to-day conduct of randomised controlled trials in the acute stroke 
environment. 
1.2.3 Results 
In Chapters 5, 6, 7 and 8, I present my empirical findings. In Chapter 5, I 
demonstrate how organisational issues shaped the temporospatial context of the 
research team, exerting both positive and negative influences upon access and 
interaction with patients and colleagues. In Chapter 6, I consider the way in which the 
clinical team perceived and positioned research and the research team as something 
‘separate and mysterious’. In Chapter 7, I explore the ways in which the research nurses 
performed their research identity, extending the traditional role and negotiating new 
boundaries. Finally, I draw these elements together in Chapter 8, to illustrate the work 
of the clinician-researcher and the performance of research within this acute stroke 
environment.  
1.2.4 Discussion 
Whilst the data provide empirical evidence in support of some of the theoretical 
and conceptual literature, they also provide a more detailed account of pragmatic issues 
encountered and managed every day by health care professionals in the acute stroke 
environment. In Chapter 9, I discuss these findings with reference to the literature, 
before considering implications for practice and recommendations for change.    
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Chapter 2. Literature Review And Background  
2.1 Introduction 
In Chapter 1, I outlined the need for clinical research in emergency medicine, and 
in stroke management in particular. In the first section of this chapter, I review some of 
the theoretical and conceptual issues that are perceived to be problematic in this area. 
Next, I review relevant empirical work which aims to explore lay opinion regarding 
emergency research, with or without prospective informed consent; perceptions of 
alternative forms of consent, including the option of waiver; and the accuracy and 
acceptability of proxy consent (or substituted judgement). Finally, I review literature 
examining the advantages and disadvantages of integrating research within clinical 
practice and the role of the nurse in this setting.  
2.2 The Need For Clinical Trials In Emergency Care   
As noted in Chapter 1,  high quality clinical trials are crucial in order to improve 
the treatment and outcome of life threatening emergency illness or disease, but 
controversy persists regarding the ways in which persons incapacitated by such events 
can be successfully enrolled in research whilst being adequately protected from 
associated risks (Booth, 2007). Because of these difficulties, many current critical care 
interventions implemented and embedded before the introduction of our current 
rigorous regulatory procedures, are at best untested and at worst inappropriate, but are 
perpetuated due to custom and practice and remain unchallenged by empirical evidence 
(McRae and Weijer, 2002; Gefenas, 2007). This has been described as an ‘illusion of 
efficacy’ whereby therapies and procedures in everyday practice are perceived to be 
beneficial , but do not stand up to closer scientific scrutiny in terms of effectiveness or 
safety (Lewis, 1999; p.771).  
Such optimism is not restricted to the lay public. In a study of Emergency Medical 
Service (EMS) providers in the US, it was reported that despite the large proportion of 
cardiac deaths resulting from out of hospital cardiac arrest, 57% of respondents thought 
that treatments for cardiac arrest were effective, and 40% believed that trauma 
treatments were effective (Schmidt et al., 2009). Lewis suggests that accident and 
emergency practitioners should openly and honestly inform patients about the 
uncertainties and limitations of some of the therapies currently employed in the 
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emergency situation. It is postulated that greater public understanding of the limitations 
of current interventions may result in greater awareness and understanding of the need 
for research in this field. Limited understanding is not the only barrier however, as I 
demonstrate in the following section, in which I review some of the theoretical and 
conceptual issues purported to restrict the conduct of emergency research. 
2.3 Theoretical And Conceptual Issues 
It is generally accepted that the enrolment of neurologically compromised patients 
to clinical trials presents a number of difficulties, often including complex ethical 
dilemmas, for healthcare professionals (Miller, 1993; Tobias, 1997; Watts, 1997; Fost, 
1998; McHale, 1998; Flanagan et al., 2011). Whilst much is written on this subject from 
a theoretical or conceptual perspective there is considerably less empirical evidence 
about the practical impact of these difficulties upon the day to day conduct of research 
in acute and/or hyperacute situations. In this chapter I explore the difficulties discussed 
in the medical and bioethical literature.  Some are common across a number of research 
environments, whilst others are specific to, or exacerbated in, emergency research 
situations, such as acute and hyperacute stroke. 
The literature abounds with theoretical and conceptual pieces on the difficulties of 
conducting research in the emergency setting, issues which are also pertinent to the 
acute and hyperacute stroke situation. A substantial proportion of this work suggests 
that most of the problems in these areas of research are related to ethical and regulatory 
issues. These in turn are usually distilled to matters pertaining to decision making 
capacity and informed consent, and it is this latter topic that I explore first. 
2.3.1 Informed Consent 
Ethical issues raised in emergency research often focus upon the requirement to 
protect the patient’s autonomy by means of informed consent. In 1914, Justice 
Benjamin Cardozo  recognised the individual’s right to refuse medical treatment, when 
he declared that ‘every human being of adult years and sound mind has a right to 
determine what shall be done with his own body’ (Schloendorff v. Society of New York 
Hospitals, 1914; p.1).  Subsequently, the principle of informed consent was extended to 
encompass all treatment, whether standard or experimental, and is one of the 
fundamental underlying ethical foundations of biomedical research (Watts, 1997).  In 
most Western societies informed consent is recognised in law, and by acknowledging 
the right to autonomy in the medical context (Miller, 1993), aims to uphold the right of 
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the autonomous individual to self determination and freedom of choice. Ethical issues in 
clinical research had long been recognised, and codes established, before the end of the 
nineteenth century, for example, Percival’s Medical Ethics (Leake, 1927), and the 
Prussian ‘Directive on Human Experimentation’ (Vollman and Winau, 1996). However, 
it was The Nuremburg Code, formulated after the ‘research’ atrocities of World War II, 
that emphasised that the ‘voluntary consent of the human subject is absolutely essential’ 
(The Nuremberg Code, 1946-49 p.181) . The Code provided the basis for further 
regulation and legislation regarding the involvement of human subjects in clinical 
research, although the World Medical Association’s (WMA) Declaration of Helsinki, 
Clause II.5 (1964) and the International Conference on Harmonisation (ICH) 
Harmonised Tripartite Guideline for Good Clinical Practice (GCP) (4.8.15), adopt a 
slightly more liberal approach, and acknowledge rare exceptions to this rule.  
Informed consent serves two purposes, the first of which is to respect the 
individual’s right to self determination, thus fulfilling the ethical principle of respect for 
autonomy. Whilst respect for autonomy is undoubtedly one of the cornerstones of 
medical ethics, the apparent supremacy it is afforded in the West is not universal 
(Tzamaloukas et al., 2008). In fact it has been argued that the current western 
preoccupation with the primacy of individual autonomy may jeopardise the quantity and 
quality of clinical research undertaken in incapacitated patients and in emergency 
research in particular. It has been stated that an over emphasis on autonomy, growing 
individualism, and an increasing litigiousness is likely to adversely influence carers in 
their decisions about incapacitated  relatives participating in research, and thus deterring 
research amongst these populations (Warner et al., 2008). Although referring 
specifically to dementia studies, Warner’s concerns could be similarly applied to those 
experiencing other incapacitating illnesses or events such as stroke.  
A broad definition of autonomy is that it is the ability to determine one’s own 
course of action according to one’s own wishes (Beauchamp and Childress, 2001). 
However, some reflect that full autonomy is an ideal notion (Henry and Pashley, 1990) 
that can only be approximated, as in reality, circumstances are such that a person’s 
autonomy may be restricted for various reasons. It is often argued that in the emergency 
situation, autonomy is almost always compromised to some extent by either 
physiological, neurological or emotional factors. Thus protection of the potential 
research participant must encompass and balance broader fundamental principles, not 
just autonomy, but also non-maleficence and beneficence. (Gefenas, 2007).  
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The ethical conduct of research involving critically ill patients requires 
consideration of complex issues relating to the seriousness and severity of the illness or 
injury, as well as the patients’ vulnerability, resulting from a combination of functional, 
neurological and/or cognitive impairments, any or all of which may render the patient 
unable to provide their valid and informed consent. Even without cognitive impairment, 
the complexities of assessing decision making capacity are familiar to all involved in 
the care of acutely ill patients. Further, the very context of the emergency situation may 
impact upon one’s decision making capacity, giving rise to barriers that are ‘conscious 
and unconscious, intellectual and emotional’ (Roth et al., 1977;  p.282), but these issues 
are further amplified in acute stroke. In some cases communication may be impaired 
giving a false impression of impaired capacity, whilst conversely, language may be 
preserved despite impaired executive function, implying that a patient has capacity 
when in fact this is not the case (Savage, 2006). In such circumstances, to insist on 
prospective, informed consent may mean that only those who suffer a mild stroke would 
be able to provide consent and thus be eligible to participate. This situation is 
problematic both in terms of recruitment – which may lead to delays in completion of 
the study, and of outcome measurement – which may lead to flawed interpretation of 
results (Warlow, 2005).  
A number of alternatives to prospective informed consent have been proposed and 
are discussed below. 
2.3.2 Proxy Consent 
Those who experience diminished capacity and are unable to consent themselves 
require extra protection from research risks, and with this in mind, the World Medical 
Association recommends that an investigator should obtain proxy consent from a legal 
representative in accordance with applicable law (Declaration of Helsinki, 2000). Until 
2007, and the enactment of the Mental Capacity Act 2005 , English law did not include 
a concept of legal representative, nor did it recognise the notion of ‘proxy-consent’ for 
incapacitated adults. In any event, it is questionable whether this requirement truly does 
afford protection to the vulnerable patient (Alves and Macciocchi, 1996).  
Proponents of proxy-consent (also referred to as substitute decision-making) 
claim that it represents an attempt to maintain autonomy by elucidating, from someone 
close to the incapacitated person, what their wishes would have been had they not 
become incapacitated (Lazar et al., 1996). Although incapacitated persons have the 
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same right to self determination as those who have the capacity to consent, Lazar 
observes that in practice they are unable to exercise this right. However, it is 
acknowledged that even those close to the incapacitated person do not always accurately 
convey that person’s wishes (Mason et al., 2006) and tend to make their enrolment 
decision based on what they believe will maximise the patient’s wellbeing (Karlawish et 
al., 2008). Nevertheless, Lazar claims that although flawed, substitute decision making 
is a means of making decisions on behalf of incompetent patients, and that it attempts to 
extend the patient’s control over his/her own health care. For this to be possible it is 
important that the proxy should be the person(s) with the best knowledge of the 
patient’s specific wishes, values and beliefs, related to the present situation. Lazar 
suggests that in most cases this would be a close relative, who could reasonably be 
expected to base their judgement upon their knowledge and experience of the patient’s 
own values and beliefs, and would approximate what the patient would want if they 
were able to decide for themselves, rather than what they themselves would do in a 
similar situation (Dickens, 1994). Others however, suggest that in practice this is not 
always the case (Seckler et al., 1991; Emanuel and Emanuel, 1992; Biros et al., 1995; 
The Law Commission, 1995; Alves and Macciocchi, 1996; Sulmasy et al., 1998; 
Coppolino and Ackerson, 2001; Demarquay et al., 2005) and postulate that these people 
are not always best placed to make such decisions (Fost and Robertson, 1980; McHale, 
1993; Dickens, 1994; Biros et al., 1995; Capron, 1999). 
Lazar (1996) suggests that where a patient is estranged from family members, a 
friend or primary care physician may be a more appropriate proxy. He also raises the 
question of what should be done when relatives disagree, but is unable to suggest a 
solution. He quotes studies by Emanuel and Emanuel (1992) and by Seckler and Meier 
(1991), demonstrating that next-of-kin cannot accurately predict patients’ preferences 
for life sustaining treatment. Other commentators identify similar issues in emergency 
and intensive care settings (Weijer, 2005; Del Giudice et al., 2009; Kasner et al., 2009) 
and in patients with terminal diagnoses (Sulmasy et al., 1998) thus raising concerns 
about substitute decision making per se.  The overall goal of substitute decision making 
is to ‘replicate the decision the patient would make if [they] were still capable’ (Lazar et 
al., 1996;  p.1436). However, Brazier notes that whilst this approach may appear 
attractive,  because next of kin may often be aware of the patient’s beliefs, values and 
desires, it may also potentially be dangerous, because they may also be the persons most 
likely to encounter conflict between their own interests and those of the patient (Brazier, 
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2003). Similarly, McHale refers to a Consultation Paper from the Lord Chancellor’s 
Department (1997) questioning the objectivity of a proxy, when their own welfare, or 
that of a close friend or relative may be at stake (McHale, 1998). Emanuel and Emanuel 
(1992) also refer to the potential conflict of interests which may also be influenced by 
psychosocial issues (Bramstedt, 2003). Thus, although proxy consent is the most 
commonly employed alternative to traditional informed consent, it is not without its 
own problems.  
Despite acknowledgements that next-of-kin may not always be the best persons to 
act as proxy (McHale, 1993; The Law Commission, 1995) the Mental Capacity Act 
2005, for the first time in the UK bestowed legal status on such an arrangement. 
However, unlike The Human Tissue Act (2004) no family hierarchy is defined and 
therefore domestic disputes between family members may give rise to further dilemmas.  
Such disputes may hinder the decision making process both with regard to the decision 
itself and the time taken to reach consensus. Even amongst close knit families, proxies 
may be asked questions about the patient’s values, preferences and beliefs that they are 
unable to answer (Bigatello et al., 2003). Some patients may have no living or known 
relatives and it seems unjust to deny them the opportunity to participate in potentially 
beneficial research on this basis alone. Further, some may be estranged from their 
families and it would therefore be unrealistic to expect them to be aware of what the 
incompetent patient would want (McHale, 1993).  
In acute stroke care, as in other emergency situations, delay in locating next of kin 
may place the patient outside the therapeutic time window for routine (e.g. 
thrombolysis) or experimental intervention. Even where next of kin are available it 
should be borne in mind that they have just received devastating news that their loved 
one had sustained a potentially life threatening medical event and are consequently 
usually somewhat distressed (Abramson and Safar, 1990; Miller, 1993; Biros et al., 
1995; Watts, 1997; Pochard et al., 2001; Jones et al., 2004; Pochard et al., 2005). 
Whilst some of the work cited here refers to patients and relatives requiring clinical care 
in the critical care setting, Abramson and Safar (1990) reported that the wife of a patient 
involved in a cardiac arrest study, suffered a myocardial infarction herself on being told 
of her husband’s condition – even without the added stress of considering his enrolment 
in a research study.  
More recently, stroke researchers undertaking the FAST-MAG study have 
successfully applied an innovative ‘in-field’ consent process where patients were invited 
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to participate in a  stroke study pre-hospitalisation if either they, or an appropriate adult 
person at the scene were able to speak to an investigator via a dedicated mobile phone in 
order to obtain prospective proxy-consent (Saver et al., 2006). The process was reported 
to be acceptable to patients and proxies (38% refused, including 17% competent to 
consent), with no subsequent withdrawals. Researchers also reported a reduction in the 
time from ictus to administration of study intervention, without prolonging the time 
period for delivery to the emergency department.  
As with in-hospital arrangements for proxy consent however, there remains a 
potential concern with this method as it does not fulfil the requirement stated in the ICH 
Harmonised Tripartite Guideline for GCP (1996), that where proxy consent is sought, 
the proxy must be allowed time to consider all treatment options, the implications of 
study involvement, to ask questions and to seek further advice if necessary. In practice, 
in the emergency situation time is a luxury that can rarely be afforded, as efficacy of 
treatment is often time dependent. Lazar (1996) recommends that the healthcare 
professional should act as facilitator to the process of proxy-consent, guiding the 
substitute to consider the patient’s previously expressed wishes, values and beliefs, or 
(where unknown) best interests. 
Even if the proxy is able to safeguard the patient’s best interests however, many 
authors reject the suggestion that proxy consent respects patient autonomy, and consider 
it a violation of this fundamental principle (Miller, 1993; Biros et al., 1995; Corrigan 
and Williams-Jones, 2003). These authors and others (Tobias, 1997; Fost, 1998), 
acknowledge the potential conflict posed by clinical research, between the obligation to 
provide personal care to the patient and the obligation to develop better treatments for 
future patients. Miller (1993) makes clear however, that future patients do not have a 
right held against current patients that they participate in research. He argues that proxy 
consent does not respect patient autonomy and claims that there are few cases where the 
proxy can be certain that their decision is synonymous with that which the patient 
would have made. The proxy can therefore only consent or refuse on the basis of ‘best 
interest’ – an argument which cannot truly be upheld in the research situation. Seeking 
to address some of the difficulties noted here, and referring to clause II.5 of the 
Declaration of Helsinki, attempts have been made to establish criteria identifying 
situations where further alternatives to prospective informed consent may be more 
appropriate (Miller, 1993; Biros et al., 1995; Doyal, 1997). These include deferred, 
advanced, presumed and waived consent and are outlined below. 
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2.3.3 Deferred consent 
Until recent changes, deferred consent was permitted in some emergency research 
studies where a study intervention is administered to a, usually unconscious or 
otherwise compromised, patient in the absence of prospective informed consent, on the 
grounds that potential efficacy is so time critical that to seek out next of kin or a legal 
representative would be prohibitive. ‘Deferred consent’ is sought either from the 
patient, when his/her condition is stabilised, or from next of kin if the patient remains 
incapacitated. Referring to the work of Abramson and Safar (1990), Miller condemns 
deferred consent as nonsense. Although it has the advantage of being undertaken after 
initial enrolment, when there is time to fully explain the protocol and the patient or 
proxy has had time to regain composure, it is not possible, as Miller (1993) states, to 
consent to something that has already taken place, and describes the concept more 
accurately as ‘ratification’ or ‘consent to continue’. It is not the same as waiver of 
consent, which requires specific preconditions and processes which must be reviewed 
by Institutional Review Boards, Research Ethics Committees or equivalent.  
2.3.4 Advanced consent 
A further alternative aiming to avoid some of the difficulties evident in the 
emergency situation is ‘advanced consent’. Although sometimes confusingly referred to 
as prospective consent , this refers to a process whereby individuals who may 
potentially become eligible for study enrolment consider and give their consent in 
advance of eligibility (for example, elective surgery patients who may unexpectedly 
require subsequent intensive care management) (McHale, 1993; Olson, 1994; Watts, 
1997; Bigatello et al., 2003). At the time of writing I have been able to identify little 
evidence of application of this policy, except for some work in a South African 
Intensive Care Unit which used this method, with limited success to secure enrolment to 
one of three antibiotic pharmacokinetic studies and a study investigating the use of a 
haemoglobin substitute in acute anaemia (Pinder et al., 1998). 
2.3.5 Presumed consent  
The concept of presumed consent is based upon what a ‘rational patient’ would 
do. Miller (1993) claims that any rational patient with a life threatening condition would 
consent to immediate treatment, if they were able to do so. Consent, he suggests, should 
therefore be presumed to any treatment demonstrating a favourable risk/benefit ratio, on 
the assumption that the patient’s values, goals, plans, lifestyle and preferences are 
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within the ‘normal range’ – although unfortunately this is not defined. Nonetheless, 
Miller states that this temporary infringement of the patient’s autonomy is only justified 
whilst a situation of medical emergency exists; once the emergency is over, consent (to 
further involvement) must be sought. 
Throughout his criticisms of these approaches, Miller reaffirms the individual’s 
right to autonomy, but, like Doyal, contends that this may be over-ridden for a narrow 
range of reasons (Miller, 1993; Doyal, 1997), where research may proceed under waiver 
of consent.  
2.3.6 Waiver of consent 
In the run up to and following, the implementation of the European Directive (EU 
Directive, 2001) by means of the Medicines for Human Use (Clinical Trials) 
Regulations 2004,  and (in the UK, except Scotland) the Enactment of Mental Capacity 
Act 2005, concerns were raised about the potentially limiting, and damaging effects of 
what many considered to be over-regulation of clinical research (Singer and Mulner, 
2002; Stocchetti et al., 2003; Druml and Singer, 2004; Pincock, 2004; Stobbart et al., 
2006). Although acknowledging the usefulness of the recognition of proxy consent for 
Clinical Trials of Investigational Medicinal Products (CTIMPS) (EU Directive, 2001) 
and the requirement to confirm ‘lack of objection’ for enrolment in non-CTIMPS 
(Mental Capacity Act, 2005), concern persisted about the vagaries of some of the 
terminology and the lack of provision for situations in which the time dependent nature 
of the intervention under study precludes the procurement of prospective consent, 
whether from patient or proxy (Coats and Shakur, 2005; Coats, 2006). Citing the 
Medical Research Council (MRC) funded CRASH Study (Corticosteroid 
Randomisation After Significant Head Injury) as an example, there was widespread 
concern that answers to important health questions would be delayed (Roberts, 2004; 
Wright et al., 2008) or flawed (Warlow, 2005).  
Data from the CRASH study illustrated the delay incurred when proxy consent is 
mandatory (Roberts, 2004). Time from injury to randomisation was just over one hour 
in hospitals allowing waived consent, compared to almost two hours in those where 
proxy consent was sought, with lower recruitment rates in the latter group. The 
requirement for prospective or proxy consent could jeopardise both the quantity and 
quality of hyperacute research. For example, UK centres were unable to participate in 
the TROICA study (Böttiger et al., 2008) because at the time of recruitment (January 
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2004 – July 2006) waiver of consent was not permitted and the concept of ‘legal 
representative’ was not recognised in the UK. Similarly, it was estimated that the 
National Institute of Neurological Disorders and Stroke (NINDS) rtPA (recombinant 
tissue plasminogen activator) Stroke Trial, which completed recruitment in three years 
and nine months, would have taken over 12 years to complete had proxy consent not 
been permitted. Apart from the delay, this would very likely have introduced a selection 
bias which may have invalidated study findings (Flaherty et al., 2008). The requirement 
for prospective informed consent may have meant that only those who had suffered a 
mild event would have been eligible to participate. For these patients the hazards of 
treatment might outweigh the potential benefits because they may recover without 
treatment. Outcome for these patients would be quite different from those with more 
severe symptoms, where the treatment hazard may be worth accepting for the greater 
potential benefit. This may result in a situation where stroke studies are undertaken in 
only moderately ill individuals and could thus lead to the abandonment of potentially 
useful treatments for severely ill patients. The autonomy of more severely impaired 
individuals would have been respected but possibly to their detriment as well as the 
detriment of millions of future stroke patients (Warlow, 2005). 
For some, the need to not only allow but facilitate such research, rests on the 
premise that, contrary to the first principle of the Nuremburg Code, the voluntary 
consent of the human subject is ‘neither necessary nor sufficient for ethically and 
legally responsible research’ (Fost, 1998; p.163; Emanuel et al., 2000; p.2701). In a 
consensus statement on Informed Consent in Emergency Research, recommendations 
are offered to help resolve some of the problematic issues related to informed consent 
and waiver of consent in emergency situations (Biros et al., 1995). Biros et al claim that 
patients should not be denied the opportunity to participate in acute resuscitation 
research simply because they or a legally authorised representative are unable to give 
consent. Subsequently, in the U.S., provision now exists to allow an exception to the 
requirement for informed consent in well defined circumstances (Title 21, Code of 
Federal Regulations [21 CFR] Section 50.24). Some argue that this is the only way that 
emergency research is possible (Lemaire, 2007), but the associated complexity of 
research design means that this waiver is rarely employed (Nichol et al., 2004; Hiller et 
al., 2005; Mitka, 2007).  
In Europe however, the Ger-Inf 05 Study, a sepsis study conducted in France 
between 1995-1999 (i.e. prior to EU Directive 2001/20/EC), introduced waiver of 
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consent 10 months after the start of the study, with the effect of accelerating the 
recruitment rate from four to ten patients per month (Annane et al., 2004). And in the 
UK, in an attempt to address some of the issues raised, a subsequent amendment 
(Rodrigue et al., 2004) endeavours to outline situations in which prospective informed 
consent may be waived, in very specific circumstances and according to very strict 
protocols, along similar lines to those suggested in the U.S. Exception From Informed 
Consent in Emergency Research (EFIC). In addition to the points already raised, such 
provision is necessary because it is postulated that the default position of exclusion, is 
inappropriate (Baren and Fish, 2005), and is arguably no less likely to undermine the 
autonomy of a potential participant than inclusion with waived consent (Harris, 2005). 
It is also argued that according to the ethical principles of beneficence or social justice, 
citizens have a moral obligation, or at least a civic duty, to participate in medical 
research, provided that safeguards against malpractice are in place (Evans, 2004; Harris, 
2005; Schaefer et al., 2009).  
Despite recognising the need for research in the emergency situation, it has been 
emphasised that the determinant for application of the emergency exception rule should 
be related to the efficacy of the treatment (i.e. time dependent) rather than the 
availability of proxies. Robertson, on the basis of her review of family availability for 
proxy consent,  suggests that if time to treatment is not expected to influence the 
outcome, the recruitment time window should be widened, in order to maximise the 
likelihood of being able to contact relatives or other authorised persons (Robertson et 
al., 2007) 
It is a well rehearsed argument that patients would not want to be entered into a 
research study without consent. However, it has also been noted that it would be helpful 
to know what patients and their representatives feel about waiver of consent (Fost, 
1998). It has been suggested that the way to promote public acceptance of the need for 
emergency research without prospective consent is to develop ‘the level of public 
knowledge, trust and credibility in the healthcare system’ (Gonzalez and Helling, 2008; 
p.1670). More recently attempts have been made to empirically address the question of 
patient and public opinion, some of which are outlined below. 
2.4 Empirical Research About Conducting Emergency Research 
Much of the debate about the difficulties encountered in emergency research 
and/or research involving incapacitated persons, is theoretical in nature, primarily 
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because conducting research about conducting emergency research is both practically 
and ethically challenging.  However, in recent years a number of empirical studies have 
been undertaken in this area with a view to informing policy and practice pertaining to 
emergency research. These fall broadly  into the following areas:  lay individuals’ 
perceptions about consent in research, including proxy or waived consent; views and 
experiences of patients and/or potential participants; research participants’ 
understanding of research information as perceived by themselves and/or their clinician-
investigators; and the accuracy of proxy decision making.  
2.4.1 Lay individuals’ perceptions of consent procedures in research: next of kin and 
emergency department attendees  
In 1998, Fost cited the work of Abramson and Safar (1990) as the most extensive 
study of public opinion on the subject of emergency research without prospective 
informed consent although it addressed only one aspect – i.e. the views of next of kin 
(Fost, 1998). Abramson and Safar (1990) conducted a randomised controlled trial of 
brain resuscitation after cardiac arrest, where in order to be efficacious, the treatment 
had to be commenced within 30 minutes of restoration of circulation. The participants 
(n=558) were, by definition, unconscious and therefore unable to give consent. Because 
treatment had to be administered immediately, proxy consent was not practicable and 
therefore deferred consent was employed. Family members were contacted after the 
initial dose of study medication (or placebo) had been administered, and were asked to 
consent to continuation in the study. This process, referred to as ‘deferred consent’, was 
employed in 531 (95%) cases and reactions to the process were available in 78% 
(226/343) of American and 47% (102/215) European cases. In 12 cases, families 
refused consent to continue. In all cases however, the refusal was based upon quality of 
life issues rather than the nature of the experimental intervention. Six negative reactions 
to the use of deferred consent were documented, half of which related to concerns 
regarding survival, not about the experimentation itself. The results indicated that the 
‘vast majority’ of families were in favour of the deferred consent mechanism and 
provided no evidence that waiver of consent was perceived as morally problematic (in 
this instance). Where prospective consent was obtained however, it was reported that 
families often felt ‘pressured into making a decision before they were ready’ (p.782). 
Some relatives had no objection to study involvement but declined the responsibility of 
16 
 
 
signing the consent form explaining ‘it’s for doctors to decide’, ‘I don’t want to be 
responsible’ (p.783) (Abramson and Safar, 1990).  
A more recent French study of 56 patients entering acute stroke trials found that 
only 23 patients were able to provide consent. The responsibility for consent usually fell 
upon relatives, of whom over half felt uncomfortable because of psychological stress 
induced by the need for urgent decision-making (Demarquay et al., 2005). Other studies 
have reported similar findings in relation to family members’ desire for involvement in 
clinical decision-making in the critical care environment (Azoulay et al., 2004). More 
recently, work has been undertaken to determine the ability of patients enrolled in 
studies without prospective informed consent, to subsequently ratify their inclusion and 
continued participation (Harvey et al., 2006). Less than 3% (13/498) of patients 
provided consent before randomisation. Relative assent was secured for 81% of the 
remaining patients.  Of the 482 patients for whom consent was not secured prior to 
randomisation, 188 (39%) survived. Retrospective consent was obtained from 93% of 
these patients and was withheld in 3%. The remainder did not regain mental capacity.   
As noted, with the exception of Harvey’s work, the studies noted above address 
only the views of the next of kin rather than those enrolled in, or eligible for enrolment 
in, emergency research. Attempts have been made to address this issue by investigating 
the opinions of emergency medicine patients concerning waiver of informed consent for 
emergency research (Smithline and Gerstle, 1998; McClure et al., 2003). In a survey of 
a convenience sample of 212 patients attending a tertiary care, academic, urban 
emergency department, 73% stated that they would be willing to be entered into an 
emergency research study if unable to consent but where absolute risks were minimal. 
Where absolute risks were more than minimal, 50% would still be willing to participate 
if incremental risks were appropriate, and 74% of those surveyed indicated that a family 
member could decide on their behalf. Responses were influenced by educational status 
and acuteness of their illness, but not by age, gender or social group. Others have 
addressed similar issues (Agard et al., 2001; Wilets et al., 2003; Gammelgaard et al., 
2004b; Kenyon et al., 2006; Saver et al., 2006) 
2.4.2 Views of potential research participants 
A further study collected data on the actual preferences and values of a group 
most likely to be directly affected by the Exception from Informed Consent (EFIC) – 
those at risk of stroke. Interviews were undertaken with 12 patients hospitalised as a 
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result of stroke in the preceding 12 months. All felt that the development of new 
treatments for stroke was important, but they were unclear about the distinction between 
‘research for stroke’ and ‘emergency research for stroke’. Following clarification of 
these terms, 10 patients stated that they would be willing to participate in the latter, and 
in the absence of a surrogate, 11 were willing to be enrolled by a physician (Blixen and 
Agich, 2005). These patients may have already been eligible to participate in research or 
may become so in the future and therefore this work is not entirely hypothetical. It is 
likely however that their apparently positive experiences and outcomes may have 
predisposed a more positive and accommodating attitude towards EFIC. Most of the 
respondents expressed confidence in family members’ ability to act on their behalf and 
in accordance to with their wishes. However, this is a population that may have 
discussed such issues following their previous stroke. It cannot be assumed that such 
discussions would have occurred spontaneously. Further interviews and focus groups 
were planned to inform development and testing of a validated questionnaire about 
values and preferences for emergency (stroke) research involvement.  
Work has recently been undertaken to ascertain the views of emergency 
department attendees who have been approached to participate in clinical research 
(consenters and non-consenters.) Having obtained consent whilst the patient was in the 
department, telephone questionnaires were conducted seven days post-discharge in 
order to explore patients’ perceptions of participating in research in the emergency 
department. Whilst exploring actual rather than hypothetical experiences, the study 
included only patients who were not critically ill, and who were considered to have 
capacity to make their own decision about research participation. A further limitation of 
this study is its small sample size (n=46), which is probably due to the timing and 
process of data collection (Paradis et al., 2010). 
Similar work in the UK included a qualitative study conducted with women 
recruited to a randomised controlled trial (RCT) of antibiotics in preterm labour. Results 
suggested that women in this critical situation may not have been able to absorb the 
information given about the RCT, despite that fact that the quality of written and verbal 
information was generally considered to be good. Their accounts also suggested that 
decisions were made based not only on the information given, but were influenced by 
socioemotional aspects of their interactions with healthcare professionals (Kenyon et 
al., 2006)  
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With the exception of Kenyon’s study, much of the work attempting to ascertain 
the views of patients and the public on the subject of emergency research, is U.S. based 
and is hypothetical in nature. For the most part it relies on accounts of  intended, rather 
than reported or observed behaviour, in response to questions that are mostly generated 
from theory, rather than identified by the patients/participants themselves. Nevertheless 
despite the limitations of these studies,  they make a start to address what patients want, 
rather than solely what ‘experts’,  whether ethicists or clinicians, think is ‘right’ for 
them and provide a starting point from which to explore these issues in greater depth 
and perhaps to provide the basis for further work. 
2.4.3 Willingness to participate in clinical research 
Abboud et al note that in their survey of 420 patients (207 emergency department 
attendees and 213 geriatric out-patients) a greater number of patients were more likely 
to be willing to receive an experimental treatment outside a study protocol than as part 
of a research study. (Abboud et al., 2006). Perhaps this is because they have an overall 
mistrust of the non-individualised process of research, but feel that they are being 
treated more personally if a clinician offers them a ‘special’ treatment because they 
believe that it offers them a better chance. Paradoxically however, their safety is more 
likely to be upheld and properly scrutinised within the confines of a ‘non-
individualised’ research protocol. 
2.4.4 Participants’ understanding of research information in the critical situation: 
clinicians’ and patients’ perceptions 
More recently, those concerned about regulatory threats to emergency research 
have endeavoured to conduct empirical work in this area, focussing upon the ability of 
emergency department attendees to understand research information documentation and 
therefore, their ability to provide autonomous informed consent. Foex (2004), reviewing 
the work of others in the field, noted that in Agard’s study of  544 Swedish 
cardiologists, 86% felt that patients were unable to understand all of the information 
given to them and therefore, by definition, were unable to give informed consent (Agard 
et al., 2004; Foex, 2004). In the same study, patients themselves felt that their level of 
consciousness was too low to understand the information given and some were in too 
much pain to engage with the process (Agard et al., 2001). A review of ISIS-4, (Fourth 
International Study of Infarct Survival) revealed that of 150 participants who returned a 
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questionnaire, only 31% perceived that they fully understood the nature and purposes of 
the trial, whilst 19% felt that they had no understanding (Yuval et al., 2000).  
Likewise, in the HERO-2 (Hirulog and Early Reperfusion or Occlusion) Consent 
Sub-study, few patients were considered to have given consent that was ‘truly 
autonomous and informed’ (Williams et al., 2003; p.920). Similar findings have also 
been reported with respect to understanding of other research protocols in unstable 
angina and acute myocardial infarction (Kucia and Horowitz, 2000), as well as capacity 
for, and recall of, consent in subarachnoid haemorrhage (Schats et al., 2003). These 
findings are not universal however; in a study exploring how patients in the acute phase 
of myocardial infarction experience the research consent procedure, only 28% of 
participants and 7% non-participants read the information sheet before making a 
decision. Nevertheless, 76% and 63% felt able to make a decision and 50% and 34% 
found it acceptable to ask in these circumstances. These authors therefore suggest that 
clinicians should ask potential participants whether they feel able to make a decision 
(Gammelgaard et al., 2004a). 
Research in the critical care arena is commonly thought to pose serious risks to 
participants. Weijer suggests that a more useful approach to the information and consent 
process in this area would be to focus on the incremental risk incurred by study 
involvement, rather than the unavoidable risks associated with the illness/event itself. 
Potential participants would then need to consider the question ‘what difference will it 
make to me to participate in this study as opposed to being treated in accordance with 
routine clinical care?’ (Weijer, 2004; p.86) 
2.4.5 Other lay perceptions of medical research 
Outside the emergency arena, work has been undertaken to ascertain the views of 
patients in waiting rooms of medical oncology, radiation oncology and radiology 
outpatient departments about their attitudes towards medical research. Whilst some 
respondents reported that they had experience as participants in medical research (30% 
of the 1882 respondents), for the majority of those interviewed their responses were 
hypothetical. Most respondents (90%) expressed a favourable, or very favourable, 
attitude toward medical research and 70% believed that it usually or always advances 
medical science. However, 42 % were concerned about exposure of participants to 
unreasonable risks, and 6% felt that participants are often unduly pressured (Sugarman 
et al., 1998). 
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In Sugarman’s study there was a wide range of reasons for participating in 
medical research, from exclusive self-regard to altruism. In addition, a rationale that I 
have not noted to be reported elsewhere, was that there was ‘no reason not to’ (64%) 
(1998; p.4). Even those who advance altruistic reasons for participation however, 
usually hold concomitant hope for some personal benefit and have faith in their 
clinician’s recommendations, implicating factors other than assimilation of facts and the 
application of rational thought in the decision-making process. Sugarman (1998) notes 
that of those who did, or said they would, decline participation, 59% did so because 
they wanted to make decisions regarding their treatment and care, either themselves or 
in partnership with their doctors; they did not want these decisions to be made by 
medical researchers. Whilst this might suggest that potential participants may be more 
comfortable about participating in research if the clinical team is involved, such 
familiarity may be a double-edged sword, enhancing trust but potentially engendering 
coercion and undue influence.   
2.4.6 Accuracy of proxy decision-making. 
Whilst the above studies concentrate on lay views about deferred and waived 
consent, another focus of research in this area is the accuracy of proxy-consent and 
substitute decision-making. Although not conducted in the context of research 
involvement, these studies raise important questions about these concepts. Studies 
investigating the accuracy of substituted judgement in patients with terminal diagnoses 
have concluded that the likelihood of proxies making the same judgement as that of the 
patient is dependant upon a number of factors relating to both patient and proxy 
(Sulmasy et al., 1998). The authors claim that by examining these factors the clinician 
may determine whether the patient is at risk from an inaccurate proxy decision. 
However, if one of the arguments against proxy consent for emergency research is the 
time factor, carrying out such an assessment is unlikely to be practicable. 
A similar study involving geriatric rather than terminally ill patients, 
demonstrated that the concept of proxy decision making may be ‘seriously flawed’, and 
provided data to illustrate that resuscitation preferences of the patients studied were not 
adequately understood by their proxies (whether these were physicians or family 
members) (Seckler et al., 1991; p.95). These authors cited several other broadly 
comparable studies demonstrating similar findings (Uhlmann et al., 1988; Ouslander et 
al., 1989; Zweibel and Cassel, 1989; Lo et al., 1990; Emanuel and Emanuel, 1992). 
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Emanuel and Emanuel (1992) review some of the aforementioned studies and 
acknowledge the serious implications of their findings, suggesting as an alternative, the 
promotion of advance directives and living wills.  
Other concerns about informed consent for clinical research hinge on 
investigators’ focus on the information giving aspect of informed consent rather than a 
more robust concept encompassing competence and voluntariness (Silverman, 1996). 
As well as affording the patient (or their family members), the opportunity to make an 
autonomous choice about research participation, a secondary purpose of the consent 
interaction is to alert them to the fact that, in the research situation, their doctor’s 
actions are dictated by scientific protocols, and are hypothesis driven, rather than patient 
directed and needs driven (Hallowell et al., 2009). It is argued that the moral dilemma 
inherent in the clinician-investigator role rests within the conflicting values of science, 
which searches for truth, medicine, which seeks to act beneficently towards the patient, 
and the personal and/or professional aspirations of the investigator (Pellegrino, 1992). 
Questions about emergency research however, are not entirely limited to issues of 
consent; nor are they limited to when, or who to ask. There are also issues about who 
should do the asking, who should subsequently conduct and manage research activities, 
and where this should all take place. Focussing on arguments for and against the 
integration of clinical and research activity, I explore these issues in the following 
section.  
2.5 Theoretical And Pragmatic Issues For And Against The Integration Of 
Research And Clinical Activities  
Research aims to generate medical knowledge to benefit future patients, with or 
without potential benefit for the patient participating, whilst clinical practice focusses 
on achieving therapeutic benefit for individual patients. They are thus often viewed as 
dichotomously split, if not opposing, concepts. Despite the theoretical distinction, at a 
pragmatic, practical level, associated activities overlap and become blurred such that the 
two are often conflated by researchers and participants alike (Hallowell et al., 2009). A 
confounding factor is the apparent interchangeable use of the terms, clinical ‘practice’ 
and ‘care’ which, if research and practice are to be separated, seems to imply an absence 
of care, or caring behaviours, in the research role. Hallowell (2009) questions whether 
research and clinical activities really are so different; whether researchers and 
participants can always tell them apart; and whether this is important.  
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In North America and Europe it has been common practice to undertake clinical 
research within the clinical care setting (Lemaire, 2004a). For many clinicians, research 
is seen as an essential component of clinical care with up to 70% of paediatric cancer 
patient in the U.S. enrolled in clinical trials (Joffe and Weeks, 2002) because their 
oncologists feel that this is the best way to provide the best care. Some argue that this 
combined practice should become the reigning standard; the clinician’s daily work 
should include a combination of patient care, research and quality assurance and that 
such integration should be a matter of routine, rather than an unusual exception 
(Rhodes, 2005). Others note, but reject this approach and in the sections that follow I 
discuss the rationale behind separation of these activities. 
Although many commentators discuss the difficulties encountered in the broader 
area of emergency research Slyter (1998) contends that logistic and ethical 
considerations make the design of acute stroke trials even more difficult. In some areas 
of investigation it is possible to conduct research in a separate physical environment, 
but in emergency research, pragmatic concerns and limited resources generally preclude 
such an approach. Research suggests that outcome following stroke is improved if 
patients are cared for in specialist stroke facilities and recommendations are made 
accordingly (Stroke Unit Trialists’ Collaboration, 2004). However, capacity issues, such 
as inadequate provision of 24 hour imaging facilities and a national shortage of allied 
health professionals required to staff multidisciplinary teams for stroke care, mean that 
high quality stroke care, let alone research, continues to be compromised. In 2005, the 
National Audit Office reported that fewer than 20% of stroke units had access to 
computerised tomography (CT) imaging within three hours of admission (National 
Audit Office, 2005) and even by 2009, only 25% of sites were able to provide 
thrombolysis at nights and weekends (National Audit Office, 2010). Further, few stroke 
staff actively participate in research because there is no career framework for them in 
research (Jenkinson and Ford, 2006). Thus, in many institutions, resources dictate that 
stroke specialists or teams provide both clinical care and conduct research, delivering 
practical efficiencies on the one hand but bestowing conflicting roles of care giver and 
researcher on the other (Slyter, 1998). Routine and experimental interventions are 
delivered in the same setting, thus blurring the boundaries between these activities for 
patients, families, and their clinicians, particularly if some are occupying dual roles 
(Morin et al., 2002; Williams and Haywood, 2003). In such situations, and for the 
reasons noted, pragmatic necessity may sometimes be afforded greater weight than 
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certain ethical considerations, but does not eliminate them, as discussed in the following 
section. 
2.5.1 Therapeutic misconception 
Ethical arguments for the separation of clinical and research activity are 
predicated mainly upon concerns that the integration of the two can lead to coercion of 
vulnerable persons and can perpetuate the ‘therapeutic misconception’ (Appelbaum et 
al., 1982) whereby study participants are convinced that they will receive at least some 
therapeutic benefit, even if they have been told –and claim to understand – that this is 
quite categorically not the case (Fisher, 2006b).  
Those who advocate the separation of research and clinical activity, argue that by 
merging them and by conducting them in the same space, or under the auspices of the 
same clinician(s) one denies the differences previously noted (Brody and Miller, 2003; 
Fisher, 2006b). Fisher suggests that the conflation of research and clinical roles gives 
rise to a ‘procedural misconception’ (p. 253) which occurs when a situation is 
constituted by aspects which are both familiar, such as the hospital setting and 
clinicians, and foreign – such as clinical research. She considers that this in turn 
contributes to the therapeutic misconception (Appelbaum et al., 1982).  
A further factor potentially contributing to the therapeutic misconception is the 
notion that study participants derive benefit from participation, regardless of 
randomisation  (Chalmers, 2000). Those who advance this claim suggest that such a 
benefit might be due to the additional monitoring and superior care associated with 
academic centres of excellence, but such findings are not consistent (Edwards et al., 
1998), and an ‘inclusion benefit’ has not been verified (Lemaire, 2004b; Peppercorn et 
al., 2004). It is evident then, that the therapeutic misconception is not exclusive to 
patients and the lay public, and cannot therefore be attributed solely to differences 
between lay and professional knowledge or understanding. For example, in a study 
involving Emergency Medical Service (EMS) providers, 61% of respondents stated that 
investigators in medical research would act in patients’ best interests even though, by 
definition, this cannot be the case (Schmidt et al., 2009). 
Despite these concerns, the fact that a patient/participant holds a therapeutic 
misconception does not in and of itself render a study unethical and failure to dispel 
such a belief does not necessarily invalidate an individual’s consent (Sreenivasan, 
2003). Further, Snowdon et al (2007) suggests that a potential participant’s or proxy’s 
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ability to separate research from clinical practice does not necessarily equate to an 
enhanced decision making process. On the contrary, she suggests that for some, the 
process of clarifying the distinction between the two may propagate ‘an overstated sense 
of risk and threat’ (p.199), resulting in what she terms an ‘injurious misconception’ 
which, like the therapeutic misconception, may give rise to a ‘decision borne of 
misunderstanding’ (p.199), rather than an autonomous and voluntary choice (Snowdon 
et al., 2007). In addition to these potential misunderstandings however, the patient’s (or 
proxy’s) vulnerability may also influence their decision making, particularly where 
clinicians occupy dual roles, as discussed below.  
2.5.2 Coercion of vulnerable patients: dual roles and conflicting responsibilities 
When participants are patients, research can be difficult because of their 
vulnerability and lack of power in the clinical situation (Holloway and Wheeler, 1995). 
If patients and their families cannot, or do not, always distinguish between routine care 
and research, they will usually do what the doctor recommends, based on the 
expectation that the duty of the treating physician is to promote and safeguard their 
welfare. This is a particularly sensitive issue in the case of critically ill patients whose 
decision making capacity is often compromised to the extent that it may impact upon 
the voluntariness of a decision made to enter a clinical trial when their treating 
physician occupies the dual role of clinician-investigator (Silverman and Lemaire, 
2006).  
Whether the clinician-investigator is a doctor, nurse or other healthcare 
professional, there exists a duality and dichotomy of roles, attempting to balance 
research integrity with the welfare of the individual (Beale and Wilkes, 2001; Karigan, 
2001). A quandary exists between professional responsibility to perform the role of 
caring and maintaining patient welfare, versus contributing to the scientific and medical 
knowledge base with the aim of benefitting not (only) current patients but the future 
patient population. Renée Fox describes this dilemma very clearly in her seminal work 
‘Experiment Perilous’ and refers to a ‘rather complicated moral titration process’ 
undertaken by clinician-investigators (Fox, 1998 p.241).  
Silverman contends that there may be an element of coercion if patients or their 
family members perceive that a decision to decline participation will adversely affect 
the delivery of care (Silverman and Lemaire, 2006). He suggests therefore, that 
someone other than the treating physician should obtain informed consent, whilst others 
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advise that the roles of treating physician (or team) and researcher should be separated 
entirely (Beecher, 1959; Spiro, 1975; Brody and Miller, 2003). In order to avoid 
deception or exploitation of study participants, it is important that they are made aware 
of the difference between research participation and care (Brody and Miller, 2003). One 
way of explicating this difference is to employ dedicated research staff, often nurses, to 
undertake the day to day administration of clinical trials, although this too presents 
dilemmas, which I explore in the following section. 
2.5.3 The role of the clinical research nurse 
It is 40 years since the Briggs Report identified a need for formal recognition of 
‘research mindedness’ among nurses (Briggs Report, 1972). Since then, numerous 
publications and initiatives have advocated a broadening scope of professional practice, 
including the development of research roles (United Kingdom Central Council for 
Nursing Midwifery and Health Visiting, 1992; UKCRC Subcommittee for Nurses in 
Clinical Research (Workforce), 2007; Nursing and Midwifery Council, 2008). These 
publications were accompanied by a proliferation of specialist nursing roles, as nurses 
extended their roles to undertake traditionally ‘medical’ roles such as venepuncture, 
cannulation and prescribing.  Although poorly defined, and functioning under a range of 
titles, one such role was that of (Clinical) Research Nurse (Deave, 2005). Clinical 
research nurses are registered nurses employed to facilitate and conduct clinical 
research; they may be based in research sites (not defined), or within a clinical 
environment (Jeong et al., 2007; UKCRC Subcommittee for Nurses in Clinical 
Research (Workforce), 2007; Spilsbury et al., 2008). It is noted that their role differs 
from that of the nurse researcher (Deave, 2005; Gordon, 2008), who not only conducts 
research, but is also considered  central to the integration of research findings within 
inpatient settings (Dennis and Strickland, 1987).    
In a literature review seeking to determine the nature of the clinical research 
nurse, Raja-Jones was unable to identify many articles examining this role (Raja-Jones, 
2002). Those that exist were mainly anecdotal but most noted the issue of title 
confusion, and identified typical components of the role as administrator, educator, 
clinician/practitioner, consultant and researcher. Others have noted considerable 
variations in background, expertise and remit of those undertaking these roles (Deave, 
2005). Deave also notes that those who enter research nurse roles, as opposed to nurse 
researcher roles, often do so without specific research training or expertise, and function 
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primarily as data collectors or research assistants, usually under the auspices of medical 
principal investigators. This has knock-on effects in the perception of the role, and may 
contribute to what some consider to be the incompatibility of nursing and research roles 
(Hicks, 1996).  
Hicks suggests that the term ‘nurse researcher’ is an oxymoron. She states that the 
core values embodied within research are entirely different from those of nursing and 
that the ways in which nurses construct themselves as professionals are at odds with 
those characteristics required by a good researcher. More recently, similar perceptions 
have been noted elsewhere (Woodward et al., 2007). Although Hicks’ and Woodward’s 
work refer to nurses’ reluctance to undertake and/or implement the recommendations of 
nursing research, such incompatibility may also extend to some degree to nurses’ 
reluctance to engage with medical research. This may also illuminate the findings of 
others who describe difficulties faced by those who take on research nurse roles, in 
distancing themselves from the clinical routine (Easter et al., 2006; Fisher, 2006a). The 
argument that research and clinical work should not be conducted in the same 
environment or by the same personnel is broadened to encompass the idea that those 
who ‘care’ i.e. nurses, do not possess the requisite skills for analytic thought and vice 
versa.  
For some, caring represents nursing’s moral ideology (Smerke, 1990). Referring 
to Larson and Ferketich (1993), Greenhalgh defines caring as ‘intentional actions that 
convey physical care and emotional concern and promote a sense of security in another’ 
(Larson et al., 1993; Greenhalgh et al., 1998; p.927). James, presents a formula for care 
and suggests that it is the sum of ‘organisation +physical labour +emotional labour’; she 
claims that the provision of care is fundamental to the nurse’s caregiving role (James, 
1992; p.488). It seems, however, that physical labour itself is quite specific, and is 
generally considered to refer to performing or assisting the patient to perform their daily 
activities, particularly those that are considered more intimate. In my own clinical and 
research experience, and noted by others, for some nurses, physical care is nursing 
(McFarlane, 1976; Leininger, 1986; Staden, 1998). A role without this aspect is 
therefore not considered to be ‘real’ nursing (Bassett, 2002) and there is often suspicion 
regarding nurses who wish to pursue a career outside this traditional perception of the 
role. This criticism has often (though usually light heartedly) been directed towards 
psychiatric nurses in particular, but as we will see in subsequent chapters (Chapter 5) 
this perception is also becoming associated with the role of the research nurse.  
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In opposition to the views noted above however, it is also suggested that the 
research co-ordinator/nurse requires dynamic creativity and strong clinical skills, sound 
ethical principles and exemplary interpersonal and organisational skills. He/she should 
be able to develop good rapport with participants, maintain accurate study records, 
demonstrate administrative and leadership skills and understand research terminology 
(Raybuck, 1997). In addition to these transferrable skills, new skills such as 
management of clinical, ethical and financial concerns are required. Contrary to claims 
of role incompatibility however, some commentators suggest that nurses are ideally 
placed to contribute to successful trial coordination because of their dedication to ‘care 
work’ and their nursing related knowledge and interactional skills, identifying these as 
facilitatory factors, rather than sources of conflict (Mueller, 2001; Mueller and Mamo, 
2002; Colbourne and Sque, 2004). The liaison element of their role, between patient, 
principal investigator, study sponsor and administrative staff is considered vital and has, 
it is claimed, contributed to greater research activity in terms of number of ongoing 
studies and patient recruitment, retention and completion rates (Isaacman and Reynolds, 
1996; McKinney and Vermeulen, 2000). Given the commonality apparent in the first set 
of skills noted above, Raybuck (1997), unlike some other authors, contends that ‘[T]he 
goals of nursing practice and clinical trials are mutually compatible’ (p.18, my 
emphasis). 
Amongst the aims of the UKCRN are noted, improving patient recruitment and 
retention rates, improving research coordination, improving care of patients enrolled in 
clinical trials, maintaining and enhancing quality and improving links between research 
and treatment (Department of Health, 2004c). However, there is a considerable body of 
work in the nursing literature pertaining to the reluctance of nurses to conduct or act 
upon the findings of research. Much nursing practice is still fundamentally rooted in 
custom and practice and is historically entrenched rather than empirically validated. 
Although referring to the acceptance and integration of nurse researchers (and nursing 
research), rather than research nurses, Mulhall suggests that in order to achieve 
implementation of research based practice, the process and culture of research must be 
embedded within the world of practitioners who are expected to utilise its outputs 
(Mulhall, 1997).  
Earlier sections of this chapter have focussed upon theoretical, conceptual, or 
perceived barriers to emergency research. In the following, and final section, I review 
some of the motivating factors that may facilitate the achievement of the aims of the 
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UKCRN, and the embeddedness espoused by Mulhall, but also consider ways in which 
these factors may present conflicts of interest.  
2.6 Reasons For Participating In Clinical Research: Motivation Versus Conflict  
Motivation for undertaking research as a healthcare professional can be as diverse 
as the reasons for participating as a patient, and can vary at in individual or professional 
group level. Paradoxically, these motivating factors can also represent conflicts of 
interest.  
2.6.1 Professional motivators 
Conflicts of interest in relation to the integration of clinical care and research are 
not limited to those discussed previously, pertaining directly to the patient and the 
conflict between individual and societal benefit. Perceived to be a hallmark for good 
practice, quality, efficiency and innovation, research activity is often considered an 
indicator of professional credibility (Porter, 1993). It has thus been suggested that in the 
UK, research has been taken up by nursing in an effort to professionalise its activities 
and to proffer a means for the advancement of this social group (Mulhall, 2002). It is 
evident therefore, that research is far more than a means of providing evidence upon 
which good practice should be based. Mulhall (2002; p.49), states that research is ‘not 
simply a value free exercise conducted to benefit patients and clients’ but rather, has 
been ‘constructed as an ideology’  which some consider incompatible with the care-
giving definition of nursing (Hicks, 1996).  
Mulhall (2002) also suggests that since the shift of nurse training to higher 
education, and its metamorphosis to an academic, rather than a solely clinical discipline, 
the coming together of these different cultures has further highlighted a gap between 
research and practice. Traditionalists may not feel that nurses ‘fit’ into research roles, 
and research itself is often perceived with an element of fear (Gordon, 2008).  
Whilst a motivating factor for many clinicians is the development of more 
effective interventions and thus the improvement of patient healthcare outcomes, 
participation in research necessitates acknowledgement of uncertainty, and conveying 
that uncertainty to the potential research participant. Thus, there are concerns pertaining 
to the potential impact of disclosure of study rationale and processes upon the doctor-
patient relationship (Ellenberg, 1997). Traditionally afforded a position of authority and 
respect, it is not unusual for clinicians to experience difficulty in admitting that they do 
not know which treatment is best, and some may feel that to do so will  damage rapport 
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with their patients (Ross et al., 1999). Ross also notes that clinicians may perceive a 
loss of clinical autonomy due to the requirement to follow a study protocol. 
2.6.2 Financial and reputational motivators, and external accountability 
When considering conflicts within the clinician-investigator role, we are most 
commonly alerted to those arising between their duty to the patient and the goals of the 
investigation (Slyter, 1998), but there may also be other conflicts pertaining to financial, 
academic and reputational status of both the individual clinician(s) and the institution 
(Hewlett, 1996; Morin et al., 2002).  
Financial conflicts may relate to the provision of equipment or stock, 
remuneration or salary support, whilst academic or reputational stakes may include 
publications or the potential for promotion. The industrialisation of medical research 
also introduces a further potential conflict – that pertaining to the requirements of the 
sponsor. Academic and healthcare institutions are economically pressured to meet the 
goals of their pharmaceutical sponsors and may thus lose sight of the human purpose of 
medical research (Tzamaloukas et al., 2008).  
2.7 Summary 
The bioethical literature suggests that a major factor restricting the conduct of 
clinical research in the emergency situation is the problem of securing informed consent 
from, or on behalf of, eligible individuals who are incapacitated. We have seen that 
there are some theoretical alternatives, such as deferred, proxy or waived consent, but 
these too are problematic, and their uptake appears limited. Whilst gaining prospective 
informed consent is clearly the preferred option, an obvious knock-on effect of the lack 
of clinical research in the emergency situation, is that research about emergency 
research is also limited, and thus alternative approaches have not been empirically 
explored or evaluated. Despite the wealth of theoretical and conceptual literature 
therefore, there remains a gap regarding the actual day to day conduct of clinical 
research in a hyperacute or acute clinical situation.  
Although there is a developing body of empirical research about the conduct of 
emergency research, it is often based on hypothetical scenarios and is usually confined 
to exploration of reported, or intended behaviour. My research therefore aims to address 
this gap by means of an ethnographic study focussing upon the conduct of research 
activities (randomised controlled trials) in an acute stroke unit. I aim to determine 
whether the issues noted in the literature, namely obtaining informed consent, and the 
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organisation of research and clinical activity, were indeed the main obstacles 
encountered in practice, and whether, how and to what effect, the distinction between 
research and clinical practice was maintained. 
I describe my methodological approach more fully in Chapter 4, but first, in the 
following chapter, I provide data in order to contextualise the area in which I conducted 
this research.    
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Chapter 3. Situating the Study  
3.1 Introduction 
In Chapter 2, I discussed the theoretical and conceptual literature pertaining to 
difficulties encountered or anticipated in conducting clinical research in the emergency 
situation. I also reviewed the growing, but sparse, body of empirical work examining 
these difficulties, and alternative ways in which these issues may be addressed. Having 
identified that there remains a gap in the literature as regards actual conduct of 
emergency research within the acute clinical environment; my study aims to address 
some of these issues. In Chapter 4, I will outline my theoretical position and the 
methodological framework adopted, but first, it is necessary to situate the study in the 
context of the local stroke service provision, as well as current issues influencing 
pharmaceutical company activity in acute and hyperacute stroke research.   
The issues postulated in the literature focus mainly upon difficulties in obtaining 
informed consent, as well as ethical issues associated with the conflation of research and 
clinical activity. Here, I describe the context in which I sought to observe the impact (if 
any) of these factors.  I briefly describe practicalities and policies relating to the 
admission and management of patients in the acute stroke unit, the working 
arrangements of clinical and research staff therein, and recent changes in availability of, 
and arrangements for, the conduct of clinical research. I begin by outlining the way in 
which suspected stroke patients were received at the study site.  
3.2 Recognition, Referral, And Admission Of Suspected Stroke Patients 
Clearly the number of patients participating in research is determined by the 
number eligible to do so, which is dependent upon early recognition of stroke 
symptoms, appropriate referral and prompt diagnosis and intervention. Although few 
treatments have so far been demonstrated to be effective in the treatment of acute 
stroke, those that are, i.e. thrombolysis, and those under investigation (e.g. 
neuroprotectors) have been shown to be, or are mostly likely to be, effective if 
administered immediately post ictus (stroke event). The optimum time period is 
considered to be within 3 hours, when there may be a possibility of restoring blood flow 
to the ischaemic brain, thus preventing (further) infarction (Marler et al., 2000). 
Therefore, the single most important factor in optimising outcome for an acute stroke 
patient is prompt transfer to an appropriately equipped stroke unit (Stroke Unit Trialists’ 
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Collaboration, 2004). Despite increasing emphasis on the notion that stroke is a medical 
emergency of similar magnitude to a heart attack and that ‘time is brain’ (Hill and 
Hachinski, 1998), delays in time to admission, or time to investigation, have sometimes 
meant that otherwise eligible patients have been unable to receive thrombolysis (in the 
clinical context), and time delays may similarly influence study eligibility. Locally, in 
the study site examined, steps had been taken to address this issue, and are outlined 
below. 
The Acute Stroke Unit (ASU) where I carried out my fieldwork was housed in 
Nearstreet Hospital, one of three hospitals comprising the Northend NHS Foundation 
Trust. Despite housing the ASU, Nearstreet had no accident and emergency (A&E) 
facility. Until the establishment of the Rapid Ambulance Protocol in 1997 (Harbison et 
al., 1999) patients admitted by ambulance were often taken to the A&E facility at Union 
Hospital, prior to transfer across the city to the ASU, a practice which delayed 
assessment, diagnosis and treatment.  
The rapid ambulance protocol aimed to bypass unnecessary transfer to the A&E 
facility at Union Hospital, thus expediting admission to ASU of those patients who 
contacted the ambulance service directly by dialling 999. Following introduction of the 
protocol, when attending a call to a suspected stroke patient, paramedics undertake 
assessment using a stroke identification instrument known as the Face, Arm, Speech 
Test (FAST) (Harbison et al., 2003). If this test is positive, the crew contact ambulance 
control, who notifies the Emergency Assessment Suite (EAS) at Nearstreet Hospital that 
a suspected stroke patient is en route.  
Patients who contact their own general practitioner can be referred by telephone to 
the EAS via a centralised admissions office. If stroke is not diagnosed by the ambulance 
crew, or if stroke is diagnosed but head injury is also suspected, or the patient’s 
Glasgow Coma Score (GCS) is less than eight, patients are taken to A&E in the first 
instance (not least because neurosurgery is located at the same site as A&E).  Self 
referring patients who continue to present via A&E are assessed and resuscitated as 
required, prior to transfer to the EAS or ASU.  
When the EAS is notified of the impending arrival of a suspected stroke patient, 
they contact the Stroke Research Team and/or the stroke nurse practitioner, who then 
attend to undertake initial patient assessment and liaise with the medical team. The 
patient trajectory is outlined in Fig 1 overleaf.  
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Figure 1: The patient trajectory 
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Involvement of the Stroke Research Team in the initial assessment of suspected 
stroke patients came about at least in part, because of the way in which the clinical 
provision of a thrombolysis service has developed. Thrombolysis was initially offered 
only either off licence, on an individual patient basis, or as part of a RCT (e.g. ECASS 
II). Research nurses, and for a time, the stroke nurse practitioner (in order to minimise 
costs and duplication of effort), were responsible for assessing stroke admissions for 
study eligibility, and as such underwent specific training in stroke assessment. Although 
early thrombolysis is now established as a proven therapeutic intervention (Hacke et al., 
2004) and has become part of the clinical service provision, the skills and training of the 
research and specialist nurses are still utilised in the initial assessment of new stroke 
admissions.  
3.3 Potential External Influences Affecting Research Activity 
3.3.1 Effects of changes in pharmaceutical companies’ activity 
Aside from the number of people referred and admitted with stroke, another factor 
influencing recruitment to RCTs of acute and hyperacute stroke therapies is the 
perceived decline in the number of studies in recent years. In the six years prior to 
commencement of my fieldwork, approximately 15 acute and hyperacute studies were 
conducted at the study site, compared with three currently ongoing (see Chapter 5).   
Several reasons were offered for the dearth of research activity. A ‘chicken and 
egg’ situation appeared to exist, whereby it is difficult to determine whether there are 
fewer studies because of previous problems with recruitment (due to ethical and 
regulatory restrictions in the UK), or whether the recruitment rate has diminished 
because inclusion criteria have become more restrictive over recent years.  
Negative outcomes, particularly in some of the neuroprotective studies, were 
likely to have been due to the long time windows for treatment, which meant that 
patients were treated beyond the point at which treatment was likely to be effective. 
Further, many previous studies were too small to demonstrate an effect. Resultant 
changes in recruitment criteria, particularly with regard to the tightening of the time 
window, have in turn reduced the potential number of participants (Kidwell et al., 
2001).  
Whilst these changes have arisen on the basis of scientific evidence, there are also 
financial considerations. The stroke population is very heterogeneous with numerous 
comorbidities and physiological instabilities; therefore a large gap exists between 
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practice and controlled animal experiments. From an industry point of view, 
homogeneity of sample is preferred in order to maximise chances of demonstrating an 
effect, but restrictive criteria may mean that it takes longer to recruit an adequate sample 
size, thus driving up research costs. Conversely, some funders prefer a more pragmatic 
approach whereby recruitment criteria allow for the inclusion of all patient groups likely 
to receive a treatment should it become licensed. Such a design reflects variations 
between patients that occur in real clinical practice, but as such, demands a larger 
sample size.  
Other financial considerations may also impact upon the pharmaceutical 
industry’s investment in research activity at specific sites. A general lack of awareness 
of stroke signs and symptoms, and deficiencies in stroke care in the UK (Intercollegiate 
Stroke Working Party, 2002; National Audit Office, 2005; Intercollegiate Stroke 
Working Party, 2009; National Audit Office, 2010), has meant that only a limited 
number of sites are adequately resourced  to participate in acute and hyperacute stroke 
research. Although these centres usually achieve satisfactory recruitment rates, the cost 
of establishing an infrastructure to manage such a small number of sites is prohibitive, 
and therefore some pharmaceutical companies prefer to concentrate their efforts 
elsewhere. 
Historically, commercial studies were well remunerated and usually generated 
sufficient income to employ a full time research nurse. This is no longer commonplace, 
and the decline in stroke research activity among the bigger pharmaceutical companies 
means that funding is no longer available to support staff on ‘soft’ money. Nevertheless, 
none of the research nurses expressed concern about their job security, although some of 
the clinical staff quizzed me about the financial precariousness of contract research 
work.  
3.3.2 Regulatory influences 
Another financial consideration beyond the direct control of the host organisation 
is that relating to the implementation of the European Working Time Directive (1993) 
and its subsequent amendment (2003). The restrictions on working time and stipulations 
regarding rest time are yet another reason why it is not currently cost-effective to offer 
an on-call service for research purposes because, in effect, more staff are required to 
provide adequate cover. Even without provision of an on-call service the research team 
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struggled to provide cover for holiday, sickness or other unexpected absences, therefore 
offering extended availability was not feasible. 
3.4 Impact Of Local Stroke Management Policy  
In the case of studies such as ECASS III (Third European Cooperative Acute 
Stroke Study - administration of rtPA up to 4.5 hours post ictus), the clinical policy of 
thrombolysing all eligible patients within three hours of ictus reduced the pool of study 
eligible patients. No patients were enrolled to this study at this site, despite having been 
open to recruitment for over two years. This was primarily because patients who may 
have been eligible, were usually assessed within the three hour time frame that allowed 
them to receive thrombolysis as per clinical practice. It would therefore be unethical to 
delay their treatment and/or introduce the possibility of them receiving placebo. 
Recruitment was further restricted by what some considered to be an unwritten policy 
not to include a patient in more than one study, although this need not be problematic 
where one of the studies is non-interventional.  
3.5 Personnel And Resource Issues 
3.5.1 Clinical staff 
Inpatient stroke care is usually physically demanding and labour intensive with 
many patients requiring maximum nursing care. Almost all of the participants in my 
study commented that staffing levels on ASU were suboptimal for the purposes of daily 
management, let alone taking on additional workload related to the conduct of clinical 
trials. The ASU is a 30 bedded ward, but for most of the duration of my fieldwork, six 
beds were closed due to inadequate staffing levels. The clinical team operated a shift 
system comprising: 
· Early shift: 07.15 – 14.15hrs 
· Long day: 07.15 – 20.15hrs 
· Late shift: 12.45 – 20.15hrs 
· Night shift: 20:00 – 07:45hrs  
It was usual to have three qualified and four non-qualified staff on an early shift, 
and two qualified and three non-qualified on a late shift (including those on a long day, 
who spanned both shifts). There were usually three nurses on duty overnight. During 
my field work there were usually two student nurses allocated to the ward. They were 
not always present on the ward however, and in any event were supernumerary, so the 
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figures noted refer only to qualified staff and healthcare assistants. Allowing for breaks, 
ward rounds and accompanying patients visiting other departments, this meant that the 
workload was considerable.  
3.5.2 Research staff 
The research nurses were funded either from payments made to the Trust by the 
sponsor companies, or more recently, by the Stroke Research Network. Funding from 
sponsor companies is made on either a ‘per patient’ basis, depending on recruitment 
rates, or pro rata, according to the amount of time a nurse is expected to allocate to a 
particular study. This usually means that it is necessary to host more than one study in 
order to generate enough funds for a whole time equivalent research nurse or research 
fellow.  
In 1999, when Nurse Higgs (one of the key informants) took up his research post, 
research activity in the ASU generated sufficient income from pharmaceutical company 
funding to fund three full time and two part time research nurses, and a research fellow. 
This funding also supported provision of a limited on-call service , if not 24 hours per 
day, at least from 17:00hrs – 23:00hrs (it was unusual, though not impossible, for stroke 
patients to be admitted during the night as those who have a stroke during the night are 
generally unaware of this until waking in the morning). Although the on-call service 
was primarily to support research recruitment it also facilitated the provision of clinical 
thrombolysis. The volume of research made it possible to employ more staff, which in 
turn enhanced recruitment rates. This generated a positive spiral of activity, raising the 
profile of the research team and awareness about ongoing studies. Now that 
thrombolysis is purely a clinical service and there are fewer research nurses, it is not 
feasible, due to cost and resources, to offer an on-call service, and thus it has not been 
possible to sustain the previous level of research activity. 
At the time of my fieldwork there were initially two full time research nurses and 
a research fellow. On completion of her one year contract the junior research nurse was 
replaced, after a brief hiatus, by two research nurses, seconded on a job share basis from 
research posts in another specialty. There were insufficient studies running 
simultaneously to warrant the cost of an on-call service and thus the research nurses 
usually kept regular working hours of  09:00 -17:00hrs, Monday to Friday. They 
occasionally worked extra hours but were expected to take time in lieu rather than 
receive overtime payments, which then also impacted upon further recruitment, as it 
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reduced their availability. This situation arose partly from limited availability of funds 
to support such a service and partly as a result of the European Working Time Directive, 
as noted previously.  
3.5.3 Availability of resources/facilities 
In 2004 government targets recommended that suspected stroke patients should undergo 
diagnostic CT scanning within 24 hours of hospital admission (Intercollegiate Stroke 
Working Party, 2004). This was reduced to three hours, in view of the fact that 
diagnostic imaging is required prior to initiation of thrombolysis, which should be 
commenced within three hours of ictus. The National Stroke Strategy, following the 
lead of the NICE guidelines on head injury management, recommends that suspected 
stroke patients should undergo urgent CT scanning within 60 minutes of admission, 
with skilled radiological and clinical interpretation available 24 hours a day 
(Department of Health, 2007; Intercollegiate Stroke Working Party, 2009) but is as yet 
some way from meeting this target. Despite these targets, some units still did not have 
24 hour immediate access to CT scanning facilities and even those that had the facilities 
did not always have adequate personnel. At the time of my study, even at Nearstreet, 
with its Acute Stroke Unit, they relied on a non-resident, on-call radiology service 
outside office hours, and shared this facility with the rest of the hospital.  
3.6 Conclusion 
In this chapter I have outlined a number of organisational or external factors that may 
influence working practices and the integration (or otherwise) and conduct of research 
activity within the Acute Stroke Unit at Nearstreet Hospital. I provide these data as 
background to the more detailed analysis which follows in Chapters 5-8, but before 
moving on to this, I describe my theoretical position, the methodological framework 
underpinning my study and the methods by which it was undertaken.  
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Chapter 4. Methodological Framework and Methods  
4.1 Introduction And Description Of The Research  
The aim of this thesis is to explore how recruitment to randomised controlled 
trials of acute and hyperacute treatments for stroke is achieved in an acute stroke unit. 
Research in this area is considered by many to be hugely problematic, particularly in the 
case of patients who are unable to fulfil the requirement for prospective informed 
consent. In Chapter 2, I illustrated the perceived difficulties in conducting such 
research. The focus falls largely upon the requirement for informed consent and its 
resultant ethical and legal implications. Centrally, this is largely drawn from theoretical 
and conceptual literature or from expert opinion; there is little empirical work to 
confirm or refute these claims. As noted in Chapter 2, research about emergency 
research recruitment tends to focus upon the quality of informed consent, and does so 
by measuring information given, recall and understanding. Medicolegal concepts of 
consent tend towards a positivist stance, whereby the appropriate information for 
obtaining consent is treated as an almost tangible ‘thing’ which is ‘given’ to patients or 
family members during a specific ‘event’. Research recruitment however, including 
obtaining consent, is more than an isolated event (Goodenough et al., 2004; Sin, 2005); 
it is a process beginning before, and continuing after, the face to face, researcher-
participant discussions about interventions, schedules and potential risks and benefits. 
This pragmatic study therefore aims to examine not an event but a process, constructed 
through the formative actions of participants, including patients and their families and 
healthcare professionals involved in clinical and research practices within a research 
active, acute stroke unit.  
I begin from the perspective of social constructionism (Berger and Luckmann, 
1966), a theoretical orientation drawing upon philosophy, sociology and linguistics and 
underpinning critical psychology, discourse analysis, deconstruction and post-
structuralism (Burr, 1995). Social constructionism is interested in the social practices 
engaged in by people and their interactions with each other. More specifically, but not 
exclusively, I draw on the assumptions of symbolic interactionism as espoused by Mead 
(1934) and Blumer (1969b). I outline the reasons for adopting this approach below.  
4.1.1 Methodological issues and framework 
The approach of this thesis is located within a relativist ontology and a 
subjectivist, constructionist epistemology (researcher and researched co-create 
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understandings). I adopt naturalistic methodological procedures and aim to address 
issues of credibility, transferability, dependability and confirmability rather than 
internal/external validity, reliability and objectivity (Denzin and Lincoln, 2005a). 
Drawing upon the assumptions of symbolic interactionism I employ ethnographic 
methodology as a mode of inquiry congruent with this paradigm. 
4.1.2 Social Constructionism 
Social constructionism can be considered both realist and relativist or anti-realist. 
It rejects the notion that the person possesses any ‘pre-given content’ but purports that 
one ‘becomes’ a person by means of one’s interactions with and toward objects within 
one’s ‘life-world’. Its proponents are interested in the performative role of language and 
in the social processes engaged in by people and their interactions with each other. 
According to constructionism we do not ‘create’ meaning from thin air, but construct it 
from ‘materials’ that are available to us i.e. things that are ‘always, already there’ 
(Heidegger, 1962; Merleau-Ponty, 1962) - the world and objects in the world. Potter 
(1996) contends that language does not ‘reflect’ reality, rather it is a representation of 
reality, of which there may be many.  He rejects the ‘mirror’ or ‘correspondence’ model 
of language and instead draws upon the metaphor of the construction yard, whereby a 
house is built, but depending upon the persons building it may consist of different 
materials, employ different techniques and result in a different end product (Potter, 
1996). Similarly we construct reality by the ways in which we talk or write about it. 
This means that accounts do not simply represent reality by mirroring ‘what is there’ 
but rather the sense we make of them (Crotty, 1998; p.64). An extreme constructionist 
view would be that there can be no ‘objective fact’, but as noted somewhat more subtly 
by Rose: ‘The realities that are fabricated, out of words, texts, devices, techniques, 
practices, subjects, objects and entities are no less real because they are constructed’; 
what is perhaps more important than what things ‘are’ is how they are ‘made to work’ 
(Rose, 1998; p.168). 
Crotty (1998) (and others) also notes that there is some dispute as to whether 
social constructionism denotes ‘the construction of social reality’ or the ‘social 
construction of reality’ (p.54). The argument for the former notion would be that 
physical objects exist whether or not any individual is aware of their existence and thus 
such objects are not ‘socially constructed’. The latter assumption however, contends 
that constructionism refers to meaningful reality and thus makes epistemic rather than 
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ontological claims, i.e. although a chair may exist as a physical object independent of 
anyone’s consciousness of it, it only exists as a chair when conscious beings construe it 
as such. Thus a chair, like social class, is indeed socially constructed, this does not 
however render it any the less ‘real’. In relation to the area of study in this thesis, a 
positivist argument may be that the pathophysiological diagnosis of ‘stroke’ is not 
constructed but is defined by physical evidence arrived at by means of medical and 
scientific techniques. Nevertheless, what patients, families, and healthcare professionals 
perceive to be a stroke, and the meanings therein, are constructed from their 
experiences, knowledge and perceptions, which are in turn contingent upon historical 
and cultural factors. For example, lack of awareness of stroke treatments and fatalistic 
perceptions of outcome may contribute to the delay observed in seeking medical advice. 
These issues of interpretation and meaning are taken further within the tradition of 
symbolic interactionism which I outline further in Chapter 4.1.3.  
Social constructionism can be considered to be relativist because it is open to the 
possibility of multiple realities and the absence of ‘ultimate truth’. It suggests rather, 
coexisting, multiple and varied ‘situation-dependent ways of life’ (Burr, 1995; p.9).  
Different people, even within the same environment inhabit different worlds, which 
constitute different ways of knowing and different sets of meanings. Thus, separate 
realities are experienced and presented, depending upon the standpoint taken (Plummer, 
1996). 
According to Gergen (1985), and summarised by Burr, social constructionism is 
founded on one or more of four basic assumptions, namely: 
· Social constructionist inquiry takes a critical stance towards taken for granted 
knowledge, challenging the view that conventional knowledge is based on 
objective, unbiased observations, 
· The ways in which we understand the world are historically and culturally 
specific, 
· Knowledge is sustained by social processes; people construct their knowledge of 
the world between them, 
· Knowledge and social action are interlinked.  
(Burr, 1995; p.3-5)  
It should be noted however that as any individual proponent may adopt any or all 
of these assumptions, any commonality between those identifying themselves as such is 
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merely a ‘family resemblance’ rather than a definitive identifying feature (Burr, 1995; 
p.2). I describe below how these assumptions relate to my research.  
I have shown in Chapter 2 that despite the paucity of empirical evidence it is 
generally accepted that emergency research, including acute and hyperacute stroke 
research, presents ethical and regulatory dilemmas for those involved in their conduct 
and that inadequate resolution of these dilemmas is assumed to contribute to the 
difficulties in enrolling patients to such studies, and consequently their failure to 
demonstrate an effect. In the main, these dilemmas are seen as related to the 
maintenance of respect for the autonomy of patients who, due to functional or cognitive 
impairment relating to the stroke, are unable to provide prospective informed consent 
for study involvement and are therefore considered ineligible for participation. In 
relation to the first of the assumptions noted above, my research will challenge the 
notion that informed consent is the main obstacle to undertaking emergency research, 
that autonomy is the foundational ethic and that exclusion (from clinical research) is the 
appropriate default position.  
This is related to the second assumption regarding historical and cultural 
specificity.  I suggest that these commonly perceived difficulties are not necessarily the 
only, or even the main barriers to successful patient recruitment, but that they are 
perceived as such in a society that gives prominence to individualism, the self, and 
autonomy above other values. Historical and cultural changes have altered our 
perception of medical and nursing professions, patients and their rights, and have 
promoted the notion of the ‘agentic’ individual (Bandura, 2001). Agency is important to 
those living in a culture influenced by Judaeo-Christian traditions that emphasise 
personal choice, and therefore the language of such a culture is that of choice, free will, 
autonomy, personal strength or weakness (Burr, 1995). This may not be the case in 
other cultures however, such as those based on Buddhist philosophy, which emphasise 
the nonexistence of the bounded self (Hughes, 2007) or in those where a ‘duty-based’ 
rather than ‘rights-based’ worldview predominates, such as in South Asian bioethics 
(Coward, 2007). As noted by Geertz, our construction of the individual is not universal. 
He states: 
‘The Western conception of the person as a bounded, unique, more or less 
integrated motivational and cognitive universe, a dynamic centre of awareness, 
emotion, judgement and action, organised into a distinctive whole and set 
contrastively against other wholes and against a social and natural background 
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is, however incorrigible it may seem to us, a rather peculiar idea within the 
context of the world’s cultures’ (Geertz, 1974; p.31).  
Even within our own culture, not all ‘people’ have always been considered 
‘persons’ in a legal or political sense, and have therefore not always been able to 
exercise agency. Whilst Geertz is concerned with alternative concepts of personhood, 
historical and cultural factors also contribute to the fluidity of other notions and also 
share a reciprocal relationship with the development of knowledge. This brings us then 
to the third assumption of social constructionism, that knowledge is sustained by social 
processes and that people construct their knowledge of the world between them, 
Cromby notes that:  
‘[i]t is the social reproduction and transformation of structures of meaning, 
conventions, morals and discursive practices that principally constitutes both our 
relationships and ourselves’ (Cromby, 1999; p.4).  
Thus, in the context of this study, what people understand about the experience of 
stroke or the process, practices, and nature of research may be said to be derived from 
their interactive experiences. The way that stroke patients are managed and cared for 
has changed significantly in recent years, with the development of medical knowledge 
and scientific diagnostic and therapeutic techniques, and this will influence subsequent 
perceptions of the nature of stroke and those affected by it. For example, the wife of a 
patient suffering a stroke today may have a very negative outlook regarding his 
prognosis if she has previously experienced say, a grandparent suffering a stroke when 
interventions, whether curative or rehabilitative were less advanced. She may however 
have an entirely different outlook if she is familiar with someone who has undergone 
thrombolysis and subsequently made a full recovery.   
Finally, to exemplify the assumption that knowledge and social action go 
together, I refer to the proliferation of guidelines and regulations surrounding clinical 
research noted in Chapter 2 (for example The Nuremburg Code, 1947 and the 
Declaration of Helsinki, 1964 and subsequent), and the way in which they demonstrate 
and arise from ‘punctuated equilibrium’ and ‘moral panics’ (Fitzgerald, 2005). A recent 
example can be seen following the TeGenero 1412 incident at the Northwick Park 
Hospital in 2006. The incident in which six young men suffered serious adverse events 
whilst taking part in a Phase 1 pharmaceutical study prompted an investigation and 
subsequent report from the MHRA Expert Scientific Group on Phase One Clinical 
Trials. Their report, published in December 2006 made 22 recommendations for 
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changes to the way in which ‘first-in-man’ Phase 1 studies are reviewed and conducted 
in order to increase the safety of future clinical trials involving first human exposure to 
agents with potential high risk (MHRA., 2006; Stobbart et al., 2007). This example 
simultaneously illustrates the effects of the ‘controversy machine’, whereby crisis cases 
and ‘moral panic’ precipitate regulatory change whilst also demonstrating how 
knowledge and social action are indeed interlinked.  
4.1.3 Symbolic Interactionism 
Sharing similar epistemological claims to those of constructionism, symbolic 
interactionism arises from pragmatism and the social philosophy and social psychology 
of G.H. Mead (1863-1931). For the pragmatist, practical, problem solving application is 
paramount.  Pragmatism, constructionism and symbolic interactionism, all take account 
of the historical and cultural contexts of meaning, acknowledging that there is not 
necessarily one, or even multiple truths that will be so for all time and in all locations 
(geographical or cultural). Embedded in the reality of life, pragmatism is concerned first 
with the individual’s direct experience of the world which s/he inhabits. Echoing Kant 
(1929), the pragmatist view suggests that the existence of an ultimate reality cannot be 
known, and thus we have to make do with a sufficiency, rather than a totality, of 
understanding. Pragmatism therefore purports that nothing is inherently true or false, 
but that ideas or theories can be treated ‘as if’ they are true, if to treat them thus makes 
the world ‘work better’. Contrary to accusations of extreme relativism, this means that a 
laissez faire attitude is avoided because ideas such as ‘the earth is flat’ would be 
rejected, because believing so would not ‘make the world work better’ than believing it 
to be round.  
Symbolic interactionism has been described as ‘pragmatism in sociological attire’ 
(Crotty, 1998; p.62). Although attributed largely to Mead, his work was subsequently 
and posthumously published and taken forward by Herbert Blumer, who coined the 
term and presented three basic interactionist assumptions: 
· That human beings act toward things on the basis of the meaning that the things 
have for them; 
· That the meaning of such things is derived from, or arises out of, the social 
interaction that one has with one’s fellows; 
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· That these meanings are handled in, and modified through, an interpretive 
process used by the person in dealing with the things he encounters.   
(Blumer, 1969a; p.2) 
Arising from pragmatism, symbolic interactionism is based on the precept that we 
are constructed as persons by means of our interactions(s) within our society and via the 
use of ‘significant gestures’ - primarily language and other symbolic tools. Mead (1934) 
suggested that the use of language allows the human actor to engage in an internal 
dialogue in which he is both an acting subject and object of self and other.  Mead 
identifies the ‘I’ as the origin of action, whilst the ‘Me’ is the object of self awareness. 
This dichotomy, as well as allowing the actor to interpret and define his own actions, 
also enables him to take the role of the other and to imagine another’s responses to 
those actions. Thus he is able to monitor and modify his own behaviour according to the 
other’s anticipated or perceived perceptions. His actions are therefore not merely a 
process of stimulus-response but involve definition and interpretation. Furthermore, the 
‘me’ is the ‘self made visible’ but may be displayed differently in a number of social 
contexts. For example, one presents a different ‘self’ in the company of friends, 
employers, children etc. However this is neither automatic nor deterministic but 
represents a response to one’s interpretation of the current ‘reality’.  Each time we 
interact with another the ‘other’ summons up a different ‘self’ (Rock, 2001) - but even 
so, this is not to say that the same ‘other’ will always summon up the same ‘self’, as a 
performance will always be edited or modified according to the situation. For example, 
as I will discuss in Chapter 8, whilst some clinician-researchers are able to freely switch 
between their clinical and research roles within the same patient/participant encounter, 
others remain firmly fixed in either one role or the other, sometimes in order to fulfil the 
expectations of the patient/participant, but at other times completely at odds with them. 
In conjunction with this social production of the self, symbolic interactionism 
proposes that the ‘world’ of an individual or group is composed of ‘objects’ and that 
these too are socially constructed by means of our interaction both with the object, and 
with others who also act toward the object. An object is therefore defined in terms of the 
meaning that it has for any given individual, and may thus be different for different 
individuals. To employ an example from my data, a patient, for the radiographer is 
someone upon whom a diagnostic procedure must be performed; for the research nurse 
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both patient and potential study participant, and for the patients’ family, husband, bread-
winner and now vulnerable, sick person.  
The enrolment of patients in clinical research involves communication of often 
complex and unfamiliar information and concepts to and between patients, families and 
distinct but related professional groups. Focussing upon issues such as language, 
communication, inter-relationships and community, symbolic interactionism is therefore 
an appropriate approach within the context of my research.  Its central precept is its 
focus on the views and meanings of those studied rather than those imposed by a 
detached observer. Unlike a more general social constructionist approach symbolic 
interactionism considers interpretation and responsiveness. It goes beyond the 
expectation that a nurse (for example) will behave in a certain way because she is a 
nurse and because this is how nurses behave in accordance with the social construction 
of their role. It takes a step further, to say that the nurse behaves in this way because she 
has a certain goal she wishes to achieve and because the patient behaves toward her in 
such a way as to indicate that she should respond in a particular way. Similarly it cannot 
be said that all patients are the same and will behave in a similar fashion according to 
the way in which they are socially constructed. As I will demonstrate in Chapters 5, 6, 7 
and 8, patients, their families and healthcare professionals behave differently in 
different contexts, depending upon what they wish to achieve and what is, and what is 
perceived to be expected of them; identity and meaning are developed within their 
interactions, not imposed upon, or by them.  
Whilst Rock acknowledges that one determines one’s own behaviour by 
rehearsing the action and anticipating the other’s action, he also notes that we do not 
always have the capacity or the desire to ‘check’ every action in this way and so ‘much 
interaction must be taken on trust and much must be conventionalised’ (Rock, 2001; p. 
29). Also, he suggests that we employ ‘formalism’ - a system of general forms via 
which we organise, interpret and identify experience. Although we may never encounter 
the same experience twice, Rock suggests that we refer to a general ‘grammar, lexicon 
or logic of forms’ (2001; p.28) based upon previous experiences in order to help us 
assess and respond to new but perhaps similar situations. Thus, for example, when 
approached by a doctor to participate in clinical research, unless one has already had a 
similar experience it is likely that one will refer to other interactions with medical 
professionals and will engage in the interaction accordingly. Only when one realises 
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that the doctor is not interacting as anticipated might one then modify one’s own 
behaviour in accordance with the ‘new’ situation. 
For symbolic interactionists, social constructionism in its broader sense may seem 
too deterministic, failing to allow for the ongoing interpretation and definition that is 
inherent in social life. Rock (2001) notes the constant action (c.f. Strauss, 1993), 
formulation and reformulation of ideas and questions that are fundamental to symbolic 
interactionism. It seems that within a specific version of the social constructionist 
perspective any given ‘construct’ changes at a macro level, in a similar way to which 
‘paradigm shifts’ occur as postulated by Kuhn (1970). Within symbolic interactionism 
however, there is room for constant and continuous change and manipulation. Symbolic 
interactionism is perhaps therefore less deterministic and more flexible than a more 
general social constructionist approach.   
Interactionist work appears to be popular in healthcare such as Becker’s work 
with medical students, Atkinson’s exploration of suicide, and Jeffrey’s observation of 
categorisation of patients in casualty departments (Becker et al., 1961; Atkinson, 1978; 
Jeffery, 1979). Fox outlines what she considers a basic property of social interaction 
itself, and also of participant observation:  
‘... The roles that a person assumes - the ways they are defined, structured and 
played out - are never completely self determined. Rather, they emerge as the 
joint product of the dynamic relationships between an individual and other 
persons with whom he or she is interacting’ (Fox, 1998; p.215). 
Much of Erving Goffman’s work (1959; 1961; 1963) is often cited as espousing 
the interactionist tradition although Goffman himself denied this association. Some 
consider the symbolic interactionist approach to be primarily suited to the investigation 
of micro-level social analysis, claiming that the emphasis on identities, specific 
situations/encounters and interpersonal management preclude analysis of social 
structures, institutions or organisations.  Others however challenge this criticism, 
arguing that the approach can be equally well applied to joint or collective action 
involving a number of individuals, such as an army for example, as such interaction is 
still ‘constructed’ following a process of interpretation whether individual or collective 
(Blumer, 1969a). Similarly, responding to the charge that symbolic interactionism 
represents an overly individualistic approach to social life it is countered that this is not 
so because ‘personhood and identity are inescapably social, collective and cultural 
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processes’ (Atkinson and Housley, 2003; p.63); interactionists do not accept this 
micro/macro dichotomy (Plummer, 1996). 
Despite Goffman’s rebuttal of the interactionist label I refer to him here because 
some elements of his dramaturgical approach appear pertinent to my research. He refers 
to ‘back’ and ‘front stage’ and the way in which actors employ roles, scripts and ‘stage 
props’ (Goffman, 1959; p.32 and 124), concepts which are empirically demonstrated in 
Chapter 5. His concept of impression management also seems particularly relevant to 
my study of the interactions between researchers and other staff groups or patients and 
families and is further discussed in Chapters 6, 7 and 8. Goffman suggests that 
interaction is a performance, undertaken by the actor, and shaped by the environment 
and target audience. The performance is framed in such a way as to convey an 
impression consistent with the actor’s desired goals and is thus highly dependent upon 
the situation. For example, undertaking a research consent interaction in the controlled 
environment of an outpatient clinic, compared to the unpredictability of the emergency 
assessment suite. In addition to these goals, individuals differ in the way in which they 
respond to the interactional environment; some may be unresponsive to the audience’s 
reactions whilst others actively respond in order to elicit positive results, as I 
demonstrate in Chapter 8. 
Other elements of symbolic interactionist thought which may have some bearing 
on the findings of this study include ‘negotiated order theory’ whereby societal 
arrangements and procedures are in constant flux, subject to readjustment and 
reassignment, and shifting responsibilities (Strauss et al., 1963). Strauss et al developed 
this theory from their work in American psychiatric institutions, but it has since been 
applied to healthcare settings more generally and latterly to other organisations where 
there is a diversity of professional inter-relation. In keeping with their general symbolic 
interactionist approach, Strauss et al conceptualised social order as relatively fluid and 
constituted through the social act, challenging conventional organisational sociology 
which emphasises formality, bureaucracy and rule following. Within its application in 
the hospital setting, the concept of negotiated order is often applied to professional-
patient or doctor-nurse interactions. Allen’s work in this area however suggests that 
although blurring of the boundary between some nursing and medical roles may be 
widely accepted there is little explicit face-to-face negotiation (Allen, 1997). Like Allen, 
I will demonstrate in Chapter 5 that overt verbal negotiation is not always evident in 
practice, and that as Strauss later suggested, the term ‘processual ordering’ might be 
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more appropriate, indicating the action but not necessarily overt and explicit negotiation 
(Strauss, 1993). Within my research, although such negotiation is probably most evident 
in the role of the researchers, it can also be seen in the way in which other staff groups 
and patients interact with the researchers in different environments and is explored in 
Chapter 5 in particular, which illustrates an apparent temporary role reversal between 
medical and nursing staff in the initial assessment of a newly admitted stroke patient.   
Having established my theoretical position, I now outline my chosen 
methodological approach, before presenting an account of how the research was 
actually undertaken. 
4.1.4 Ethnography  
As noted in section 4.1.1, ethnography is a mode of enquiry considered congruent 
with the constructionist paradigm and the symbolic interactionist approach. Developed 
from anthropology, a minimal definition of ethnography is that of iterative-inductive 
research, that evolves in design throughout the study, drawing on: 
‘[a] family of methods, involving direct and sustained contact with human 
agents within the context of their daily lives (and cultures). The ethnographer 
watches what happens, listens to what is said, asks questions, and produces a 
richly written account that respects the irreducibility of human experience, that 
acknowledges the role of theory, an open-endedness in the direction of study, as 
well as the researcher’s own role and that views humans as part object/part 
subject.’ (O'Reilly, 2005; p.3) 
More specifically, the focus is usually on a single setting or group, with data being 
gathered from a range of sources, including but not limited to:  participant observation, 
informal interviews, documentary analysis, diaries, life histories, and discussion or 
focus groups. The predominant methods however are participant observation and 
informal interviews and it is this combination that I have employed within this study.  
Ethnographers study behaviour in everyday contexts and in an unstructured 
fashion. The method is considered by some to be too subjective and individualistic, 
taking little account of wider historical or cultural implications. The work of the Lynds 
(1956) however, contradicts this claim. In consecutive studies of American culture 
conducted in Middletown they interpret their findings differently in accordance with the 
economic and historical context and their own shifting political allegiances. New issues 
surfaced as being more important in their second study as the Lynds' own world views 
had changed, thus shifting their focus from religious to political values (Lynd, 1956).  
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Rock (2001) places ethnographic methods, and participant observation in 
particular, at the heart of interactionist enquiry. As he noted, in conducting such enquiry 
the ethnographer is in effect doing what the participants (the ‘observed’) do on a daily 
basis - they go into the world and interpret it.  
Ethnography, like symbolic interactionism, focuses upon taking the place of the 
other. It is:  
‘…a form of research in which the social settings to be studied, however 
familiar to the researcher, must be treated as anthropologically strange; and the 
task is to document the culture - the perspectives and practices - of the people in 
these settings. The aim is to ‘get inside’ the way each group of people sees the 
world.’ (Hammersley, 1985; p.152) 
This can be facilitated by observing the group(s) in its day to day practice and also 
by discussing these practices in informal interviews, methods which I outline below. 
4.1.5 Participant observation 
Participant observation allows for close contact with actors interacting and 
constructing reality in their own particular meaning worlds. Only by observing, 
interpreting and making sense of the shared symbolic meanings and microsociological 
interactions which occur between ‘socially situated’ actors can the researcher gain an 
accurate understanding of their social world (Silverman, 1985). To be a participant 
observer is to adopt a role within the research field which enables access to the chosen 
setting and allows the researcher to gain a close and intimate familiarity of the 
population to be studied and their everyday practices, activities, beliefs and 
organisational structure. This requires intense involvement with people in their ‘natural’ 
and social environment. It also involves the researcher drawing upon a range of data 
collection methods: direct observation, conversations, structured to unstructured 
interviews, collective discussions, analyses of personal documents produced within the 
group, self-analysis and life histories, all whilst monitoring and adapting their own 
behaviour and its effects. Data collection is facilitated when the researcher is to all 
intents and purposes metaphorically ‘invisible’ to those observed but attaining such 
invisibility is perhaps best achieved by participating at least peripherally rather than 
making oneself conspicuous by avoiding doing so. By this I mean that the researcher 
should aim to become ‘part of the furniture’, seen and acknowledged by those she 
observes, but exerting minimal influence upon their activities.   
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Patterns, customs, conflicts, ambiguities, surface and hidden details (like taboo 
behaviour) are more easily observed and understood over a prolonged period of time. 
Participant observation is therefore usually undertaken over an extended period of time 
ranging from several months to many years. Prolonged immersion means that the 
researcher will be able to obtain more detailed and accurate information about the 
people he/she is studying, whilst also lessening the effect his/her presence may have on 
the group observed as the ‘novelty’ of being observed wears off. 
Participant observation involves the generation and collection of an immense 
volume of words, events and texts including the researcher’s personal thoughts, feelings 
and experience. The richness of observational data is fundamental to the understanding 
of how and what the actors do in the environment and situation(s) under examination. 
In order to develop a better understanding of why they act in a certain way however, an 
additional approach such as informal interviewing may offer greater explanatory depth.    
4.1.6 Ethnographic interviewing 
Ethnographic interviews aim to describe the cultural knowledge of the informant 
(Sorrell and Redmond, 1995). Whilst participant observation allows the researcher to 
collect data pertaining to the social group’s observable behaviour, customs and daily 
life, ethnographic interviewing requires the collection of linguistic data from individual 
group members to help the researcher understand why group members do what they do. 
Such investigation of ideas, beliefs and knowledge shared (or not) by the group 
facilitates understanding of their behaviour and allows the researcher to compare what 
they do with what they say they do, and to explore the reasons why discrepancies might 
exist. The interviewer is interested in what people say they think, and how one person’s 
perspective compares with another. This comparison helps the interviewer to identify 
both shared values and differences among members of a cultural group.  Ethnographic 
interviews differ from those conducted in isolation because they are informed by and 
conducted within the context of the concurrent fieldwork observations and relationships. 
They allow for follow up and clarification of aspects of observational work. 
Furthermore, the ethnographer may develop a more nuanced understanding than one 
approaching interviewees ‘cold’.  The sense that the researcher has shared in the ‘world’ 
of those observed allows a greater sense of reciprocity and facilitates a relationship of 
trust between researcher and researched.  
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In this chapter so far I have outlined my theoretical position and my rationale in 
selecting these particular research methods. Below I present an account of how the 
research was conducted. 
4.2 Research Design, Selection Of Methods And Conduct Of Research:  
In this section I describe the conduct of the study including setting and 
participants, negotiation of access to the field, method of obtaining informed consent as 
well as detailing the actual conduct of participant observation, recording of consent 
interactions and the conduct of interviews with healthcare professionals. I conclude this 
section by considering matters of methodological rigour, ethical issues and initial 
reflexive considerations which influenced my decisions about how I would undertake 
this research. A reflexive account of issues arising during the study is presented in 
Chapter 4.4. 
4.2.1 Setting and participants 
Sampling of the setting and individual participants was purposive. I selected a 
research active site where I would be able to elicit the views of professionals who had 
experienced the phenomenon under investigation and where I would be able to observe 
the type of activity that I wished to study. Thus the primary study site was the Acute 
Stroke Unit at Nearstreet Hospital, in the north of England. The unit comprised one 
thirty bedded ward and admitted patients via the Emergency Assessment Unit on the 
same site (although this policy changed during the course of the study). During the 
period of fieldwork three acute/hyperacute randomised controlled trials of stroke 
treatments were ongoing. These studies were:  
· ECASS III, a thrombolysis study aiming to assess the safety and efficacy of 
extending the treatment time window and recruiting patients between 3 to 4.5 
hours post ictus, 
· Two blood pressure management studies (using already licensed medications), 
one with a 24 and one with a 48 hour time window. 
An acute observational study and a number of secondary preventions studies were 
also actively enrolling patients at this time. The unit admits around 500 patients per 
year, of which I was advised that approximately two patients per month are enrolled in 
acute/hyperacute stroke treatment RCTs. Nurse staffing levels at the time of the 
fieldwork consisted of a Senior Sister (Grade G), a Junior Sister (Grade F) 14 Staff 
Nurses at Grade E/D (one on maternity leave and one on sick leave), and 10 unqualified 
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healthcare assistants. There were four junior doctors at Foundation Level 1 or 2, as well 
as a Specialist Registrar. Five consultant stroke physicians covered the unit. In addition 
to the ward based staff, there was a stroke nurse practitioner and a stroke research 
fellow as well two whole-time equivalent research nurses (constituted differently 
throughout the study and explained more fully in Chapter 5). Table 1, below, provides a 
list of staff observed during fieldwork, identified by role and pseudonym.   
Table 1: Dramatis Personae 
Pseudonym Role Gender 
Dr Green Consultant Stroke Physician F 
Dr White Consultant Stroke Physician M 
Dr Suni Consultant Stroke Physician M 
Dr Brown Consultant Stroke Physician M 
Dr Silva Consultant Stroke Physician (formerly Stroke Research Fellow) M 
Dr Sterling Consultant Stroke Physician (Seaford Hospital)  M 
Dr Black Consultant Stroke Physician, Principal Investigator M 
Maxine Potts Dietician F 
HCA Dixon Health Care Assistant  F 
HCA Atkinson Health Care Assistant F  
HCA Wilson Health Care Assistant F 
HCA Wallace Health Care Assistant F 
HCA Winn Health Care Assistant F 
HCA Taylor   Health Care Assistant  F 
HCA Clark  Health Care Assistant  F 
HCA Mitford Health Care Assistant F 
HCA Jackson Health Care Assistant F 
HCA Barker Health Care Assistant  M  
HCA O’Neil Health Care Assistant  M 
HCA Simpson Health Care Assistant F 
Dr Foster  Junior Doctor, Foundation Level 1 F 
Dr Persaud Junior Doctor, Foundation Level 1 F 
Dr Jones Junior Doctor, Foundation Level 1 F 
Dr Carr Junior Doctor, Foundation Level 1 F 
Dr Bates Junior Doctor, Foundation Level 1 M 
Dr Raey Junior Doctor, Foundation Level 1 M 
Dr Scott Junior Doctor, Foundation Level 2 F 
Dr Craig Junior Doctor, Foundation Level 2 F 
Dr Modha  Junior Doctor, Foundation Level 2 F 
Dr Wright Junior Doctor, Foundation Level 2 M 
Sister Mitchell Junior Sister ASU F 
Claire Effard Occupational Therapist F 
Steph Barnes Physiotherapist F 
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Pseudonym Role Gender 
Mr Young  Physiotherapist M 
Research Nurse Fowler Research Nurse F 
Research Nurse Webb  Research Nurse F 
Research Nurse Slater  Research Nurse F 
Senior Research Nurse Higgs Research Nurse M 
Sister Hatfield Senior Sister, ASU F 
Sr Mackay Senior Sister, EAS F 
Marion Miller Social Worker F 
Dr Narendran Specialist Registrar M 
Dr Hutchinson  Specialist Registrar M 
Joanne Armstrong  Speech & Language Therapist F 
Melanie Cox Speech & Language Therapist F 
Linda Hill  Speech & Language Therapist F 
Nurse Lynch Staff Nurse F 
Nurse Smith Staff Nurse F  
Nurse Kane Staff Nurse F 
Nurse Lawson Staff Nurse F 
Nurse Ramsay Staff Nurse F 
Nurse Oliver Staff Nurse F 
Nurse Norton Staff Nurse F 
Nurse Ross Staff Nurse F 
Nurse Cooper Staff Nurse M  
Nurse Evans Staff Nurse M 
Nurse Johnson Staff Nurse M 
Sister Stone Stroke Nurse Practitioner F 
Dr Chatterjee Stroke Research Fellow M 
Student Nurse Mallen Student Nurse F 
Student Nurse Parker  Student Nurse F 
Student Nurse Robson Student Nurse, EAS F 
Mrs Bridges Ward Clerk F 
Mrs  Hirst Ward Housekeeper F 
 
At the time this work was undertaken there were only a handful of units 
conducting similar acute and hyperacute stroke research in the UK. In his capacity as 
Principal Investigator (PI) for most of the ongoing studies in the unit, and as Director of 
the UK Stroke Research Network, Dr Black (pseudonym) advised me that the activity 
ongoing at Nearstreet was fairly typical of these units. 
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4.2.2 Gaining access to the field 
Access was negotiated via the Clinical Director responsible for the Acute Stroke 
Unit and the lead researcher within the Stroke Unit. They acted as gatekeepers and were 
fully apprised of the plan of work and were also members of my supervisory team. With 
their approval, and prior to submitting an application for ethical opinion, I contacted 
senior nursing staff, research nurses, consultant medical staff and the research fellow, in 
order to introduce myself and the study protocol. I arranged preliminary, individual, 
face to face meetings so that I could address any queries that staff might have. I also 
discussed the proposed study with the Directorate Manager. These meetings facilitated a 
useful exchange of ideas and informed my plans for fieldwork and timetabling 
arrangements, and allowed me to secure agreement in principle and verbal consent to 
undertake this study at this site.  
During the course of the study it became apparent that fewer patients than 
anticipated were being admitted and/or being approached for consent to participate in 
the ongoing acute and hyperacute studies. This in turn limited my opportunities to 
observe and record consent interactions. Therefore, following discussion in supervision 
meetings it was agreed that I should extend this aspect of the study to include another 
stroke unit in a different NHS Trust but within the same Strategic Health Authority. The 
site chosen was the Stroke Unit at Seaford Hospital because it was known that the same 
studies plus an additional hyperacute study were underway at that site. I spoke to the 
Consultant Stroke Physician, Dr Sterling, and provided him with my study protocol and 
supporting documents, following which he agreed, in principle to audiorecord any 
acute/hyperacute research consent interactions that he undertook. Given the timescale 
and logistics of the project it was not feasible for me to conduct observational work at 
this site. I applied for, and successfully obtained, approval from the Research and 
Development Department at Seaford Hospital prior to advising the Research Ethics 
Committee of my intention to extend the study.   
4.2.3 Participant observation 
Participant observation was undertaken in the Acute Stroke Unit at Nearstreet 
Hospital over a 13 month period from June 2006 to June 2007, in four phases, totalling 
279.5 hours of observation as detailed in Table 2, overleaf. 
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 DATE OBSERVED NO. DAYS HOURS 
Phase 1 June - Aug 2006 
Stroke team 
12 
76 
Ward 6 
Phase 2 Oct-Nov 2006 
Stroke team 
17 
39 
Ward 72.75 
Phase 3 Mar-April 2007 
Stroke team 
9 
30.25 
Ward 21.00 
Phase 4 June 2007 
Stroke team  
6 
14 
Ward 20.5 
Table 2: Observation periods in the Acute Stroke Unit 
The observation periods were phased in order to allow adequate time for write-up, 
reflection and refinement of the research plan, to allow the participating clinical area 
some respite from constant observation, and to avoid oversaturation of the researcher. 
Observational work, particularly when undertaken in such an acute environment, 
requires intense concentration and focus from the researcher. It can be difficult to 
‘switch off’ from this mind set when outside the setting under observation and this can 
contribute to researcher fatigue. These planned breaks helped me to disengage from the 
observer role and thus avoid these potential problems. I also used this time out of the 
field to undertake further methodological and theoretical training and development.  
Participants included all those engaging in daily activity on the ASU, including 
patients and family members. Although the more specific focus of the study was that of 
the research consent interactions, observation included all aspects of daily activity in 
order to provide contextual data. Observation took two forms; either general 
observation, by basing myself at the nurses’ station or ward bay and observing activity 
within that space, or a more focussed approached during which I shadowed an 
individual member of staff. I undertook shadowing with three of the four research 
nurses and with the stroke nurse practitioner because they were more likely to be 
specifically involved in assessment of stroke patients, and any subsequent approach for 
research participation. Furthermore, clinical staff were more likely to be involved in 
more intimate and personal patient care, and I considered that my intrusion in this 
aspect of their activity was not warranted.  Patients, family members, or staff were 
excluded from observation only if they declined to participate. Any interaction where 
consent was sought for participation in a randomised controlled trial of stroke treatment 
within 48 hours of onset of stroke symptoms was considered eligible for 
recording/observation (i.e. acute/hyperacute studies). Patients and family members were 
excluded from observation of consent interaction if verbal consent was not given for the 
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first stage or if written consent for data analysis was subsequently refused. 
Arrangements for consent for this study are detailed more fully below.  
4.2.4 Consent   
The ward sister agreed to display an information sheet regarding the observational 
aspect of the study at the nurses’ station, and also on a notice board displaying 
information for patients and their visitors near the entrance to the ward. I also arranged 
with the ward clerk that she would provide copies of this document to all members of 
staff, and to patients and their families on admission to the ward. On a daily basis I 
chose to base myself either at the nurses’ station, or within one of the six bedded bays. I 
always reaffirmed verbal consent from the nurse in charge and advised other staff that 
they should let me know if they did not want me to observe their activity. On occasions 
when I based myself in the bay areas, I confirmed with the nurse responsible for that 
area that he/she was happy for me to do so. I advised the patients that I would be 
observing the staff in the bay and depending upon their level of awareness and 
understanding, explained a little about the nature of the observation.  
Staff members’ verbal consent to allow general observation also included 
observation of research consent interactions occurring within the unit but with the 
proviso that this consent could be withdrawn at any time, and for any individual case, 
where this course of action was not considered appropriate. During the fieldwork 
periods I was based within the clinical area for three days per week and at these times I 
was immediately available to attend during a consent interaction. In such a case the 
initial approach was made by the attendant clinician who introduced me to the patient 
and sought verbal consent for me to observe and record the consent interaction. As the 
RCT consent process was the primary focus of my study it was unavoidable that the 
patient/family member was required to make a decision virtually immediately as to 
whether to allow me to observe and record the consent interaction (ethical implications 
are discussed later in this chapter, section 4.6). However, as soon as possible after this 
interaction, I visited the patient and/or family member and gave a full explanation of the 
study, along with an information and consent document. Written consent to transcribe 
and analyse these data was sought after the acute period, when the patient or family 
member was able to take time to fully consider the implications of participation. They 
were encouraged to take as much time as they required in deciding whether or not to 
allow transcription and analysis of the data collected. 
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On occasions when I was not on site, the research nurses agreed to contact me by 
mobile phone to invite me to observe the interaction. This process was implemented 
once (unsuccessfully, see Chapter 4.3.2) during my periods of fieldwork.   
As I was not present at Seaford Hospital, the arrangement for obtaining consent 
for audiorecording and transcription of research consent interactions was slightly 
modified. Dr Sterling (Consultant Stroke Physician) obtained verbal consent to record 
the RCT consent interaction and provided the patient with written information about my 
study. He advised the patient that I would visit as soon as possible thereafter, in order to 
explain the study more fully, and to obtain written consent to use the audiorecording. 
He made clear to the patient that this would not be made available to me until written 
consent had been secured. When the RCT consent interaction was completed Dr 
Sterling advised me that a recording had been made and provided me with the patient’s 
name so that I could visit the patient on the stroke unit and seek consent for transfer, 
transcription and analysis of the recording. Having confirmed that consent had been 
obtained, Dr Sterling transferred the recording to me via encrypted electronic transfer 
for subsequent transcription.    
4.3 Data Collection 
4.3.1 Participant observation 
Observations at Nearstreet Hospital were conducted on different days and at 
different times in order to develop a broad picture of the ward activity and the daily 
routine of the research staff. Individual periods of observation were usually 
approximately eight hours, with or without a meal break, and covered the period from 
7:30am to 8:45pm. I did not observe at weekends or overnight as changes in admission 
policy meant that patients were not admitted during these times. Also, staffing levels 
were particularly poor on night duty and I considered that the potential disruption my 
presence may cause could not be justified in relation to any further insight I might gain. 
Most of the clinical staff rotated to night shift and some referred to this experience in 
their interviews or in informal discussion during my periods of observation.  
My initial sessions on the ward allowed me to familiarise myself with the routine 
and environment, to introduce myself to the staff, and also allowed them to get used to 
my presence. Subsequently, I either attached myself to a member of staff for a span of 
duty or confined myself to one area of the ward and focussed on activity within that 
space. During the period of fieldwork the ward also accepted non-stroke patients if other 
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wards within the medical directorate were full. For this reason, when choosing an area 
of the ward for observation, I endeavoured to choose the bay which housed the most 
stroke patients. Although the main focus was on research related activities I observed 
and made field notes regarding general behaviours and interactions which would enable 
me to describe and examine areas including but not limited to the research culture, 
introduction of new projects, methods of information/knowledge sharing, 
teaching/training, awareness of existing studies, understanding of research concepts, 
integration with clinical work and resource issues.  
Initially I felt somewhat uncomfortable making notes whilst in the clinical area, 
but this became less problematic as I became more familiar with the setting and daily 
routines, and as the staff got used to my presence. Nevertheless, I found it easier to 
make notes whilst at the nurses’ station, as this was the point where most of the 
administrative work was conducted and therefore my activity ‘fitted in’. 
Contemporaneous note taking was slightly more difficult whilst accompanying the 
research nurses in their daily tasks, not least because of their almost constant transit. At 
such times I relied on recording key words and phrases for further expansion later. I 
usually managed to develop my notes whilst the research nurses were occupied with 
their own administrative work when they were back in the research office. 
4.3.2 Observation and recording of consent interactions 
I was able to attend one acute research consent interaction, for which verbal 
consent for my observation and audiorecording was secured from the patient.  In 
addition to the audiorecording I made detailed field notes about my observations. 
Transcription and analysis were not undertaken until written consent was obtained from 
the patient’s next of kin, who did not feel their mother was well enough to give her own 
consent. 
I observed, but was unable to record, two further acute consent interactions. In the 
first case, the research fellow had already begun to present the RCT to the patient before 
I arrived and therefore I made fieldnotes only. On the second occasion, the patient 
lacked capacity to participate in the decision making process regarding consent and on 
approaching the patient’s family regarding study participation the discussion was 
curtailed by a family member before a request for audiorecording could be made. 
Again, fieldnotes only were made.   
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Two consent interactions were recorded at Seaford Hospital. In the first case, the 
process of obtaining consent for the use of the audiorecording proceeded according to 
plan. Dr Sterling advised me that he had made the recording and I visited the patient on 
the ward the next day to explain the study more fully and to obtain written consent. Dr 
Sterling accompanied me onto the ward in order to introduce me to the staff and to the 
patient before leaving me to explain the study and secure consent. In the second case, 
although the same procedure was followed and I made arrangements to visit the patient 
on the ward, the patient was discharged before schedule and was therefore not present 
on the ward when I arrived. Dr Sterling was confident that the patient wished to 
participate in the study and therefore obtained the patient’s permission for me to 
telephone him at home to answer any questions about the study and to make 
arrangements to obtain written consent. I telephoned the patient and he confirmed that 
he wished to participate in the study and that Dr Sterling could pass on the 
audiorecording. He also agreed that I should post the consent documentation to him 
along with a stamped addressed envelope, and that he would forward the signed consent 
form by return. On receipt of the signed consent form Dr Sterling released the 
audiorecording to me. 
4.3.3 Interviews with healthcare professionals  
On commencement of my fieldwork I was able to identify all nursing and medical 
staff within the ASU from the nursing duty rotas and medical on-call rotas. During the 
period of study all nursing staff (qualified and unqualified) and consultant medical staff 
in the ASU, including research staff were invited to participate. Rotating medical staff 
and new staff were invited to participate when possible. Other healthcare professionals 
(e.g. physiotherapists, occupational therapists, speech and language therapists) were not 
approached for interview as they were not involved in ongoing research within the unit 
and patient involvement in the ongoing RCTs was unlikely to impact upon their 
workload. Furthermore, a larger sample size was unlikely to be manageable within the 
wider context of the study.  Nursing and medical staff were invited to participate 
regardless of whether they had been involved in the enrolment of patients to 
acute/hyperacute stroke treatment RCTs as I wanted to explore their views and 
perceptions about research, not just their experience of it. All staff received a 
personalised letter of invitation and an information sheet with a return slip for 
expression of interest. The majority of respondents simply informed me verbally that 
61 
 
 
they were willing to participate. Participants had at least 24 hours, and in most cases 
several weeks to decide whether or not to take part in the interview study.  
Twenty one staff members verbally expressed an interest in taking part in a face-
to-face interview, none explicitly declined but 20 did not respond either in writing or 
verbally.  Of those who expressed an interest 16 were interviewed between November 
2006 and October 2007, at which point thematic saturation was considered to have been 
reached. The main reason for not interviewing the remaining five staff members who 
had expressed an interest was time restriction, both in terms of actual time available and 
in co-ordinating my time with the individuals themselves, one of whom had an extended 
period of sick leave and another of whom had a period of maternity leave. 
Interviewees were given pseudonyms and are listed in Table 3 below.  
Name (pseudonym) Discipline and/or Grade Gender 
Dr Black  Consultant Stroke Physician M 
Dr White Consultant Stroke Physician M 
Dr Brown Consultant Stroke Physician M 
Dr Silva Consultant Stroke Physician M 
Research Nurse Higgs Senior Research Nurse (F) M 
Research Nurse Fowler Research Nurse (E) F 
Research Nurse Slater Senior Research Nurse (F) F 
Research Nurse Webb Senior Research Nurse (G) F 
Sister Stone Stroke Nurse Practitioner (H) F 
Sister Hatfield Senior Sister (G) F 
Sister Mitchell Junior Sister (F) F 
Nurse Kane Staff Nurse (E) F 
Nurse Lawson Staff Nurse (E) F 
Nurse Cooper Staff Nurse (D) M 
Dr Chatterjee Stroke Research Fellow M 
Dr Bates Junior Doctor (Foundation Level 1) M 
Table 3: Interviewees (pseudonyms) 
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Face-to-face, semi-structured audiorecorded interviews were conducted at a time 
and location convenient to the interviewees, usually within the ASU in as quiet a 
location as possible or in the respondent’s office.  Every effort was made to avoid 
interruptions although on occasion the interviewee was required to be available in case 
of emergency. Where possible I endeavoured to conduct the interviews during my 
allocated spells of fieldwork but some were conducted outwith these sessions for the 
convenience of participants and to minimise attrition. Inevitably some interviews had to 
be rescheduled due to clinical considerations. With the written consent of each 
participant the interviews were audiorecorded. Recording did not commence until I had 
reviewed the information and consent document with the participant, including purpose, 
aims and methodological approach of the research.  I also clarified at this time that the 
interviews formed part of my empirical work for my doctoral research.  
All interviews were conducted by me, as researcher. Interviews were guided by a 
schedule (Appendix B) which was informed by the literature, as well as drawing upon 
the findings of an unpublished, qualitative study undertaken during my MSc in Health 
Science (Research Methods) (see Chapter 4.4.1), and my own experience as a research 
nurse in a neurosciences environment. As the observational aspect of the study was 
conducted concurrently with the interview study, ongoing observation also contributed 
to the iterative process of schedule development. I advised the interviewees that the 
schedule was a guide only and that they may discuss any aspect that they found 
relevant. As all interviews were audiorecorded I did not make notes during the 
interviews but made notes as soon as possible thereafter regarding my general 
impression of the process. The interviews lasted on average 60 minutes (range 29 
minutes to 93 minutes). 
4.3.4 Transcription of consent interactions, field notes and interviews 
With the consent of participants I transcribed the audio-recordings of the consent 
interactions verbatim into a word processing package. The decision to transcribe the 
consent interactions myself was made in consideration of the fact that the environment 
and circumstances in which an acute or hyperacute consent interaction takes place is 
unpredictable and beyond the researcher’s control. These factors may influence sound 
quality and clarity, and there may also be important contextual factors which would not 
be known to the professional transcriber. Furthermore, it was considered an important 
part of the analytic process for me to become immersed in the interaction as a complete 
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scenario rather than purely as a textual representation. For the interaction at which I was 
present I was able to transcribe the recording with reference to my field notes, which 
prompted recall and identification of passages which may have otherwise been difficult 
to decipher. Completed transcripts were then re-checked alongside the original 
recordings.  
As noted above (Chapter 4.3.1) the extent to which I was able to make detailed 
notes whilst in the field varied depending upon the location and the activities ongoing at 
the time. Transcription and expansion of my fieldnotes was undertaken as soon as 
possible on leaving the field. This was usually the same day, but on some occasions 
when I had observed a ‘late shift’ (i.e. finishing at 20:45hrs) the notes were transcribed 
the following morning. When notes could not be transcribed immediately, I 
endeavoured to avoid activities that would disrupt my subsequent recall of events 
(Emerson et al., 1995). I transcribed my notes using colour coding to identify those that 
were made ‘in the field’ and those that were substantially expanded in the process of 
transcription. Any details or preliminary analytical additions that were made on 
subsequent readings were also allocated a different colour code. Thus my writing was 
both a method of data collection and a method of data analysis (St. Pierre, 2005).  
Interviews were transcribed verbatim, either by an external transcription service or 
in-house, by a secretary experienced in research and transcription. As well as adhering 
to the standards proscribed within the Data Protection Act, 1998, employees of the 
transcription service were bound by the University’s data protection regulations. 
Transcriptions were checked alongside the original recordings by myself. They include 
my questions as well as the participant’s responses. Short comments such as those 
indicating encouragement or requests for clarification were included as were nonverbal 
‘um’s and ‘er’s. Pauses and interruptions were also included but intonations and speed 
of delivery were not recorded as this was not considered necessary for the type of 
analysis to be undertaken. Identifying data such as names of people, places or specific 
studies were changed to preserve anonymity. The transcribed documents were imported 
into NVivo7®, a computerised qualitative data analysis and storage package, in order to 
facilitate data management. 
4.3.5 Data analysis and interpretation 
Although I separate data collection and analysis here for explanatory purposes, 
they were, in practice inextricably linked as illustrated above in the evolutionary nature 
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of my fieldnotes. In ethnographic work some element of data analysis is inherent even 
at the data collection stage as the researcher is always already deciding what is or is not 
to be recorded. As noted above, during transcription and re-reading of my fieldnotes I 
used colour coding to identify notes that were made ‘in the field’ and those that were 
‘recalled later’ or expanded in the process of transcription (Lofland and Lofland, 1995). 
Any details, theoretical notes or preliminary analytical additions that were made on 
subsequent readings or during coding were also allocated a different colour code as 
were reflexive notes (Schatzman and Strauss, 1973; Emerson et al., 1995; Hammersley 
and Atkinson, 1995).  
This process of reflective writing allowed me to develop my analysis by moving 
through the steps outlined below: 
· Descriptive writing, which formed my initial fieldnotes; 
· Descriptive reflection, which added depth to the above; 
· Dialogic reflection, where I was able to consider rationale for, and possible 
alternatives to, my own judgements in my writing up of my observations, 
· Critical and multidimensional reflection, in which I considered and presented 
my observations in the light of differing perspectives, professional and 
organisational contexts, and other relevant literature. 
 (Hatton and Smith, 1995; Moon, 2002). 
In analysing the data I have drawn on some of the principles of first generation 
grounded theory, originally referred to as the constant comparative method (Glaser, 
1965), in combination with aspects of framework analysis. A later version of grounded 
theory (Glaser and Strauss, 1968) has tended to be associated with a more positivist, 
objectivist stance, whereas a more recent incarnation, proposed by Strauss and Corbin, 
reflects Strauss’s interactionist roots and allows for greater flexibility (Strauss and 
Corbin, 1998). In both grounded theory and framework analysis, emergent themes or 
categories are identified from the data. In addition however, Strauss and Corbin (1998) 
also allow for interaction between researcher and the data, where the researcher openly 
and reflexively  draws on his/her own experiences in the process of analysis (O'Reilly, 
2005).  
In framework analysis, data are sifted, charted and sorted according to key issues 
identified a priori from the aims and objectives of the study and from conceptual and 
theoretical literature (Ritchie and Spencer, 1994; Pope et al., 2000). As with other 
methods of qualitative data analysis, framework analysis begins with a process of 
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familiarisation. Data are then coded (or indexed) according to the  a priori themes, 
before being charted so that data can be read across the whole data set.  
As noted by Charmaz, who takes a constructivist approach to grounded theory, 
‘conceptual categories arise through our interpretations of data rather than emanating 
from them’ (Charmaz, 2005; p.509) and thus must take into account issues beyond the 
data. Thus, the decision to combine these approaches in order to undertake my analysis 
was a pragmatic one. As noted above, the framework approach allowed the exploration 
of themes identified a priori and considered to be important (even in their absence), 
whereas my analysis was also inductive, with themes emergent and emerged in and 
through the constant comparative element of grounded theory.  
Verbatim transcription and coding of the interviews was an iterative process 
concurrent with further data collection. After multiple readings of the transcribed 
interview data I summarised each interview in order to identify general categories. 
Codes were applied to early stage issues derived directly from the data, in the terms 
used by the study participants, in accordance with the constant comparative method. 
Having imported the interview transcripts and fieldnotes to NVivo®, codes were 
applied to sections of text within each data source (interviews and fieldnotes). 
Subsequent data sources were interrogated for similar themes and coded accordingly. 
New themes were identified and added as they emerged and new sources interrogated 
for these also.   
Following the constant comparative method, categories were generated in, and 
through codes, or by merging collections of codes. Simultaneously, and following the 
framework approach, categories were also derived from the literature and from more 
theoretical ideas which may not have been raised directly by the participants.  
For example, in Chapter 5, I discuss the category of Temporospatial Dislocation, 
which emerged from the data and, as the title suggests places an emphasis on time. 
Passages and quotes referring to time were coded under the main heading ‘time’ but 
were also allocated subcodes (48 in total) of which 18 (Time\availability; Time\care 
trajectory; Time\constraints; Time\filling time; Time\initial contact; Time\management; 
Time\on call facility;Time\preparation; Time\recruitment; Time\related incidents; 
Time\time of admission; Time\'right' time; Time\time in transit; Time\time to 
admission; Time\time to assessment; Time\timing of investigations; Time\timing of 
treatment; Time\use of time) were then condensed within the category ‘Temporospatial 
Dislocation. The multidimensional development of this category thus retains detail and 
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sensitivity, allowing exploration of its constituent parts, rather than as a more general 
code.  
Reflecting the framework component of the analysis, Chapter 7 draws upon a 
priori issues such as those noted in the literature with regard to the lack of clear 
definition of the research nurse role and the perceived incompatibility of such roles with 
those of the ‘traditional’ nurse (Hicks, 1996; Raja-Jones, 2002; Woodward et al., 2007). 
The individual characteristics and components described therein are then drawn together 
to illuminate the research nurses’ performance of identity.  
Having combined these analytic approaches, and demonstrating compatibility 
with each, categories were then summarised across all data, data were compared with 
data, data with categories and category with category (Charmaz, 2005). This facilitated 
charting of each category across all individual sources (interviews and fieldnotes) and 
all categories across each source (Ritchie and Spencer, 1994)    
Codes and categories were applied to the expanded fieldnotes and any additional 
or sub-categories identified. A similar process was undertaken with the transcribed 
consent interactions. Moving between the data and the literature this process continued 
until no further categories were identified and thematic saturation was considered to 
have been reached.  
Having described how my research was undertaken, I provide below, a reflexive 
account of some of the issues I was required to consider, acknowledge and address prior 
to, and during, my completion of this work. 
4.4 Situated Reflexivity  
In this section, I reflect on my values, preconceptions, behaviour or presence, as 
well as those of the respondents, with regard to the ways in which they may have 
affected the outcomes of this research (Parahoo, 1997). The researcher is an integral 
part of the social world studied and will always have an effect upon the research setting 
and its methodological rigour. Adopting a reflexive approach to one’s research involves 
a commitment to understanding the effects of oneself upon the research scenario, an 
acknowledgement that the researcher is a participant in the research process rather than 
just a detached outsider, and an acceptance that the theories developed to explain the 
behaviour of those researched also apply to the activities of the researcher. As 
acknowledged by Blaikie (1995) there is no such thing as a value free position; there is 
no view from nowhere (Haraway, 1988; Blaikie, 1995), all interpretation must be seen 
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as subjective. In this section, I will explore how aspects of myself, namely my 
situatedness, foreshadowed and influenced my approach to this inquiry and reflected my 
particular views about patient safety, the advancement of medical and scientific 
knowledge, personal responsibility and moral obligation.  
4.4.1 My professional background 
On completion of my nurse training in 1987, I took up a position as staff nurse in 
a Regional Neurosciences Centre where much of my experience involved caring for 
neurologically compromised patients who had suffered neurotrauma or other 
neurological emergencies. After a period of clinical experience I took up a research post 
which mainly involved investigational products for the treatment of acute head injury, 
subarachnoid haemorrhage, ischaemic stroke or cerebral tumour; surgical intervention 
for intracerebral haemorrhage; and intracranial pressure monitoring studies. 
During my time as research nurse and then as clinical trials manager, I developed 
an interest in research ethics, specifically pertaining to the difficulties of enrolling 
neurologically compromised patients in randomised controlled trials for which, by 
definition, they are unable to provide their own prospective informed consent. I 
witnessed a number of situations where enrolment could not be secured either because 
next of kin were unavailable to give their consent on the patient’s behalf, or where 
questions were raised about the suitability of the patient’s next of kin to provide proxy 
consent due to lack of understanding or strained family relations and socioemotional 
issues. For example, I once overheard the brother of a head injured patient, who was 
eligible for study participation, ask the patient’s wife if she would marry him if her 
husband died. I was forced to question what impact this may have on their response to a 
request for study participation. Similar circumstances may occur when a family member 
believes that study participation may result in their family member surviving in a 
severely disabled state and requiring constant, and possibly costly, nursing care, rather 
than imminent death and the prospect of inheritance. In either case, McHale (1993) 
contends that assent from such a party would seem inappropriate and unrealistic.  
In the light of these and other issues, I was concerned that patients may become 
‘therapeutic orphans’ (Shirkey, 1968) and may miss opportunities for potential benefit  
if no next of kin was available to give proxy consent. Equally, they may be 
inappropriately enrolled if family members did not understand the proposed research or 
did not respond of the basis of what they perceived to be the patient’s values and 
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beliefs. My concerns were all the more pointed because in the area of head injury and 
stroke in particular the effects are often devastating and treatments very limited; high 
quality research is therefore urgently required, as noted in Chapter 1.  
As well as difficulties pertaining to potential trial participants, I also noted some 
degree of antipathy amongst clinical staff towards myself and other members of the 
research team, whose role involved the enrolment of unconscious patients in emergency 
research, and to the research protocols themselves. In an attempt to explore the nature of 
some of these difficulties, as part of an MSc in Health Sciences (Research Methods), I 
undertook a qualitative study investigating the experiences of healthcare professionals 
involved in caring for neurologically compromised patients (and their families) enrolled 
in randomised controlled trials (Treadwell, 2001). As a result of this work, it became 
apparent that the issues that were important to me as a researcher, seeking to ensure the 
safe and ethical enrolment of patients into clinical trials, were less important to the 
clinical team striving to save the patient’s life. However, this was a very small study and 
investigated only reported opinions and behaviours. Thus, in the current study, I sought 
to investigate observed practice in a different, but similar, acute care environment, by 
means of an ethnographic approach. 
4.4.2 Why did I choose to explore stroke? 
I chose to investigate the area of stroke research for a number of reasons. First, as 
noted above, it is an area in which therapeutic interventions are lacking. Second, it was 
a diagnostic area with which I was familiar both clinically and in a research context, and 
in which I had encountered the problems noted above. Third, a senior stroke physician 
with a strong research interest was part of my research group within my (then) school, 
and was keen to support my research, as was an academic colleague with an interest in 
my chosen methodology as well as research ethics. The stroke physician also facilitated 
access to lead clinicians and researchers in the local stroke unit. Although I had been 
involved in ECASS II (European Cooperative Acute Stroke Study, II) the majority of 
my clinical research work had been with head injured patients. However, given its 
epidemiology, to undertake the kind of ethnographic work that I intended in the head 
injured population would have been too demanding for a single researcher, as it would 
have necessitated an overnight on-call arrangement in order to ensure adequate, 
appropriate and timely observation. Stroke admissions tended to occur within slightly 
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more sociable hours and therefore, in theory, observation would be more convenient to 
manage. 
When seeking feedback in the initial stages of study design a potential drawback 
highlighted by colleagues was related to my close professional experience with the topic 
under investigation, specifically regarding observation of consent interactions and 
subsequent interviews of staff members. It was suggested that this familiarity may lead 
to difficulties in maintaining a critical analytic perspective and may cause ‘blinding’ to 
some aspects that an outsider may be able to decontextualise and to view in a different 
light (Lipson, 1991; Streubert and Carpenter, 1999). However, although my clinical and 
clinical research experience involved a similar patient group and was within the same 
NHS Trust, it was in a different hospital and therefore involved different staff. There 
were also however potential advantages. There were similarities between the two sites 
in the way that clinical research was managed and therefore it was anticipated that there 
would be at least some commonality in terms of the issues raised.    
4.4.3 Why study stroke now, and in this place? 
The main factor in terms of timing of this work was a pragmatic one, related to 
my securing a longer term contract in my host organisation. Beyond this local issue 
however, stroke was becoming a national concern and developing a higher profile, and 
at the time of my application for funding to the Department of Health National 
Coordinating Centre for Research Capacity Development (since superseded by National 
Institute for Health Research) the improvement of stroke care, and thus recruitment to 
stroke studies, were high priorities. It therefore seemed politic to tap into a national 
initiative. 
As noted above, the stroke physician who was part of my research group was able 
to facilitate links with the local stroke unit and I was keen to conduct the research at a 
local site for obvious reasons including convenience and ease of access. Further, 
although the unit was known to have a strong research portfolio, the Principal 
Investigator was keen to explore ways to improve recruitment and retention to stroke 
studies. Access was greatly facilitated by the fact that my supervisory team included the 
Director and Associate Director (Patient Involvement) of the Stroke Research Network, 
and the Clinical Director responsible for the Acute Stroke Unit. However, this also 
meant that I was observing and reporting on their behaviour within these environments. 
There was the potential for conflict of interest here in that a) in discussing progress at 
70 
 
 
supervisory and project meetings I did not wish to divulge information that may 
influence subsequent behaviours and thus potentially skew study findings, and b) 
difficulties may have arisen in the unlikely event that I became aware of misconduct or 
malpractice. Whilst clearly this latter issue may arise in any research situation, the fact 
that my observations were likely to include members of my supervisory team meant that 
it was possible that I would find myself faced with similar issues to patients who are in 
a dependent relationship with their clinician-investigator. These issues were discussed 
in supervision and it was established that during the data collection period, ongoing data 
collection and analysis would only be discussed with the nonclinical members of the 
team. I also established and documented an agreed course of action to be followed if 
malpractice or misconduct became evident.  
Despite the advantages noted above, as all members of my supervisory team were 
named in the participant information documentation it was possible that the study may 
be perceived to be an audit or service evaluation on behalf of management and that this 
may have influenced the quality and content of information disclosed. I endeavoured to 
minimise the opportunities for this misunderstanding arising by personally contacting 
healthcare professionals at the study site rather than relying on the Clinical Director or 
Research Lead to introduce my work. I continued to clarify the nature and purpose of 
the research throughout my periods of fieldwork and at the time of the interviews. Such 
considerations also impacted upon the way in which I presented myself at the study site, 
which I discuss below. 
4.4.4 How did I present myself during the period of data collection and why? Insider/ 
outsider issues 
Throughout my study, as will be demonstrated in subsequent chapters, an 
important issue was the way in which researchers presented themselves to patients and 
other healthcare professionals. This was equally important in the way that I presented 
myself in the study environment and managed my insider/outsider position. There was 
no question that my observations would be anything other than overt, but boundaries 
were required regarding the extent to which I would ‘participate’ in either clinical or 
clinical research activities, and whether or not I would wear a nurse’s uniform (research 
or clinical) whilst doing so. Although still holding active first level registration on the 
Nursing and Midwifery Council (NMC) Register, I chose not to present myself as such 
or to display this status by means of a uniform. Whilst there were some advantages 
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conferred as a result of my nursing background, I do not believe that it was essential to 
the successful conduct of the study for me to appear as a nurse. Further, in the same way 
that I do not see the necessity to point out that someone is a ‘male’ nurse, I do not feel 
obliged to explicitly identify myself as a ‘nurse’ researcher. I consider myself to be a 
researcher who happens to come from a nursing background. I therefore referred to 
myself as a researcher, and if asked, acknowledged my nursing background.   
Whilst a uniform may convey an advantage of recognition and perhaps acceptance 
in the clinical area, amongst healthcare professionals and patients, it may 
simultaneously promote misrecognition and raise expectations of action that I was not 
able to fulfil. From my experience as a clinical research nurse I was aware that patients 
and the public (and some staff) did not appreciate the subtle difference indicated by 
nursing uniforms. I did not want to place myself in a position where I was misidentified 
as a nurse but unable to provide patients and their families with information or 
assistance should they request it. Further, I did not want patients or their families to feel 
pressurised to take part in my study because they thought that I was in some way 
involved in, or could influence, their clinical management. I considered that it would be 
misleading at best and coercive at worst, to staff, patients, and families alike, if they 
were to perceive my role as a clinical one.  
Another factor influencing my decision not to wear a uniform was that I was thus 
able to circumvent the hierarchical structure that exists in the healthcare environment 
and in hospitals in particular. My intention was to communicate with the study 
participants at their own level and thus to develop trust and rapport. I therefore 
considered it important that I was not perceived to be part of the NHS hierarchy or to 
have greater status than the healthcare professionals participating in the study. If they 
thought that I was reporting directly to senior NHS staff this may have led to them 
altering their behaviours, withholding information, or giving responses driven by a wish 
to provide answers that they felt would meet with my approval. Whilst I avoided taking 
up an ‘NHS identity’ this did not negate the difference between my researcher role and 
the role of clinical or research nurse. However, the co-construction of the research 
relationship and the data garnered therein can be facilitated and enhanced by means of a 
reciprocal approach. Oakley (1981), for example, as well as advocating  a non-
hierarchical relationship between research participants, also suggests that the interview 
is most successful when the interviewer is prepared to ‘invest his or her own personal 
identity in the relationship’ (Oakley, 1981 p.41). I aimed to achieve this by engaging in 
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general conversation during fieldwork and prior to interviews, briefly disclosing 
personal details regarding my career and experiences in order to encourage mutual 
sharing of information. I was open and honest regarding the aims of the research, 
including my personal goal of achieving a PhD. I was also able to reciprocate by 
helping the research team with ethical issues, on the basis of my experience on the local 
NHS Research Ethics Committee. Humour was also found to be valuable; the sharing of 
an ‘in’ joke was very useful in breaking the ice and was used as appropriate with good 
effect.  
Traditionally, the social science researcher is an ‘outsider’, entering the research 
setting as a visitor for the sole purpose of undertaking the research. Much healthcare 
research however is undertaken by practitioners, former or current, who subsequently 
find themselves situated upon a continuum from ‘outsider’ to ‘insider’, with a hybrid 
position falling somewhere between these two extremes (Reed and Procter, 1995). 
Although an ‘insider’ at least by virtue of my professional background and current 
NMC registration, my lack of clinical remit positioned me towards the ‘outsider’ end of 
the spectrum. Nevertheless, to some degree I shared language, meanings and 
assumptions, mutual acquaintances and experiences with the clinical and research staff, 
which was advantageous in developing a trusting relationship (Gearing and Dant, 1990) 
and facilitated disclosure of information. My previous experience also meant that I was 
familiar with some aspects of custom and practice, and understood something of the 
culture and values of the interviewees, a factor which contributed to the co-construction 
of the data for analysis. The positivist tradition has implied that to view research data 
from the practitioner perspective is to threaten the ‘purity’ of the research; I share the 
view of Reed and Proctor (1995) however, that to disregard the practitioner view is to 
lose important knowledge.  
These issues were discussed at the design stages of my study and further at annual 
progress reviews. However, debriefing sessions with my supervisors who were not 
familiar with this clinical area, enabled me to expand upon and further explore issues 
which I may otherwise have taken for granted as a result of my familiarity with this 
field of work.  
4.4.5 Level of engagement with patients and the public 
Throughout my fieldwork, the ad hoc interactions, observations and discussions 
were for the most part conducted with the healthcare teams rather than patients and their 
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families. I have considered this at great length and have wondered whether I should 
have endeavoured to seek greater interaction with the patients, asking them how they 
felt, or might have felt, about participating in clinical research. There were several 
reasons why I chose not to do so however. First, I was involved in another study, 
running parallel to my observational study, which sought to interview patients and/or 
their family members if they had been eligible to participate in any of the ongoing acute 
or hyperacute studies. They were interviewed about their experiences of being 
approached for study participation (whether or not they were enrolled) or if they were 
eligible but not invited to participate, they were asked about their views on emergency 
stroke research, particularly in situations where patients are unable to consider 
participation. I did not want to influence these interviews by having similar ad hoc 
conversations with patients in the ward environment. Second, I did not wish to have 
such conversations entirely randomly as I did not want to give patients or their families 
either false hope, or the impression that they had missed out on something that could 
have been tried and may have influenced their outcome. Futhermore, in most cases this 
would have resulted in hypothetical discussion and conjecture, where my main concern 
within my study was to document what actually happened in the clinical area on a day 
to day basis. A third consideration was undoubtedly my neophyte status as an 
ethnographer. This was a new research role to me, being accustomed as I was to doing, 
rather than watching, and I can state with confidence (and now on the basis of further 
experience) that my approach to participation has developed during the course of, and as 
a result of, this work.  
Having chosen not to present myself as a nurse, it was necessary to consider what 
role I would adopt in the study environment. On the basis of my previous experience 
and skills, it could be argued that I could have adopted a more active participant role, 
with regard to either clinical or clinical research activity. However, as well as issues of 
potential misrecognition as noted above, greater participation in day to day activities 
also raised the possibility that I might miss the research activity that I was seeking to 
observe in one area, if I became embroiled in clinical or research activity, which I could 
not easily leave, in another.  
Nevertheless, although it was never my intention to participate directly or 
indirectly in clinical or research activity, the term ‘participant observer’ is perhaps 
misleading as this does not necessarily indicate that the researcher participates in the 
same way as those ‘native’ to the research setting (Delamont, 2004). For example, 
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although I have maintained my nursing registration, I did not, in the course of this 
study, participate as a nurse in the research environment. I did, however, participate in 
general conversation, social activities - such as joining group members at lunch or 
coffee breaks - and occasionally helping out with more mundane matters, for example 
collecting a piece of equipment from another ward.  
There were also occasions when some level of involvement could not realistically 
be avoided, or occurred almost involuntarily. For example, whilst observing activity in a 
six bedded bay, I became aware that an aphasic patient had been given a bowl of water 
with which to wash herself, but that she could not reach either it, or her toiletries. Nor 
could she reach the call bell to summon a nurse. My options were to continue to observe 
and to take no action at all, to seek a nurse, or to move the bowl closer to the patient. I 
chose the latter option, but clearly this had no impact upon the type of activity that I was 
hoping to observe.  
On other occasions however, when shadowing the research nurses, I occasionally 
became more involved than I had anticipated, and sometimes in such a way that I felt I 
did influence research activity. This sometimes occurred because the research nurses 
directly asked my opinion or advice in an area which they knew me to have 
considerable experience, or because my act of seeking information about a study or 
course of action prompted a behaviour or intervention on the part of the research staff. 
For example, by inquiring about the inclusion criteria of a particular study, I drew one 
of the research nurse’s attention to a potential patient (Mrs Clarke – The Consent 
Interaction That Never Was, Chapters 7 and 8). This was not a deliberate intervention 
on my part, but this was the effect nevertheless, demonstrating that one can rarely be 
entirely non-participative.  
Related to the subject of participation and inclusion, the eclectic nature of 
ethnographic research raises the question of what may be included as ‘legitimate data’. 
Are there any topics which are ‘off limits’? Are some spaces ‘private’ and thus not 
amenable to data collection? I endeavoured to make it explicit that my observational 
work included all aspects of activity unless someone specifically requested otherwise. 
Thus I included comments made in general conversation, or even those overheard, as 
legitimate data. In the event that a participant stated that they were telling me something 
‘off the record’, or requested that I did not document a particular activity, I complied 
with their request. Nevertheless, such information, even if not formally recorded cannot 
be un-heard or un-known, and therefore may have exerted some influence on my 
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interpretation of the data, a fact that I acknowledge in order to uphold methodological 
rigour, which I discuss further in the following section 
4.5 Methodological Rigour 
Having described the design and conduct of my study, I now consider its 
evaluation. The lack of defined guidelines for the conduct and presentation of 
ethnographic work, whilst allowing for creativity, raises questions regarding rigour. 
Qualitative and quantitative researchers neither employ the same research methods nor 
seek to address the same issues and therefore their work cannot be evaluated by the 
same positivistic canons (Cutcliffe and McKenna, 1999). Rather than striving for 
evidence of reliability and validity, terms which some researchers consider semantically 
incompatible with qualitative research (Slevin and Sines, 1999), the qualitative 
researcher aims to demonstrate rigour by other means.  Numerous proposals have been 
made suggesting criteria more appropriate to qualitative work but the terms suggested 
are often defined differently, used interchangeably or simply employed as a ‘qualitative 
translation’ of the original quantitative criteria. Criteria such as congruence, truth-value, 
applicability, and neutrality have been proposed (Guba and Lincoln, 1981; Sandelowski, 
1986; Marshall and Rossman, 1989; Rose et al., 1995), but disagreement persists as to 
which of these are ‘criteria’ in themselves, and which are means of evaluating whether 
criteria have been met.  Furthermore, whichever criteria are ultimately accepted, this is 
based on a misguided assumption of homogeneity of qualitative research and seems 
likely to ignore the researcher’s epistemological claims. Drawing together the work of 
several qualitative researchers, Hammersley (1992) identifies seven criteria for the 
evaluation of ethnographic studies including consistency, credibility, transferability, 
reflexivity, novelty, and production and development of theory. He notes however that 
these criteria are neither always necessary nor sufficient. These criteria can be distilled 
still further, to  suggest that we review the topic’s importance or relevance; its 
plausibility, based on existing knowledge; and the degree to which the evidence 
presented in the study supports the credibility of its claims (Seale, 2004). 
Lack of consensus notwithstanding, for the purpose of demonstrating rigour 
within this thesis I consider the issues of congruence, consistency, credibility, 
transferability and relevance. In the following section, I briefly describe what I 
understand by these terms in the context of my research before evaluating the degree to 
which my research meets these criteria.  
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4.5.1 Congruence 
Congruence refers to the degree to which the methods and conduct of the study 
are compatible with the research question and the researcher’s epistemological position. 
The approach of this thesis is located within a relativist ontology and a subjectivist, 
constructionist epistemology. Drawing upon the assumptions of symbolic interactionism 
I employ ethnographic methodology as a mode of inquiry congruent with this paradigm 
as outlined earlier in this chapter. 
4.5.2 Consistency 
Guba and Lincoln (1981) uphold ‘auditability’ as the measure of consistency in 
qualitative studies and propose that the reader should be able to follow a ‘decision’ or 
‘audit’ trail in order to replicate either the study, or the analysis. It has been suggested 
that the maintenance of a reflexive journal or research diary, other than that in which 
fieldnotes are recorded, enhances the collection of rich data, so that the work will be 
credible and recognisable to others (Koch and Harrington, 1998).  Although I did not 
maintain a separate reflexive journal, I employed a research diary and kept reflexive 
notes within but distinguishable from, my field notes. I referred to both these data 
sources during analysis, and in my writing, in order to demonstrate consistency by 
explicating my rational for decision making at all stages of the research process. 
Nevertheless I acknowledge that the subsequent analysis is my own interpretation and 
therefore, whist this decision trail may enable the reader to apprehend my position, it is 
unlikely to guarantee that they would come to the same conclusions should they attempt 
to follow that trail to replicate either the study or the analysis. For the reasons noted in 
Chapter 4.4 above, whilst they would undoubtedly observe similar activities and events, 
they may select a different focus or alternative interpretations. 
Like Hagemaster (1992) and others I contend that the researcher must identify 
personal preconceptions, responses, theories and training at the beginning of a study, 
and I have done so above. However, my aim in doing so was not, as Hagemaster 
suggests, to segregate them from later interpretation of the data, but rather to 
acknowledge that they are instrumental in that interpretation (Hagemaster, 1992; Koch 
and Harrington, 1998; Draucker, 1999).   
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4.5.3 Credibility 
Often replaced by the term ‘truth value’, credibility can be considered in relation 
to three elements of the research: the researcher; the researched and the data provided; 
and the research findings.  
 Credibility of the researcher 
In ethnographic practice the researcher is the main instrument of data collection 
and inevitably has some effect upon the researched, the research data, interpretation and 
output. The personal biography of the researcher means that she speaks from a 
particular class, gender, racial, cultural and professional perspective. This gendered, 
multiculturally situated researcher approaches the world with a set of ideas, a 
framework that specifies a set of questions that can be examined in different ways. 
From the outset I was aware that in my own case, my identity as a former nurse and 
more specifically, my experiences as a research nurse and clinical trials manager in 
neurosciences, were likely to have considerable impact on the conduct of the study and 
my interpretation of study findings. I had considerable experience of nursing 
neurologically compromised (i.e. incapacitated) patients, and of facilitating their 
enrolment in RCTs of pharmaceutical agents, and surgical and monitoring techniques. I 
had managed and co-ordinated such studies and was also an active member of an NHS 
research ethics committee. Furthermore, during the course of my research I became a 
clinical trial participant, although this was later in the research process, and may 
therefore have influenced analysis and interpretation, rather than data collection and 
interaction.  
My participation in clinical research illustrates my own prioritisation of research, 
and reflects my views that as beneficiaries of previous patients’ or volunteers’ 
contributions, we are morally obliged, or at least have a civic duty to contribute to 
research in some way. Whilst I acknowledge that this need not necessarily involve 
direct participation as a patient, I consider it a professional obligation to maintain an up 
to date knowledge of one’s area of practice and to contribute to its evidence base by 
facilitating high quality research. My study was therefore directed not only by an 
interest in what was happening, but by a desire to improve and develop research 
capacity and activity. These factors also contributed to the way in which I chose to 
analyse, interpret and subsequently present the data, which I describe more fully below. 
It may be argued that these experiences, views and aims constitute potential sources of 
bias that may detract from my credibility as a researcher. However, I suggest that they 
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added depth of knowledge and understanding, not previously accessible to me, about 
the ways in which clinical research is managed in different clinical areas. In particular, 
my participation in research conducted on an outpatient basis contrasted with, and thus 
further highlighted, issues specific to medical emergencies and the conduct of clinical 
trials in an acute environment. By owning these experiences and acknowledging their 
impact, I believe that they contribute to, rather than detract from, my credibility. 
 Credibility of the data and subjects 
Ethnographic inquiry allows for the collection of both (relatively) objective (for 
example, staffing levels, geographical layout), and subjective data (such as behaviours, 
interactions and processes) by means of observation, in order to establish the practices 
and inter-relations of the group studied, and interviewing to establish why group 
members engage in such behaviours. Other methods such as documentary or policy 
analysis may also be included, although I have not done so here. Whilst these methods 
do not constitute a hierarchy of data credibility, each may enhance the other and provide 
an ‘in-built triangulation’ of methods, data and sources. It should be noted however that 
whilst each aspect confers advantages and disadvantages it cannot be assumed that 
triangulation will ensure that the deficiencies of one method will be addressed by the 
precision of another.  
Interviewing is flexible and adaptable to many diverse situations. Particularly 
where audiorecording is used, the researcher has the opportunity to observe 
surroundings and non-verbal behaviour, to correct any misunderstanding and to record 
spontaneous comments and responses not made explicit in the interview guide. It has 
been postulated that in addressing research questions involving highly complex, 
subjective and emotional issues, relying on reflection upon experiential and humanistic 
perceptions rather than what is perceived to be more clearly defined, factual knowledge 
and theories, the semi- or unstructured interview can dig deeper, allowing a richer 
understanding of peoples’ experiences, opinions, attitudes and feelings (May, 1997) and 
providing rich and detailed descriptions of previously unexplored phenomena (Morse, 
1991). Unstructured interviews allow the interviewee to respond within their own frame 
of reference. Although this may lead to what some consider as ‘rambling’, others argue 
that this is in fact advantageous as it reveals something about the interviewees concerns 
(Bryman, 2001).  
It may be argued that a significant disadvantage of the interview component is its 
inherent potential to introduce various sources of bias, at a number of levels. 
79 
 
 
Commensurate with my epistemological position however, bias is not a central issue 
here. Although the data may indeed be influenced by the respondents’ poor memory of 
events, embarrassment, misunderstanding or outright lying, these factors are no less 
important than what is actually reported. For example, why do some of the clinical staff 
report that the research nurses endeavour to provide teaching sessions when it is 
apparent from the observational data and from other interviews that this is not currently 
the case? 
The interviewer may unintentionally misrepresent or omit questions; she may 
misunderstand the response, or if not audiorecording the interview may record 
inaccurate data. Equally, she may intentionally subvert the interview by altering or 
omitting responses or by influencing answers by appearance, tone, attitude and reaction 
to previous responses. Gender, race, political beliefs and linguistic characteristics of 
either party may influence the interview (Briggs, 1986) and it must be acknowledged 
that each come to the interview with their own agenda. It has been suggested that the 
information given by the interviewee must be considered to be accurate (Burns and 
Grove, 1987). However, the concepts of accuracy and truthfulness are somewhat 
nebulous and thus, following Appleton (1995), and in keeping with my interactionist 
approach I acknowledge that the expression of subjective perceptions and values does 
not render an account any less pertinent; the reasons why a respondent chooses to 
present a particular account can be as illuminating as the account itself.  
The chosen method of recording the interview is also important. Note-taking is 
time consuming and may disturb the natural flow of the interview, and if the interviewer 
chooses to paraphrase, this will automatically introduce bias by her choice of what to 
record and equally importantly, what to leave out. Audiorecording tends to be the 
preferred option providing that the interviewee is in agreement with this. Nevertheless, I 
made brief notes after each of the interviews recording data such as participant’s affect 
and body language and my own feelings and impressions (Bogdan and Taylor, 1975).  
 Credibility of study findings 
With regard to the study findings it is important that steps to ensure credibility are 
built into the process of data analysis. Convention upholds verbatim transcription of 
recorded data as a means of enhancing credibility if the interpretation is plausible. 
Ashworth suggests that this rests in the data being judged by the participants as 
revealing accurately their portrayal of the life-world of the phenomenon and many 
recommend the process of ‘member checking’ or ‘respondent validation’ as one of the 
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most robust means of assuring truth and consistency in qualitative research (Ashworth 
1993; Burnard 1991; Holloway & Wheeler 1996; Lincoln & Guba 1985; Baker 1992).  
There are some difficulties in seeking the views of respondents on the honesty and 
consistency of findings. Where research is undertaken in an environment of continuing 
change, as was the case in this study, verification of accounts may be difficult if in the 
interim participants have moved on or have had other new experiences which may have 
altered perceptions and attitudes. Additionally, this method implicitly privileges one 
person’s viewpoint over another, which is incompatible with my acknowledgement of 
‘multiple realities’. The respondent can only provide verification from their own view 
point and not from an ‘overall view’ available to the researcher. Finally, member 
checking gives rise to the generation of further data which then necessitates further 
analysis, particularly where feedback is contradictory to the researcher’s perspective 
and thus raises the question, where does one stop? (Bloor, 1997) . In this regard member 
checking may undermine rather than support the trustworthiness of a project 
(Sandelowski, 1993). For these reasons I did not follow this procedure. 
Involvement of an independent researcher to generate categories from the 
transcripts without prior knowledge of those already identified has also been advocated 
to promote credibility of the identified themes if congruence is demonstrated (Burnard, 
1991). This in itself is not foolproof however. Agreement may demonstrate that the 
original category analysis was reasonably complete and accurate, but may equally 
indicate that it was too broad and general in nature and thus easily corroborated, or that 
the colleague anticipated the researcher’s categorisation and offered the researcher 
‘what she wanted to hear’. 
Whilst I did not seek wholly independent review of my data, presentation of the 
data and resultant analysis to my supervisors ensured rigorous examination of the 
categories identified. I also presented aspects of my work at academic conferences 
throughout the process thus opening the analysis to scrutiny by my peers.  
Triangulation has been proposed as an alternative to, rather than a method of 
validation. Whether relating to data sources, data collection, theory or analysis, 
triangulation, it is suggested, affords a strategy that adds rigour, breadth, complexity, 
richness and depth. Ethnographic inquiry, drawing upon a suite of research methods, 
may be considered to demonstrate ‘built in’ triangulation. It has been suggested 
however that the term ‘crystallisation’, rather than triangulation, is perhaps more 
appropriate (Richardson, 2005a). Richardson states, ‘Crystals are prisms that reflect 
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externalities and refract within themselves, creating different colours, patterns and 
arrays casting off in different directions’ (p.963). In crystallisation the writer tells the 
same tale from different points of view. There is no ‘correct’ telling - each ‘story’ 
simply reflects a different point of view, which is what I endeavour to achieve in the 
empirical chapters that follow. 
4.5.4 Transferability 
Whilst quantitative work usually seeks a degree of generalisability of its findings 
(Hammersley, 1992; Slevin and Sines, 1999),  transferability, applicability or fittingness 
are more often the terms of choice in relation to qualitative approaches (Guba and 
Lincoln, 1981; Rose et al., 1995). Although generalisation was not the aim of this 
research it is not unreasonable to expect that findings should be at least transferable to 
similar situations outwith that researched and familiar to similar professional groups or 
individuals.  
Purposive sampling allowed identification of sites where relevant activity was 
ongoing and personnel who had the relevant experience and information, potentially 
enhancing the transferability of the study findings to other similarly structured stroke 
units. It could be argued that a multisite investigation may have further enhanced 
transferability but this was not logistically possible within this single researcher study 
and given the unpredictable nature of the phenomenon under investigation.  
Nevertheless, whilst not addressed formally within the remit of this study, in informal 
discussions with clinical and research colleagues in similarly structured units, many of 
the issues raised here were recognisable. 
4.5.5 Relevance 
Social research is often concerned with particular situations and groups and 
cannot therefore always be considered relevant to society as a whole. It should, 
however, be of importance to researchers, should contribute to what is taken by 
researchers to be established knowledge, and should be useful to practitioners in terms 
of their daily experiences (Hammersley, 1992). This study was conducted in a research 
orientated environment in a teaching hospital where there is a firm emphasis on 
evidence based medicine. It is therefore anticipated that the study will be relevant to 
personnel employed in similar facilities.  
More broadly, it is relevant to the conduct of emergency research and to the 
organisation of stroke care and stroke research.  The government White Paper 
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‘Choosing Health’ promotes people’s right to make their own decisions about health 
related choices (Department of Health, 2004a). It has been proposed that this choice 
should extend to decisions regarding research involvement. However, as described in 
Chapter 2, stroke patients (amongst others) are not always able to exercise their right to 
choose and may therefore face restrictions regarding participation in hyperacute RCTs 
which may jeopardise the quantity and quality of research conducted in this area.  
Following the report of the Research for Patient Benefit Working Party (Dept 
Health and DTI, 2004), the UK Clinical Research Collaboration (UKCRC) sought to 
develop research capacity and excellence by promoting specialist research into the 
treatment of four major diseases, one of these being stroke. This topic of research is 
therefore relevant in relation to this initiative, aiming to enhance research capacity 
within the NHS in general, stroke in particular and also a focus on developing careers 
for nurses in research. Despite practical and ethical difficulties, RCTs are crucial to 
understanding and developing effective treatments for acute stroke. This study sought to 
address some of the complex issues encountered in hyperacute stroke research in order 
to promote research capacity in this area. Whilst the findings of the research are perhaps 
not widely transferrable, it is anticipated that the study will be relevant to personnel 
employed in similar facilities.  
4.6 Ethical Issues 
As this study involved NHS staff, patients, and their families, and was conducted 
on NHS premises, scrutiny by an NHS Research Ethics Committee was required. 
Within the application for ethics committee review the following issues were identified 
and addressed. 
As noted in Chapter 2, one of the concerns about conducting research in the acute 
and hyperacute situation is the potential additional distress to patients and their family 
members. In seeking consent for the observation and audiorecording of the RCT 
consent interaction there was the potential to cause further stress and place further 
pressure on the patient and/or family member. The very nature of the research question 
itself meant that it was unavoidable that the patient or family member would be required 
to make an almost immediate decision whether or not to allow me to observe and record 
the RCT consent interaction. Clearly this meant that I would potentially cause or add to 
one of the problems that I was endeavouring to avoid and/or investigate. For this reason, 
having sought the advice of an academic ethicist, consent for this aspect of the study 
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was a staged process, whereby only verbal consent was sought in the first instance. My 
rationale for this approach was that if I had attempted to obtain written consent at the 
outset it would have had to be secured prior to seeking consent for RCT participation. I 
considered that this would cause an unnecessary and unacceptable delay in the patient 
being enrolled to the RCT which often have very short recruitment windows. I did not 
wish to jeopardise either the individual patient’s enrolment or overall recruitment to a 
treatment study by introducing further obstacles at this point.  
As outlined in Chapter 4.2.4 above, having secured verbal consent I provided the 
patient and/or family with written information and returned to discuss this and to obtain 
written consent as soon as possible thereafter dependent upon the patient’s condition. 
Although the situation arose only twice (the second was not recorded) even this method 
proved problematic because the section of the interaction pertaining to consent was not 
always easily identifiable and it was unclear at which point to request permission to 
record or indeed to begin recording.  Nevertheless, this compromise allowed me to 
obtain prospective, observational data rather than relying solely on retrospective 
subjective accounts or presenting hypothetical scenarios to a non-patient population. 
A second area of concern was that of placing an undue burden upon the patient. 
Multiple research participation is generally avoided, especially in interventional studies 
but by definition, this research included people who were being approached to take part, 
or to allow their family member to take part in a randomised controlled trial. 
Furthermore some patients and family members who agreed to participate in the 
observational aspect of the study were also later invited to take part in the parallel, 
linked interview study. This meant that some patients would be participating in two, or 
perhaps three, research studies. Some may consider that these additional invitations to 
participate in further studies, albeit observational and/or low risk, constitute an 
unjustified burden and may exacerbate some of the perceived problems that I was 
seeking to avoid and/or investigate. There was however no other way to investigate this 
phenomenon. Although this may be seen as problematic, I considered that if handled 
sensitively multiple participation would strengthen study findings by providing the 
opportunity for triangulation of observational, recorded and interview data (Patton, 
1980; Denzin and Lincoln, 2005b).   
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4.7 Conclusion 
Having outlined in this chapter my theoretical position, methodological 
framework and the methods by which the study was undertaken I now move on to 
present the empirical findings of the study. 
As noted in Chapter 2, much of the bioethical and medical literature suggests that 
the main obstacles to the conduct of clinical research in the emergency situation are 
related to obtaining informed consent, and include concerns regarding the existence of a 
therapeutic misconception which may result, at least in part from the integration of 
research and clinical activities and personnel. In Chapter 5, and in light of these 
considerations, I describe the degree to which research and clinical practice are 
integrated (or not) at the study site, and how this is determined by pragmatic and 
operational, rather than ethical, factors. In Chapters 6 and 7, I illustrate the way in 
which the resultant distinction between research and clinical practice, and between those 
delivering each, is perceived and enacted by the clinical and research nurses 
respectively. Finally, I draw these strands together in Chapter 8, to demonstrate the 
effects of this distinction upon the day to day transaction of clinical research, and its 
recruitment processes, in an acute stroke unit.  
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Chapter 5. Separating Research and Care: The Temporospatial 
Dislocation of Research and Care  
5.1 Introduction 
As noted in Chapter 2, it has been hypothesised that clinical research and routine 
practice should be segregated in order to avoid the ethically troubling notion of the 
therapeutic misconception, and also to minimise the potential for intrapersonal conflict 
for the clinician-researcher, with regard to the potentially conflicting aims of research 
and clinical practice. Indeed when I went to undertake my observations in the Acute 
Stroke Unit, I found that research and clinical activity are separated in a number of 
ways, the most immediately obvious being that different staff are employed for the 
specific purpose of undertaking research. This chapter will focus on the temporospatial 
split between research and clinical teams, and their associated activities, within the 
acute stroke unit; looking at the spaces in which the activities of these separate groups 
are conducted and the temporal organisation of their work. I demonstrate how the 
geographical mobility of the research team, juxtaposed with temporal restrictions upon 
its activities resulted in its occupation of liminal spaces, both physically and 
metaphorically, and how this in turn gave rise to a stratification of legitimacy (c.f. 
Goodwin et al., 2005), which determined to whom and what the research nurses had 
access to and what they were permitted to do in these spaces. I also illustrate how and 
where clinical and research teams came together and the functional significance of such 
collaborations. 
5.2 Identifying The Focus Of My Research: Ongoing Acute And Hyperacute 
Research In The Acute Stroke Unit  
The way in which stroke patients were managed within the study site, including 
potential study participation, was in part determined by practical issues, including 
departmental custom and practice, and Trust policies. These in turn impacted upon 
operational and resource issues, including the overall organisational structure (physical 
and operational) and resource allocation. These factors influenced the way in which 
research was conducted and how non-research staff embraced and embodied the 
research culture (or not). Current practice at the study site was that research 
responsibilities were discharged by research specific staff; it was therefore necessary 
that these staff were appropriately trained and were afforded suitable accommodation.   
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At the study site, research was undertaken alongside but separate from clinical 
practice; alongside in that there was overlap and sharing of some of the physical spaces 
in which each was conducted, but separate in that different staff fulfilled clinical and 
research roles. As noted in the literature review (Chapter 2.5) strong ethical arguments 
exist for and against the physical and/or symbolic integration of research and clinical 
activity. Whilst no such arguments were explicitly noted during the conduct of my 
study, related issues such as the potential for research requirements to divert attention 
and resources away from clinical needs and activity, were often proffered as reasons 
why clinical staff did not, could not, or should not, take a more active and consistent 
role in research activity. Some facilities were shared (for example, patient 
accommodation, hotel services, and radiology and laboratory services)  and there was 
some overlap of roles and responsibilities varying from research only, to clinical only, 
with a considerable area of blurring and ‘hybridity’ in between (Bhabha, 1994). For 
example, some of the stroke research nurses I observed were involved solely in research 
activity, whereas others participated in a very specific aspect of clinical care - 
assessment for and administration of thrombolysis - but did not participate in more 
general clinical activities. Also, in conjunction with the administrative aspect of his 
research role, Senior Research Nurse Higgs furnished senior clinicians and managers 
with information pertinent to clinical service provision. I did not observe the stroke 
research fellow undertaking clinical duties on the ward, although he did on occasion 
assist with the Joint Stroke Clinics. Apart from the stroke nurse practitioner (SNP), a 
very specific case which will be discussed further later (Chapter 5.5), there was very 
little involvement of the clinical staff in any research related activity – a finding 
supported by both observational and interview data. Other departments and staff were 
involved in research activity by necessity (e.g. radiology and laboratory staff), 
performing investigations and/or assays for clinical, research or combined purposes and 
with varying levels of cooperation.  
It has been suggested that in order to attain and uphold research based practice 
‘research must become embedded within the culture of […] practitioners’ (Mulhall, 
1997; p.973). On entering the clinical area to begin my fieldwork, my first most striking 
observation was the distinct lack of embeddedness, highlighted by the fact that the 
stroke research nurses were temporospatially dislocated from their clinical counterparts 
and their potential participant population. Although there were some points of 
connection, research and clinical teams were for the most part ‘misaligned’ both in 
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terms of their temporal and spatial availability and by varying degrees of mobility and 
flexibility. Whilst the geographical disjuncture was the most immediately obvious 
manifestation of the distinction between research and care it soon became apparent that 
the organisation of work, particularly in relation to working hours, also served to 
segregate clinical and research staff and consequently their activity. Table 4, below, 
summarises the clinical research ongoing at the study site at the time of my fieldwork. 
STUDY 
ACRONYM 
FULL TITLE RECRUITMENT 
WINDOW 
INTERVENTION NO. RECRUITED 
(during 
fieldwork) 
ECASS III European Cooperative 
Acute Stroke Study.  
3-4.5 hours post 
ictus 
Hyperacute stroke 
management:  
Placebo controlled 
trial of alteplase 
(rtPA) in acute 
ischemic 
hemispheric stroke 
0 
CHHIPS Controlling Hypertension 
and Hypotension 
Immediately Post Stroke 
36 hours post 
ictus 
Acute management 
: blood pressure 
control  
5 
COSSACs Continue Or Stop post-
Stroke Antihypertensives 
Collaborative Study 
8 hours post 
ictus 
Acute management: 
blood pressure 
control 
4 
PROFESS Prevention Regimen For 
Effectively avoiding 
Second Strokes  
 
120 days post 
ictus 
Secondary 
prevention – anti 
thrombotic therapy  
0 
CRESCENDO Comprehensive 
Rimonabant Evaluation 
Study of Cardiovascular 
ENDpoints and Outcomes 
Up to 3 years 
post ictus 
Secondary 
prevention: appetite 
suppressant  
0 
PERFORM Prevention of 
cerebrovascular and 
cardiovascular Events of 
ischaemic origin with 
teRutroban in patients 
with a history oF 
ischaemic strOke or 
tRansient ischaeMic 
attack 
>48 hours, < 3 
months post 
ictus 
Secondary 
prevention – anti-
thrombotic therapy 
21 
Table 4: Ongoing clinical research at Nearstreet Hospital: June 2006 – July 2007  
In sequential order rather than order of importance, the primary task of the 
research nurses was to assess new patients’ eligibility for a) clinical thrombolysis, b) 
hyperacute/acute clinical research and c) other clinical research, such as secondary 
prevention studies. This was the most obvious example of clinical and research roles 
overlapping (the research nurses and the SNP assessed the patients for eligibility for 
clinical thrombolysis and/or research participation) but nevertheless, assessment for 
thrombolysis took priority because it was the only treatment currently known to be 
effective and the time window was very short. At the time of my fieldwork the licensing 
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criteria for administration of rtPA was such that it should be administered within three 
hours of the ictus, and subject to confirmation by CT scan that the stroke was not 
haemorrhagic in origin. It has been reported however, that even within that time 
window there is evidence that earlier administration yields better results (Marler et al., 
2000). Patients who presented outside this time window but within 4.5 hours of onset of 
symptoms could be considered for inclusion in the ECASS III study (Hacke et al., 
2008)
1
. Two further studies focussing upon blood pressure management were ongoing, 
as were three secondary prevention studies which had much wider recruitment time 
windows. For the purpose of thrombolysis and/or hyperacute study eligibility 
assessment the research nurses needed prompt access to their potential participant 
group. However, it was immediately apparent on entering the field that they were not 
based where new patients were first received, - the Emergency Assessment Suite (EAS) 
- or where they were subsequently managed, - the Acute Stroke Unit (ASU). In order to 
understand the research nurses’ working environment it is necessary to outline here the 
areas encompassed within the patients’ care trajectory. 
5.3 Landscape Of The Research Team  
As noted in Chapter 3, despite housing the ASU, Nearstreet hospital had no 
A&E facility. There was however an Emergency Assessment Suite (EAS), where 
suspected stroke patients were received prior to transfer to the ASU. The EAS was 
located on Level Two and was accessed directly from the main service road to the 
hospital. The radiology department, to which patients were transferred for CT scanning, 
was only a short distance along the corridor from EAS and a patient could be 
transported between the two in approximately three minutes. The ASU was a 30 bedded 
ward (Ward 2) located four floors above EAS. It comprised four six bedded bays and 
six single occupancy cubicles. Typically, two bays accommodated male patients whilst 
the remaining two were occupied by female patients although this arrangement was 
flexible according to need. Each of the six bedded bays had its own toilet and shower 
facilities. There was also a separate bathroom and further sluice facilities. Hotel 
facilities included a patient day room (rarely occupied by patients but sometimes 
utilised for multidisciplinary team meetings), a physiotherapy room, and a small kitchen 
housing cupboards, a water boiler, fridge and microwave. Administrative space on the 
ward included the nurses’ station – a centrally located open area with workspace and 
                                               
1 Time window increased to 4.5 hours in accordance with the findings of the ECASS III Study. 
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computer terminal - where most of the clinical staff congregated when not engaged in 
hands-on, physical, patient related activity. There were also several offices occupied by 
the Sister/Ward Manager, junior doctors, Clinical Director and three other Consultant 
Stroke Physicians (separate offices). There was a small preparation room for preparing 
intravenous drugs and decanting blood and other samples for investigations. Several 
storage areas were available for clinical supplies and equipment and laundry, with one 
of these areas doubling as a staff cloak-room. 
The research nurse role comprised a considerable administrative component and 
therefore required an administrative base; the Stroke Research Office (SRO). Due to 
physical limitations of space, this office was not in the clinical area to which stroke 
patients were received and/or cared for but was located directly across the landing from 
ASU on Ward 1. Ward 1 had no clinical connection with the Acute Stroke Unit; it was 
simply the closest place in which office space was available to house the research 
nurses. The patient group residing on Ward 1 was considered ‘at risk’ and access to the 
ward was therefore strictly controlled by the Trust ID swipecard system. The research 
nurses had no connection with the clinical staff on Ward 1 either clinically or 
managerially (but were granted swipecard access).  
Not only were the research nurses located in a different area but they moved 
throughout different areas. Several authors have described how organisation of work 
creates boundaries for the groups or individuals undertaking that work and that the 
physical workplace is instrumental in the formation of identity (Gergen, 1991; Miller 
and Rose, 1995) . Others note that nurses are generally confined to a single ward or 
clinical area whereas medical teams may be involved in patient care across several 
wards, clinics and operating theatres (Allen, 1997; Reeves and Lewin, 2004; Goodwin 
et al., 2005). The effect of the research nurses’ mobility therefore, was to set them apart 
from the clinical nursing team who were based in a specific area and to whom the 
patient was ‘delivered’. Simultaneously, however, they were aligned to some extent 
with members of a different discipline – doctors - who as noted above are similarly 
mobile. Such mobility is not typical of the nurses’ role, although it is perhaps becoming 
more prevalent with the advent of Clinical Nurse Specialists and Nurse Practitioners, 
who are ascribed a particular diagnostic group rather than bounded within a physical 
clinical area. Thus, the research nurses traversed not only territorial boundaries, but also 
those of professional (and social) groups and identities, and as such, they can be seen as 
occupying a liminal space. Liminality has been defined as a state of being ‘betwixt and 
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between the positions assigned and arrayed by law, custom, convention, and 
ceremonial’ (Turner, 1969; p.95). Moving and working within and across different 
boundaries the research nurses were neither in between nor all-encompassing, but 
occupied a liminal identity and liminal spaces at the penumbra of the clinical sphere.  
In order to identify new, and follow up existing patients, the stroke research 
team made numerous trips between the SRO, ASU and EAS each day – a time and 
energy consuming activity. The ward staff as well as the research nurses were aware of 
this almost constant transit and commented that it would be more convenient for the 
research nurses if they were based within the ASU. The effect of their mobility reached 
far beyond temporal inconvenience however – it also rendered their role ‘other’ than the 
traditional role of the nurse, as noted above. Those who suggested that the research team 
would be more conveniently located within the stroke unit did so not only because it 
would save time and energy for the research nurses but also because it would make the 
team visible and raise its profile on the ward, thus enabling the clinical staff to see and 
learn something about the research nurse role. I explore this theme more fully in the 
following chapter.  
The process of patient assessment was not static but ongoing, and took place 
across and within a number of clinical areas. The primary role of the stroke research 
nurses was to identify, assess and facilitate enrolment of patients to RCTs of stroke 
treatments or preventive therapies and to manage their study related procedures 
thereafter. It was striking that despite the need to identify patients as a matter of urgency 
in order to facilitate prompt treatment and/or study enrolment the stroke research nurses 
were not based in either the Acute Stroke Unit or the Emergency Assessment Suite. 
Instead they worked within and across several discrete areas which I categorise as first 
and second order spaces. Within these spaces a ‘stratification of legitimacy’ (cf. 
Goodwin et al., 2005; p.863) existed which determined to whom and what the research 
nurses had access and what they were permitted to do in therein. I describe these 
permissions and their impact below. 
5.3.1 First order spaces 
I have defined ‘first order spaces’ as those spaces where stroke patients were 
legitimately admitted and managed, for example the ASU, EAS and the radiology 
department. In these spaces, legitimacy of access for the patient was determined by 
suspected or actual diagnosis of stroke, whilst for the research nurse it was determined 
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by the presence of, and interaction with, the stroke patient. The patient’s presence 
within these spaces legitimated the presence of the research nurse, who visited or 
accompanied them as a ‘guest’.  
Reinforcing the concept of guest status, the research nurses seldom visited EAS 
or the ASU without first arming themselves with various documents which represented 
a symbolic ‘key’ allowing access to patients and their records. The ward clerk or a 
member of nursing staff was usually at or near the nurses’ station and was aware of the 
research nurse’s arrival but if this was not the case the research nurses did not explicitly 
announce their presence. In this respect they were perceived as ‘insiders’ by clinical 
staff, patients and their families, with a legitimate role and purpose necessitating access. 
Conversely, although they were not obstructed in this data trawling, information was 
rarely volunteered to them; they were positioned outwith the clinical management of the 
patient, both geographically and metaphorically and thus crossed the boundary into an 
‘outsider’ role. In this context they were procedurally invisible because this particular 
aspect of their activity fitted within the area in which it was undertaken and in a sense 
this invisibility can be taken to indicate acceptance. Within these various spaces the 
research nurses were facilitated or restricted in the discharge of their duties in a number 
of different ways. The privileges conveyed by their ‘guest’ status were not exhaustive 
however, even within first order spaces, because they were first order spaces for the 
patient; the research team had no specific place that was wholly and singularly their 
own, as I illustrate below. 
The research nurses often visited the ASU for reasons other than patient contact, 
and in these instances were afforded less freedom of access. For example, one of the 
study drugs was stored in a cupboard in the ASU and the pharmaceutical company 
required daily temperature recordings to be taken from the cupboard to ensure that the 
drug was stored at the correct temperature. The cupboard was locked and the research 
nurse had to locate the member of staff holding the keys in order to obtain access. The 
cupboard did not contain controlled drugs and there was no reason, in terms of safety or 
security, that the research nurses may not have their own key to this cupboard. Both the 
act of seeking permission and the means of access to the cupboard symbolised 
legitimacy of purpose, a territorial hierarchy and the ‘guest’ status of the research nurse 
in the ASU. Although I have categorised the ward as a first order space because of the 
legitimate presence of stroke patients, even within this spatial hierarchy there were 
degrees of legitimacy and corresponding rights and privileges. In the example given 
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here, although within a first order space, the research nurses’ legitimacy was diminished 
because they were not engaged in direct patient activity. The situation was something of 
a paradox. On the one hand the drug was stored in a cupboard on the ward and was 
therefore under the control of the ward staff. On the other, the ward staff took no 
responsibility for the drug, or its appropriate storage. Recording the room temperature 
required no specialist skill; there was no reason why the clinical staff could not maintain 
a daily temperature chart which the research nurse could then retrieve on a daily or 
weekly basis. This would facilitate research involvement of the clinical staff and would 
reduce the time taken by the research team to conduct this very basic activity. Although 
time would be saved by the research team, as they would not have to make another visit 
to the ward, maintaining the log would not unduly impact upon the workload of the 
ward team because the cupboard was located within their area of practice. Furthermore, 
as the activity was quite straightforward there was no reason why delegation of this 
basic task should impact upon study integrity. However, the clinical staff did not 
perceive any research related activity to be a part of their role. In fact, a kind of 
stalemate existed, whereby the research team did not ask for assistance and the clinical 
team did not volunteer it. 
The ‘otherness’ of research was demonstrated much more clearly in an incident 
involving the storage and administration of study medication. A patient had been 
enrolled in one of the acute blood pressure management studies the previous evening 
and was due to receive her second dose of study medication the following morning. I 
observed the following interaction: 
Nurse Lynch comes to check I.V. antibiotic with Nurse Smith. Nurse Smith asks 
did she give “that stuff” [study medication] – Nurse Lynch replies that she has 
not because she couldn’t find it and that Research Nurse Higgs is looking for it 
now. Nurse Lynch wanders off and Nurse Higgs comes to the nurses’ station, 
looking on and under the benches etc. I ask what he’s lost and he replies “A 
greet [sic] big box of study drug!” […] Nurse Smith is on the phone and no one 
is really taking much notice of Nurse Higgs rummaging about. He wanders off; I 
think he’s still looking. A few minutes later Nurse Smith hands over her patients 
on the board round. When she gets to [study participant] she mentions that the 
patient is on [the study] and that “Nurse Higgs is sorting her drug out”. No 
further information is given or requested regarding the study. [FIELDNOTE: 
November 2006].  
It is notable that the nurse refers to the study medication as “that stuff”, 
engendering a sense of ‘otherness’, denying ownership and associated responsibility. In 
this particular study the medication was not actually a novel compound but was a 
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licensed drug familiar to the clinical staff; it was the regimen rather than the drug itself 
that was experimental. The sense of mystery regarding “that stuff” illustrates a 
commonly claimed misconception that research must involve new or novel compounds 
or treatments and is therefore associated with a commensurate level of risk.  
Notwithstanding this lack of understanding, the fact that the study medication was 
temporarily missing was not an issue of mismanagement, rather a perception that 
responsibility for the safekeeping or administration of study medication lay solely with 
the research staff. The delay in administration of the study medication was of no 
apparent significance to Nurse Smith and was therefore, not communicated to the rest of 
the team. However, this lack of engagement was not unilateral; Nurse Higgs did not 
take the opportunity to join the round and advise the team of the patient’s study 
involvement or educate them regarding the importance of adhering to the study 
protocol. Clinical and research activity on the ASU were performed in parallel rather 
than in communion. 
5.3.2 Second order spaces  
I have defined ‘second order spaces’ as those unconnected with the day-to-day 
clinical management of stroke, such as the Stroke Research Office and a treatment 
room, both located on Ward 1. In these spaces, unlike first order spaces, neither the 
patient nor the research nurses had a clinical reason for being there and thus both patient 
and practitioner were ‘guests’. This ‘guest’ status impacted upon the research nurses’ 
identity and perception of their role and is examined more fully in Chapter 7. 
Although the research nurse role involved almost continuous transit, it also 
comprised a considerable administrative component and thus required an administrative 
base. Housing two or three research nurses and sometimes shared by the research fellow 
and the stroke nurse practitioner, the Stroke Research Office was located, as previously 
noted, on Ward 1, directly across the landing from the ASU. It was not a ‘purpose built’ 
office and had previously been utilised as a treatment or preparation room. As such it 
was small, approximately 9 x 11ft
2
, and poorly equipped. There were no desks. 
Workspace consisted of benches with shelves above that were not easily accessible. 
There was one cabinet of desk drawers, several filing cabinets, a fridge, a freezer and 
some monitoring equipment. This equipment was squashed into a corner and could not 
be used without reshuffling most of the other items in the room. There was a fax 
machine and two telephones, one of which was connected to an answerphone. Initially 
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there was one computer in the room, which was primarily the senior research nurse’s 
domain. Later, the stroke nurse practitioner had her computer moved to this room but 
for the duration of my fieldwork it was never connected to the network and therefore 
served as a notice board displaying numerous post-it notes. This conveyed a lack of 
recognition of the importance of her role and an impression of transience which she 
shared with the research nurses. 
The size and contents of the stroke research office rendered it unsuitable for 
patient consultations; hence an alternative space was required. For this purpose, the 
Senior Sister on Ward 1 allowed the research team access to another ‘second order 
space’ – a treatment room, which was not currently being used for that purpose. The day 
to day function of this room was to provide storage space but it was utilised on an ad 
hoc basis should the research nurses need to see a patient post-discharge, for example, 
for study screening or consent. The research nurses were permitted to use the room 
because the ward staff rarely did so, but they had little or no control over this 
environment. There was a desk and chair where the patient and doctor or nurse could sit 
for the ‘consultation’ but the rest of the room was untidily packed with equipment 
including bath hoists, drip stands, weighing scales (on which I sat to observe a consent 
interaction, there being nowhere else easily accessible) and electronic blood pressure 
machines – the trappings of clinical work. During my observation of a consent and 
screening visit in this room there were several interruptions by ward staff. Although 
they always knocked they did not wait for a response before entering, thereby negating 
the opportunity to delay the intrusion or ‘put the setting in order’ (Goffman, 1959; 
p.223). The knock simply signified an intention, rather than a request for permission, to 
enter and at one point prompted a comment from the patient (after the person had left 
the room) “It’s a good job we weren’t in the nuddy [naked]” (FIELDNOTE: August 
2006). Had this room been required for some other clinical function, for example, a 
patient returning to the ward for a standard clinical procedure such as changing of a 
dressing or suture removal, it seems highly unlikely that it would have continued to be 
utilised, simultaneously, as a store room.  
The fact that the room was not cleared out to allow an uncluttered, clean and tidy 
space in which the research team could see patients privately and without interruption 
seems indicative of the value placed upon research and researchers. Nursing is often 
perceived by others to be synonymous with physical care (Bassett, 2002) and those who 
are not seen to fulfil this aspect of the role are often viewed with suspicion or are not 
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considered to be ‘real’ nurses. The example above illustrates that whilst the research 
nurses are perceived not to be ‘real’ nurses, patients participating in research are in 
some ways, and at some moments, perceived not to be ‘real’ patients and as such do not 
always warrant the same level of care and respect from clinical staff. In this space both 
the research team and the patient were ‘guests’ or perhaps ‘squatters’, left to their own 
devices and receiving no hospitality from the ward staff. In contrast to the procedural 
invisibility experienced within first order spaces in these second order spaces, 
particularly the treatment room on Ward 1, the research team was physically 
accommodated but not embraced.  
Some time after the completion of my fieldwork the senior research nurse, told 
me that the research team was no longer able to use the treatment room on Ward 1. 
Without any consultation with, or prior warning to the research nurses, the desk and 
chairs had been removed in order to provide more storage space, demonstrating the 
apparently low prioritisation of research and those undertaking and participating in it. 
The research nurses found alternative accommodation in a clinic which had no direct 
link to the patients or their diagnostic group so once again both patients and 
practitioners were ‘squatters’. Although the research nurses worked within and between 
a number of areas they were in effect ‘homeless’, occupying a liminal space both 
literally and metaphorically. They moved between clinic, ward and emergency areas but 
‘belonged’ to none of them and had few rights, a situation which impacted upon their 
identity and the enactment and perception of their research role. Their mobility 
therefore, although essential, was instrumental in reinforcing their liminal status as were 
the tasks which they performed.  
The research nurses were dislocated from their clinical counterparts temporally 
as well as spatially. In the following sections I describe the effects of their temporal 
separation and also how the combination of these two factors impacted upon their 
working practices and ultimately upon the recruitment of patients, an issue which is 
more fully explored in Chapter 8. 
5.4 Temporal Dislocation  
At a very practical level, the ward staff’s day was fairly formally structured 
around patients’ meal times and clinical ward rounds. It was usually the case therefore, 
that ward staff tended to have their meal and/or coffee breaks at around the same time 
each day, whereas the research nurses tended to have a coffee whilst working in the 
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Stroke Research Office (if at all) and took their lunch break as and when a suitable 
break in their workload arose. This temporal disjuncture, along with their geographical 
separation meant that the clinical and research teams rarely spent ‘social’ time together 
and therefore, missed a potential opportunity to develop some insight into each other’s 
respective roles.   
I have already noted that the research nurses were in almost constant transit 
throughout a number of different spaces at Nearstreet Hospital, but their peripatetic 
existence began to have an even bigger impact upon their time when, towards the latter 
period of my fieldwork, there was a change in stroke admission policy. Under the new 
policy, all new stroke patients were received at King’s Hospital in the first instance, 
prior to subsequent transfer to the ASU at Nearstreet. This change meant that in order to 
promptly identify patients for acute stroke studies the research team had to visit the 
Medical Admissions Unit at King’s Hospital on a daily basis. Although less than three 
miles from Nearstreet, its city centre location meant that travel to and from King’s 
Hospital could be quite time consuming depending upon volume of traffic. On average 
the journey between sites took approximately 30 minutes (each way) and was somewhat 
disruptive to the research nurses’ daily schedule, as they were clearly unavailable during 
transit.  Paradoxically, the research team needed to be mobile in order to identify and 
assess potential study participants promptly, but their almost constant transit reduced 
the time available in which to do so. Their mobility, however, was not the only factor 
that impacted upon their temporal availability as I discuss below.  
Financial restrictions meant that unlike their shift-working, clinical colleagues 
the research nurses did not provide 24 hour cover. The research nurses provided an 
assessment service for clinical thrombolysis, and it would therefore have been useful for 
them to provide an ‘out of hours’ service which could also have covered research 
activity. However, as there was no funding for such a system, they usually worked from 
09:00 -17:00 hours, flexibly depending upon workload. This effectively limited the 
enrolment of research participants to ‘office hours’ even though this did not necessarily 
correspond with the time of presentation of potential participants. Nor was this 
arrangement necessarily convenient for consultation and communication with patients’ 
family members/carers as visiting hours were 11:00-13:00hrs and 16:00-19:30hrs.  
An example of the impact of this temporal disjuncture occurred during my third 
phase of fieldwork, an incident that I have called ‘The Consent Interaction That Never 
Was’. The following three extracts pertain to this incident, which occurred when 
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Research Nurse Webb identified a patient, Mrs Clarke, on the ASU who was potentially 
eligible to participate in an acute blood pressure management study (COSSACS). This 
study had a recruitment time window of 48 hours from onset of symptoms – much 
wider than that of the hyperacute studies. Nevertheless, it was still important to initiate 
the assessment and enrolment process as soon as possible, as time was often lost prior to 
arrival at hospital. Further delays sometimes ensued when patients were admitted 
outside the working hours of the research team, and because the team was not based in 
the clinical area, they did not usually find out about new patients until they actually 
visited the ward and trawled admission records and patient notes. Mrs Clarke, however, 
was well within the 48 hour recruitment window (more than 24 hours remaining) and 
appeared, on first review of her notes, to fulfil most of the eligibility criteria. Nurse-led 
consent was not permitted for this study and therefore Research Nurse Webb contacted 
the research fellow, Dr Chatterjee, to advise him of this potential participant. It is 
important to note that although more than 24 hours of the recruitment period remained, 
this did not mean that the research team had 24 hours in which to assess and recruit the 
patient. The research team did not work a shift system; they did not provide 24 hour 
cover and thus would not be available to undertake recruitment throughout the whole of 
the time remaining. It was therefore important that they made prompt progress but on 
visiting the patient they were reluctant to act, as can be seen in this exchange: 
Mrs Clarke is in bed and appears to be asleep. [...] Standing at the bottom of the 
patient’s bed Nurse Webb and Dr Chatterjee look at the patient, look backwards 
and forwards at me and at each other. They debate whether or not to wake her. 
Should they wake her now or come back later, or wait until tomorrow? Research 
Nurse Webb suggests that they could wake her and give a brief explanation then 
leave the information with her to discuss with her family if they return this 
evening then they could come back to take consent from either the patient, if 
appropriate, or her family when they come to visit tomorrow morning. Visiting 
time is 11:00-13:00 hrs and they have until 14:30 tomorrow to randomise her. 
Dr Chatterjee ponders this for a minute or two then agrees that it is a good idea 
but makes no move to wake the patient. [...] After a few minutes Mrs Clarke 
begins to cough and wakes up.  [...] She closes her eyes again and looks like 
she’s going to drift back off to sleep but she has another couple of coughing 
spells. Dr Chatterjee is still wondering what to do [...] Eventually he decides to 
approach her but it is established in conversation that the patient lacks capacity 
to give her own consent to participate in the study. [FIELDNOTE: April 2007, 
Extract 1] 
Although at this point questions about the patient’s capacity curtailed the 
interaction, if the clinical team had taken a proactive approach and had informed the 
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research team of the patient’s admission, while family members were present, it may 
have been possible to secure proxy-consent to enrol the patient in the study. This 
interaction demonstrates the way in which the timing of research activity was 
constrained by the perceived dichotomy between research and care, and also by the 
somewhat hierarchical dimension of this split. The research nurse and the research 
fellow negotiated between themselves regarding the time available and the priorities for 
the patient at the present time. In their negotiations they orientated to Mrs Clarke as a 
patient who was eligible for a study, not simply a potential participant. As well as the 
exchange noted here, they discussed various possible scenarios, with the aim of 
maximising the chances of recruitment. Ultimately however (and properly), they 
recognised the patient’s basic need for rest, and prioritised this over immediate study 
enrolment. In doing so they positioned themselves within the more traditional aspects of 
their role as carers rather than investigators/scientists.  
Based on numerous observations throughout my fieldwork, this reluctance to 
approach/wake the patient was unlikely to have occurred had the intrusion been a 
clinical one, such as to take the patient for a scan or other investigation. If a junior 
doctor had arrived to clerk the patient he/she would most likely have woken her 
because, a) an assessment of the patient is required in order to establish a treatment 
plan, and b) there is a need to fit a number of tasks into their busy schedule, but this 
intrusion was different because it was seen as something extra and not clinically 
necessary – a distinction made by the research fellow himself in his subsequent 
telephone conversation with the patient’s son (see Fieldnote, Extract 3, below). Their 
reluctance, whilst demonstrating concern for the patient’s physical needs, suggested that 
despite the relatively short time window, even the researchers themselves did not 
consider the research to be a priority.  
 Whilst time was of the essence for the research team, the ward staff’s lack of 
familiarity with the various research protocols meant that they were unaware of the 
urgency and therefore failed to appreciate how they could facilitate communication and 
subsequent recruitment. When Mrs Clarke was admitted three family members/friends 
were in attendance. Had the ward staff been familiar with the research protocols and 
taken a proactive role in recruitment, they could have informed the research team of the 
patient’s admission and potential eligibility thus enabling the research team to visit the 
patient when her relatives were present. Mrs Clarke’s family members would have 
received the information sooner, had more time to consider their mother’s participation 
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and to discuss this between themselves. They would also have had an opportunity to 
discuss the study with the researchers, who would have still been available on site for 
consultation. Such cooperation and collaboration may have facilitated patient 
recruitment. In the absence of such cooperation and in light of the patient’s diminished 
level of capacity it became necessary to contact her next of kin in order to discuss 
potential research involvement, but even this decision involved much discussion and 
negotiation:   
Dr Chatterjee asks Mrs Clarke if she will be having any more visitors today and 
she says yes. After a bit of a struggle he manages to establish that she thinks her 
son, Graham, will come in tonight. She is unable to say what time this might be. 
Dr Chatterjee apologises for troubling her and says he will speak to her family 
later. Nurse Webb and Dr Chatterjee then leave the bay. In the corridor they 
ponder what to do next. Dr Chatterjee suggests that they [...] keep popping back 
to see if any visitors turn up but visiting time is restricted and the next session 
will not begin until 16:00 hrs. Nurse Webb suggests that they ask the ward staff 
to ring them if anyone else turns up but Dr Chatterjee remarks that they might 
not come back until after 17:00hrs [by which time neither he nor Nurse Webb 
will be available]. Nurse Webb suggests that Dr Chatterjee could ring the 
relatives to see if and when they might come in and could arrange to attend 
when they are present, but as this may be after 17:00hrs he seems reluctant to 
make such an arrangement. [...] Nurse Webb then suggests that they ring the 
patient’s next-of-kin and if they aren’t coming in till later this evening ask if it 
would be ok to leave some information for them to read and then catch up with 
them when they come to visit tomorrow to discuss fully. Dr Chatterjee agrees to 
do this. They look in the patient’s records and find telephone numbers for two 
family members. [...] The nurses’ station is quite crowded and noisy so Dr 
Chatterjee and Nurse Webb return to the Stroke Research Office to make the 
call. [FIELDNOTE: April 2007, Extract 2] 
In the example above , the research staff endeavoured to manage their time in 
order to comply with organisational restrictions and the effects of those restrictions such 
as the fact that the patient’s family were prohibited from returning to the ward before 
16:00 hours and in fact were unlikely to return during the researchers’ span of duty. 
They also endeavoured to do this in such a way that impacted as little as possible upon 
the workload of the clinical staff. Unfortunately, in their consideration of other people’s 
priorities their own were relegated.  
As well as trying to avoid increasing the workload of the clinical team, the 
research team was also reliant upon the cooperation of the patient’s family. 
Communication with the patient’s family however was dependent upon the time 
available to the research team and the degree to which this coincided with the 
availability of others, whilst also minimising any impact on third parties (i.e. the clinical 
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team). This negotiation between different actors and their temporospatial availability is 
demonstrated in the following extract:  
After several failed attempts Dr Chatterjee eventually manages to contact Mrs 
Clarke’s son. [...] He explains that he is a doctor from Ward 2, Nearstreet and 
that ‘we’ were wondering when someone would be coming in because we would 
like to speak to someone about including Mrs Clarke in a research study [...].  - 
something extra from her usual care. [He mentions that the patient seems a 
little confused so we cannot ask her personally for her consent and therefore 
need to ask her next of kin]. He explains the voluntary nature of involvement but 
does not give any details about the study itself. [...] The patient’s son [...] says he 
will try to get in before 19:00hrs but cannot be certain about this. Dr Chatterjee 
asks whether he may leave an information sheet at the patient’s bedside for him 
to have a look at and take away to discuss with other family members if he 
wishes, to see what they think and then he will catch up with whoever comes to 
visit tomorrow. He agrees to this and Dr Chatterjee thanks him. [...] Dr 
Chatterjee plans to leave the information sheet on Mrs Clarke’s bed table or 
cabinet. I suggest that he could give it to Sr Mitchell and ask her to make sure 
that Mrs Clarke’s relatives get it. He is concerned that if the ward gets busy Sr 
Mitchell won’t have time to do this so instead he sticks post it on the front of the 
document which says “Study information for Mr Clarke”. Research Nurse Webb 
takes it to the ward and leaves it on patient’s bed table but also asks Sr Mitchell 
to point it out to relatives if she sees them. Sr Mitchell agrees to do this. 
[FIELDNOTE: APRIL 2007, Extract 3, my emphasis] 
It can be seen that the recruitment process was threatened because of the 
research team’s disjuncture with the clinical team and because their working hours 
restricted their ability to be present when the patient’s family were likely to be in 
attendance.  Whilst a formal shift system like their clinical counterparts may not be 
absolutely necessary, an arrangement for on-call and/or overtime payments may have 
helped to address this issue. Although there was some degree of flexibility in the 
research team’s working hours, this generally meant that they were expected to take 
time off in lieu for any additional hours worked. This had a knock on effect however in 
that if they took time off to make up for extra time worked in order to meet with a 
patient’s family (for example) they then risked missing another potential patient during 
the time taken in lieu. A vicious circle therefore developed where research staff were 
reluctant to work extra hours, even in order to secure recruitment, because in doing so 
they may jeopardise future recruitment opportunities, particularly in the hyperacute 
situation, unless they forgo their time to be taken in lieu. ‘Care’ was required and 
provided 24 hours per day, seven days per week; research was not, and this presented 
difficulties when trying to make contact with family members when patients lacked 
capacity to provide their own consent.  
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The catalogue of events outlined above indicates how time and timing of events 
and interactions can impact enormously upon the conduct of the research team and the 
outcome of research activities. Whilst the research team was mobile and thus, flexible in 
a geographical sense, this flexibility did not extend to team members’ working hours, 
thus limiting their availability and potentially placing a constraint upon the number of 
patients that they were able to recruit to research protocols, particularly in the acute 
and/or hyperacute situation.  The interaction outlined above, provided further examples 
of the circular relationship between time, space and execution of research duties the 
following day when a plan of action was required in order to facilitate recruitment of 
Mrs Clarke. This scenario is discussed further in Chapter 8.  Nevertheless, whilst these 
temporospatial splits may have impeded the progress of research, to some extent, this 
did not mean that clinical and research teams led a totally separate existence. As the 
next section shows, researchers and clinical staff came together in some circumstances 
to work as a ‘virtual team’.  
5.5 Clinical And Research Connections: Forming A ‘Virtual’ Team 
Logistical and operational issues notwithstanding, there were some situations 
where researchers and clinical colleagues worked together as a ‘virtual team’. This was 
usually advantageous for the clinical staff in that it frequently involved the research 
staff temporarily relieving the clinical team (nursing and medical) of an element of their 
clinical workload, for example, the research nurses’ assessing patients for, or 
administering, thrombolysis. As previously noted (Chapter 3) thrombolysis was 
originally offered at the study site only either off-licence or as part of a RCT, and as 
such, was delivered by the research team. Although thrombolysis had now become part 
of clinical service provision, the research team was still instrumental in providing this 
service because they were already trained and experienced in the specialist skills 
required to undertake assessment and administration. Furthermore, ongoing 
reconfiguration of emergency medical services at the study site (in terms of facilities 
and personnel) meant that for a period of time, the stroke nurse practitioner, and some 
members of the research team, were required to share the out of hours rota with the 
medical staff, in order to provide cover for the thrombolysis service. The effect of this 
research-clinical amalgam was that research and specialist nurses were at least 
temporarily repositioned on what may be becoming a nurse-doctor continuum 
(Baumann et al., 1998). 
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Following the patient trajectory, as outlined in Chapter 3, the research team’s 
first point of contact with new patients potentially eligible for acute/hyperacute research 
was in the Emergency Admission Suite, where new patients were initially accepted. The 
actual time of contact as well as frequency and duration were also important. At the 
time of interaction with EAS staff the patient’s situation is critical and the focus is on 
undertaking assessment and initiating appropriate investigations and treatment as soon 
as possible. In conjunction with the stroke nurse practitioner, on arrival in EAS, the 
research team took over the admission assessment procedure although EAS staff 
assisted with observations, prepared equipment and attended to the general comfort of 
the patient and relatives. The resident medical officer (RMO) was advised of the 
patients’ admission but, in the interactions I observed, usually had minimal involvement 
at this stage. In the following extract I describe a fairly typical stroke admission episode 
in which a patient, Mr Adams, had been admitted with self reported onset of symptoms 
approximately one hour previously. Having been advised of the patient’s imminent 
arrival Research Nurse Higgs and Sister Stone (SNP), were waiting for him when he 
arrived and took a brief handover from the paramedics.    
Nurse Higgs introduces himself to the patient as a research nurse and explains 
that the research team assess patients who have had or may have had a stroke to 
see whether they are eligible for emergency stroke research and that he’ll be 
“asking a lot of questions and running around a lot”. […] Nurse Higgs 
completes neurological examination. RMO pops head into cubicle during this 
procedure but does not interrupt and leaves immediately. Nurse Higgs exits 
cubicle after completing examination but I hear him just the other side of the 
door describing patient’s presentation and indicating that urgent CT is required. 
Sister Mackay asks if Nurse Higgs needs the RMO now and Nurse Higgs 
indicates that this would be helpful. However the RMO asks what he can be 
doing if Nurse Higgs and Sister Stone aren’t finished. He says he’s “not sure 
what his role is in all of this”. (I discuss this with Nurse Higgs later and he tells 
me that he used to feel very uncomfortable about asking the RMOs etc. to let 
him do his trial assessments when he first started but feels more confident now 
and he is probably more experienced in conducting neurological examinations 
than a lot of the RMOs, especially immediately after the medical staff 
changeovers such as now [August]). […] Nurse Higgs says that it would be 
useful if the RMO could insert a couple of cannulae, take some bloods, do an 
ECG and sign a CT request form. RMO asks whether the patient needs to be 
clerked and should he do it. Nurse Higgs responds that patient will need to be 
clerked but stroke team will probably do this as it seems very likely that the 
patient will be thrombolysed. Nurse Higgs is very forthright in asking the RMO 
to undertake these tasks for purely pragmatic reasons so that he and Sister Stone 
can get on with preparing for thrombolysis. […] Whilst Nurse Higgs and Sister 
Stone are out of the cubicle RMO introduces himself to patient and as he’s siting 
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the venflon explains that he gets to do all of “the mean jobs”. [FIELDNOTE: 
August 2006] 
This extract illustrates the flexibility of the research nurse’s role and others’ 
understanding and acceptance of that role. Here, Nurse Higgs quite openly took control 
of the situation. By telling the patient at the outset that he would be “running around a lot” 
he implied a sense of controlled urgency. In contrast to behaviour I often observed in less 
acute situations, he did not defer to the medical staff. For example, if a member of the 
clinical team needed case notes that a research nurse was reviewing to determine a 
patient’s eligibility for secondary prevention studies, the research nurse invariably handed 
them over immediately, often without any direct request being made, thus privileging 
clinical need over research requirements and differentiating between the two. This 
negotiated ordering of roles, responsibilities and priorities was not verbalised but was 
based upon the actors’ anticipation and/or previous experience of the actions of their 
colleagues. However, where the research nurses did defer to their clinical colleagues this 
further perpetuated the notion that research activity was separate from, and somehow less 
important than, clinical ‘care’. 
Because the first course of action was thrombolysis wherever possible, patient 
assessments were undertaken with this in mind, prior to consideration for study 
involvement. The RMO or specialist registrar from the stroke team could perform this 
assessment but this would necessitate repetition and loss of valuable time if the patient 
was then to be screened for study involvement. Time, therefore, primarily determined 
task allocation and, thus, the research nurses or the stroke nurse practitioner undertook 
the assessment for clinical and research purposes, ensuring that neither was delayed. 
This was not intended to exclude or undermine the clinical team however, rather it was a 
purely pragmatic response to the urgency of the situation and a recognition of each 
individual’s skills and attributes. Many nursing staff now extend their role to include 
venepuncture and cannulation, often in order to alleviate some of the demands on junior 
medical staff; this was not the purpose here. It was simply that economy of time was 
maximised if the research nurse and the stroke nurse practitioner concentrated on 
preparing for thrombolysis, a procedure which the RMO was unlikely to be familiar 
with. In other words, all parties involved here responded to each other’s actions rather 
than acting upon predefined role attributes and functions (Blumer, 1969b; Rock, 2001). 
The above interaction illustrates a role reversal between medical and nursing staff, 
with nurses leading the process and the doctor undertaking tasks as required by the 
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nurses. In addition, it demonstrates how, for a moment within this clinical episode, 
individuals from otherwise disparate research and clinical teams came together to 
function as a ‘virtual team’ in order to ensure prompt completion of the task in hand, i.e. 
patient assessment and appropriate treatment. It also demonstrates how both the 
research nurse and the stroke nurse practitioner functioned beyond the traditional 
boundaries of their nursing role.  
In the scenario described above, although not strategically engineered, the RMO’s 
lack of specific knowledge about thrombolysis and/or study protocols worked to the 
research nurses’ advantage because by directing his activity the research nurses were 
able to concentrate on their own tasks unimpeded by other medical or administrative 
requirements. This malleability of the relationships between the doctor and the clinical 
and research nursing staff was predicated upon the urgency of the task in hand and the 
experiential knowledge of the practitioners; each assumed the role and completed the 
tasks that they were most familiar with. However it was specific to this particular set of 
circumstances and was fluid and negotiable. I did not observe reciprocal engagement of 
clinical nursing staff in research activity or interactions. Furthermore, the dynamic 
shifted in other areas and at different time points within the patient’s trajectory, 
impacting both positively and negatively upon the research nurses’ performance of their 
role and described more fully in Chapter 7 (Performing Research Identity). 
Whilst connections between the research and clinical teams were generally 
transient and variable, a more permanent although equally fluid link was that between 
the research nurses and the stroke nurse practitioner. Like the research team, the SNP 
also discharged her role in a number of clinical areas and travelled to and with the 
patient rather than residing in a fixed environment. She was allocated office space even 
further away from patients than the research team, on site, but separate from the main 
hospital building. During my fieldwork she seldom used this office space, but 
frequently took up guest status, not within the stroke ward, but in the stroke research 
office, as I recorded on more than one occasion in my fieldnotes: 
Sr Stone must be in today as her coat is on the back of the chair [in the SRO] 
[FIELDNOTE: April 2007]. 
Like a vagrant, she transported her personal and work related belongings into the 
SRO on a daily basis, rather than leaving them in her other allocated office space or 
taking them into the ward area, even though there was not really sufficient space to store 
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them. She evidently felt more ‘at home’ in this environment and with other ‘migrant 
workers’ than in either of the other two spaces, and it was the physical presence of her 
belongings, rather than her name on a duty rota, which facilitated colleagues’ awareness 
of her whereabouts. 
Because the SNP moved between spaces, and was often the first point of contact 
for new suspected stroke patients, it was she, rather than the ward staff, who was more 
likely to advise the research team of new admissions. Her close liaison with the 
consultant medical staff also meant that when the more research active staff were on-
call she was likely to be advised of potential research eligibility, which she was asked to 
convey to the research team. Whilst such interactions illustrated some cooperation and 
collaboration between the clinical and research teams they occurred only between 
specific personnel and in specific circumstances, facilitated by the very factors – 
mobility and hybridity –that prohibited or at least restricted such interactions between 
research and ward based staff. On one occasion, when based in the Stroke Research 
Office I observed the following interaction:   
Sr Stone turns up just then and tells Nurse Higgs about a patient that Dr Silva 
thinks might be eligible for PERFORM. […] A discussion follows regarding 
which study, if any, the patient may be eligible for. […] In discussion about the 
patient/study Sr Stone says “which study he goes into has nothing to do with me, 
Dr Silva just said let Nurse Higgs know he might be eligible for PERFORM”. 
Dr Chatterjee says ‘so what are you now then, Ward 2 nurse?” “No” replies Sr 
Stone, “I just float about - I keep an eye over there and get involved over here”. 
[FIELDNOTE: April 2007] 
Even the SNP’s closest colleagues were uncertain where she ‘belonged’. It is 
significant that the question was not ‘where are you based now?’ but ‘what are you 
now?’ (my emphasis) - suggesting that one’s base is a defining factor of one’s identity. 
In some respects the level of independence and autonomy experienced by the research 
nurses and the SNP may be considered to be liberating and empowering, but there was 
also a sense that their individuality could be alienating and isolating (as will be further 
explored elsewhere – Chapter 7). Born out of their shared mobility, fluid role definition 
and their physical and temporal dis-connection from the ward based staff, the stroke 
nurse practitioner and the research nurses were united in their difference, even though 
that difference was not the same. This scenario is reminiscent of Carmel’s description 
of the obscured boundaries which exist between medical and nursing staff in Intensive 
Care Units (Carmel, 2006). Here the boundaries of nursing and research were obscured, 
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as specialist nurses and research nurses were brought together, whilst simultaneously 
differentiated from ‘the ward nurse’. 
5.6 Discussion: The Temporospatial Dimensions Of The Relationship Between 
Research And Clinical Activity 
As noted earlier (Chapter 2.5), it is argued that it is advisable to separate 
research and clinical activity, mainly in order to avoid procedural and therapeutic 
misconceptions and promotion of unrealistic hope of benefit in research participants 
(Miller and Brody, 2003; Fisher, 2006b; Miller and Joffe, 2006; Charuvastra and 
Marder, 2008). There is also a presumption that by separating the two activities, 
clinician-investigators are less likely to feel the burden of competing interests embodied 
in their responsibilities to the individual patient, to society and to their pharmaceutical 
sponsors (Brody and Miller, 2003). In practice however, particularly in the emergency 
context, to split the two may be no less ethically fraught, not least because of the 
logistics of setting up a research specific service and the effect that this may have on the 
provision of clinical facilities and care. Provision for stroke care in the UK, although 
improving, is not optimal (National Audit Office, 2010). To insist upon separate 
facilities for stroke research would either be wholly unworkable or would necessitate 
shifting specialist personnel (already in short supply) from the clinical area to the 
research forum, which would seriously disadvantage those patients ineligible for, or 
unwilling to participate in, research protocols. For these reasons collaboration, if not 
total integration, was the aim within the study site. 
Integration however was beset by a number of difficulties, some of which have 
been illustrated throughout this chapter. Although geographically mobile, the research 
team was temporally restricted, both in terms of actual working hours and also in 
relation to when, within those hours, they can perform research tasks. With the 
exception of initial assessment which tended to be a combined effort, research activities 
typically happened after clinical activities had been completed, and were perceived to 
be secondary. Depending upon the nature of the research activity, (for example 
recording of vital signs or retrieval of blood samples), it may take place within the 
patient’s clinical area, but was frequently undertaken in a different location altogether 
(for example, completion of case report forms and screening logs). Thus both space and 
time impacted upon task orientation.   
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The separation of clinical and research activities that I witnessed in the ASU 
seemed incongruous, given that the focus of the activity – the patient – cannot be 
similarly physically compartmentalised. The ‘wholeness’ of the patient seems self 
evident. Whilst a patient cannot be physically divided into ‘the part that is participating 
in research’ and the ‘part that is receiving clinical care’ in practice such differentiations 
are made every day, usually for good reason and to good effect. In different departments 
and across different disciplines, different configurations of the patient exist, for example 
in the radiology department, laboratories, finance. The differences are relatively obvious 
and can be considered to lie in the physical closeness of the staff group to the physical 
body of the patient. Radiology staff, for example, have physical contact with the patient 
whilst they perform diagnostic tests, but thereafter their representation of the patient 
resides in the radiological films which they have taken. For laboratory staff the 
connection with, and their configuration of, the patient is even more fragmented, and is 
represented by one or more samples of bodily fluid or tissue. None share the same 
physical closeness as the ward based nursing staff. They all deal with patients, but 
construct them differently in different spaces and in relation to different activities and 
outcomes.  
The dichotomised view of the ‘stroke patient’ versus ‘patient plus’ (i.e. patient 
and research participant) is perhaps more difficult to uphold than the perspective of the 
radiologist or the lab worker. For example, when a blood specimen is sent to the 
laboratory it has no contemporaneous effect on the patient on the ward until it is 
analysed and the results acted upon. When a patient is enrolled in a study and receives 
study intervention it is likely to affect the whole patient, not just the part that the study 
intervention aims to treat. It seemed that this dichotomisation of research and care was 
more prevalent amongst the clinical team than the research team. Perhaps this was 
because they had no experience of the research arena, whereas the research team 
members had previously been employed in the clinical field. The research team and the 
SNP saw and interacted with patients in some of the same spaces as clinical staff, and 
might therefore be expected to orientate towards them in the same way, but they did not. 
They constructed the patient differently, as did clinical staff when the patient was 
somewhere other than their legitimate clinical area. This can be seen in Chapter 5.3.2 
above, in which I discuss activity in second order spaces and describe interruptions to 
the consultation between the research team and a potential study participant. The 
interactions that went on in the research room (the ward store)  were not seen - by the 
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ward staff - as care, and the participant in this instance was therefore, not afforded the 
same level of dignity and respect as a ‘real’ patient. This was surprising, because an 
argument raised several times throughout the interviews with the clinical staff was that 
they ‘know’ and were responsible for their patients in a far more holistic sense (c.f. 
May, 1992b); it seemed incongruous then that they were unable or unwilling to 
incorporate their patients’ research involvement within their delivery of care.  
Similarly, in relation to the incident regarding the missing study drug for 
example, if the patient had been diabetic and her insulin could not be found, one would 
not wait until a diabetes nurse specialist arrived on the ward to look for it; nor would 
he/she be responsible if the insulin could not be found. Whilst patient participation  in 
research is ‘non-compulsory’, once a decision has been made to do so, study related 
procedures become compulsory and are then part of his/her care. Equally, timely 
adherence to the study protocol and schedule is important not only for the individual 
patient, but for the integrity of the study and, by extension, the safety of future 
participants and the wider stroke population. However, it is important, at this point,  to 
acknowledge that the clinical staff were responsible for the care of up to 30 patients, 
whilst the research nurses were responsible only for patients enrolled in research 
protocols, and even then, only for very specific aspects of their management. Although 
the drug in question was being administered within the context of a study, it should be 
delivered with at least the same precision and accuracy as any of the patient’s other 
medications or interventions. Due in part to poor ward staffing levels, a large proportion 
of highly dependent patients, and less than optimal communication between clinical and 
research teams, some elements which could (and arguably should) be shared, remained 
the sole territory of the researcher. 
Organisational factors relating to the provision of care meant that the research 
nurses necessarily moved between clinical areas regardless of their base. They followed 
the patient and, as a result, some aspects of their work always took place beyond the 
observation of the clinical team. However, even when undertaking activities within the 
clinical area, the research nurses did so largely without input from the clinical team, 
even in the case of joint research/clinical tasks such as history taking and initial 
assessment. The research nurse or research fellow was invariably unaccompanied when 
discussing study involvement with patients, thus the clinical staff were not privy to 
decision making processes enacted by the researchers in these situations. Completing 
the ‘virtual exclusion zone’, the research team’s subsequent administrative work was 
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conducted in the SRO, away from the clinical area where stroke patients were managed. 
This meant that the clinical staff were unable to observe other aspects of the research 
nurse role and therefore did not comprehend its scope. The impact of their sequestration 
is discussed further in the following chapter.   
Following Goffman’s dramaturgical theory we may consider the Stroke 
Research Office to be a ‘backstage’ region where the research nurses relaxed from and 
prepared for the role that they enacted in the clinical area (Goffman, 1959), but such 
removal perpetuated lack of awareness and thus, limited their colleagues’ understanding 
of the research nurse role.  
Like the temporary employees described by Garsten, the research nurses were 
perceived as ‘insiders’ (Garsten, 1999). However, the relative ease with which the 
research nurses accessed the patients and became their ‘intimate guests’ contrasted with 
the way in which they were required to request access to the store cupboard (ASU) or 
the treatment room (Ward 1). The research nurses were able to access patients because 
they were conducting research into the treatment/prevention of stroke and these patients 
were thus diagnosed; they accessed the ward bays and cubicles in the ASU without 
express time-limited permission because that was where these patients were.  
Conversely, they sought explicit, time bounded permission to access the treatment room 
on Ward 1 because stroke patients would not normally be seen on this ward and 
therefore neither they, nor the research nurses, had legitimate, unrestricted access to that 
area.  The patient did not act as a ‘key’ to these settings; the ‘guest -host’ relationship 
took on a more formal note and the researchers became ‘outsiders’. They traversed the 
boundaries not only of social groups and identities, but also their associated territories, 
thus occupying a liminal space both physically and metaphorically. 
5.7 Conclusion 
In this chapter I have illustrated ways in which the research nurses in the ASU 
were temporospatially differentiated from their clinical counterparts. This 
temporospatial dislocation impacted upon the enactment of their role, in that certain 
things must be done in certain places, and within a relatively fixed time frame. They 
occupied liminal spaces, both physically and metaphorically, and were constructed and 
constructed themselves in different ways, according to their location and the activities 
they were legitimately allowed or expected to undertake there. In the next two chapters I 
explore other ways in which doing research impacts upon identity, first discussing the 
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clinical staff’s perceptions of research and the research nurse role before considering the 
research nurses’ performance of their role identity. 
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Chapter 6. Separating Research and Care: Positioning of 
Research by the Clinical Staff 
6.1 Introduction  
 As I have described in the previous chapter, one of the main ways in which 
research and clinical activities were separated at the study site was that they were 
undertaken in different places, by different personnel, who were available at different 
times. The distinction between clinical and research staff  however, was as marked in 
what their activities entailed, as in where and when those activities were undertaken and 
invoked a range of responses from their clinical colleagues. It is crucial to note that 
nursing involvement in the conduct of clinical trials has evolved considerably in recent 
years.  The role of research nurses has shifted from duties of a technical or support 
nature to those of implementation, administration and co-ordination. The role has thus 
become a dynamic hybrid of nursing, medical, technical and administrative tasks 
encompassing surveillance, communication, diagnostic tests, teaching, support and care. 
Research nurses traverse several boundaries, such as those between medical science and 
medical practice; research and care; doctors and nurses, but may also encounter 
boundaries within the discipline of nursing. In this chapter, I examine how the roles of 
the clinical nurse and the research nurse serve to further separate these two areas of 
practice. In Chapter 2, I explored how the literature positions the research nurse within 
the discipline of nursing; here, I explore how and/or why research activities are 
considered by some to be alien to the role of the clinical nurse.  Further, I look at how 
clinical staff observe, understand and integrate (or not) the research nurse role and 
research activities within the clinical area.  
6.2 The Positioning Of Research By The Clinical Staff  
At the study site, the stroke research nurses needed to follow the patient in their 
pathway through the healthcare system. Thus, their activities took place in a number of 
different areas (see Chapter 5). This led to difficulties in maintaining identification with 
a specific clinical team or service. In effect the research nurses were dislocated, not only 
in time and space, but also with regard to their professional identity. This disconnection 
raised a number of issues which were echoed throughout the data and were clearly 
summarised by one of the clinical nurses in the extract below: 
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[T]he research nurses, they used to come and get the information off us how 
well were the patients? how poorly? Diagnosis and things like that, and then it 
was sort of taken out of hands and then that was like a separate department 
coming in, [...][R]esearch nurses come in and look at the files as in blood 
pressure and things like that, but we don’t know what you’re looking for. If, if 
we, if we can assist it would, it would be- it would be beneficial, but at the end 
of the day we don’t know what you wa- what you’re doing. You’re getting all 
this information, but what information are you getting, what are you doing with 
it, where is going to? We don’t know. [INTERVIEW: Staff Nurse Cooper, 
August 2007, my emphasis]   
 Nurse Cooper conveyed an impression of a unilateral relationship existing 
between clinical and research nurses, one in which the research team ‘take’ data from 
the clinical staff, but give little in return. The clinical staff, their records and systems, 
were accessed as if they were a resource to be interrogated, but were not treated as if 
they required, or warranted, information about the studies or about interactions with 
potential participants. This lack of reciprocity led to a sense of exclusion on the part of 
the clinical staff, as if the research team was an entirely separate department, despite 
their commonality of training and interaction with the same patient group. They were 
viewed as being ‘the same but different’; a position which rendered both research and 
the researchers separate and mysterious. The clinical nursing staff concluded that they 
did not know what the research nurses did, needed or wanted and that they were 
therefore, unable to assist them. It was demonstrated here and throughout the data that 
research was generally perceived to be important and valued, but for a number of 
reasons, which often were ill-defined, the clinical staff felt excluded and unable to 
participate in the research process.   
So, the main issues this interviewee explicitly raised were that: 
· The research team was “like a separate department”, that ‘took’ data from the 
clinical staff with little reciprocity, 
· The clinical staff did not know what the research nurses needed, did or wanted, 
because they did not understand study protocols 
· The clinical staff were willing, but unable, to help either the research team in 
their tasks, or the patients/families in their decision making about potential 
research involvement, although they recognised that there may be potential 
benefits in doing so. 
 A fourth issue, related to, but not made explicit in the quote above, was that the 
clinical staff were limited in the extent to which they could participate in research 
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activity, not only because of their lack of knowledge, but also because of competing 
priorities.  In the sections that follow, I will expand upon these issues in order to explore 
the way in which the clinical staff experienced and understood the activities of the 
research team, and how this impacted upon the integration and conduct of research 
within this acute stroke environment.  
6.3 The Nature Of The Clinical-Research Team Relationship: Separate And 
Mysterious 
 In the interview fragment above, Staff Nurse Cooper suggests that the research 
team was like a separate department, but acknowledges that it was not entirely separate; 
clinical and research teams were the same in that each included nurses (and doctors) and 
dealt with stroke patients, but there was something about what the research team did (or 
did not do), that rendered them ‘other’. At the heart of this perception of difference was 
what the research team was seen to do. 
 The temporospatial dislocation of the research team (see Chapter 5) meant that 
the clinical staff were presented with only a ‘snap-shot’ of the research team’s work, 
mainly data collection and paperwork. The research team was seen as taking 
something from the ward staff and/or the patient, shifting activity out of the ward 
staff’s hands and by implication, removing these data and activities from their control. 
Whilst ward staff were aware that the research team visited and assessed patients, and 
obtained informed consent for study enrolment where necessary, they did not 
understand the whole recruitment procedure or subsequent management, because they 
were neither invited, nor did they volunteer, to participate in research activities.  
They typically saw the research nurse arrive on the ward, review the ‘bed board’ 
(a wall mounted white board beside the nurses’ station displaying in tabular form 
patients’ names and location on the ward), admission book (recording patient 
demographics and admission details), ‘ward returns’ sheet (a document detailing 
admissions, discharges, transfers and deaths which is ‘returned’ on a daily basis to 
patient services) and relevant patient notes. These data were required for completion of 
study screening logs, determination of patients’ potential study eligibility, and 
completion of the European Stroke Database (ESDB) proforma. The research team was 
then sometimes seen to approach potential study participants to discuss involvement, 
but these approaches were rarely accompanied by clinical staff. The clinical staff were, 
therefore, unaware of the interpersonal skills required, or demonstrated by, research 
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staff. As noted in Chapter 5, the ‘virtual exclusion zone’, of the SRO, in which the 
research team’s subsequent administrative activity was conducted meant that the clinical 
staff did not see or comprehend the scope of the research nurse role. They were thus 
unaware of negotiations regarding potential new studies and participants; ethical debates 
about individual patients or studies; the time consuming and repetitive nature of data 
collection, recording and electronic data entry; and the labour intensive nature of 
addressing data queries.  They were not party to discussions in which the research 
nurses drew on their relational and interpersonal skills to decide if, when and how to 
approach a patient or family. Nor did they observe the research team’s deliberations 
about study involvement, based on criteria other than those stipulated in the study 
protocol. The clinical staff were not privy to these, often internal debates that the 
research staff engaged in, regarding appropriateness at a human level, of a study for a 
patient, rather than eligibility, at a procedural level of a patient for a study. 
 It is unsurprising then that the clinical nurses made numerous comments about 
the research nurses’ apparent focus on data collection and interrogation - comments that 
were echoed by other members of the clinical team, including junior medical staff, who 
observed that the research nurses come onto the ward and “ask a lot of questions” 
(INTERVIEW: Dr Bates, November 2006). Such comments were typical and reiterated 
the idea of a ‘one way’ flow of data. The junior medical staff, like the clinical nurses, 
had very little interaction with the research team, usually only answering basic 
questions pertaining to patients’ study eligibility. They did not, and were not expected 
to, engage in discussion with patients about study participation, because they were not 
considered experienced enough to do so. I was advised that some of the middle grade 
medical staff occasionally assisted in such negotiations, but only in situations when the 
Principal Investigator or research fellow was unavailable, and when arrangements had 
been made in advance to provide research cover if necessary. However, I did not 
witness this during my fieldwork. 
 Whilst interactions between clinical and research nurses were more frequent 
than those between the doctors and research nurses, they were equally superficial.  As 
Sister Stone noted, this perpetuated the sense that there was a marked difference 
between ‘the research team’ and ‘the nurses on the ward’, prompting a sense of ‘them’ 
and ‘us’. She also noted, by referring to the period of her previous employment as 
Senior Sister in ASU, that there had been little input from the ward staff in research 
activity but equally, the research nurses appeared to have expectations of the clinical 
115 
 
 
team which they did not help or support them to fulfil. Referring to a previous study 
which relied considerably upon input from the clinical team, she commented that this 
had directly impacted upon the clinical team’s workload but that this had not been taken 
into consideration by the research team. Situations had arisen that may not otherwise 
have done so outside the context of the research protocol: 
…[these events were] something else that you had to sort out, the research 
nurses weren’t around, to help with this, they purely felt it should be nurse led, 
[…] I think I probably didn’t give it the support that I could have done had I felt 
as though we were being a bit more supported […] I felt it was a case of “Oh, 
the nurses can do that, and the nurses can do this” without really being that 
supported by the research team. [INTERVIEW: Stroke Nurse Practitioner (and 
former Stroke Unit Senior Sister), May 2007] 
 This perceived disregard precipitated a lack of support for research by the 
clinical team. Importantly however, the SNP also suggested that there was something 
about research itself, not just those conducting it, that contributed to the clinical staff’s 
sense of exclusion:  
I think people [she includes herself here] are a little bit frightened by research 
and they think it’s going to be something that’s […] maybes above them or, 
[…] ‘Oh, we’re not going to understand’ [INTERVIEW: Stroke Nurse 
Practitioner, May 2007; my emphasis] 
 For her, the perceived academic element of research, that this was something 
potentially complex, added to the sense of distance and mystery, and ‘a little bit’ of fear. 
Nevertheless, some nurses do choose to embrace research, although with differing 
reported, and perceived reasons for doing so, as I now explore. 
6.3.1 Moving to a research nurse role: a way up, or a way out? 
 Whilst the research nurses were separated from their clinical colleagues by 
virtue of what they did, this distinction was reinforced and perpetuated by the clinical 
staff’s suggestions regarding why nurses chose to take on research roles. Having 
previously been employed as a research nurse herself, in the same stroke unit, the senior 
ward sister stated that she had taken on a research role for the purposes of developing 
her own career. She stated that she had enjoyed the experience and had learned from it, 
but did not want to continue in a research role because she felt that there was something 
fundamentally different about research and clinical nurses. She went on to say that she 
felt that she embodied the characteristics of, and fulfilled the requirements of, the latter 
rather than the former:  
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I did the research erm, because I felt that I needed it for my career, [...] but 
towards the end I thought no, this isn’t for me, I’m not a research nurse. [...]I 
think that you are either a research nurse or you’re not. [...] Erm, I think 
[research nurses are] harder, I think I’m too soft. [INTERVIEW: Sr Hatfield 
(Senior Ward Sister and former research nurse), July 2007] 
 When new nursing roles began to be discussed towards the beginning of the 
1990’s it appeared to be the case that career progression would be contingent upon (at 
least in part) one’s experience and skills in conducting clinical research; indeed Mulhall 
notes that in the UK the drive for nursing involvement in research has primarily been 
grounded in its desire for professionalisation (Mulhall, 2002).  Whilst this appeared (at a 
personal level) to have been a positive factor in Sister Hatfield’s decision to take on a 
research role, the desire for advancement, whether at a group or individual level is often 
viewed with suspicion. This was noted by Dr Black (Consultant Stroke Physician), 
during his interview. A highly active researcher himself, Dr Black suggested that some 
took the cynical view that researchers were motivated by the prospect of ‘fame and 
fortune’.   
 Other interviewees offered alternative rationale for what they perceived to be a 
marked distinction between research and clinical staff: 
We do and they don’t, we do a lot - we do a lot of the nasty things, well, you 
know, things like beds and whatnot, […] - we work out things socially, we work 
out the problems, family-wise, they don’t deal with anything like that, and again 
if they, we couldn’t do what they do because we haven’t got the time to do what 
- I know that they’re on the computer a lot [...] - they go to a lot of conferences 
and things, but we haven’t got time to go off the ward and do things like that [...] 
as I say, that’s why they got out of nursing, because they were sick of er bed 
baths and things like that. [INTERVIEW: Nurse Cooper, August 2007] 
The clinical team prioritised care – the main aspect of which was considered to be 
physical labour and emotional work. The perception of the research nurses’ 
disengagement from clinical activity, especially that involving direct physical contact, 
contributed to notions such as those outlined by Hicks (1996) regarding the mutual 
exclusivity of the roles of nurse and researcher. From their own accounts, and illustrated 
clearly above, clinical staff saw their role as including those tasks complying with the 
traditional expectations of the ‘nursing’ role, such as physical work, social work and 
‘dirty’ work (c.f. James, 1992), and therefore they did not have time to undertake 
research tasks. Research staff, on the other hand, were considered to be largely office 
bound, mostly undertaking administrative and technical work and travelling the country 
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to attend meetings and conferences – a luxury which was not open to ward staff who 
complained that they could not even get away from the ward to attend in-service 
training sessions. It was noted however by Dr Black, and by some of the research team, 
that it may be the case that these issues were heightened in a stroke unit, as the nursing 
work was physically demanding and staffing levels and skill mix were never adequate 
for the level of patient dependency compared to other wards. This was supported by 
Research Nurses Webb and Slater, who held joint posts and noted a much more 
integrated approach in cardiology, for example, but noted that staffing levels were better 
and patients generally less dependent. They reported that the cardiology team, both 
medical and nursing, appeared more interested in ongoing research but also noted that 
there was usually only one, or perhaps two, studies ongoing at any one time, whereas 
historically there have been several studies running concurrently in the stroke unit. 
Although, as noted in Chapters 3, 4 and 5, there were fewer studies in the recruitment 
phase at the time of my fieldwork, there were still three acute or hyperacute studies 
ongoing, as well as a number of secondary prevention studies; unless one is involved on 
a daily basis it is difficult to keep up with all of the various inclusion/exclusion criteria, 
study procedures and requirements. 
 Whilst it was taken for granted that the research nurses were not expected to 
engage in delivering routine care such as feeding and personal hygiene tasks, some 
clinical staff found the research nurses’ ability to disregard call bells (for example) 
counter intuitive to the ethos of nursing. However their own practice was not entirely 
dissimilar. In the ASU a variation of team nursing was employed, with the aim of 
promoting continuity and quality of care for the patient, and a greater sense of 
autonomy and job satisfaction for the nurses (O'Connor, 1993). It also ensured a clearly 
designated accountability attribution.  Conflicting definitions of team nursing exist and 
many equate it with task allocation (Bloom and Alexander, 1982). In the ASU however, 
it would be more accurate to say that it was a system where a small group of nurses 
carried out all of the care for a smaller group of patients, rather than all of the nurses 
carrying out different elements of care for all of the patients on the ward (Watkins, 
1993). As applied in ASU, a number of nurses were grouped together and allocated to a 
group of patients for a substantive period of time.  
The ward staff claimed that this enabled them to care for and ‘know’ their patients 
in a much more holistic sense, and to develop a relationship that they did not consider 
possible for the peripatetic research team. In practice however, during my periods of 
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observation I witnessed little of the type of interaction that would furnish such a holistic 
picture (c.f. May, 1992a). This was in part due to reduced staffing levels and limited 
resources, which meant that clinical staff were not necessarily on the same ‘team’ every 
day, or that patients might be moved to different geographical areas of the ward, thereby 
switching teams. Nevertheless, despite their perceptions regarding the research nurses’ 
disengagement from clinical activity, the ward nurses demonstrated similar behaviour, 
as a consequence of their team nursing approach, whereby Nurses from Team A 
invariably passed on requests of patients from Team B to that team, rather than 
addressing them themselves.  
 The clinical staff’s contact with patients was often primarily functional and 
conversation, if it involved the patient at all, tended to be superficial. In fact, patient 
interactions with therapy staff were observed to be more prolonged and more 
substantive, if less frequent than those with clinical nursing staff. Paradoxically, despite 
being based outside the ASU, the research nurses’ mobility and smaller patient group, 
meant that they had more, rather than less, of an opportunity to develop relationships 
with their patient participants.  
Centrally, research was perceived to be something extra, over and above clinical 
activity, that the clinical staff did not have the capacity to take on. This reflects Sr 
Hatfield’s observations - and relates to the rationale of labelling psychiatric nurses as 
not real nurses (Bassett, 2002) - because research staff were not seen to undertake 
physical care they were therefore considered to hold fundamentally different values to 
their clinical colleagues. More tellingly however was the reasoning as to why this was 
the case. Echoing the idiom that ‘He who can, does. He who cannot, teaches’, (Shaw, 
1903; p.253) it was suggested that clinical staff did not get involved in research because 
of resource (particularly time) limitations; research nurses however chose not to 
participate in clinical care because they either could not, or did not wish to do so. The 
suggestion was that this was a personal choice, unimpeded by other restrictions and 
based on the divergence of values and characteristics that some consider to be evident 
between clinical and research nurses (Hicks, 1996). In fact, Nurse Cooper suggested 
that this distance from ‘hands on’ clinical work or doing “nasty things” was why some 
nurses left traditional clinical roles, although this implied, erroneously, that there was no 
equivalent to this unpleasantness in research work. In addition to the concerns raised 
above, there were other, more subtle demonstrations of this role distinction and 
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divergence of priorities, as illustrated in the following exchange which I observed whilst 
shadowing Research Nurse Fowler: 
One of the Stroke Unit Staff Nurses told Research Nurse Fowler that she was 
leaving as she had been offered a job at another hospital in Care of the Elderly].  
She explained that although she thought that the type of care required would be 
similar she felt that there would be more time in this new job to deliver that care. 
Describing activity in the ASU she remarked to Nurse Fowler “no disrespect but 
it’s all about this [leaning with both hands on Nurse Fowler’s paper work] and 
not about that [indicating patients in ward bay area]”. [FIELDNOTE: June 
2006] 
 Although not referring specifically to research, it was noteworthy that the staff 
nurse cited Research Nurse Fowlers’ work as an example of what she considered to be 
gratuitous and disproportionately time-consuming paperwork. This was particularly 
significant as this interaction took place at the nurses’ station, surrounded by a plethora 
of paperwork and administrative props. However, as paperwork was probably the most 
frequently observed aspect of the research nurses’ work, it was hardly surprising that it 
seemed to symbolise and be synonymous with research. By suggesting that the 
proliferation of paperwork in her own role was preventing her from doing what she 
wanted to do and what she thought nurses should want to do, i.e. deliver care, she also 
implied that the research nurse role and its perceived abundance of paperwork was 
devoid of any element of care. The logical conclusion of this statement was that real 
nurses did not do paperwork/research, the corollary being that research nurses were not 
real nurses, a distinction which exerted its impact beyond the teams’ professional remit, 
as I describe below.  
6.3.2 The socio-professional impact of doing research 
 The effect of the separateness of clinical and research staff impacted not only on 
the ‘doing’ of research but on the opportunity for informal social interaction between 
the two teams. Professional issues notwithstanding, it has been suggested that nursing 
teams exhibit a ‘social’ component, exchanging small talk about professional and 
personal issues, providing each other with social support and sharing a degree of 
physical intimacy (Reeves and Lewin, 2004). In contrast, my data demonstrated a lack 
of integration of the research nurses with the clinical teams. Geographically and 
professionally, relationships between research nurses and clinical staff and therapists 
(speech, physiotherapy, occupational) differed from those between the latter two 
groups. When discussing management of patient trajectories, reference is made to ‘co-
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operative work’ and ‘interdependence in work’ (Schmidt, 1992; p.13) and indeed 
observations of general interactions in the ASU suggested mutual dependence and 
reciprocal exchange of information and support between ward staff and therapists. 
However, this reciprocity was less evident between clinical and research staff and 
reflected the suspicion with which we tend to view those who engender ‘otherness’ 
(Bauman, 1991). Ward staff and therapists appeared to answer research nurses enquiries 
about current or potential study participants to the best of their ability but did not 
volunteer information and rarely elaborated, with more general information about the 
patient’s ongoing management or progress. However, nor did the research nurses 
volunteer opinions on clinical or nursing management, even regarding patients enrolled 
in the studies within their portfolio.   
 Additionally, this lack of integration was reflected beyond the realm of 
geographical and professional disjuncture and exhibited social manifestations as 
indicated in the following extract:  
Research Nurse Higgs arrived [at nurses’ station] to review some patient data. 
Whilst there, he noticed two large boxes of sweets and asked Sister Hatfield 
(Senior Ward Sister) if he could open them. She refused to let him do so. The 
following day I joked with Nurse Higgs about this and he told me that Sister 
Hatfield does this every year “for the ward staff” but explained that this doesn’t 
include him or even Sister Stone (SNP). [Research Nurse Fowler was not 
employed here last Christmas]. As it gets nearer to Christmas, Sister Hatfield 
puts away any gifts donated by patients and relatives and has a free ‘tombola’ 
for the staff so that they all get a gift. [Despite their frequent presence on the 
ward and their participation in clinical thrombolysis] the research nurses are 
excluded from this activity. [FIELDNOTE: November, 2006]  
 Despite frequent ward visits, and engagement with patients for either research 
purposes or following administration of thrombolysis in the Emergency Assessment 
Suite, the pervading perception of difference led to the research team being entirely 
excluded from this sharing of rewards.
 
The fact that the stroke nurse practitioner was 
also excluded however, demonstrated how these two groups were conflated and 
considered similar in their difference. Thus, like the liminal entities described by 
Turner, who ‘tend to develop an intense comradeship and egalitarianism’ (Turner, 1969; 
p.95) they provided support to each other, whilst isolated from the wider clinical team. 
6.3.3 The desire to support research, and the commitment to deliver care 
The dichotomies between research and clinical practice, however manifest, 
contributed to an ongoing tension between ideals and practice that impacted upon the 
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accommodation of research activity within clinical practice. In general, most of the 
clinical nursing and medical staff spoke enthusiastically about research and appeared to 
appreciate its importance, although operational difficulties were observed which 
impacted upon its achievement in this setting. It was evident throughout the fieldwork 
that clinical and research staff, without exception, considered  cooperation and 
communication between the teams to be fundamental in conveying the value and 
importance of research, not only amongst clinical and research staff, but also to patients 
and their families and, equally importantly, managerial and administrative staff. 
However, contrary to the argument that research should be incorporated within clinical 
care (Rhodes, 2005), some of the clinical staff deemed research separate from clinical 
management and nursing care and therefore, considered the involvement of clinical staff 
optional – a goodwill gesture – resources permitting. Nevertheless, senior staff, 
including one of the consultant stroke physicians, were keen to promote integration and 
collaboration in order to demonstrate that the clinical team was supportive of research 
and to avoid sending out what Dr Black described in his interview as “mixed messages” 
that may precipitate an impression of dissent, disinterest and/or confusion.     
 Successful research therefore required more than a dedicated research team; it 
was also heavily reliant upon the support of all those involved in the care and 
management of potential participants, and thus the disjuncture previously highlighted 
was a major potential barrier both to recruitment and ongoing management of study 
participants.  
6.4 Suggestions For Change 
Several suggestions were made regarding ways in which integration and 
subsequent research capacity could be enhanced, and I illustrate some of these below 
before moving on to present and discuss some possible reasons why this did not happen 
during the period of my fieldwork.  
6.4.1 Promoting visibility and continuity  
 Throughout the data collection period, both clinical and research staff 
acknowledged that Dr Black was the most research active of the senior medical staff. 
This was hardly surprising; for as well as being a consultant stroke physician, Dr Black 
was Principal Investigator for most of the ongoing studies and was Director of the 
associated Research Facility. He acknowledged in his interview, “research is, is very 
much part of what I do”, and was very keen to promote integration wherever possible. 
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He had endeavoured to facilitate this by appointing a former nurse from the research 
team (Sister Hatfield) to the post of Senior Ward Sister but this had not resulted in 
integrated practice. Nevertheless, despite his enthusiasm Dr Black acknowledged that 
complete integration was difficult, due to the lack of 24 hour teams to provide research 
cover, and that a critical mass of ongoing research and research personnel was required, 
so that both the process and the people were visible on a continuous basis. However, he 
cautioned that even with improved integration and better staffing levels on the ward, it 
would still be necessary to have a core research team because the privileging of clinical 
work meant that it would always expand to occupy the staff available and that “the 
service side just tends to suck people in completely” [INTERVIEW: Dr Black, March 
2007].  
 Some of the ward nurses also had ideas and suggestions about potential 
facilitators. One of the issues that concerned some members of the clinical team was 
that they perceived a lack of continuity of research related care because the research 
nurses worked ‘office hours’ but patients’ questions were not similarly confined. Ward 
staff stated that their own inability to address these questions and to provide appropriate 
information may have meant the difference between someone staying in a study or 
dropping out, which had implications for research practice and findings. As well as 
being a potential source of discord between clinical and research staff the clinical staff’s 
lack of familiarly with the research protocols had implications for both the 
patient/professional relationship, and the patients’ trust in these teams. In addition to 
potentially jeopardising study recruitment and retention, the clinical staff were also 
concerned that their inability to address research related queries may undermine their 
own expertise and patients’ trust therein.  
 For example, Sister Mitchell described the research team as “insular”. For the 
reasons already noted, the researchers spent only brief moments in any one clinical area 
during the course of their working day and even within that time, not least because of 
workload commitments for all parties, there was little opportunity to establish 
meaningful connections between teams whether at a professional or personal level. 
Sister Mitchell shared a view with several of her clinical colleagues that a more visible 
research presence on the ward, with or without the provision of out of hours cover, 
would facilitate the development of a rapport between research and clinical staff and 
would thus provide an opportunity for each to become more familiar with the roles, 
responsibilities and commitments of the other. By extension, there was also a 
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suggestion that this would be beneficial in terms of recruitment to, and retention in, 
clinical trials, because by learning more about the ongoing studies the clinical staff 
would be better equipped to address the queries and concerns of patients and relatives 
already enrolled or considering participation in clinical trials, for example:  
“we are limited, you know, if a patient asks me, I can give them [...] the basics 
but anything more than that I’ll phone the research office […] sometimes they’re 
not there, they work Monday to Friday, sometimes they’re busy and sometimes 
the patients don’t necessarily want to talk to them before they make their 
decision or “I’ve got a headache, could it be that..that tablet you think that he’s 
given me?” [INTERVIEW: Nurse Kane, November 2006]. 
 It should be noted that these suggestions applied not only to the research nurses. 
The research fellow was rarely seen to participate in clinical activity and tended to visit 
the ward, clinic or EAS only to check for new patients or to visit those referred to him 
by the research nurses. He had little interaction with either nurses or doctors from the 
clinical team. He sometimes shared office space with the research nurses, but also had 
some space in another building. Very few of the ward staff mentioned the input or role 
of the research fellow although some did refer to the previous incumbent, and described 
his involvement and visibility as being considerably greater. Related to this observation, 
Dr Brown described a very different model which he had found to be effective in his 
previous employment as research fellow in another hospital: 
... there was much more of a quid pro quo thing going on between the research 
cover and the clinical cover.  Having said that there were more [...] of us, I know 
at one time [...] I had three other colleagues who were- […] in inverted commas 
‘research people’. […] at any given time there was one research person rotating 
through the ward that we would do like a month on the ward, doing the sort of 
registrar bit on the ward, which meant that the, unlike here where it’s a Care of 
the Elderly Registrar- […] It was actually a registrar who was interested in 
stroke medicine, [...] patients just were never missed for studies, because there 
was always somebody around who knew what was going on, on the research 
side.  Whereas here, the research person, that’s really all they do and they don’t 
dip in and out of the ward really doing clinical work. [INTERVIEW: Dr Brown, 
October 2007] 
 Visibility and a more continuous presence, as suggested by Sister Mitchell, 
appear to have been instrumental in achieving prompt communication and patient 
recruitment in Dr Brown’s previous employment. He acknowledged however that the 
complement of research staff (nursing and medical) was considerably greater than at the 
study site. Operational issues and recent structural changes (such as on-call 
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arrangements) at this study site presented challenges to the establishment of a joint 
research-clinical middle grade doctor team. Thus, being reliant on only one research 
fellow, integration was highly dependent upon the individual.   
6.4.2 Secondment of clinical nurses to research teams  
 A further suggestion raised by some of the ward nurses was that a period of 
rotational secondment of clinical nurses to the research team would improve 
communication, integration and understanding. There was also an expectation that 
secondment would have an ongoing educational impact, as on return to the ward the 
secondee would be able to share their knowledge and experience with the rest of the 
clinical staff. It was anticipated that a ‘snowball’ effect would be achieved in raising 
awareness, knowledge and participation (of both staff and patients). It was often stated 
by members of both teams, that clinical nurses could not participate in research activity 
because they did not know enough about it; however, it was also postulated that one of 
the reasons that they did not know enough about it, was that they did not get involved. 
Clinical staff suggested that a secondment rota might help to address this situation in the 
two ways.  First, involvement of the clinical nurses would address a gap which had 
arisen because of the temporospatial dislocation of the research team and second, it 
would facilitate unbiased and unpressured discussion with patient and family members 
about potential study involvement. Thus, secondment would enable the clinical nurses 
to help the research team, whilst also helping them fulfil their advocacy role in 
facilitating patient decision making. Ultimately, it was felt that this would enhance 
recruitment and retention. Senior nursing staff however, felt that this was not possible 
because of the already diminished staffing levels and poor skill mix in the Acute Stroke 
Unit – a recurring theme throughout the fieldwork that was recognised by all.  
6.4.3 Feeding back research results 
 In more general terms, there were concerns that the clinical team received little 
or no feedback on research studies that had been completed and therefore, were not 
encouraged to engage in other studies. Nurse Cooper stated that he had never been made 
aware of the results of any of the studies that had been completed, and noted that 
awareness of study results would enable the clinical staff to support patients making a 
decision about current participation:  
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these results as well would be handy for us to know, because we can give the 
information to the patient, say well the last trial this happened, that happened, 
the other [INTERVIEW: Nurse Cooper, August 2007] 
Lack of feedback may have been due to the significant number of previous studies 
that had failed to demonstrate an effect, but reporting of negative outcomes is important 
as this may provide rationale for future studies.  There was also a perception that ‘drug 
studies’ were not ‘nurse orientated’, and that clinical nurses may be more willing to 
incorporate research in their daily practice if it was seen to be more directly related to 
patient care.  
The SNP in particular stated: 
… if you did some research pertinent to their particular area, which I think 
would probably […] work more, maybes nurse-nursey orientated as opposed to 
drug orientated. […] I’d like to think that that area of research could be taken 
forward by the ward staff […] so I think maybe something which was geared 
towards patient care and improving patient care […] you might get the nurses 
taking it on board […] if it wasn’t going to increase their work load too much 
[…] and if they can understand the benefits of it [INTERVIEW: Stroke Nurse 
Practitioner, May 2007] 
 It can be seen from the extracts above, that the clinical staff were ostensibly 
willing to assist the research team, and recognised the importance and value of research, 
but its conduct remained problematic nevertheless. In the sections that follow, I explore 
some of the reasons for these difficulties, and the tensions evident in accommodating 
research activity within daily clinical practice. 
6.5 Limited Knowledge And Understanding Of The Research Protocols 
 As previously noted, organisational and operational issues precluded the total 
integration of research and care. However, another reason proffered for the clinical 
staff’s lack of engagement was that they did not know what the research nurses did, 
needed or wanted, and how their activities and requirements related to the ongoing 
study protocols. I have already illustrated that lack of knowledge about the role of the 
research nurse was attributable at least in part to the fact that the clinical team witnessed 
little if any of this activity, but there were also issues of communication pertaining to 
the study protocols themselves. 
and all we got to know is if they were signed up to [a study] we had to give a 
certain drug at a certain time of day, and that was it, that was as much as knew 
about it. […] Because half the time we don’t know, it’s, it’s sometimes, it’s 
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box A and box B sometimes, box A in the morning, box B at night-time, we 
don’t know what, what they are  - well I know yous don’t know what they are, 
but we don’t know what potential that they could be. [INTERVIEW: Nurse 
Cooper, August 2007; my emphasis]   
 Having already expressed concern about what happened to the data that the 
research team collected, the extract above exemplifies the clinical staff’s frustration that 
they knew little about the potential effects and side effects of study medication. They 
were given brief instructions about administration of study treatment, rather than 
information and explanations about the intervention. Thus although they knew what to 
do, they were sometimes uncertain why they were doing it, and perhaps more 
importantly, what the outcome of their actions might be.  In order to avert potential 
criticism regarding issues of accountability the clinical staff were careful not to declare 
total ignorance, but nevertheless recognised, and seemed concerned, that this lack of 
information, particularly regarding expected effects or possible side effects, had 
implications for individual patient safety. Whilst this was indeed so, the implications of 
potentially omitting to recognise and report an adverse event extended far beyond any 
individual patient. If an event was not appropriately managed subsequent patients may 
be unnecessarily exposed to similar risks which may ultimately influence the integrity 
of study findings.  
 Still further, this exclusion and lack of information impacted upon the clinical 
staff’s conduct of their own duties, not just their engagement with the research team. 
Despite the aim of collaboration and the oft repeated concern regarding the lack of 
involvement of clinical staff, they did not proactively take the opportunity when 
research staff were present in the clinical area, to engage in information giving and 
consent interactions. Echoing the research team’s reluctance to intrude in the clinical 
situation some of the clinical team noted similar reservations about intruding in research 
interactions, despite their claims to patient advocacy and the provision of holistic care. 
Research was viewed as something other, separate and extra, and the clinical team did 
not spontaneously engage in this arena. This demonstrated a marked difference from the 
way in which they interacted and engaged with other professional groups and 
disciplines. For example, when therapy staff were working with a patient it was not 
unusual for the ward nurses to ask questions or to offer ad hoc contributions to the 
assessment or exchange between therapist and patient. It was far less likely however 
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that they would contribute, or even listen to, a consent interaction or discussion about 
possible research participation.  
 The explanation offered for the reluctance to participate was that the clinical 
staff did not know enough about research, at either a general or study specific level to 
offer a knowledgeable and meaningful contribution to such an exchange:  
…if [Research Nurse is] talking to a patient and I’m around, you do have a 
tendency to sort of listen in, but that’s as much as - information. [...] I think wh- 
that’s between the patient and er, the research nurse and I think it’s, it’s not nice 
for me to interrupt and say “Oh, can I listen?”, because […] sometimes these 
patients might have a, a question they want to ask without the nurse being there, 
sometimes we’re an advocate for the patient as well because often they come 
back to us and say “Oh, the doctor said this, what’s that?” So - but it works in 
both ways, so we often listen but we don’t - I don’t interrupt anyway, so, and 
again I can’t interrupt because I don’t know enough anyway [INTERVIEW: 
Staff Nurse Cooper, August 2007]    
 Nurse Cooper stated that he had never been given any direct information about 
the ongoing studies, other than how, and when, to administer the study medication. He 
had never been directly involved in discussions between research staff and patient; he 
had occasionally ‘overheard’, but considered it rude to interrupt or to invite himself into 
the discussion. In his subsequent remarks however, it was unclear whether his hesitancy 
was a matter of politeness or whether his lack of confidence limited his willingness to 
participate. Whatever the reason, this was not an unusual situation.  
 Other ward staff also reported that they did not usually participate in, or even 
observe, the information and consent procedure and I did not witness any such 
involvement. As a consequence, they knew little about ongoing studies, to the extent 
that the SNP expressed concern that if questioned, the clinical nursing staff would not 
be able to articulate study aims, objectives or the balance of risks and benefits. This was 
also a cause for concern in her own practice, as illustrated here:  
... [a patient] asked me my opinion about [secondary prevention study] and 
basically I said to her errm I don’t feel as though I can give you adequate 
information about the trial in order to…to help you make a decision one way or 
the other [...] I didn’t think I’d handled it very well because I need to know more 
about the trial myself because they keep ask..you know if […] a patient asks me 
what’s the best thing to do then I felt a bit uncomfortable […] because I didn’t 
feel [...] as though I’d given her a good answer […] I think I was honest in 
saying I don’t know enough about it, which makes me think I have to find out 
more about it because people are going to ask me questions, [INTERVIEW: 
Stroke Nurse Practitioner, May 2007] 
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 She was uncertain about, and lacked confidence in, her own level of knowledge, 
and was aware that this limited her ability to adequately help and support the patient in 
her decision making. Here, as in some of the other examples noted, it was evident that 
the clinical nurses considered themselves to be disadvantaged by their lack of 
knowledge. As well as being cited as a reason why they were unable to help the 
research team, this was also seen to compromise their ability to fulfil an important part 
of their nursing role, that of patient advocate.  
 Clinical staff felt uncomfortable when they were not able to respond to patients 
who asked “what do you think?”, or those who had questions about possible side effects 
of treatment. Such issues were reported by a number of the clinical team, who suggested 
that their inability to respond to patients’ or family members’ queries engendered a 
sense of incompetence and lack of confidence.  
you can’t always answer them but […] you’ll say that we’ll get in touch with 
yourselves or whatever but I think that’s hard […] they think ‘oh well if they 
don’t know what it’s about then…’ [INTERVIEW: Junior Sister Mitchell, 
October 2007, interviewee’s emphasis] 
 The clinical team felt that patients valued honesty and integrity, and 
demonstrated both in acknowledging their own limitations, but they were also cognisant 
of the fact that this might impact adversely on recruitment and retention if patients felt 
that the whole team was not fully appraised of or engaged with, ongoing research work.  
 A paradox was evident here, in that clinical staff expressed a desire for 
information from the research team but did not appear to pay much attention to the 
information that was provided, and spoke about this in very vague terms, for example: 
There is a [research] file …. I surmise we’ve still got it [INTERVIEW: Staff 
Nurse Kane, November 2006] 
 Because the research team was not housed within the ASU, documents such as 
Investigator Brochures and Study Protocols, which contained information pertaining to 
anticipated side effects and potential adverse events, were not conveniently accessible to 
the clinical team. Once a patient was enrolled to a study, the most obvious place to find 
study information was via the Study Information and Consent Documents. These were
 
filed in the patient’s case notes and easily accessible by the nursing staff, although this 
did not address the issue of learning about, and thus being prepared for, new studies 
prior to recruitment.  
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 Clinical staff stated that they did not have time to look at the research 
information on the noticeboards during working hours and had no desire to stay after 
the end of a shift to do so. However they also hinted that the overabundance of 
information on display around the ward (not just pertaining to research) was sometimes 
counterproductive:  
you don’t look at these noticeboards, because they look the same all day every 
day, [someone] takes one down and puts another one up, you think “oh it’s the 
same thing”, you don’t read it. [INTERVIEW: Staff Nurse Cooper, August 
2007] 
 Nurse Cooper suggested that a newsletter, placed in each member of staff’s 
individual post ducket, might be a more efficient and effective way of conveying study 
information. This method would not promote the research team’s presence in the 
clinical area, but may be more successful than the information displayed on notice 
boards in enhancing the clinical team’s knowledge about the study treatments and 
progress to date.  
6.6 Prioritisation Of Learning And Activities  
 A further reason for the lack of engagement between clinical and research 
nurses, was the fact that the ward was invariably very busy and demanded a lot of 
physical nursing work, such as bathing, catheter care, and feeding, which was privileged 
above other activity. This physical work was seen to be part of the holistic care 
delivered by the clinical nurse to the patient and his/her family members, and was 
considered essential. Clinical work was undertaken with the intention of improving the 
health outcome of the individual patient with whom one was engaged at any one time, 
and also to maintain a safe environment for all patients in their care. The aim of 
research however, was concerned with the wider population, current and future, that 
may stand to benefit from the products of research, and as such was considered to be 
non-essential, for either patients or those healthcare professionals not directly involved. 
What the clinical staff seemed not to appreciate, was that although a patient’s initial 
decision to participate in research was indeed voluntary, having made that decision 
there were certain aspects of his/her management that then became, for the duration of 
the study period, essential.   
 Whilst differences in time, space and function contributed to the sense that the 
research team was a separate department, there were occasions when it appeared that it 
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was considered not only separate but less important. This applied to both training and 
workload distribution issues as illustrated below: 
... there’s other things happening within the ward, so we, from a nursing point of 
view we’re prioritising on those, rather than the research where there’s - you’ve 
got research nurses to do things like that, we are prioritising the res-, that, to, any 
in-house training on what we need to know, things like SNOBS and 
observations, incontinence, everything like that, even, even classification of 
stroke, it’s what we as nurses need to, need to do and look for, [INTERVIEW: 
Staff Nurse Cooper, August 2007] 
 Despite having identified a need for research training, ongoing in-house training 
was prioritised to address issues that were perceived to be important from a nursing 
point of view. It is clear from the extract, that research was not included, implying that 
it was not a priority and/or that it was not considered to be a nursing task. By extension 
this also implied that nurses who chose to engage in the research arena were therefore 
not real nurses, a theme repeated both implicitly and explicitly throughout interviews 
and fieldwork. Yet, it was noteworthy that one of the issues that was considered 
pertinent to the nursing staff was stroke classification, which was actually a diagnostic 
issue, usually addressed by medical staff, the stroke nurse practitioner or research 
nurses. Nevertheless, by expressing willingness, but claiming to be unable to take up 
opportunities for learning and engagement, the clinical staff were able to eschew 
responsibility for this deficiency; it was considered beyond their control.  
 Several tensions and contradictions were evident here. On the one hand there 
was concern amongst clinical staff that they were inadequately trained and informed 
regarding research activity both at a generic level during their basic training and more 
specifically regarding individual research protocols ongoing within the clinical area. 
Simultaneously however, when attempts were made to facilitate research training (see 
Chapter 7.5), this was not perceived to be a priority. In fact several training sessions had 
been cancelled due to failure to register viable numbers of attendees. Similarly, whilst 
the clinical team claimed to feel excluded by their lack of involvement, they made little 
effort to become involved, and expressed the opinion that research tasks were the 
research nurses’ responsibility. There was a strongly held and very clearly articulated 
view that these were two separate areas of work:  
what also the research nurses have to remember is that the qualified nurses have 
got their own work to do [INTERVIEW: Senior Sister Hatfield, July 2007 – my 
emphasis] 
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 Previous research experience notwithstanding, Sister Hatfield considered that 
individual patient and research requirements could not share equal priority. As argued 
by many (for example, Beale and Wilkes, 2001), she stated that the clinical nursing staff 
were responsible for the safety and wellbeing of all of the individual patients in their 
care, and could not compromise their individual safety by becoming diverted to research 
activity  Paradoxically however, if the clinical team did not engage with the ongoing 
research protocols, they would not be able to protect those patients participating in 
research by anticipating risks and identifying research-related adverse events if and 
when these occurred. The claim that they could not become involved in research activity 
because they were too busy ‘protecting’ the patients, may unintentionally result in lack 
of protection. Conversely, whilst the individual patient could not be the research nurses’ 
sole priority, that was not to say that their safety and wellbeing were not important both 
at an individual personal level, and in terms of study integrity and benefit to future 
patient populations.  
 There was also a sense that the research nurses had only their research duties to 
attend to and that these were primarily administrative and technical (see Chapter 7). The 
ward nurses on the other hand, expected and were expected to, fulfil a number of 
diverse roles, but did not consider research to be one of them. One of the more senior 
staff nurses, appeared to be very much in favour of research being undertaken in the 
stroke unit but could not reconcile this as being part of her role because, she stated, she 
had “such a lot of other roles that are, you know, that I need to…to fulfil” 
[INTERVIEW: Staff Nurse Lawson, June 2007]. These ‘other roles’ were more clearly 
identified in the following extract, which placed further emphasis on what was 
considered to be important as a nurse, physical care again being privileged; study 
participation was not considered a priority: 
We’ve got more other things worrying than whether they’re going to go on a 
trial, I know again that sounds nasty, but we’ve got a lot of – you know as a 
nurse there’s, there’s too many things going on and you’re looking after their 
physical sides than – and you look at things holistically but to me that’s 
[research], that’s another part of the jigsaw [INTERVIEW: Staff Nurse Cooper, 
August 2007 – my emphasis]. 
 Here too a paradox exists, whereby although research was considered “another 
part of the jigsaw” it was evident that for Nurse Cooper, it was actually a piece of a 
different jigsaw – one that he did not engage with. This seemed to be at odds with 
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claims that the clinical staff delivered a holistic approach to care, and further 
demonstrated the lack of understanding of the research nurse role.  
 The tensions that existed between research and care in daily practice were 
clearly illustrated in the following account, in which a patient who had consented whilst 
in EAS to participate in a study investigating blood pressure control was then 
transferred to ASU for further management.  
The ward staff gets [the patient] into bed and Research Nurse Higgs starts to 
prepare for his first dose of study medication. ¼ or ½ hourly observations have 
to be made for the first few hours and if the research nurses are around they 
would normally do this […] but if they fall outside their normal hours the 
research registrar would do it. […] Dr Chatterjee […] (half) jokingly asks, I 
don’t have to stay till [8pm] though do I? […] Research Nurse Higgs says he’ll 
stay if Dr Chatterjee doesn’t want to but after bringing a BP machine into the 
patient’s cubicle he begins to explain the protocol requirements to Nurse Oliver 
and one of the students who will be looking after the patient tonight. He explains 
that they will need ¼ hourly blood pressure recordings for 4 hours then ½ 
hourly. Nurse Oliver says she’ll set up the BP machine to do them automatically 
and asks do they just want them recorded (in the machine) or do they want them 
actually written down on the observation chart. Research Nurse Higgs says it 
would be helpful if they could be written on the observation chart but not to 
worry if it’s not possible as long as there’s a record actually on the machine. 
[…]Dr Chatterjee asks the student if she will do this and she is agreeing but 
Nurse Oliver just says that they’ll do the best they can because ‘we have got 
other patients to see to you know’ [ABRIDGED FIELDNOTE: November, 
2006; my emphasis]. 
 Again, this episode conveys the sense that engagement of the clinical nurses in 
research activity is optional, resources permitting. The need to involve them in such 
activity arose because the research nurses, due to resource limitations were unable to 
provide 24 hour cover. Although this meant that recruitment was usually limited to 
‘office hours’, subsequent care and study management was not similarly restricted. 
Once enrolled a patient’s participation was continuous and observation could not be 
confined between the hours of 09:00 – 17:00. This being so, the research team had 
either to delegate some of the ongoing research tasks to other staff, namely members of 
the clinical team, or, to rely upon automated monitoring equipment. A conflict between 
research and clinical practice was clearly illustrated here; whilst the student nurse was 
willing to help, Nurse Oliver made it clear that patient care – for all of the patients was 
their priority – implying that in her opinion research activity is not care. It is worth 
noting here however, that if a patient required this level of observation for clinical 
reasons they would typically be deemed to be medically very unstable and would 
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probably be on an intensive care unit, or at least high dependency unit, where there is a 
greater nurse:patient ratio. Taking this into account, the research demands may be 
perceived as unreasonable, especially on a late shift, when there were frequently only 
four nurses (two qualified) on duty. As reported repeatedly, the pressures on clinical 
staff were enormous - dealing with families, doing drug rounds, as well as attending to 
the usual demands of highly dependent patients. 
 Similar conflict of priorities was highlighted by another nurse, who described an 
earlier period when a particular study was being undertaken, and it became necessary to 
ask the research team to restrict the number of patients that they enrolled to the study, 
because the workload implications for the clinical team were such that this was 
impinging upon their ability to undertake their clinical duties. Therefore, clinical 
resource limitations impacted upon the successful conduct of research. It was this 
nurse’s perception that in the interests of patient safety (all patients) and study integrity, 
in some cases, it would be better to limit recruitment than to fail to adhere to study 
protocol.  During this period, the research team had appeared unaware that the clinical 
staff was becoming overwhelmed by the requirements of the research protocol, a 
situation possibly indicative of the fact that the research team spent only brief moments 
on the ward. Although they had all previously had some clinical experience, and 
therefore had an idea of the workload, they may not, unless they had witnessed it, 
understand how their activity impacted upon it in the context of these particular studies 
at this particular time.  
 It should be noted however that the prioritisation of clinical practice over 
research was not restricted to the nursing staff. One of the consultant clinicians, who 
had previously been employed as a research fellow in the same unit, explained that in 
his former role he was completely focussed on research and was disappointed if patients 
did not participate. Currently however, as a clinician with a research interest, he stated 
that he found himself “juggling between two responsibilities” [INTERVIEW: Dr Silva, 
June 2007] but that delivery of care was now his first priority and he did not experience 
such an emotional or personal response if unable to recruit. 
6.7 A ‘Deviant’ Case – Where Research Helps Care  
 Despite the prevailing sense of separation and exclusion, there were moments 
when the research nurses became ‘visible’ and their input and involvement was actively 
sought. There were a number of examples of the senior research nurse in particular 
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delivering ‘fringe benefits’ to the organisation as a by-product of research activity. For 
example he regularly extracted data from the European Stroke Database (ESDB) for 
clinical applications such as, identification of service use, or for clinical audit purposes. 
Such activities however demonstrated a blurring of the research nurses’ role with 
managerial or administrative functions which still went largely unnoticed by the clinical 
nursing staff.  They did however take advantage of the assumption (whether based on 
gender or perceived research role attributes) that the senior research nurse would 
possess a certain level of technical competence:  
Senior Research Nurse Higgs stops [at the nurses’ station] to ask me a question 
[…]. Whilst we are talking we’re politely interrupted by Nurse Lawson (senior 
staff nurse). Excusing herself she tells Nurse Higgs that she can’t get ECG 
machine to work, and asks him to have a look at it. Nurse Higgs jokes that he’s 
not an ECG technician but goes to have a look anyway. [FIELDNOTE: 
November, 2006]   
 It was not clear whether Nurse Lawson’s assumption that Nurse Higgs would be 
able to resolve the problem was contingent upon his gender or his researcher status, but 
whichever was the case, Nurse Higgs attempted to do so. Because research was not 
integral to the clinical nurses’ daily routine, a considerable degree of goodwill was 
involved in securing their cooperation, not to say assistance, in the enrolment and 
management of study patients. Research Nurse Higgs’ willingness to help with matters 
outside his scope of expertise served to develop and reinforce a more reciprocal 
relationship and foster good relations between the clinical and research team.  This was 
in sharp contrast however to his instruction to Research Nurse Fowler not to become 
involved in clinical tasks (see Chapter 7). 
6.8 Discussion 
 There is a considerable body of work in the nursing literature pertaining to the 
reluctance of nurses to conduct or act upon the findings of research (Hicks, 1999). Much 
nursing practice is still fundamentally rooted in custom and practice and is historically 
entrenched rather than empirically validated or evidence based. The examples discussed 
throughout this chapter suggest that this reluctance may be related to perceptions 
regarding prioritisation, concepts of professional role definition, and expectations and 
previous experience.  
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6.8.1 Perceptions regarding the prioritisation of clinical versus research demands 
 Although sometimes frustrated at what was perceived to be a lack of cooperation 
or enthusiasm from the clinical staff, the research team acknowledged that practical 
pressures restricted the clinical staff’s opportunities to become involved in research 
activity. A recurring theme throughout my study, and evident in both observation and 
interviews, was the poor staffing levels in the ASU. Clinical staff reported they felt that 
this limited their capacity to contribute to research, and moreover, potentially adversely 
influenced study recruitment and retention, which suggested that they were aware that 
they potentially had a role to play. Research staff adapted their own behaviour and 
expectations accordingly and endeavoured to cause as little impact as possible upon the 
clinical team’s workload. However, there was a fine line between unobtrusiveness and 
exclusion, which was on occasion, perceived to be crossed. 
6.8.2 Concepts of professional values and role definition 
 Cognisant of the staffing issues, the research team was mindful not to criticise 
the clinical staff too harshly and found ways to rationalise their lack of involvement in 
research. The clinical staff however, was not quite so accommodating of what they 
perceived to be less desirable traits on the part of the research team, and interpreted 
these characteristics as a conscious decision to move away from hands on care and 
‘dirty work’. The clinical nurses perceived their own rebuttal of research related tasks as 
a reflection of other extraneous factors beyond their control, but considered the research 
nurses’ withdrawal from ‘hands on’ care, to be a personal, values-based choice. Being 
unfamiliar with the duties and responsibilities undertaken and held by the research staff, 
they perceived them to have abandoned the very relational and interpersonal skills that 
these unseen aspects of the research role required. 
 As will be expanded upon in the following chapter, the research nurses adopted 
different positions depending upon the clinical environment and the requirements of 
their role at any given time point. In the Acute Stroke Unit they endeavoured to cause as 
little disruption as possible to the clinical staff’s workload and for the most part fulfilled 
their own responsibilities in parallel to whatever clinical interventions were ongoing. 
However, this perceived detachment represented another way in which their role blurred 
with that of their medical colleagues and thus contributed to their alienation from their 
clinical nursing counterparts.  
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6.8.3 Expectations and previous experience 
 A very specific version of the role of the nurse was presented and expected by 
the clinical staff and it was for the most part, the socially constructed stereotypical 
image of the caring professional ‘tending the fevered brow’. Those who operated 
outside the boundaries of this circumscribed role – in this instance the research nurses - 
were viewed with suspicion and were more or less socially excluded.  
 The research nurses were able to empathise with the clinical team and the 
difficulties that they faced because they had all also worked in a clinical environment. 
This was not the case for the clinical team however, who, with the exception of Sr 
Hatfield had not experienced a research nurse role. They therefore expected the research 
nurses to behave like nurses, i.e. like them – and found this difficult to assimilate when 
they did not.   
 A further, unfulfilled expectation was that of reciprocity. The clinical team 
expressed a sense that the research team ‘took’ from them but did not reciprocate. This 
is perhaps an unfair interpretation of the research nurses’ activity, as they did indeed 
contribute to clinical care, for example in the assessment and management of patients 
eligible for and receiving thrombolysis. However, although this helped the clinical 
team, it was a different clinical team, outwith ASU, and again, the activity was 
unobserved. Nevertheless, direct reciprocation may have been helpful in building 
relationships with the ward staff and raising the research profile. This could possibly 
have been achieved by providing feedback about the research findings; including 
members of the clinical team in meetings, and feedback in order to promote a sense of 
academic involvement, and also an offer of help with understanding the patient’s needs, 
diagnosis or aspects of their treatment (as was reported to be the case with researchers 
in other specialties).  
 In this chapter then, I have demonstrated the way in which the clinical staff 
perceived the research nurses, how they engaged with them, and the basis for some of 
the functional difficulties, as perceived by the clinical team. In the following chapter, I 
explore the research nurses’ perception of their own role and identity, before finally 
considering how these two standpoints come together to sustain (or not) the research 
endeavour.  
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Chapter 7. Separation of Research and Care: Performing 
Research Identity  
7.1 Introduction 
With the proliferation of new nursing roles, spawned at least in part by the 
publication of the UKCC Framework on the Scope of Professional Practice (United 
Kingdom Central Council for Nursing Midwifery and Health Visiting, 1992), there 
came confusion and conflict regarding role responsibilities and definition. 
Commentators who have attempted to define the role of the research nurse frequently 
struggle to identify supporting literature, and that which exists is often predominantly 
anecdotal (Raybuck, 1997; Raja-Jones, 2002). There is however, a recurrent theme of 
title confusion and conflation, including research nurse, study site co-ordinator, data 
manager and clinical nurse specialist in research. The title chosen, or imposed, is 
instrumental in determining the identity of the title holder and the way in which their 
responsibilities are recognised and enacted; the title ‘data manager’ for example, 
conveys quite different expectations from those of ‘research nurse’ but both have been 
used to signify similar, if not identical, roles. Nevertheless, at the study site, even those 
sharing the same titles i.e. Research Nurse or Senior Research Nurse, described broadly 
similar aspects of their role, but prioritised these components differently and engaged in 
them to a variable extent. 
Among their roles and responsibilities the research nurses listed:  patient 
assessment and delivery of care (for clinical as well as research purposes), facilitation of 
thrombolysis where appropriate, and longer term follow up, including resolution or 
investigation of other health problems, whether or not they appeared to be related to 
study involvement. They also facilitated study enrolment and informed consent, 
provided information to staff, patients and family members, acted as patient advocates 
and undertook administrative and technical tasks. In order to achieve the overarching 
aims and objectives of their role they performed all of these component parts. In the 
sections that follow I describe and illustrate these discrete elements, but also outline 
how the research nurses were more than the sum of these parts, and how the 
amalgamation of these elements shaped their overall identity and function. 
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7.2 When Is A Nurse Not A Nurse? When S/he Is A Research Nurse? 
Although limited in their level of clinical commitment, members of the research 
team at the study site still bore the title ‘nurse’ and some chose to retain the visual 
identity afforded by this affiliation. The argument that we manage our appearance and 
conduct in order to present ourselves in a certain way to certain other individuals or 
groups is well rehearsed. Goffman (1959) has described how management of 
appearance affords access to different settings and determines how one is perceived and 
accepted (or not) therein, whilst Gergen suggests that by adopting a particular style of 
clothing one ‘becomes’ what that clothing represents (Gergen, 1991). Others suggest 
that the workplace is instrumental in the formation of identity, but the research nurses 
inhabit a liminal space, both temporospatially and operationally, and therefore perhaps 
this visual identity was one of the few concrete or enduring identities available to them 
(Miller and Rose, 1995). The wearing of a uniform conveys many messages, both 
positive and negative, to the wearer and to the observer (Livingston, 1995; Mangum et 
al., 1997). In some circumstances however the decision to wear a uniform is not a 
matter of personal choice but is governed by external influences such as institutional or 
professional policies (Hochschild, 2003). Healthcare organisations are by no means 
exceptional in utilising uniforms in order to communicate membership, status and role 
both within the group and to those external to it. When my fieldwork began there was 
no mandatory uniform policy in place for research staff and it was left to the individual 
to decide how they wished to present themselves. Whilst it would be naïve to suggest 
that appearance alone determined the socialisation and acceptance of the research nurses 
in the clinical setting, it would be equally disingenuous to suggest that it did not 
influence the way in which they were perceived by their clinical colleagues, patients and 
the visiting public. The options available, decisions made, and implications of these 
decisions are discussed below. 
7.2.1 Being a research nurse: dressing the part   
The designated research nurse uniform was distinct from that of the clinical staff 
and consisted of maroon tunic/navy trousers or a maroon dress for females, or navy blue 
trousers/white tunic with maroon epaulettes for males. The research nurses had three 
options: do not wear a uniform; wear a uniform at all times; or wear a uniform only 
when in the clinical area/conducting clinical tasks. Each of the research nurses 
demonstrated clear, though different, rationales regarding their choice of dress. Nurse 
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Fowler’s preferred option was to wear a uniform at all times. Her rationale was 
pragmatic; the uniform was free of charge and she did not have to waste time and 
energy thinking about what to wear. Her choice allowed her to continue to identify with 
her professional colleagues whilst at the same time demarcating the difference in her 
role. In practice however, although her uniform was distinct from that of the clinical 
staff, the functionality of this distinction was questionable, as illustrated below.  
One of the cleaners asked me the other day what was my job and she’s seen me 
for the last year  […] I think it was just the uniform, you know, they see all these 
different uniforms and they were just curious… [INTERVIEW: Research Nurse 
Fowler, January 2007] 
Nevertheless, despite, or perhaps because of, this lack of distinction, the wearing 
of a uniform conveyed some advantages, as noted by Research Nurse Slater, who 
switched from everyday clothes to a uniform after a few weeks in post. She stated that 
she ‘[felt] more comfortable’ wearing a uniform on the ward and seemed to be ‘more 
accepted’ by other staff (summarised from fieldnotes). Holliday likens uniforms to 
masks, with positive or negative connotations (Holliday, 1999). The esteem (or other 
attributes) attached to the group is bestowed upon the individual thus identified, along 
with associated rights, such as access. Echoing this observation, Nurse Slater reported 
that she was questioned less often about who she was and what she was doing if she was 
in uniform. Her decision was therefore based upon her interpretation of other people’s 
reaction towards her. It was also context dependent, as she explained that if she was 
conducting a blood pressure clinic for example, she would not wear a uniform because 
of the so-called ‘white coat effect’ (Mancia et al., 1983). 
It was evident that whilst no mandatory uniform policy was in existence for the 
research nurses they faced a cost-benefit analysis regarding their decision to adopt a 
particular visual identity. In its favour, the nurses’ uniform facilitated access to different 
areas and may also have facilitated execution of the research nurse role, by influencing 
others’ perception of that role. It conferred rights – such as access – but also obligations 
related to the commonly perceived characteristics of the nurse i.e. the delivery of 
physical care – which the research nurses were not always able to fulfil. Thus despite 
the potential advantages, this misidentification may have resulted in subsequent 
discomfort for the research nurses if they were asked to perform clinical tasks that they 
could not or would prefer not to undertake (Zuzelo, 2007), and disgruntlement for the 
patient if a ‘nurse’ failed to address his/her needs.    
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Some of the research nurses chose not to wear a uniform, and offered several 
reasons for their decision. Some did not see themselves as fulfilling a clinical role and 
did not wish to be called upon to do so. They therefore chose not to wear a uniform in 
order to avoid the misrecognition previously noted.  Further, some equated the wearing 
of a uniform with diminished autonomy and told me:  
‘I wouldn’t like to have to work in uniform again. I could wear uniform here 
[ASU] but I choose not to; I like the fact that I have more autonomy here.’ 
[Direct quote from fieldnotes, Senior Research Nurse Higgs, October 2006].  
Research Nurse Higgs indicated that when the mandatory uniform policy was 
introduced he would endeavour to schedule his workload so that he wore the uniform on 
days when he needed to access the clinical area, but not when working solely in the 
office. The ASU Sisters already employed this policy one day per week, when they 
undertook solely administrative tasks. In response to suggestions that doctors should 
also wear some form of uniform he responded that this would not happen ‘Doctors will 
never [wear uniform], they’ve got too much power’ [FIELDNOTE: April 2007]. 
Although some writers suggest that uniform signifies professionalism, status and 
power amongst nurses (DeKeyser et al., 2003; Allen, 2004) Research Nurse Higgs 
considered it a demonstration of power that doctors did not wear uniform and therefore 
believed that amongst doctors (and perhaps managers), the nurses’ uniform was 
perceived as a symbol of subordination.  
For some a uniform may instil confidence and engender respect, whilst for 
others it presents a barrier and undermines the clinician/patient relationship (Brennan et 
al., 1995; Mangum et al., 1997). These opposing arguments were partly illustrated in 
Nurse Slater’s rationale. On the one hand, she stated that her uniform facilitated 
recognition and access, but simultaneously noted that there were some situations where 
she thought she quite definitely should not wear it. For example, such as when 
conducting the clinic for a blood pressure study (cardiology), because she knew from 
experience that patients’ blood pressure recordings are often significantly higher when 
she approaches them wearing a uniform rather than everyday clothes. 
Despite the pros and cons associated with the symbolic function of a uniform as 
noted above, a decision not to wear a uniform was no less problematic. Although 
avoiding misidentification as a clinical nurse, and the accompanying expectation of the 
provision of physical, clinical care, the non-uniformed research nurses, carrying some of 
the paraphernalia usually associated with doctors and und
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medical tasks (e.g. venepuncture, electrocardiograms), may be misaligned with medical 
staff or managers/administrators. Doctors on the ASU seldom wore white coats, so even 
though the (non-uniformed) research nurses introduced themselves to patients as such, it 
was possible that they may have been mistaken for doctors. Such misrecognition may 
alienate them further from the clinical nursing team. Indeed one of the ward nurses 
noted that he initially mistook some of the research nurses for doctors and believed that 
some patients had been similarly confused.  Considering the traditionally gendered 
nature of nursing there is also the possibility that this may have contributed to role 
confusion regarding Research Nurse Higgs, but this was not evidenced in my data (c.f. 
Fletcher, 2007)  As noted above, the ASU Sisters had allocated ‘management days’. On 
these days they remained in their everyday clothes, which was perceived as signifying 
that they would not participate in any clinical activity. On these occasions other staff 
oriented to them differently, primarily as administrator, not clinician or researcher. 
Perhaps this also addresses the assumption that the (non-uniformed) research nurses 
were primarily occupied with administrative issues – synonymous with paperwork, 
which brings us to another of their identified roles, that of data collector. 
7.3 Research Nurse Or Data Collector    
When a ward domestic asked Research Nurse Fowler what her job was, her first 
response was that she ‘collected data’.  
I told her I was a research nurse, that I collected data and that’s what my job was 
and trying to get people to take part in trials…[INTERVIEW: Research Nurse 
Fowler, January 2007] 
A criticism levelled at many research nurses is that they are little more than data 
managers who ‘collect numbers for doctors’ [personal experience], and for a number of 
those interviewed this was initially the way in which they were introduced to research. 
I got into research through Dr Black […] I did some work […] for him […] 
mainly just blood sampling and 24 hour observations [INTERVIEW: Senior 
Research Nurse Higgs, November 2006] 
It has been noted that this is often a source of derision (Hill and MacArthur, 
2006) from other nurses but it was suggested by the research nurses that this may be due 
to the fact that the ward staff in general did not understand the importance of the data 
collected, or the precision and degree of rigour required in collecting it, as noted here.  
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[Research Nurse Higgs says that the ward staff] do not appreciate the precision 
required for completion of study procedures and documentation. He offers the 
example that all of the observations (e.g. blood pressure recordings) on the ward 
are documented as being assessed at 6 o’clock, when clearly it is not possible to 
check every single patient at exactly the same time. [FIELDNOTE: June 2006, 
my emphasis] 
Accuracy is important in recording study data because unlike assessment for 
clinical purposes, which relates solely to the individual, observations and measurements 
for study purposes need to be correlated with other variables and with the administration 
of study intervention. The ward staff was not familiar with study protocols or 
procedures and therefore did not appreciate this.  
Whilst the research nurses in this study agreed that data collection was a major 
part of their role, it was apparent that they did not view it in the same way as their 
clinical counterparts. The research nurses recognised the relevance and importance of 
data collection in ensuring the effective and safe management of research protocols and, 
thereby, the safety and wellbeing of participants recruited to them.     
the clinical side […] has a lot of paperwork that’s unnecessary, […] care plans 
[...] that you just slotted the patient’s name in, […] this is just ridiculous and it’s 
pointless […] research paperwork is sometimes very tedious and very 
monotonous and very repetitive but, it’s just making sure you’re collecting all 
the right data and, you know, you can see the point to it, you know, you’re 
writing down all the medications, you’re writing down all the medical history 
and they have to, you know, reference each other, so if they’re on a tablet they 
have to be on a tablet for a reason and that reason has to be on their medical 
history, you know, it makes sense to me so I don’t have a problem with it 
[INTERVIEW: Research Nurse Webb, June 2007] 
Centrally, the research nurses’ data collection was about safety. Thus, whilst the 
majority of the clinical team equated research with copious amounts of paperwork, the 
research nurses viewed this as purposeful, when compared to the clinical and 
organisational bureaucracy associated with some of the clinical team’s paperwork. One 
of the research nurses even reported that she had left the clinical arena, and indeed the 
NHS altogether shortly after qualifying (she emigrated to Australia), at least in part 
because of the proliferation of ‘ridiculous and pointless’ paperwork that occupied so 
much of the clinical staff’s time that it took them away from direct patient contact and 
hands-on caring.  
Nevertheless, whilst research data collection was seen to be important, it took 
second place to clinical activity.  For example, although the research team was seen to 
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take control in the emergency assessment of new patients (see Chapter 5.5), the 
situation was quite different when reviewing patient case notes for potential study 
eligibility on the Stroke Unit. The research nurses invariably handed the notes over 
almost immediately to the clinical team, often without any direct request being made, 
thus privileging clinical need over research requirements, and differentiating between 
the two. This negotiated ordering of roles and responsibilities was not verbalised but 
was based upon the actors’ anticipation and/or previous experience of the action of 
colleagues. Such indiscriminate deferral to the clinical team further perpetuated the 
notion that research was separate from and somehow less important than clinical care. 
Consequently, whilst research itself appeared to be perceived to be less important, there 
was concern amongst the research nurses that their chosen speciality was not afforded 
the status of a recognised professional role in its own right, but rather as support role to 
another professional group (usually doctors), as illustrated in the following section.  
7.4 Research Nurse Or Research Assistant: Hand-Picked Team Or Handmaiden?   
At the study site, rather than an overall acceptance of, or commitment to, a 
research ethos, individuals were seen as research champions. For example, Dr Brown 
referred to ‘Jack’s’ (Dr Black’s) research fellow’, as if Doctor Black commanded a hand 
picked team of ‘helpers’. Perhaps such perceptions could be addressed by reviewing the 
historical assumption, noted by Mulhall, that research is the responsibility of individuals 
rather than professions or organisations (Mulhall, 2002), but in the meantime, some of 
the research nurses remained concerned that their role was perceived by others as one of 
‘doctor’s assistant’. They worried that they continued to be perceived as hand maidens, 
and the struggle for seniority and status therefore persisted, although ways in which 
they could demonstrate their expertise and exercise their authority were often 
undermined. 
Research is widely perceived to be a symbol of professionalism; a hallmark for 
good practice, quality, efficiency and innovation and therefore goes beyond the role of 
providing evidence upon which good practice should be based. It is suggested that 
research has been ‘constructed as an ideology’ (Mulhall, 1997) – according to Hicks 
(1996), one incompatible with the care giving definition of nursing.  Most senior 
doctors who undertake research still undertake clinical activities identical to non-
research active senior medical staff (albeit less). This integration of research within 
medical practice in a structural way has avoided senior research medical staff being 
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considered a completely separate group (comments about glory seeking and lack of 
experience notwithstanding). Unfortunately, whilst there are some exceptions, this 
model of practice is not widely available to senior nursing researchers (or for that matter 
senior nurse administrators) within the study site, and inevitably means that they are 
seen at best as doctors’ research assistants or at worst, as a different, clinically 
incompetent group.  
Several of the research nurses, like others known to me personally and including 
myself, initially became involved in research at the request of senior medical 
colleagues, and on a relatively small, and sometimes informal scale. Regardless of the 
means of their initiation to research however, they have since gained considerable 
experience, undergone training and assimilated substantial specialist knowledge. They 
argued that they dealt with their ongoing research protocols every day, and were 
therefore more familiar with all aspects of their management, whilst the doctors, even 
the research fellow, were less familiar, an observation exemplified in the following 
interaction:   
… at the nurses’ station [...] there are boxes [of study drug] all over the desk. 
[...]  They have just seen a patient in EAS and randomised her to CHHIPS [...] 
Research Nurse Higgs is explaining to Dr Chatterjee how to titrate, prescribe 
and administer the initial doses including how to use the tablet crusher [...]. He 
reminds Dr Chatterjee that labetolol also needs to be prescribed. […] Research 
Nurse Higgs is explaining to him that he will have to administer all of the 
titration doses and complete the observations but once the patient is onto the 
maintenance dose the ward nursing staff will be able to administer this. [...] 
Research Nurse Higgs is whizzing very quickly through the instructions with Dr 
Chatterjee, although he reassures him that he can ring at any time tonight if he 
has any queries or problems. [FIELDNOTE: 13th November, 2006] 
[Referring to the above] Research Nurse Higgs notes ‘at least you did see me 
babying Dr Chatterjee through the procedures’ [FIELDNOTE: 14th November 
2006] 
Research Nurse Higgs felt that he had had to coach the research fellow through 
the procedures and processes required, in order that he could regurgitate this 
information for the patient. When interviewed however, the research fellow provided a 
very different description of his role and responsibilities, stating that this particular 
study was ‘doctor oriented’ and was managed solely by him, although some of the other 
studies, mainly those in secondary prevention, included greater nursing involvement. It 
was interesting that the research fellow perceived the management of these studies in 
this way because what I actually observed, as noted in the extract above was the 
145 
 
 
research nurse(s) guiding him through most aspects of study processes and procedures, 
regardless of their acuity. Moreover, this element of guidance and instruction was not 
restricted to the medical staff’s interaction with study participants. I also observed 
several occasions where the research nurses had to guide medical staff through the 
electronic randomisation process, completion of case report forms, and adverse event 
documentation.  
The concept of ‘assistant’ thus seems somewhat misplaced, and gave rise to 
frustration amongst the research nurses, not least because despite being more familiar 
with most of the studies than the medical staff, they were not generally permitted to 
obtain informed consent from patient or family members and were not allowed to 
prescribe study medication.  
I feel…regret the fact that as nurses we can give all the information and guide 
the patient through and guide the doctor through to an extent about what the 
study is and then at the end of the day it’s the doctor’s signature that goes on the 
bit of paper […] if you accept the risk of extending your role and, and you 
understand the implications of that, you’re still working closely with the doctors 
anyway […] does it really make any difference whose signature it is on that bit 
of paper as long as it’s somebody that’s representing the study and representing 
the research, who knows the research and knows the implications to that patient? 
[…] that’s part of the responsibility of you being a professional nurse; […] you 
have to take responsibility for your own practice. [INTERVIEW: Senior 
Research Nurse Higgs, November 2006] 
Research is a highly regulated practice which inevitably requires a high level of 
administration and coordination. The research nurses’ therefore identified their main 
role as the identification and subsequent facilitation of recruitment of potential study 
participants. They undertook this role with variable input from their medical colleagues. 
The research nurses searched for, and identified patients who were eligible to be 
approached for consent to participate in the ongoing studies. They provided information 
which the patient was able to consider in order to decide whether or not to give consent 
to participate. Having provided this information, they assessed, albeit mainly tacitly, the 
degree to which potential participants understood the information and therefore had the 
capacity to consent. They answered questions that may influence a patient’s decision to 
consent, and yet, in this particular environment, were not permitted to actually obtain 
consent from the patient, or agreement from their family members. The research nurses 
felt that referral to the research fellow or other medical staff was tokenistic, and 
undermined their authority and expertise amongst their clinical counterparts, – 
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reinforcing the notion of ‘doctor’s little helper’ - and patients alike. This lead to 
dissatisfaction on the part of the research nurses in situations where they felt that they 
were willing and able to extend their role, e.g. prescribing and obtaining informed 
consent, but where this was not accepted at a medical or policy level. Some of the 
research nurses argued that they should be able to write up a prescription arising from 
an approved randomisation procedure. As they were always working under the auspices 
of the Principal Investigator (PI) and as part of the research team, they argued that as 
long as the PI was consulted, and was in agreement that the patient fitted the inclusion 
criteria, patient safety would not be compromised.  
It can be seen above that the element of ‘assistant’ comprised a considerable 
element of communication and information giving, to research colleagues and to 
patients/families, but there was a broader remit to this aspect of the role which I now 
move on to discuss below.  
7.5 Research Nurse Or Educator: Communicating And Informing 
The research nurses, medical staff, and ward nursing staff, all acknowledged the 
limited attention paid to research concepts and methodologies within the basic training 
of doctors, and particularly, nurses. They also noted a perception that the general public 
knew little about research, other than seeing market researchers in the street, or of high 
profile scientific advances (or blunders) reported in the media. Most people, it was 
argued, neither realised nor expected that research was undertaken in the hospital 
environment, nor that they may be approached to participate in it. Given this lack of 
awareness, it fell to the research nurses to educate the clinical staff about the specific 
ongoing research studies and also to inform potential patients of their rights and 
responsibilities should they agree to consider participating in a study.  
Senior Research Nurse Higgs reported that he considered it his responsibility to 
ensure that the clinical staff knew enough about each of the ongoing studies to ensure 
the safety and wellbeing of those patients participating in them. However, opportunities 
for him to deliver, and for them to receive, adequate and timely training were limited. 
All clinical staff noted that he tried to keep them up to date with new studies, but also 
followed these statements with various rationales as to why this was difficult, either due 
to their own or the research nurses’ workload or, to the relative paucity of patient 
recruitment. The infrequency and irregularity of recruitment meant that it was difficult 
for the clinical staff to accumulate knowledge about, and confidence in, undertaking 
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study procedures. It was also difficult for the research team to provide teaching/training 
about individual studies in the abstract. The teams therefore relied upon individual one-
to-one information giving, as and when patients were enrolled to studies. Unfortunately, 
one of the effects of this approach was that clinical staff were only ever informed, rather 
than educated. That is to say, they were provided with enough information to fulfil 
specific tasks, rather than being furnished with background information regarding study 
rationale. The focus was on short term requirements for task completion rather than 
longer term education and development.  This contributed to the chicken-and-egg 
situation previously described [Chapter 6], whereby the clinical staff did not get 
involved in research activities because they did not know enough about the studies, and 
they did not know enough about the studies because they did not get involved.  
Several staff members, clinical and research, noted that the stroke nurse 
practitioner tried to organise regular (approximately quarterly) in-house training events, 
which usually included a session from the research team covering ongoing trials 
(although not basic research concepts or methodologies). However, due to the poor 
staffing levels on the ward during my period of fieldwork, planned sessions were 
cancelled and it was not possible to reschedule them. A schism existed whereby 
attendance at training sessions was simultaneously perceived as work and not work. If 
training was not perceived to be work, then time away from the busy clinical area could 
not be sanctioned, but if it was perceived as work there was a feeling that staff members 
should not have to participate in their own time. Whatever the underlying reason, lack 
of training perpetuated the mystique surrounding research and also contributed to the 
disjuncture of the research team. This disjuncture however was also evident in what 
some consider to be the very essence of the nurse’s role – caregiving.     
7.6 Research Nurse Or Caregiver 
It has been noted that some research nurses, like Nurse Higgs, are able to 
prioritise different aspects of their role (Easter et al., 2006) but some are unable to shed 
the care-giving definition of their profession. Thus, nurses in research roles may find it 
difficult to accept that ‘research is not care’ (Fisher, 2006b). But should they accept this 
statement? Treatment is still treatment whether licensed or experimental and although 
the desired outcome may not be for the sole benefit of the patient, it will undoubtedly 
have some (hopefully beneficial) impact upon him/her. Failure to recognise this and 
subsequent attempts to separate clinical and research activity contribute to what has 
148 
 
 
been termed ‘moral distress’ (Krishnasamy, 1999; Zuzelo, 2007) – an observation 
exemplified in Nurse Fowler. ‘Good nurses’ are generally seen as being ‘hands on’ 
while the researcher must be logical, analytical, rational, and organised (Hicks, 1996; 
Woodward et al., 2007). Several respondents stated a view that research nurses and 
clinical nurses were fundamentally different in some way, although this view was more 
commonly voiced by those who had never worked in a research role, or those who had 
done so but had returned, or intended to return to the clinical arena.  
I think you’ve got to be a certain person to be a research nurse. […] in my other 
job although it […] was office based […] I was still involved with the ward 
rounds, I was still involved in the community and I was still involved in clinics, 
[…] I just miss the hands on approach and I’m more your people’s person and 
interact better […] I never come into nursing to do paperwork. [INTERVIEW:  
Research Nurse Fowler, January 2007] 
For a number of reasons, not least the desire to protect research and ensure that it 
‘gets done’, research activity was separated to a greater or lesser extent from what was 
considered more traditional aspects of nursing care, because of the tendency for staff to 
be overwhelmed by clinical demands. Nevertheless, this did not eradicate the research 
nurses’ ability, capacity or desire to ‘care’. Tensions existed with regard to research 
nurses’ relationships with patients in terms of conflicts or incongruities between what 
one would do as a nurse, and what one was expected to do as a researcher. The 
established and socially constructed identity of the nurse appears, at least superficially, 
to be at odds with the developing but as yet liminal role of the research nurse and has 
intraprofessional implications.  
For the layperson, the role of the nurse is most frequently perceived to be that of 
physical carer, undertaking or assisting in a patient’s daily and often intimate activities 
(Bassett, 2002). For Research Nurse Higgs however, although he did not consider 
himself to fulfil a clinical role, and could separate clinical and research activity, he still 
saw his role as one in which he was responsible for delivering care to the patient (c.f. 
Easter et al., 2006) 
I am concerned that one, I do a good job and I do a thorough job and two, that 
I’m […] giving the appropriate information, the appropriate advice and 
that…three, - I’m rea.. and probably should be one…that I’m looking after the 
patient above all [INTERVIEW: Senior Research Nurse Higgs, November 
2006, my emphasis] 
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It is of note, that even between the research nurses, there was a difference of 
opinion as to the caregiving element of their role. Despite the lack of sustained, or 
intimate physical contact, Research Nurse Higgs saw his job as “looking after the 
patient above all”.  Care, for Research Nurse Higgs, involved offering patients, either 
directly or via their family members, the opportunity to participate in research, which 
may or may not benefit them, but ultimately would benefit the stroke population. For 
patients who decided to take up this opportunity, it was then the research nurses’ 
responsibility to ensure that they were appropriately looked after - cared for - 
throughout their study involvement.  
Conversely however, Nurse Fowler found her role lacking in this respect and 
decided not to renew her contract at the end of her first year in post because she wanted 
to return to ‘hands on’ care. She suggested that this may have had something to do with 
the fact that she initially trained as an enrolled (Level 2) nurse, traditionally more 
involved in the practical aspects of nursing rather than administrative or managerial 
elements. Furthermore, her clinical background was primarily in the area of spinal 
injuries, which typically requires considerable physical input. 
In some cases it was considered that the care offered by the research team was 
actually more holistic because the research nurses were not bogged down in the day to 
day bureaucratic paperwork that accompanied clinical activity. This would appear to 
support claims that research participants receive better care, and hence experience better 
outcomes, than their non-participating counterparts (Majumdar et al., 2008). Such 
claims are comprehensively countermanded however, by a number of authors, including 
a Cochrane review (Braunholtz et al., 2001; Peppercorn et al., 2004; Vist et al., 2008). 
Nevertheless, the research nurses did have more time to spend with individual patients 
enrolled in their studies than the ward staff. The research nurses’ involvement with 
patients frequently continued beyond the boundaries of the patient’s current clinical 
presentation, often necessitating intervention in areas other than that for which the 
patient was originally admitted. For example, although clinical staff often stated that 
they looked after the ‘whole patient’, it would rarely be the case that a patient would 
telephone the ward, post discharge, to report a problem that they thought might be 
related to their medication. It was not unusual however, for study participants to contact 
the research team with a symptom or problem, and even if it was highly unlikely that 
this was related to their study participation, the research team made the necessary 
arrangements for a clinical appointment and/or investigations to determine the nature of 
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the problem and an appropriate course of action. Research Nurse Webb adopted the 
view that:  
It’s a trial related issue as soon as they phone you, isn’t it? […] we’re even 
making sure they get referred for care for something that’s completely unrelated 
so … […] you have to take the whole deal basically […] you want [participants] 
to report everything to you anyway so you’ve got to be seen to be helping them 
[INTERVIEW: Research Nurse Webb, June 2007]  
The extract illustrates that whilst the research nurses did not always directly 
provide physical care, they were not oblivious to this requirement and provided a route 
to appropriate care. In doing so they demonstrated care not only for study participants 
but for the integrity of the trial and of science in general.  To maintain this, they ensured 
that trial participants received appropriate and timely physical/clinical care. The 
research nurses’ engagement with the provision of care beyond their own immediate 
remit also had the effect of promoting research and research participation as a ‘good 
thing’, with some patients noting the benefits of the ‘M.O.T.’ [thorough examination] 
associated with study participation [from fieldnotes, June 2006].   
The research nurses’ role also transgressed the boundaries of clinical care when 
they undertook assessment of newly admitted patients. Even amongst the research 
nurses however, there were differences in the ways that they perceived, and undertook 
this aspect of their role. Having identified or being advised of a new patient, the 
research nurse reviewed their records in order to determine their eligibility for 
thrombolysis and/or acute study enrolment. The research nurses were trained to conduct 
stroke assessments but Research Nurse Higgs advised them only to do so when study 
eligibility had been confirmed from the patient’s records. They had no clinical 
obligation to undertake this assessment. In keeping with the holistic philosophy of 
nursing, Research Nurse Fowler stated that as a nurse, she would have preferred to 
conduct a full assessment of all new stroke patients but that guidance from Research 
Nurse Higgs was that as a research nurse she should not become clinically involved. 
Confirming this, Research Nurse Higgs mentioned on several occasions that Nurse 
Fowler spent longer than necessary on ASU or EAS and that “it’s not her responsibility 
to be giving bed pans” [Quote from fieldnotes, Senior Research Nurse Higgs, August 
2006]. However, there may have been multiple reasons for Nurse Fowler’s desire to 
participate in ‘dirty work’. First, it reinforces her own identity as a nurse and her 
commitment to the care giving aspect of the role, but secondly this willingness to 
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engage in the clinical routine, as similarly noted by Spilsbury et al, may also represent a 
strategy to facilitate the ward staff’s reciprocal participation and cooperation in ongoing 
research (Spilsbury et al., 2008) or to diminish the potentially perceived power 
differential (c.f. Allen, 2004). For Research Nurse Higgs this was primarily a resource 
issue; the difficulty here was that having become involved in a clinical situation it was 
not always possible to extricate oneself should a patient be admitted who required 
urgent assessment for study eligibility. It was therefore possible, that in undertaking 
clinical activity the team may miss a subsequent research eligible patient. By ensuring 
their availability for the assessment of potential study eligible patients the research 
nurses demonstrated ‘care’ for, and about, the trial. The associated rationale was no 
different from that of the clinical team who claimed that they could not undertake 
research tasks because they could not, and did not have time to, divert their attention 
away from the rest of their patients, a fact repeatedly acknowledged by the research 
nurses. 
In the previous chapter it was evident that the clinical nursing staff did not 
generally perceive the research nurses to be involved in the delivery of care. Contrary to 
this view however, Dr Black was of the opinion that it was the very fact that they were 
involved in care that encouraged patients and families to participate in research. 
Because the research nurses were involved in the clinical assessment of new patients, 
with a view to research participation and/or thrombolysis, they were seen to be part of 
the team delivering care and this was considered to engender a sense of trust among 
patients and their families. Dr Black claimed that this may explain why patients were 
more willing to participate in acute and hyperacute studies, because they were being 
approached by people directly involved in their care, rather than secondary prevention 
studies when their involvement with the research team was likely to have less of a 
clinical care giving component and may therefore be viewed as something extra and 
unnecessary. In either situation however, whether delivering physical care or not, the 
research nurses often delivered psychological and emotional support and described 
themselves as an advocate for patients and family members. 
7.7 Patient Advocate: Protecting Participants  
Beauchamp and Childress state that, ‘controlled trials are scientific instruments 
intended to protect current and future patients against medical enthusiasm and hunches’ 
(Beauchamp and Childress, 2001; p.321). Acting as patient advocate, the research 
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nurses also aimed to afford such protection by mediating between healthcare 
professionals in positions of power and authority, and vulnerable patients and their 
families. Whilst the safety of patients enrolled in clinical research can be safeguarded by 
the proper application of, and adherence to, rules and regulations including research 
governance edicts, strict inclusion and exclusion criteria, and standard operating 
procedures, the research nurses also employed tacit and experiential knowledge and 
skills pertaining to the patient, rather than the study.  
The role of advocate encompassed recognition of a patients’ expectations and 
concerns as well as consideration of their values and beliefs, and incorporation of these 
factors in the decision making process, and in the patient’s subsequent care and 
management. It was the research nurses’ responsibility to assess patients’ capacity to 
exercise autonomous choice (albeit informally). This included ensuring that the patient 
was able to make an informed decision, without coercion, from either healthcare 
professionals or family members. Research and clinical staff noted on several occasions 
the element of shock that often accompanied the event and diagnosis of stroke and how 
this was perceived to cause fear and anxiety for the patient and their family members.  
Whilst such a response was undoubtedly related to the condition itself and uncertainty 
regarding prognosis, it was also thought that this anxiety was potentially exacerbated 
when patients were approached to participate in clinical research. In this respect the 
research nurses were sometimes viewed as ‘independent’ practitioners who were in a 
position to judge the level of patient and family engagement and therefore the quality of 
the decision made. In order to do so, it was important that the research nurses were able 
to engender a non-threatening environment in which patients and family members were 
able to express their fears and concerns and to ask questions.  
According to Dr Brown, in his previous role as research fellow in another 
hospital, the senior clinical nurse on duty would usually accompany him when talking 
to a patient about research participation to “just be kind of reassuring” [Interview: Dr 
Brown, October 2007]. At the study site however, clinical nurses were rarely involved 
in these interactions. Thus, in such circumstances, the research nurses drew upon the 
skills and attributes perhaps more closely associated with their clinical counterparts, i.e. 
those of  caring concern, intuition, reactivity and subjectivity, kindness, compassion, 
good communication and reflectivity (Abraham and Shanley, 1992; Telford, 1992; 
Niven and Robinson, 1994; Hicks, 1996). They reported that by taking such an 
intermediary role in consent and decision making processes they provided patients and 
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family members with a ‘real’ opportunity to refuse. This notion is perhaps evidenced by 
reports that some patients/family members who initially expressed a desire to participate 
when approached by senior medical staff, then declined after discussion with the 
research nurse.  
Beyond the process of information giving and facilitating informed consent, the 
advocate’s role was not limited to those patients who decided to participate in a study. 
The research nurses also provided reassurance to those who chose not to participate, that 
their subsequent care and management would not be compromised in any way because 
of their decision.  
Nurses are traditionally seen to recognise and fulfil patients’ emotional needs 
and can do so within their advocacy role. Whilst advocacy and emotional work are not 
synonymous, the examples that follow illustrate how the research nurses’ emotional and 
humanistic responses to the status and individual circumstances of potential study 
participants influenced the way in which they exercised their role of advocacy. The 
position the research nurses took as advocate was determined by their own emotional 
and relational response to the patient, rather than solely by consideration of clinical data 
and study protocols, as exemplified below.   
7.7.1 Seeing the whole person: eligibility versus suitability 
Several of the research nurses described the influence of intuition, gut feelings, 
and tacit and experiential knowledge upon their perception of the patient’s level of 
capacity, cognition, and general willingness and ability to engage in either deliberations 
about potential study involvement or subsequent protocol requirements:   
… sometimes you get a feeling that there is something just not quite, quite right 
[…] just sometimes there is little things that they say, erm just reading in 
between what they are saying and looking deeper […] I’m thinking something’s, 
it’s just not quite ringing right […] you do have to look a little bit deeper 
[INTERVIEW: Research Nurse Slater, October 2007] 
For Research Nurse Slater, ‘looking a little bit deeper’ meant following up the 
idea that although the patient appeared to understand the information given and to be in 
agreement with the terms of study participation, she felt that there was something about 
his manner which suggested that there may be information retention issues or potential 
compliance problems. On reviewing the patient’s case notes Nurse Slater found that 
there was a history of possible alcohol dependency which may impact upon compliance 
with aspects of the study protocol. Therefore recruitment did not proceed, thereby 
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protecting the patient from unnecessary risk and inconvenience whilst maintaining 
study integrity. 
A similar account was provided by Senior Sister Hatfield, referring to her 
previous role as research nurse and her tacit assessment of patient capacity. For Sister 
Hatfield however, what she perceived to be her own intuition, emotionality and desire to 
act as patient advocate, conflicted with the requirements of her research role. She 
described such a conflict quite clearly in the following extract: 
There were occasions when I thought I don’t agree with this, but this is my job 
and I’ve got to do it. […] there were some patients who I thought you know this 
isn’t fair on this person, whether it was because […] I thought they were too old 
but their age still fitted [the inclusion criteria], or whether I thought their stroke 
is so bad and yet it still fitted, you know, there were occasions when inside I 
thought I don’t agree with this, but- [INTERVIEW: Senior Sister Hatfield, July 
2007]. 
Sister Hatfield stated that during her time as a research nurse she was confident 
in her own ability to apply inclusion and exclusion criteria, and did not worry about 
misidentifying a patient because criteria were so precise. However, as noted above, at a 
more personal level she reported that sometimes she felt that even though patients fitted 
the inclusion criteria they should not have been approached on the basis of other more 
‘humane’ reasons such as ‘too old’ or ‘too frail’. Dickson-Swift et al explore the 
emotion work/emotional labour required of qualitative researchers, but my data suggest 
that clinical research staff undertaking randomised controlled trials, or other 
quantitatively based work also found themselves experiencing conflicts between 
emotionality and rationality, and that they too employed similar skills in order to 
negotiate these difficulties (Dickson-Swift et al., 2007). In the example above Sister 
Hatfield described an emotional, personal judgment which conflicted with the 
requirements of the research nurse role and criteria of the study. She went on to say that 
she thought she was “too soft” to be a research nurse, i.e. she could not divorce herself 
from her emotional response to patients’ situations. Hunter (2004) suggests that such 
intrapersonal conflicts exist when there is divergence between differing professional 
ideologies. It is widely espoused in the literature that the ideology of nursing dictates 
that nurses care for their patients at a humanistic level, whilst the ideology of research 
dictates that the research nurse should endeavour to enrol every patient who fits the 
physiological criteria by the application of logic and reason. It is ostensibly then, at the 
recruitment moment that this ideological conflict is most pronounced. Whilst I do not 
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suggest that such tensions were not evident within my study, indeed examples are 
included throughout the thesis, the idea of the research versus care dichotomy and their 
incompatibility is that presented in much of the literature, rather than a reflection of my 
personal position. 
The extract above clearly illustrates the oft noted dichotomy and duality of roles 
whereby the practitioner finds him/herself in a quandary, faced with balancing research 
integrity with concern for patient welfare (Beale and Wilkes, 2001). As patient advocate 
the nurse has a responsibility to protect patient interests but in a research role he/she 
also has other obligations. There may be tensions between the interests of the 
investigator, the sponsor company and the individual patient and the research nurses’ 
loyalty may be split between patients’ rights, the investigator (who is often their line 
manager) and the organisation that may –directly or indirectly-  provide the nurses’ 
salary (Hill and MacArthur, 2006). Nevertheless, all nurses, whether of clinical or 
research orientation, are bound by their professional code to support the accrual of 
knowledge contributing to the advancement of medical science, and thus the health of 
society as a whole. 
Most of the respondents noted the importance of an empathetic approach and the 
need to provide emotional support in their role as patient advocate, and the previously 
described tacit objection to the inclusion of certain patients may arise from such 
empathy. However, by trying to imagine oneself in the patient/family member’s 
position it is possible that one’s own beliefs and values are projected, for example: 
I went to a lady yesterday who errrr is on Warfarin, but she’s just started and 
there’s a new trial errr coming up…a drug versus Warfarin […] I said to her 
‘Oh, I understand one of the doctors has approached you’ and you could tell by 
her face that she knew nothing, […] so when I started to explain it, although she 
was happy…she was wanting to take part, she was a bit unsure because she 
thought she was allergic….she had allergic reactions to medication…so I just 
went “no that’s it then…we’ll stop right here and she says “but you know I’m 
quite happy but you know every time I go to the doctor they go oh here she 
comes again” … and I thought, […] it’s not fair…I mean she’s… “and I’m 83” 
[...] no, I just stopped it there and then, I just thought, no it’s not….that’s my 
opinion [INTERVIEW: Research Nurse Fowler, January 2007] 
Similar to Sister Hatfield’s ‘softer’ inclusion and exclusion criteria Research 
Nurse Fowler considered it ‘unfair’ to expect some older people to participate in 
research. On occasions where she felt that the situation was too stressful, or that study 
requirements would be too intrusive or demanding of the patient, she took it upon 
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herself either to decide not to approach the patient at all or to curtail discussion before 
the patient/carer had reached a decision about study involvement, or even in 
contradiction of a provisional decision. This approach contradicted the dichotomisation 
of emotion and rationality, and the associated perception of the researcher being purely 
logical and analytical (Hicks, 1996; Woodward et al., 2007).  
For these nurses in their research role, their personal feelings about the ‘state’ 
and wellbeing of the patient and/or family conflicted with the requirements of that role 
and their own desire to promote medical research and knowledge. ‘Silent decisions’ 
such as that illustrated above contradicted the dichotomy that reifies reason and 
suggested that patient autonomy did not always come first (Whitney and McCullough, 
2007; pp.33). Further, such actions raised the question whether attempts to be ‘fair’ to 
the patient actually resulted in the opposite, if undertaken in a paternalistic, or at least 
protectionist way which infringed upon autonomy. 
Whilst it is clear from the examples noted above that the research nurses 
experienced conflict between their own ideals and values,  the requirements of the 
research nurse role, and the study criteria, Hunter suggests that such concerns are rarely 
articulated and are instead interpreted as personal dilemmas or even failings (Hunter, 
2004). The feeling of failure is noted below:  
Research Nurse Fowler […] doesn’t want to renew her contract when it expires 
[…]. She explains that she misses the “hands-on” patient contact and finds it 
hard to “step back” and limit herself purely to the research aspects of her 
involvement. […]She tells me that at first she felt that she had failed and 
couldn’t do the job but now she’s realised that it’s just not for her. […]. She also 
says that she thinks that her training has something to do with the way she feels 
about patient contact and hands-on work. She initially trained as an enrolled 
nurse where the emphasis was always on the more practical side of nursing and 
she tells me that she still feels that that’s what she wants to do. (Abridged 
fieldnote, August 2006) 
For Research Nurse Fowler however, these concerns are recognised, articulated 
and successfully managed by her decision to return to a clinical role. Much has been 
written about ‘emotional work’ undertaken by nurses (and other service related work) 
with particular emphasis upon the relationship between patient and professional. In my 
study however, the data demonstrated a greater affinity with Hunter’s findings in her 
study of midwives. In Hunter’s study, hospital and community based midwives found 
themselves undertaking emotion work in order to deal with the personal frustration 
arising from the dissonance that resulted from the coexistence of conflicting ideologies 
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of practice in these different working environments (Hunter, 2004). Some of the 
interpersonal conflicts experienced by the stroke research nurses in Nearstreet Hospital 
may be related to conflicting ideologies which are perceived to exist within one 
environment.  
7.8 Research Nurse Or Specialist Support And Facilitator 
As described in Chapter 5.5, a further role of the research nurse is one of support 
and facilitator, not only in research situations but also in conducting clinical 
assessments, specifically pertaining to eligibility for thrombolysis. I also noted however, 
that the way in which these duties are discharged is often contingent upon the 
environment in which they are undertaken and the other personnel or teams involved. 
In the following extract, we see the research nurse endeavouring to expedite a 
diagnostic procedure in order to secure the prompt treatment of Mr Briggs, a newly 
admitted stroke patient. However, unlike the clinical assessment of Mr Adams, 
described in Chapter 5.5, the research nurse is not in a position to assume authority and 
take the lead, and must therefore adopt a more passive role. Mr Briggs was received in 
EAS within three hours of the onset of his symptoms and, as with the assessment of Mr 
Adams, his clinical assessment proceeded quickly and efficiently, led by the senior 
research nurse and the SNP. Having established a likely diagnosis of ischaemic stroke, 
an urgent request for CT scan was submitted and Mr Briggs was promptly transferred to 
the radiology department. However, although the urgency remained for the patient and 
for the stroke team, it was the possession of technical expertise and ability and authority 
to handle the equipment, which determined the locus of control in the interaction that 
follows. 
Student radiographer is performing the scan and deliberating over scout films. 
Senior radiographer is explaining and taking some time. Nurse Higgs 
gesticulates, (though not actually making any comment at first) for senior 
radiographer to encourage student to speed up or to take over. Senior 
radiographer is aware of his movements and looks across reproachfully. Nurse 
Higgs begins to mouth “hurry up” and continues to gesticulate. She (fairly light 
heartedly) admonishes him for his impatience. Nurse Higgs explains the tight 
time window but she says that there’s still half an hour. Nurse Higgs explains 
that although thrombolysis can be undertaken up to 3 hours post-ictus, even 
within this period there is evidence to suggest that earlier administration gives 
an even better prognosis. Senior radiographer tells him not to harass her staff, 
‘everyone has to learn’. The exchange is generally good natured but Nurse 
Higgs is genuinely concerned about administering the drug as soon as possible. 
Dr White arrives in the middle of this exchange when the senior radiographer is 
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saying, ‘5 minutes won’t make any difference’. Research Nurse Higgs says that 
it may do - ‘do you know how many neurones will be lost in those few 
minutes?’ When she doesn’t appear to be taking this too seriously Dr White also 
stresses the tight time window and uses the analogy that if you’re stopped 
driving at 31 miles per hour in a 30 mph zone you may still be fined - i.e. even 
the smallest deviation can make a difference [FIELDNOTE: August 2006]    
Unlike the EAS scenario described in Chapter 5.5, where a new ‘virtual team’ 
was formed and worked together, this interaction illustrated interdisciplinary conflict. In 
the EAS scenario the research nurse was in possession of at least as much, if not more, 
knowledge and expertise than the RMO, and was therefore able to orchestrate events. 
The scan room however was the domain of the radiographer and she determined the 
nature and pace of activity. The research nurse, once again was an interloper, and 
moreover, an interloper operating in a clinical, rather than a research context. For the 
stroke team, the priority was to get the patient scanned promptly so that thrombolysis 
(or study intervention) could be commenced as soon as possible, if indicated, and it was 
the research nurse’s role to facilitate this. The radiographer however had dual priorities 
here; she had a responsibility to the patient to provide clear and accurate diagnostic 
views of his compromised brain but she also had a responsibility to provide training for 
the student radiographer, and to do so in an environment free from harassment and 
undue or avoidable pressure.  
This is not unusual; all healthcare professionals have an educational element to 
their role. The issue here however was the way that this aspect of the radiographer’s role 
was enacted in these circumstances, and its encroachment upon the very short time 
window within which treatment could effectively be administered. Nurse Higgs 
explained to me later that he understood the need to ensure appropriate training, but for 
him, whether in a clinical situation such as this, or in the context of research, the patient 
comes first. In the long term, the appropriate training of staff is clearly important, but 
for the patient in the emergency situation this was unlikely to be an immediate priority.  
When Nurse Higgs became frustrated with the length of time the student was 
taking, he endeavoured to speed up the process by the use of body language. In order to 
avoid distressing the student this was directed towards the senior radiographer. When 
this strategy failed, he verbalised his concern by referring, albeit in vague terms, to 
research based evidence regarding the time-critical nature of thrombolysis, quantifying 
the effect of a delay by raising a rhetorical question about neuronal damage. The 
question had the effect of inferring the potential extent of damage, whilst implying that 
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the radiographer did/should know this. The vagueness of the reference to research 
allowed Nurse Higgs to make a point without being overtly challenging and thus 
drawing the radiographer’s knowledge or expertise into question. Furthermore, citations 
of research evidence (in this environment) are more commonly associated with medical, 
rather than nursing personnel; doctors are entitled to refer to the work of other doctors 
or scientists (Potter, 1996). A more specific reference may thus have had the effect of 
making Nurse Higgs appear to be a ‘know-all’, or of being particularly didactic. It is of 
interest that he chose to make his point in this way rather than offering a more practical 
and possibly more tangible, incentive to expedite proceedings. For example, a brief 
explanation of how much time would be required to actually initiate treatment would 
have given the radiology team a more realistic indication of how much time could be 
spent on undertaking the CT scan. Healthcare professionals are encouraged to consider 
research based evidence but sometimes pragmatic issues are equally important, and 
perhaps more effective, in justifying a course of action. Such an approach however 
would mean that Nurse Higgs was directly requesting a change in the radiographer’s 
behaviour in order to meet his own, albeit professional requirements. His more subtle 
approach allowed him to avoid being identified as bossy, demanding or interfering with 
clinical practice, because the change required, i.e. to speed up the procedure, was 
recommended by an ‘unidentified other’. 
The tension throughout this interaction was palpable, and reflected other similar 
situations observed by myself and reported by a number of participants throughout the 
fieldwork, which at best conveyed a sense of lack of interest on the part of the radiology 
staff and at worst obstructiveness. It was noted by several respondents that the 
radiologists sometimes tried to ‘slot in’ a patient (particularly inpatients) for CT scan, 
even though they knew that a stroke patient was en route from EAS, mere minutes 
away. For the radiology team this meant that they were able to undertake imaging on as 
many patients as possible, and thus expedite their progress through their hospital 
experience. For the stroke team however, it meant that a stroke patient may have an 
unnecessarily prolonged waiting period prior to being scanned, with potentially serious 
consequences if the delay placed the patient outside the therapeutic time window for 
thrombolysis or for a research intervention. For the research team time was a sliding 
scale where time taken to treat and outcome were inversely proportional; the quicker 
treatment can be initiated the greater the likelihood of a favourable outcome. In the 
extract described above, the radiographer appeared to focus on the ‘absolute’ limits of 
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the time window for the conduct of the CT scan, whereas the research team were more 
aware of the prognostic impact of even the slightest changes in ‘time to treat’. The 
differing approaches of the two teams arose not from a lack of knowledge or interest on 
the part of the radiology staff, but rather a different application of knowledge and 
interpretation of the clinical situation. In light of this tension, and the sometimes 
strained interdepartmental relations, Nurse Higgs’ subtle (although ultimately 
unsuccessful) approach to expedite the scanning process appeared even more politic, as 
did the very ‘sociable’ presentation of Dr White’s analogy of a motoring offence. The 
latter had the effect of dissipating the tension whilst emphasising the research nurse’s 
point, but it too failed to influence the conduct of the procedure in progress. 
In the EAS scenario described in Chapter 5.5, the RMO’s unfamiliarity with 
thrombolysis and/or study protocols legitimised the research nurses’ authority. This was 
advantageous because having delegated specific tasks to the RMO they were then able 
to concentrate on their own tasks, unimpeded by other medical or administrative 
requirements. In the radiology setting however, the radiographer’s lack of awareness of 
the pragmatic issues of treatment/research initiation was an obstacle that may lead to 
further delays in the patient’s treatment and possibly influence the eventual outcome. 
The senior radiographer’s interpretation of the three hour time window was absolute 
rather than relative. Like the RMO, she was unfamiliar with the practicalities of the 
thrombolysis (or research) protocol beyond her own aspect of it. Thus, when she quite 
accurately stated that ‘there’s still half an hour’ she was referring only to the time 
required to perform the CT scan, not how long it was likely to take to get the patient 
back to EAS, reassess his clinical status, explain to him the proposed treatment plan and 
secure his agreement, before preparing for and initiating thrombolysis, because this was 
information that she had not been made aware of. One operates in the context of what 
one knows; in this respect, providing other professional groups with information only 
on what might be considered a ‘need to know’ basis can be counterproductive. 
In contrast to the EAS episode the research nurse took a much less dominant 
role here, despite his frustration, because the things that needed to be done could only 
be done by the radiology staff. In EAS his experiential knowledge allowed him to 
assume authority by ‘doing’, but here there was nothing that he could do, likewise Dr 
White. The research team’s position in EAS could be said to be determined by their 
expertise and the urgency of the situation, but in the radiology department their lack of 
technical equipment and capabilities meant that they had to adopt a more passive role. 
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In this situation Research Nurse Higgs was not attempting to recruit the patient to a 
research protocol, but used his research background to try to influence practice. Despite 
his limited success, he endeavoured to provide specialist support by means of practical 
application of the knowledge and expertise gained within the research role – knowledge 
and experience that was not routinely accessed or encountered by clinical staff. 
7.9 Discussion 
In the sections above I have outlined how the research nurses perceive and 
undertake their role, although it is of interest that even amongst the research nurses 
themselves there are inconsistencies regarding their perceptions of this role and its 
priorities, particularly with regard to their interpretation of and provision of ‘care’. I 
have described and illustrated the various components of the research nurse role, but as 
noted at the outset, the whole is greater than the sum of the parts. Further, there are 
areas of overlap with their clinical counterparts that may not be immediately evident in 
considering these individual aspects.  
To illustrate, a survey of registered nurses in Hong Kong identified that their 
perception of care encompassed three main categories: endeavouring to meet clients’ 
needs; effective communication; and providing a safe environment (Yam and Rossiter, 
2000). It can be seen from the examples given that whilst these values were also upheld 
by the research nurses at Nearstreet, they were enacted via different means and further, 
that their other commitments and obligations influenced the prioritisation of these aims. 
7.9.1 Endeavouring to meet clients’ needs 
Like their clinical colleagues, the research nurses endeavoured to meet their 
clients’ needs, but an important distinction was the definition of those clients and how 
their needs were to be met. Research nurses endeavoured to meet the patients’ needs by 
offering them, where appropriate, the opportunity to participate in research which might 
influence their own health outcome, but would also contribute to a body of medical and 
scientific knowledge which may improve stroke management and therefore associated 
outcomes for future stroke patients. Whether clinically or research oriented, nurses have 
a responsibility to protect patient interests. However, they also have an obligation to 
support the accrual of knowledge, which will directly impact upon the health of society 
as a whole (Johnson, 1986).  
The research nurses achieved this by caring for the individual within a research 
protocol that ultimately sought to address the healthcare needs of a wider society. This 
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therefore addressed the immediate needs of the current patient(s) in front of them whilst 
also planning and developing care for the future. They may, however, have been 
compromised in meeting patients’ more basic and intimate needs because in trying to 
meet the needs of their other ‘clients’, i.e. the study sponsor, they endeavoured not to 
become embroiled in, and therefore diverted by or to, clinical demands. For example, 
having taken a blood sample for central analysis the research nurse could not let this 
wait until she had assisted with the patient’s feeding or bathing before preparing it for 
shipping. Whilst it may be argued that ultimately the nurses’ duties to an individual 
patient are always paramount, in the situation described these everyday duties were 
delegated to the clinical team. This was necessary because it was not physically possible 
for the research nurses to adhere to the timely completion of study requirements whilst 
also participating in clinical activities. 
7.9.2 Demonstrating effective communication 
The research nurses attempted to communicate effectively with patients, their 
families, and their research and clinical colleagues by explaining their role function and 
purpose both verbally and by means of written information. Effectiveness however, was 
sometimes hindered by a number of factors pertaining either to the patients themselves, 
resource implications or issues of general awareness and knowledge. Heavy clinical 
workload also impacted upon opportunities for communication between clinical and 
research teams, as well as influencing availability and willingness of clinical staff to 
engage in research activity and to become familiar with research concepts and 
procedures.  
Effective communication between patients and researchers was sometimes 
precluded by the patient’s clinical status and the physical or cognitive effects of their 
condition. The sudden onset and severity of symptoms also had an impact, as many 
patients and their families were perceived to be in a highly emotional state, and perhaps 
not receptive to information about or requests for study participation. This perception 
influenced the way in which the research staff oriented to, and interacted with, potential 
study participants, and may have given rise to a self-fulfilling prophecy if those who 
were approached less than positively then declined to participate. Communication with 
patients was also perceived to be constrained by their limited understanding of research 
in general, and their lack of awareness of ongoing research in the healthcare 
environment. 
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Communication was also contingent upon fulfilment of expectations. In this 
respect the wearing of a nurse’s uniform could potentially facilitate or hinder 
communication with colleagues and patients/families alike. The perception of a positive 
effect of being recognised as a nurse was not restricted to the nursing staff. Throughout 
his interview, Dr Black commented on the importance of trust in the recruitment and 
retention of patients to clinical trials and emphasised that patients and their families 
were more likely to trust, and therefore respond positively to, someone whom they 
perceived to be a knowledgeable professional, committed to restoring them to health. 
The adoption of a nurse’s uniform reinforced the perception that the research nurses 
were part of the care giving team, and thus bestowed rights associated with their 
professional affiliation, such as access to patients and their medical records. However, 
this almost instantaneous recognition tended to by-pass, or at least over-shadow, 
subsequent introductions and explanations of role, and therefore may have contributed 
to patients’ conflation of research and clinical activity.  
A further aspect of communication within the research nurses’ role, and one 
which appeared to be poorly understood by the clinical nurses, was the precision 
required in order to communicate accurate and timely information to the study sponsor, 
which is also pertinent to the final category noted by Yam and Rossiter (2000) – 
providing a safe environment.   
7.9.3 Providing a safe environment 
The research nurses endeavoured to maintain the safety of participating patients 
by ensuring that only those who were eligible for study entry, and for whom the study 
was deemed suitable, were approached to consider participation. They achieved this by: 
· offering eligible patients the opportunity to participate in clinical research which 
may (but not necessarily) offer the prospect of an improved outcome, or, may 
enable the potential participant to fulfil what they may perceive to be a moral 
obligation to contribute to the advancement of medical and scientific knowledge,  
· spending time with those patients considering or consenting to study 
involvement to ensure that they fully understood their rights and responsibilities 
in relation to study participation, and that subsequent participation was voluntary 
and uncoerced, 
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· ensuring that the care of non-consenters was not jeopardised by their decision, 
and that those who did agree to participate in the ongoing studies were managed 
according to the study protocols.  
Thereafter, they continued to ensure the patients’ safety by the timely and proper 
conduct of study interventions and follow up activities. Simultaneously, by 
endeavouring to avoid placing undue workload pressures on the clinical staff, they also 
avoided jeopardising the safety and wellbeing of other patients on the ward.  
7.10 Conclusion  
It is clear from this, and the preceding empirical chapters, that members of the 
research and clinical teams considered themselves to belong to quite different groups. In 
this chapter I have explored how the research nurses perceive and discharge their role, 
notwithstanding the constraints placed upon them by policy and intraprofessional 
relations. I have demonstrated that they remain true to the values and principles of the 
nursing profession, but prioritise, experience and apply these skills, values and 
competencies, in a different way and to a different end, than their clinical counterparts. 
This is not to say that either position is right or wrong, but that each is tailored by the 
individual professional according to the requirements of their role and the desired 
outcome. In the following chapter I discuss how the amalgamation of these factors 
impacts upon the performance of the research endeavour and how the differences 
previously noted are manifest in their interactions with each other and with patients and 
family members. 
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Chapter 8. Separation of Research and Care: The Work of the 
Clinician-Researcher  
8.1 Introduction 
In the preceding chapters I have described the environment where stroke patients 
were received and subsequently managed, including the areas in which they were 
identified and approached for participation in clinical research. I have introduced actors 
or groups of actors, involved in the enrolment and management of patients participating 
in clinical research. With reference to the observed activities and reports of the research 
and clinical teams I have described the ways in which research and clinical activities 
were delineated, as well as some examples of cooperation and collaboration. In the 
sections that follow I draw these strands together to illustrate the effects of this 
delineation upon research activity, focussing on interactions between healthcare 
professionals and patients. In particular, I examine specific elements of research activity 
within the acute stroke unit, namely, the identification and assessment of new patients, 
and the process of negotiating informed consent. 
It is clear from the preceding chapters that members of the research and clinical 
teams considered themselves to belong to quite different groups. Here, in order to 
exemplify these differences, I will present three scenarios. First, I describe a fairly 
typical example of obtaining consent for emergency medical treatment of ischaemic 
stroke. Second, in contrast to this clinical situation, I explore the way in which patient 
and clinician orientate towards each other in the research consent encounter before 
finally, demonstrating the way in which the research team work together when 
attempting to enrol a potential study participant. 
8.2 Consent For Thrombolysis v. Consent For Research 
As noted in Chapters 3, 4 and 5, during the course of my fieldwork the number of 
patients admitted to the ASU who fulfilled the eligibility criteria for the ongoing acute 
and hyperacute studies was considerably fewer than anticipated. This meant that I had 
fewer opportunities to observe and record consent interactions in this context, but I did 
witness several clinical consent interactions. Here, I return to the example of Mr Adams, 
first noted in Chapter 5.5. The interaction between Mr Adams, his wife, and Dr White, 
was typical of the clinical consent interactions that I witnessed and provides a point of 
reference and contrast for the research scenarios that follow.   
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As noted in Chapter 5, Mr Adams was received in EAS with a provisional 
diagnosis of stroke, well within the three hour time window for thrombolysis. I 
described in Chapter 5, how Research Nurse Higgs assumed the lead in Mr Adams’ 
admission and assessment process, and immediately began a neurological examination. 
Meanwhile, Sr Stone (Stroke Nurse Practitioner) completed a CT request form, obtained 
a signature, delivered the request form in person to the radiology department, and 
contacted Dr White, who was the consultant stroke physician on-call for thrombolysis. 
All of this activity relieved the clinical team of most of their immediate duties 
pertaining to the care of this patient. 
Dr White arrived to asses Mr Adams at 9:45am. The following extract describes 
events: 
Dr White arrives at 9:45 hours. He introduces himself to patient and wife but 
then seeks history from patient’s wife as patient’s speech is still quite slow and 
slurred and he seems a little drowsy. Dr White explains that is seems likely that 
the patient has had a stroke and that it is probably the sort caused by a clot. He 
explains that “clot busting” treatment is an option. Nurse Higgs and Sr Stone are 
completing documentation and taking blood samples whilst this conversation is 
going on. Patient is able to confirm that his mother died of a stroke and his wife 
says that she died quite young. Dr White explains to wife and patient that a scan 
is required to determine whether it is safe to give the clot busting treatment and 
explains that the treatment itself can be dangerous but that it is a “balance of 
risks”. He explains that it can cause bleeding in the brain which would make 
matters worse, but in this case it is something that he would recommend. He 
asks the patient and his wife what they would like to do, are they happy to “go 
for it?” The patient is slow to respond and his wife interjects encouragingly “do 
you want the doctor to help you?” (rather than ‘do you want the treatment?’), 
“do you want to put your hands in his hands?” and “let him make the decision”. 
She tells Dr White that she doesn’t think her husband “is in any state” to make 
such a decision at the moment so if he’ll let her speak on his behalf she thinks 
they should take Dr White’s advice and have the treatment. The patient appears 
to consent (eye contact and facial expression). Dr White thanks the patient’s 
wife for her confidence; he explains that he is usually quite conservative about 
using this treatment but does so in cases where he feels the risk of using it is 
minimal compared with not doing so and feels that this is such a case. “You’re a 
good man” says the patient, to which Dr White replies “Thank you, I hope it 
turns out that way”. [FIELDNOTE: August 2006, Extract 1] 
It was not usual practice at the study site to obtain written consent for 
thrombolysis and therefore this interaction (i.e. Mr Adams’ and his wife’s actions) was 
taken to constitute consent. The interaction between Dr White and the Adams’ lasted 
approximately 10 minutes, during which time Research Nurse Higgs and Sr Stone 
continued to record observations, take blood samples and prepare the room for the 
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eventuality of administering rtPA. By providing practical support they enabled Dr 
White to concentrate solely upon extracting a concise history and to determine the 
appropriateness and acceptability of thrombolytic therapy. Following this interaction, 
Mr Adams was taken immediately to the radiology department for urgent CT.  
The scan confirmed that there was no haemorrhage and by 10:10hrs Mr Adams 
was back in EAS and the bolus dose of rtPA was administered. (rtPA is given 
intravenously over a period of 60 minutes. The first 10% of the dose is given as a bolus 
over 1-2 minutes, followed by the remainder by infusion.) A few minutes later, Dr 
White returned to speak to Mrs Adams:  
Dr White explains that there was no bleed on CT scan therefore this is a 
“clotting type of stroke rather than a bleeding type of stroke” and the clot 
busting treatment can be given to dissolve the clot so with her permission [in the 
‘pre-scan’ interaction] they’ve just “got on and done it”. [FIELDNOTE: August 
2006, Extract 2]  
During the brief exchange between Dr White and Mr Adams, although drowsy 
and a little slow to respond at times, Mr Adams was able to give a brief, but relatively 
clear, verbal history of the onset of his symptoms, general health status (he was a known 
epileptic) and a little about his family history, which was supplemented by his wife. In 
accordance with the Mental Capacity Act (2005) Dr White attempted to respect Mr 
Adams’ autonomy as far as possible, by including him in the discussion and allowing 
time for his responses. Nevertheless, ultimately he accepted Mrs Adams’ assent to 
proceed with investigation and treatment. 
It is noteworthy that unlike research consent interactions where the researchers 
generally attempt to maintain neutrality, in this instance Dr White proffered an opinion 
regarding the suitability of this treatment, explaining that although it was a ‘balance of 
risks’, ‘in this case it is something that he would recommend’. He reinforced his 
recommendation by stating that he ‘is usually quite conservative about using this 
treatment, but he does so in cases where he feels the risk of using it is minimal 
compared with not doing so and feels that this is such a case’ [from Fieldnote, August 
2006; for full extract see Extract 1 above]. 
By framing this nonetheless risky option as a recommendation, Dr White offered 
an element of moral relief in the form of professional guidance which was not usually 
considered possible or desirable in a research consent interaction. To illustrate, in 
interview, Dr White stated that: 
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accepting the invitation to be paternalistic in one’s management of the case […] 
under certain circumstances is entirely appropriate in the clinical scenario. […] I 
think certainly a paternalistic approach if the patient, […] actually asks for it, is 
appropriate in a clinical scenario but I don’t think in the research scenario, to me 
it reflects sort of the vulnerability that I think that one, one has a duty to protect 
so I think there is a difference [INTERVIEW: Dr White, April 2007]. 
This was further exemplified in a similar situation just a few days later, when Dr 
White assessed Mr Briggs, another patient who was admitted within three hours of the 
onset of his stroke symptoms, and therefore also potentially eligible for thrombolysis. 
Dr White arrives and is obviously aware of the very tight time frame [1 hour 
remaining]. He introduces himself to Mr Briggs and tells him that it is likely that 
he’s had a stroke. He mentions ‘clot-busting’ treatment to Mr Briggs and 
explains that he and the nursing staff need to assess his eligibility for this type of 
treatment. He mentions the very short time frame and points out that for the best 
chance of effectiveness the drug must be given within 3 hours of the onset of 
stroke symptoms. […]  
[POST CT SCAN] Dr White explains to Mr Briggs that he has had a stroke that 
is not caused by a bleed and that it is developing as they speak. He explains that 
the aim of the clot busting drug is to reduce the severity of the stroke, although 
the treatment itself has risks, for example it can cause bleeding […] Dr White 
advises that the treatment should be given, and supports this recommendation by 
mentioning that thrombolysis is recommended by NICE, if it is possible to give 
it within three hours. He asks Mr Briggs if he has heard of NICE, and also asks 
whether he patient would like to go ahead with the treatment. Mr Briggs states 
that he wants Dr White to make the decision. Dr White asks if he wants him to 
use his clinical judgement, and says that if it was his father or uncle requiring 
the treatment he would go ahead and give it. [FIELDNOTE: August 30
th
 2006] 
In this encounter, at Mr Briggs’ request, Dr White made a decision based upon his 
professional knowledge and personal opinion. However, in Mr Adams’ case, Dr White 
was not accepting a direct invitation from the patient to be paternalistic, but from the 
patient’s wife. Mrs Adams suggested that she did not think that her husband was ‘in any 
fit state’ to make a decision regarding treatment and thus asked his permission to defer 
to the doctor’s recommendation on his behalf. Later however, once the treatment had 
been initiated, she confided to me that this was not the only reason that she made a 
decision on her husband’s behalf. While she stated that she thought her husband 
‘probably wasn’t thinking straight’, she also reported that he did not like taking drugs 
and therefore may have refused the treatment. Although not framed in these terms by 
Mrs Adams herself, it may appear that she had allowed beneficence and consideration 
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of what she considered to be her husband’s best interests to over-rule maintenance of 
his autonomy.  
As others have noted, whilst proxy decision making by family members may aim 
to safeguard the patient’s best interests, it does not necessarily uphold autonomy 
(Miller, 1993; Alves and Macciocchi, 1996; Corrigan and Williams-Jones, 2003). 
However, this was not necessarily the case, and in any event her intervention may not 
have been required. Mrs Adams’ assumption that her husband would have refused 
treatment failed to take into account what Cox White and Zimbelman refer to as ‘values 
evolution’ (1998; p.448). Recognising the role of context and the problem of the 
hypothetical, they note that patients do not necessarily change their minds, but rather 
reassess the values driving their decisions when confronted with a hitherto unknown 
situation (Cox White and Zimbelman, 1998). Mrs Adams could not be certain that her 
husband did not, or would not, similarly reassess his previously held values and beliefs. 
Furthermore, although she wanted to take the decision out of her husband’s hands, she 
also stated that she did not want to ‘get the blame for agreeing to treatment if things go 
wrong’, hence her desire to defer to the clinician. This potential burden of guilt was 
noted by a number of members of the clinical and research teams as being a potential 
reason for relatives’ refusal to allow their loved ones to be enrolled in clinical research, 
particularly when equipoise and neutrality inhibited the likelihood of clinician 
recommendations. Rather than promoting patient autonomy and informed, uncoerced 
choice, the clinician’s maintenance of a neutral position may result in the patient feeling 
a sense of abandonment.  
It can be seen in this example, that despite concerns arising following scandals 
such as Shipman, Alder Hey, and more recently, the disastrous Phase I drug trial at 
Northwick Park, about the perceived erosion of trust in those in positions of power and 
authority, at an individual level, healthcare professionals are still generally held in high 
regard (Department of Health, 2001; O'Neill, 2002; Department of Health, 2004b; 
Department of Health, 2006). Thus, even within this brief interaction, Mr and Mrs 
Adams rapidly made an assessment of Dr White’s character, and were willing to place 
their trust in him.  
[Mrs Adams] interjects encouragingly “do you want the doctor to help you?” 
(rather than ‘do you want the treatment?’), “do you want to put your hands in his 
hands?” and “let him make the decision”. […]The patient appears to consent 
(eye contact and facial expression). Dr White thanks the patient’s wife for her 
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confidence; […] “You’re a good man” says the patient, to which Dr White 
replies “Thank you, I hope it turns out that way”. FIELDNOTE: August 2006] 
However, Dr White’s explanation of ‘clot-busting’ treatment was brief, and noted 
only the most serious potential side effect (excluding death). He did not explain any 
other options, which at least initially in this case would have been to do nothing except 
monitor Mr Adams’ condition.  
Like Dr White, other staff, in clinical and research roles expressed the view that 
they either were, or would expect to be, more confident in giving an opinion regarding a 
known therapeutic intervention, compared to the uncertainty associated with 
experimental interventions. For the clinical staff this reflected their lack of familiarity 
with individual research protocols, but was also related to their lack of knowledge of 
and engagement with research more generally.  The interactions above supported these 
observations and provided a point of contrast with the research interaction which 
follows.  
8.3 Seeking Consent For An Acute Stroke Study (Medical Admissions Unit, King’s 
Hospital) 
The clinical interaction between Mr Adams and Dr White took place under 
considerable time pressure, and in a potentially life threatening situation. Whilst not 
involving a hyperacute research protocol, the interaction between Dr Chatterjee and Mrs 
Banks, described below, was also time limited, and further constrained by other 
logistical factors. I begin with a summary of events that occurred leading up to the face 
to face encounter with the patient. 
8:30am on a Monday morning - the Stroke Unit is full. Revised admission 
policy now in place whereby suspected stroke patients are admitted to the 
Medical Admissions Unit at King’s Hospital outside ‘normal office hours’ and 
transferred to Nearstreet as soon as possible thereafter. Dr Black has telephoned 
ASU to advise that there is a patient to be transferred as soon as a bed becomes 
available. In the Stroke Research Office (9:05am) the Research Fellow advises 
the senior research nurse that he reviewed two potential study patients at 
weekend including Mrs Banks, a lady admitted to King’s on Sunday. He 
considered her for CHHIPS [blood pressure management study] but she was 
normotensive (blood pressure within normal limits as defined by study protocol) 
and therefore ineligible. Research Nurse Higgs, Dr Chatterjee and I return to 
ASU to join the ‘board round’, where it transpires that this is the same patient 
awaiting transfer. Dr Black reviewed her earlier this morning and found her 
systolic BP to be 190 mmHg. She is therefore now potentially eligible for 
CHHIPS although time of ictus currently unknown. At the end of the round 
(10:20am) lengthy discussions follow between Dr Black, Research Nurse and 
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Research Fellow regarding her eligibility, particularly in relation to the uncertain 
time of ictus. Recruitment window for CHHIPS is 36 hours. The Research 
Fellow telephones MAU, King’s to ascertain time of ictus, or time last known to 
be symptom free. Mrs Banks’ case notes suggest 7:30pm Saturday evening. 
Based on this information she is outside the CHHIPS time window. 
Research Fellow and Research Nurse consider COSSACs – 48 hours time 
window but time of onset still to be determined. I accompany Research Fellow 
to King’s to see the patient. A free minibus service operates between the three 
hospital sites and we leave Nearstreet for King’s at 11:15am but miss the 11:15 
minibus. We catch the next one at 11:30am and arrive at MAU approx. 12 
midday. Having introduced us both to the ward sister and explained the reason 
for our visit we see the patient, Mrs Banks, at her bedside in 6 bedded bay. Dr 
Chatterjee establishes in discussion that Mrs Banks first noticed symptoms at 
approximately 10:30pm, Saturday evening and could therefore be recruited up 
until 10:30pm Monday evening. He discusses potential study participation and 
she has no specific objection but wants to discuss with family. Dr Chatterjee 
leaves documentation for their perusal and says that he will review when she is 
transferred to Nearstreet. 
We return to Nearstreet, at approximately 1:00pm and await patient transfer. She 
arrives later in the afternoon but her relatives have not arrived by the time the 
research team finish their shift. The following day, having missed the 
recruitment deadline, there is no further discussion with Mrs Banks and she is 
not offered an explanation that option to participate had expired. [ABRIDGED 
FIELDNOTE: November 2006] 
These fieldnotes show that much work was undertaken prior to the actual ‘point of 
consent’. As previously outlined (Chapter 5), the stroke research nurses were usually 
the first to see the patient. Typically, they garnered as much information as possible 
prior to approaching the patient to introduce the possibility of research participation. 
This accrual of information usually comprised review of the patient’s case notes and at 
least some discussion with the nursing or medical staff involved in the patient’s care. 
The research nurses would then contact the research fellow for further review and 
initiation of the information and consent process. In Mrs Banks’ case however, the 
gathering of information was further complicated by the fact that she was located at a 
different site.  
The research fellow had minimal interaction with the clinical team at Nearstreet 
and was even less familiar with the team at King’s. On arrival at the ward, Dr Chatterjee 
introduced himself and me to the Ward Sister and made enquiries about the most basic 
inclusion criteria, Mrs Banks’ ability to swallow. The aim of his question was to check 
fulfilment of the criteria, rather than being a clinical or personal question about Mrs 
Banks’ wellbeing. His approach was study oriented, and the question was necessary 
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because the study may involve the patient taking oral medication; if Mrs Banks was 
unable to swallow there would be no point in proceeding further. From the outset then, 
Dr Chatterjee cast Mrs Banks as ‘potential study participant’. While the ward sister 
attempted to determine Mrs Banks’ swallow status, Dr Chatterjee reviewed her notes to 
check in particular whether any further information had come to light regarding the time 
of ictus. It was reported in the clerking notes that Mrs Banks was symptom free when 
she made herself a cup of tea at approximately 9:30pm on Saturday evening. It appeared 
therefore that she was still well within the study recruitment time window and having 
determined that Mrs Banks was able to swallow, Dr Chatterjee and I approached her.  
Dr Chatterjee introduced himself and me to Mrs Banks as researchers, but he did 
not ask permission to record the interaction at first so I did not begin recording 
immediately. Initially he was still trying to clarify exactly when Mrs Banks’ symptoms 
began and to determine her level of capacity. Thus, for the purpose of determining 
eligibility, Dr Chatterjee questioned Mrs Banks about the onset of symptoms and her 
admission to hospital. After some initial confusion regarding the day of admission, she 
was able to answer reasonably clearly, and he was able to make a crude assessment of 
her general level of capacity and to establish that she first noticed her symptoms at 
10:30pm on Saturday. This meant that she could be enrolled into COSSACs until 
10:30pm on Monday.  
Although in general, Mrs Banks was able to answer questions and give a fairly 
clear history, some of her responses were somewhat vague and not particularly helpful, 
although it could not be said that she was confused. Furthermore, her responses were 
neither unreasonable nor inappropriate given the way in which some of the questions 
were asked. For example, when trying to establish  her level of understanding, Dr 
Chatterjee asked closed questions such as: “So have you, have you so far understood 
what I have told you?” which elicited the response “Ah ha, I can understand it”. Mrs 
Banks’ responses may have been influenced by the doctor’s accent or phrasing of some 
of the questions rather than any confusion on her part. Furthermore, although Dr 
Chatterjee and I were aware that he was asking questions from a research perspective, 
there was nothing inherent within the questions or in Dr Chatterjee’s appearance or 
conduct that would differentiate him from any other doctor, or this interaction from a 
clinical one. Located as she was then, in a clinical setting, surrounded by clinical staff 
and ‘props’, it is perhaps unsurprising that Mrs Banks remained in ‘clinical mode’, and 
appeared to identify herself purely within the patient role. 
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Having established that Mrs Banks was still within the recruitment time window, 
Dr Chatterjee went on to introduce the study. For Dr Chatterjee, this was where the 
‘consent interaction’ actually began, and at this point he requested verbal permission for 
me to record the conversation. Mrs Banks had no objection to this, and I assured her 
that I would give her further information about my study later. Although this request 
heralded the start of the ‘formal’ consent approach, for Mrs Banks, nothing had actually 
changed. She was in the same environment, speaking to the same people, about 
elements of her care that were already in place for clinical reasons. 
The consent interaction unfolded thus: 
Dr Chatterjee: Now, we are doing some studies, study meaning it’s er, er, trial, 
right? As you know, after the stroke sometimes your blood pressure can be 
raised, yeah? [Mrs Banks: Ah ha] Now whether to treat it or not, is, there is no 
clear cut evidence, or in the sense people don’t know the answer to that, whether 
they should be treating it or not. Now one theory says you should not treat it 
because it, it can reduce circulation in the brain, and one theory says you should 
treat it because if your blood pressure is high it can have more swelling of the 
brain but exact answer is not known now, okay? Now this particular study looks 
at the effect of blood pressure on, on the stroke. What it means, those people 
who are willing to participate in the study either we’ll ask them to continue their 
blood pressure [Mrs Banks: Mm] or ask them to stop their blood pressure [Mrs 
Banks: Mm] and we closely monitor their blood pressure on a regular basis. At 
the same time we also see like how they are doing from a stroke point of view 
and we compare both the results, whether those who were continued on the 
treatment for the stroke did better or those who discontinued, you know blood 
pressure tablet did better [Mrs Banks: Aha]. So if you say yes, either you’ll be 
tak, continue taking your blood pressure tablet or you wouldn’t take any blood 
pressure tablet for two weeks. It would be just for two weeks. [Mrs Banks: 
Aha] After that, if medical team feels you need some blood pressure tablet then 
you go on your regular treatment [Mrs Banks: Right] Right. There are no major 
risks involved in the study except sometimes your blood pressure can go, if, if 
you are randomised, if you are, if you are selected to participate in the group 
where we stop your blood pressure your blood pressure can go high, but if it is a 
medical emergency or if it is a risk to you, we can always restart your tablets, 
that’s not a problem. So if for some medical reason you need to discontinue we 
can always discontinue this particular trial, but that’s not a problem. So always 
patients’ health and patients’ medical care come first. If there is no problem 
from that point of view we continue with the trial. [Mrs Banks: Right] 
[AUDIORECORDED CONSENT INTERACTION: November 2006]. 
Following this explanation, in order to determine Mrs Banks’ level of capacity in 
relation to this particular decision, Dr Chatterjee attempted to establish what she 
understood about the study: 
Dr Chatterjee: So have you, have you so far understood what I have told you?  
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Mrs Banks: Ah ha, I can understand it. […] 
Dr Chatterjee: Now, tell me what I have told you, like what’s your 
understanding about what we are going to do.  
Mrs Banks: Will I be alright if I don’t like, if I don’t take any tablets?  
[AUDIORECORDED CONSENT INTERACTION: November 2006] 
By asking the patient about her understanding of “what we are going to do”, Dr 
Chatterjee anticipated consent and this was reiterated later during the interaction. Mrs 
Banks’ main concern appeared to focus upon the risks of not taking her established 
antihypertensive treatment, and was grounded in her identity as a patient, rather than 
potential study participant. The research element of the interaction did not appear to 
register with Mrs Banks, and did not lead her to consider the risk of continuing her 
current treatment. Her fears about stopping a longstanding intervention were reflected in 
the staff interviews, where several participants raised concerns regarding the reluctance 
of patients to consent to a study that may alter treatment regimens that have usually 
been initiated in the context of a longstanding relationship, either with their primary 
care team or with another hospital consultant. They commented that some patients are 
reluctant to change, especially when benefit is uncertain and not necessarily personal to 
them. Moreover, it was noted that patients have usually been advised, repeatedly and 
persistently, that they must not stop taking their medication(s) abruptly. Consequently, 
to suggest that this would be a possibility if taking part in the study, can be a cause for 
concern.   
In this particular example, a decision to stop or continue antihypertensive 
treatment in the immediate post-stroke period is currently based on the clinician’s 
personal preference, experience and clinical judgement, but not, at the present time, on 
scientific evidence. Thus, even if a patient refuses to participate in the study, on the 
grounds that they are happy with their current regimen, this is no guarantee that the 
regimen will not be changed, simply that it may be changed for uncertain clinical 
reasons rather than on the basis of randomisation in a clinical trial. In essence, patients 
taking part in the COSSACs study were consenting to have their treatment randomly 
allocated; if they did not participate the same decision may still have been made without 
randomisation and without the follow up that the study offered.   
Apart from the initial discussion when Dr Chatterjee tried to establish the time of 
onset, the rest of the consent interaction focussed upon the transfer of information from 
doctor to patient. Nevertheless, although such a focus may convey the impression that 
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the interaction was controlled by the doctor and was ‘study oriented’, Mrs Banks 
frequently oriented to Dr Chatterjee’s questions in such a way that she was able to raise 
her own concerns about possible changes to her treatment regimen, rather than answer 
Dr Chatterjee’s questions directly. In response to Mrs Banks’ question “Will I be 
alright?” Dr Chatterjee reassured Mrs Banks that study involvement would only 
potentially alter her treatment regimen for a two week period. He also mentioned that 
she would be allocated to stop or continue her antihypertensives by a process of 
randomisation which he likened to flipping a coin, although he did not explain why this 
was necessary. Still he continued to furnish her with information that he was bound by 
legal requirements and professional guidelines to provide ('The Medicines for Human 
Use (Clinical Trials) Regulations,' ; Franke et al., 2000; General Medical Council, 
2008), such as reminding her about the voluntary nature of study participation, 
confidentiality and indemnity, rather than that which would answer her question, “Will 
it be alright?” Thus when he repeated his question regarding her understanding of the 
study, Mrs Banks once again reoriented the question in order to prioritise issues 
important to her, regarding the understanding of her own health status and existing 
treatment regimen, as noted below: 
Dr Chatterjee: so, tell me, […] what’s your understanding about it? What, what 
we’re going to do?  
Mrs Banks: I understand I’m not right, you see when I was at home I used to 
take one every morning 
Dr Chatterjee: Sorry? 
Mrs Banks: I used to take a one every morning. 
Dr Chatterjee: Yeah, yeah. 
Mrs Banks: And if I missed a one I, I used to get worried in case anything 
happened, with me blood pressure tablets [AUDIORECORDED CONSENT 
INTERACTION: November 2006]. 
Although the question was posed to illicit a response about what the patient 
understood about the study, Mrs Banks told the doctor instead what she understood 
about her general wellbeing; that she was “not right”. She took the opportunity to 
describe her own routine management of her chronic health condition, and began to 
explain her treatment regimen. Her oblique response seemed to cause some 
bewilderment for the doctor [“Sorry?”], and allowed her to continue to emphasise her 
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usual behaviour and how she worried about changes to her routine. Occupying a purely 
‘patient’ position, Mrs Banks described how she managed her health and her worries 
about non-compliance with prescribed drug regimens which may result if she 
participated in the study.  
After another brief attempt to explain the research, Dr Chatterjee asked Mrs Banks 
again to recount her understanding of it, but she remained unable or unwilling to do so. 
When asked how she felt about the study, Mrs Banks persisted in interpreting this 
question as a more general inquiry and stated that she felt “alright” – making no 
reference to the study. 
Dr Chatterjee: So tell me wha, what, what’s the understanding about the study? 
Wha, what do you feel?  
Mrs Banks: Oh, I feel alright. 
Dr Chatterjee: Yeah, so what’s your understanding, what we will be doing if 
you say yes?  
Mrs Banks: I don’t know. [AUDIORECORDED CONSENT INTERACTION: 
November 2006] 
Repeatedly Dr Chatterjee attempted to reorientate Mrs Banks to the role of 
potential participant by returning to issues specific to the research protocol. Mrs Banks 
however, did not engage with the study specific element of Dr Chatterjee’s question. 
She continued to locate herself firmly in the patient role, and Dr Chatterjee was unable 
to change this. He asked again: 
Dr Chatterjee: So tell me if you say yes to this study what you will be doing. 
What, what exactly will happen to you?  
Mrs Banks: Nothing will happen, will it?  
Although Dr Chatterjee was asking about the process of the study, Mrs Banks 
focussed upon its outcome, and sought reassurance that there would be no adverse 
effects. The doctor appeared not to understand her response and explained again that 
study involvement might mean that she stopped taking her antihypertensive medication 
for two weeks.  
Dr Chatterjee: So are you happy either continue to blood pressure tablet or 
discontinue blood pre.., either way you are happy?  
Mrs Banks: As long as I’m going to be alright I’ll not mind. 
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Dr Chatterjee: Sorry, as long as you are going to be alright? 
Mrs Banks: Am I going to be alright? 
Dr Chatterjee: I don’t know.  
Mrs Banks: I’m not going to die, I’m not gonna die though am I?  
Dr Chatterjee: No, you’re not going to die. Don’t worry we wouldn’t let that 
happen. [AUDIORECORDED CONSENT INTERACTION: November 2006] 
Mrs Banks continually sought reassurance, and although at first Dr Chatterjee 
answered honestly that he did not know if she would be alright, when she indicated the 
extent of her concern by asking if she would die, he gave her the answer that she almost 
certainly wanted to hear, but that he could not actually know. The entire interaction 
proceeded as if two parallel conversations, with each participant engaging in the 
encounter from an entirely different perspective. Their individual contributions to the 
conversation could be linked, but not necessarily in the way, or to the effect, which 
either required or anticipated. Mrs Banks never deviated from her self-assumed, patient 
role, whilst for the most part, Dr Chatterjee adhered to that of researcher. Only briefly, 
in the exchange noted above did his frame of reference momentarily switch from the 
position of uncertainty he occupied as a researcher, where he appeared comfortable to 
state “I don’t know”, to that of experienced clinician who “wouldn’t let” the patient die.  
Dr Chatterjee was able to make this switch because although his main focus was Mrs 
Banks, potential study participant, his clinical experience enabled him to recognise her 
concerns as a patient and respond to them as a doctor, as she required. This was only a 
fleeting departure from the research role however, following which he resumed his 
efforts to secure study enrolment. Mrs Banks however had likely had no previous 
experience of research, and therefore responded to Dr Chatterjee in the only way that 
her experience allowed, as a patient responding to a doctor.  
After this brief attempt to respond to Mrs Banks’ need for reassurance, Dr 
Chatterjee reinstated himself in the researcher role and presented Mrs Banks with the 
study information sheet. Asking her if she would like to read it, he warned her that it 
was quite lengthy (six pages of 12 point font) but suggested that he leave it with her and 
come back in “15, 20 minutes or half an hour” to obtain her signature. Mrs Banks stated 
that she would not be able to read it as she had been unable to read her newspaper that 
morning. Once again she attempted to bring what she perceived to be the doctor’s 
attention to a problem that she was having – namely, reading – by noting something that 
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had already happened, and by offering this as a reason why she could not do as he 
wished. As Mrs Banks remained firmly within the patient role, similarly Dr Chatterjee 
adhered to his research remit, and did not investigate Mrs Banks’ clinical symptoms, 
which at this point were irrelevant to him, other than in relation to the extent to which 
they may impede her ability to read and sign the study documentation. In order to 
circumvent Mrs Banks’ visual difficulties, Dr Chatterjee read some sections to her – the 
sections that he considered important for her to know, such as an excerpt regarding 
arrangements for compensation. 
Dr Chatterjee: […] what if something goes wrong, […] I will read that bit, 
yeah [Mrs Banks: Aye]  
Dr Chatterjee: It says ‘medical research is covered by mishaps in the same way 
as patients undergoing treatment in the National Health Service er, that is 
compensation is only available if negligence occurs. Regardless of this if you 
wish to complain you have, and if you are concerned in any aspect er, er, aspects 
of the way you have been approached and treated in the course of the study, the 
normal Health Service complaints mechanisms should be available to you.’ 
For comparison, the extract below represents the actual text in the Patient 
Information Sheet: 
“What if something goes wrong? Medical research is covered for mishaps in 
the same way as for patients undergoing treatment in the National Health 
Service, i.e. compensation is only available if negligence occurs. Regardless of 
this, if you wish to complain, or have any concerns about any aspect of the way 
you have been approached or treated during the course of this study, the normal 
National Health Service complaints mechanisms should be available to you” 
[From COSSACS Study Patient Information Sheet].  
It can be seen that when reading the information sheet to Mrs Banks, Dr 
Chatterjee made few deviations from the text, and did not attempt to simplify the 
language. Nor did he endeavour, either here or elsewhere during the interaction, to 
explain any concepts which might have been frightening or upsetting, such as the risks 
of further stroke or swelling of the brain, either of which may be fatal and were noted in 
the information sheet. At this point, Mrs Banks suggested that she would read the 
document, and that Dr Chatterjee should telephone her daughter. In effect, the patient 
herself subtly indicated that she did not have the capacity, or perhaps simply did not 
wish to take responsibility, to make this decision alone, and that she would like the 
input of her family. Alternatively, perhaps this was simply Mrs Banks’ strategy to say 
no – by deferral – without actually having to do so. 
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Having established that Mrs Banks did not wish to consent to study participation 
without first discussing the matter with her family, Dr Chatterjee left the information 
with her for their perusal. He did not take the opportunity to telephone a family 
member, even when the ward sister offered to do this for him. The eventual outcome 
was that this patient was not included in the study because her understanding of the 
study appeared inadequate and her family was not seen within the time window to 
enable proxy consent. Throughout the interaction, Mrs Banks engagement as a 
potential research participant was minimal, and was always constrained by her active 
adoption of the more familiar ‘patient’ identity. She maintained this role, despite Dr 
Chatterjee’s attempts to reposition her as a research participant.  
I move now to a similar situation, where the roles of the participants were 
determined not only by their own actions but by the influence and expectations of the 
other parties in the interaction. 
8.4 Seeking Consent For An Acute Stroke Study (Acute Stroke Unit): The Consent 
Interaction That Never Was. 
I first referred to the interaction between Dr Chatterjee, Research Nurse Webb and 
Mrs Clarke, in Chapter 5.4, in order to demonstrate the temporospatial dislocation of the 
research team, and its effect upon the identification and initial assessment of potential 
study participants. Here, I explore subsequent events involving the same patient, and 
demonstrating the impact of the research team’s liminal status, which ultimately 
resulted in the exclusion of Mrs Clarke, from the research protocol in question. 
Mrs Clarke was admitted to the ASU within 48 hours of the onset of stroke 
symptoms and was therefore eligible for enrolment in the COSSACs blood pressure 
management study. The research team was unable to secure consent directly from the 
patient at their initial approach because of concerns about her capacity at that time, and 
the absence of any family members to act as consultee (Mental Capacity Act, 2005). 
The research team therefore contacted Mrs Clarke’s son by telephone, and agreed to 
leave information for perusal by family members as none of the research team would be 
available to discuss the study with them when they visited that first evening. As I 
illustrate below, this situation provided further examples of the relationship between 
time, space and the execution of research duties, when a plan of action was required in 
order to facilitate recruitment of Mrs Clarke the following day. The scenario also 
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demonstrates how the roles adopted by, or assigned to, the actors were influenced not 
only by the current context but by relationships, experiences and expectations. 
The morning after the initial approach, Research Nurse Webb visited the ward to 
establish whether or not Mrs Clarke’s family had visited the previous evening, and if so, 
whether they had commented on her potential study involvement. As anticipated by Dr 
Chatterjee (see Chapter 5.4), the ward had indeed ‘got busy’ and Sr Mitchell informed 
Nurse Webb that she was not sure whether Mrs Clarke’s family had visited. There was a 
sense of deference in Nurse Webb’s enquiry which was not evident when requests were 
made of the ward nursing staff regarding clinical matters. Emphasising the perception of 
the extra-curricula nature of research, although it was noted that the ward had been very 
busy, this ‘busy-ness’ did not include research activity, however peripheral. This 
reported failure to notice whether Mrs Clarke’s family had visited relieved the ward 
staff of the task of ascertaining whether or not they had reviewed the information left by 
the research team. It also meant that they would not have to address any questions that 
the family might have raised, and which they did not feel confident or adequately 
equipped to deal with. This reluctance to communicate with family members was not 
evident in other, clinical, situations. On occasions when an aspect of care required 
communication with, and approval from, patients’ next of kin, proactive steps were 
taken to ensure that contact was established and timely decisions made. For example, 
when it was deemed necessary, on one occasion to employ physical restraints to ensure 
a patient’s safety, a meeting was promptly set up with the patient’s consultant, senior 
nursing staff and the patient’s family, in order to determine the best course of action in 
the best interests of the patient. Research requirements, in contrast, were not similarly 
prioritised, and relied on a more ad hoc approach. Engagement in any type of research 
activity was perceived, by the clinical staff, to be an optional extra for them as well as 
for patients and their families. At the micro level it was apparent that clinical activity 
almost always took precedence over research activity, whether at an individual patient 
or ward level. 
Returning to the example of Mrs Clarke, in the absence of any information from 
the patient’s family, no attempt was made to telephone them again. Instead, Research 
Nurse Webb asked Sr Mitchell to telephone her in the SRO if and when the family 
visited. However, by doing so Nurse Webb was more or less forced to confine herself to 
the office to wait for a call as at this point the research team did not have dect (mobile) 
phones. This meant that she was unable to visit other wards, sites or clinics to trawl for 
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patients. Nurse Higgs, who was out of the office assisting Dr Chatterjee with some 
technical issues, was unenthusiastic about this plan. He stated that the ward staff would 
not remember to ring, and so Nurse Webb should visit the ward regularly to check 
whether any relatives arrived. Nurse Higgs’ lack of confidence in the ward staff’s 
cooperation placed an additional burden on Nurse Webb, and resulted in an inefficient 
use of time which was unlikely to have been evident had the research team been based 
in the clinical area.  
Ultimately, the ward staff did not ring the research team when the patient’s family 
arrived and I noticed that they were present when I visited the ward for an unrelated 
reason. At approximately 11:55am I advised Nurse Webb, who went to speak to them. 
At this point, Mrs Clarke had six visitors, including a daughter, who told Nurse Webb 
that her brother (who Dr Chatterjee had telephoned) had visited the previous evening 
and had read the information sheet and signed the consent form. Nurse Webb did not 
check the documentation at this point but offered the visitors further time to read the 
information themselves and advised them that she would ask Dr Chatterjee to come and 
speak to them about the study. At this time, Dr Chatterjee and Nurse Higgs were 
working in another office, on site, but away from the main hospital concourse and had 
to be radiopaged to return to ASU. At 12:55hrs, with only five minutes of visiting time 
and 95 minutes of the recruitment time window remaining, Dr Chatterjee and Nurse 
Webb went to speak to the patient and her family. By this time only one visitor, a young 
girl (Clare), remained. Mrs Clarke was in bed with the sheets pushed back, and was 
fiddling with her compression stockings. Even before Dr Chatterjee began to introduce 
himself, as a non-uniformed male on a hospital ward, Clare identified him as a doctor 
and began to make a request pertaining to her grandmother’s care: 
‘Can I just tell you, my grandma is finding these stockings very uncomfortable 
and is keep trying to take them off. Does she have to have them on?’ Dr 
Chatterjee explains the importance of the stockings and says that although they 
might feel a little strange at first her gran will get used to them. He says it’s 
better to put up with the discomfort for a while than risk the consequences. 
[FIELDNOTE: April 2007] 
Having been asked this question as a doctor, Dr Chatterjee responded as a doctor, 
referring albeit vaguely, to the potential clinical consequences of not wearing the 
stockings. Nevertheless, in order to ensure closure of this line of discussion and to avoid 
further clinical topics, Dr Chatterjee immediately reverted to researcher role, and 
introduced us both as researchers. He then asked Clare about her relationship to Mrs 
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Clarke, even though she had already indicated that the patient was her grandmother.  
When he then asked whether she was Mrs Clarke’s next of kin and whether she could 
make decisions on her grandmothers behalf, Clare took this as a prompt and, without 
hesitation and without being asked, stated that her grandmother would not be 
participating in the study: 
… the study information sheet is still on the bed table and on the post-it on 
which Dr Chatterjee had written “Study information for Mr C” someone has 
written “NOT PARTICIPATING IN STUDY”. Clare nods towards the papers 
and says if he’s referring to ‘that study’ (nods head and eyes towards study info 
on bed table) no, she won’t be participating in it and [Clare’s] written that on 
there. She spoke to her uncle last night and they decided no, they think she’s too 
poorly […] they don’t want anything else to be done to her. Dr Chatterjee 
explains that that’s fine and that the study is entirely voluntary and he had 
explained this on the phone to her uncle. Clare says no, if she wasn’t so poorly it 
would be ok but she doesn’t think she’s well enough. Dr Chatterjee asks if she’d 
like to discuss it further or have anything else explained but she does not. She 
says she’s read the information and while she doesn’t see any problem with the 
study itself she just doesn’t think her gran is well enough. [FIELDNOTE: April 
2007] 
Nevertheless, despite her immediate and emphatic response, Clare seemed 
uncomfortable in making an unqualified refusal to allow her grandmother to participate 
in the proposed study. She therefore justified her decision on the grounds that she and 
her family thought that her grandmother was too poorly to have something else, by 
implication something unnecessary, done to her. Justification of refusals is 
commonplace in everyday life, and usually hinges on a claim for or against ability 
(Heritage, 1984). For example, we might state that we cannot accept an invitation 
because we have a prior engagement, rather than merely stating that we will not accept. 
In this case, ironically, the very factor that rendered the patient eligible to participate in 
the study, i.e. her medical status, simultaneously – in the eyes of her family – rendered 
her ‘unable’ to do so; they considered her to be too ill to participate. Framing the refusal 
in this way rendered it ‘blame free’ in two respects. Firstly, it avoided implying that 
there was anything untoward about the request to participate, or about the study itself, 
and secondly it would not reflect unfavourably upon Clare or her family because it was 
presented as a joint decision, influenced by factors beyond their control.  
It has been described how research participants position themselves upon a 
continuum from patient only, to participant only, with a range of hybrid positions in 
between (Heaven et al., 2006). In this brief exchange, Mrs Clarke exhibited a passive 
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lack of engagement, and took no active part in the research oriented interaction, thus 
accepting the patient, or sick role, by default.  She was however, actively cast in this 
role by her granddaughter who clearly considered that her grandmother was too sick to 
be anything other than a patient. Equally important, was her status as grandmother, an 
identity encompassing all of the emotionality that resides within such a relationship, and 
thus eliciting, in this context, a protective response. It is noteworthy that whilst 
paternalistic behaviour from physicians was not sanctioned in the research arena, family 
members’ paternalism generally went unchallenged. 
For Clare, research and care were clearly quite separate, a dichotomy emphasised 
by the absence of the research team at the time at which Mrs Clarke’s family were 
perusing the information documents and may have had questions to ask. When the 
research team did make contact with Mrs Clarke’s family, although it was not clear 
whether or not they had read and/or understood the information, they had already 
reached a decision about Mrs Clarke’s potential participation. They had determined that 
Mrs Clarke was “too poorly” and that research participation would incur unnecessary 
risk and burden to her, and therefore should not go ahead. Much concern has been noted 
about what has been termed the therapeutic misconception (Lidz and Appelbaum, 2002; 
Appelbaum and Lidz, 2006; Miller and Joffe, 2006), which arises when study 
participants are unable to distinguish between clinical research and ordinary treatment, 
thus bestowing unrealistic expectations upon the research element of their management. 
More recently, a counter argument has been posed, and introduces the concept of 
‘injurious misconception’ (Snowdon et al., 2007). Snowdon suggests that a potential 
participant’s successful separation of research and care does not necessarily facilitate 
informed or enhanced decision making. Rather, she suggests that for some, in making 
this distinction, the element of novelty often perceived to be associated with research, 
may be over-inflated, and as such may over-exaggerate the associated element of  ‘risk 
and threat’– or in Clare’s case, unjustifiable burden. Thus, like the therapeutic 
misconception, injurious misconception may give rise to ‘a decision borne of 
misunderstanding rather than a legitimate choice’ (Snowdon et al., 2007 p.199). 
Such is the emphasis on autonomy and voluntariness, that Dr Chatterjee did not 
feel comfortable to continue to provide a verbal explanation of the study following 
Clare’s potentially ‘uninformed’ refusal. To do so may have been interpreted as 
coercion or undue pressure to participate. He was thus, unable to explain that 
participation in the study would not jeopardise the standard of care that Mrs Clarke 
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received. Participation simply meant that the decision whether to continue or suspend 
antihypertensive medication, a decision which would have to be made regardless of 
study participation, would be made via a formalised randomisation process, rather than 
according to non-evidence based personal preference of her clinician. Clare’s decision 
exemplified Snowdon’s theory regarding the perception of novelty and risk, and also 
supported the comment made by Dr Black in interview, that he believes that the public 
perception of research is that it must always involve something new (see also Snowdon 
et al., 2006; Snowdon et al., 2007) and must therefore always be more risky. In his 
view, patients and the public do not understand that research may also be undertaken in 
order to determine the most effective existing treatments or treatment regimens. 
8.5 Discussion 
The scenarios that I have explored within this chapter have demonstrated a 
number of areas of contrast between research and clinical interactions. Primarily, these 
differences related to the way in which informed consent was sought and decisions 
made.  
The requirement to obtain informed consent for diagnostic or therapeutic 
interventions, whether medical or surgical, routine or experimental, is a cornerstone of 
medical ethics (Declaration of Helsinki, 2000; Beauchamp and Childress, 2001). Failure 
to observe this requirement may result in litigation. Nevertheless, despite consent being 
a requirement prior to the initiation of both clinical and research activities, the way in 
which consent is obtained may be quite different as illustrated in the encounters 
described.  In clinical scenarios, consent may be implied - for example a patient who 
holds out his/her arm for the application of a blood pressure cuff.  However, implied 
consent is not informed consent and while the former may suffice for treatment, the 
same cannot be said of research encounters in which consent should be both voluntary 
and informed.   
In order to give (or withhold) consent, the patient must have capacity to do so. In 
cases such as Mr Adams’ (Chapter 8.2), for clinical decisions, where capacity may be 
compromised to some degree and/or where there is a degree of urgency pertaining to the 
potential efficacy of treatment, the clinician may make a recommendation based on all 
the available evidence about the treatment and in what he/she considers to be in the 
patient’s best interests. In Mr Adams’ case, the time critical nature of the proposed 
treatment meant that at least a provisional decision regarding its acceptability was 
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required so that the necessary investigations could be undertaken. Thus, whilst 
providing information to Mr Adams and endeavouring to include him in discussions, Dr 
White accepted Mrs Adams’ instruction to make a decision on her husband’s behalf. Dr 
White’s initial interaction with the Adams’ lasted only approximately 10 minutes, but 
this was long enough for Mr and Mrs Adams to develop a sense of trust in Dr White and 
to follow his recommendation.  Similarly, Mr Briggs (Chapter 8.2) devolved 
responsibility for medical decision making to Dr White, because he trusted in his 
medical expertise and professional judgement. Patients and their families have certain 
expectations about members of the caring professions and based on these expectations, 
in the absence of any evidence to the contrary, they are generally willing to accept their 
advice, particularly in an emergency or life threatening situation. The corollary of their 
placement of trust was that Dr White was able to move to a position of paternalism and 
to do so relatively swiftly, unlike the research encounters I observed,  where paternalism 
is neither sanctioned (Declaration of Helsinki, 2000) nor overtly demonstrated.    
In a clinical scenario, the physician may treat patients who lack capacity without 
consent using the defence of necessity.  In contrast, potential research participants are 
expected to make informed decisions about research interventions when incapacitated, 
or have non-medically trained proxies consent on their behalf (EU Directive, 2001).  
Not only are they expected to consider consent when capacity may be diminished or 
fluctuating, as in the cases described above, but also, the (potential) participant is being 
asked to participate in the evaluation of an intervention of unknown efficacy. 
Participation in research, on this basis, cannot be said to be in the patient’s best 
interests, indeed, it may even harm them (sometimes fatally). Therefore, the final 
decision regarding study participation lies with the patient, who may also consult others, 
such as family members. When no decision can be reached, either because of time 
restrictions, lack of understanding, or non-availability of next of kin, the default 
position, is exclusion from the study. 
In the final scenario described, Mrs Clarke’s clinical status precluded her personal 
involvement in an information giving and consent discussion. The restrictions upon the 
working hours of the research team meant that they were not available to discuss the 
study protocol when a number of family members were present, and this limitation 
ultimately resulted in the non-inclusion of Mrs Clarke. Mrs Clarke’s granddaughter’s 
refusal of study participation on her grandmother’s behalf demonstrated a further 
difference between the clinical and research scenario. Clare’s refusal was made without 
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having received a verbal explanation of the study, and based on indeterminate reference 
to the patient information document. Her presentation of her family’s decision was 
taken as absolute and final, and was accepted without question, even though there 
appeared to be a lack of understanding about what refusal might mean (or might not 
mean – it did not necessarily mean that Mrs Clarke’s treatment regimen would not be 
altered). 
 In the clinical scenario, is not uncommon for patients to refuse the treatment that 
they are offered, or to select an option that their clinician may consider less than 
optimal. Our interpretation of autonomy requires that in the clinical situation (with the 
notable exception of abortion) all relevant information should be given, whether this is 
desired by the patient or not (Foster, 2009). The GMC outlines a course of action if 
patients expressly refuse information (General Medical Council, 2008).  Thus appraised 
of the alternatives available to them, they may refuse the treatment offered, despite 
prevailing expert opinion and often considerable evidence of expected clinical benefit. 
A common example of such ‘informed refusal’ is seen amongst patients who decline the  
administration of blood products on religious grounds (Bodnaruk et al., 2004).  
In the research scenario however, although it is incumbent upon the researcher to 
fully and adequately inform the potential participant about the nature of the study and 
implications of participation in order that they may give their voluntary and informed 
consent, it is not incumbent upon the patient to read or listen to all of the study 
information if they do not wish to do so. Nor is it mandatory that the researcher explain 
the study protocol to the potential participant in order that they may fully understand 
what they are refusing. Thus, the patient or their proxy, may express an ‘unqualified’ 
refusal rather than what has been termed ‘meaningful non-consent’ (Williams et al., 
2007; p.59). In fact, efforts to engage the patient further, when they have already 
indicated, albeit without a full explanation, that they are not interested in study 
participation, may be perceived as coercion. This discrepancy exists because in the 
research situation, by definition, it is not known which option is ‘best’ and it cannot be 
argued that the patient is placing him/herself at a disadvantage by refusing to 
participate. Nevertheless, this highlights another difference between research and care. 
As indicated in previous chapters, the role of the clinician-researcher is not easily 
defined and the effects of the permeable boundaries of such roles are demonstrated in 
the examples given above. For the most part, the clinician-researchers approached 
potential study participants as researchers, seeking to determine eligibility and 
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willingness to participate in research. For example, Dr Chatterjee’s questions about Mrs 
Banks’ clinical status were related to her eligibility to participate in a study, not a 
precursor to a clinical intervention. He approached her as a researcher and remained in 
this role throughout the interaction, with only one brief and rapidly reversed 
transgression – to assure her that she would not die. This was his only deviation from 
the ‘research script’ and the only time that he responded directly to Mrs Banks’ needs as 
a patient, rather than seeking to fulfil an important requirement of his role, i.e. that of 
patient recruitment. Similarly, in his interaction with Mrs Clarke’s granddaughter, after 
dealing with Clare’s first question he did not engage in any clinical discussion regarding 
her grandmother.  
8.6 Conclusion  
The examples discussed in this chapter illustrate that those participating in 
research participant assessment, information giving, and consent interactions have 
different expectations of themselves and of each other. The research team adhered to 
their research roles and scripts in order to ensure that potential study participants 
understood the distinction between research and care, were not seduced by the 
therapeutic misconception, and could not be said to have been coerced to participate. 
However, the researchers’ apparent lack of engagement at an individual patient level 
may have been confusing and isolating for the patient, particularly those unfamiliar with 
the clinician-researcher role and inexperienced in participating in decision making about 
their own healthcare. In contrast, a practitioner-patient relationship appeared to develop 
much more quickly, in the clinical consent interactions observed. 
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Chapter 9. Discussion 
9.1 Introduction 
In Chapter 1, I outlined the clinical manifestations of stroke and noted the dearth 
of interventions to treat this condition in the acute and hyperacute phase. I then 
reviewed some of the practical and ethical difficulties encountered, or perceived, in the 
conduct of randomised controlled trials of therapeutic interventions in the early post 
ictal period. I did not consider non-therapeutic research as this presents different 
challenges.  Much of this work in this area focusses upon theoretical issues pertaining to 
the fulfilment of ethical and legal requirements for obtaining informed consent when 
patients are neurologically, functionally or cognitively compromised as a result of their 
stroke (or other emergency condition). In particular, concerns are raised about the 
voluntariness of consent (Katz, 2002) which may be compromised by what has been 
termed the ‘therapeutic misconception’ (Appelbaum et al., 1982), and leading some to 
advocate the separation of clinical and research activity. However, there is little 
empirical work in this area and what there is, often relies upon reported or anticipated 
behaviour, based upon consideration of hypothetical situations.  
While theoretical and hypothetical work provides some suggestions as to the 
difficulties encountered in undertaking research in the emergency situation, as Brody 
noted over 20 years ago, ‘only empirical investigations can reveal to us the major 
problems actually faced by healthcare providers and the ways in which they deal (or 
think they deal) with them’ (Brody, 1990; p.162).  My aim in this ethnographic study 
was to explore whether the difficulties noted in the literature are, in fact, the main 
barriers to the conduct of emergency research in the acute stroke environment, and the 
extent to which these arise from efforts to maintain or demolish the research/practice 
dichotomy that is advocated within the bioethical literature.  
In this thesis I have presented my observations and interpretations of the conduct 
of clinical research in an acute clinical environment, in which the aim of participating 
teams and team members may be considered to be collaboration and cooperation, rather 
than the total integration of research and clinical activities.  
In this final chapter, I will discuss the findings of this study and will demonstrate 
that research is not the value free entity that some expect, believe or desire it to be. 
Beyond enrolment criteria and ethical and regulatory requirements, recruitment was also 
influenced by organisational issues such as the temporospatial dislocation of the 
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research team. This also influenced the way in which the clinical team perceived and 
positioned research and the research team, and the ways in which the research nurses 
performed their research identity. All of these elements impacted upon the work of the 
clinician-researcher and the day to day conduct of clinical research within this acute 
stroke environment. I now discuss these findings in relation to the literature, beginning 
with the need to separate research and care. 
9.2 What Are The Advantages And Disadvantages Of Separating Research And 
Clinical Practice? 
As discussed in Chapter 2, a major rationale for the separation of clinical and 
research activity is that of avoiding the therapeutic or procedural misconception 
(Appelbaum et al., 1982; Fisher, 2006b). As illustrated in the interactions described in 
Chapter 8.3, my data confirm that there are indeed occasions where potential study 
participants, for example Mrs Banks, are unable to distinguish between research and 
routine clinical activity. However, I did not, during the course of my study, witness 
interactions where misrecognition of research personnel, or misunderstanding of their 
activities, led to a therapeutic misconception resulting in unrealistic expectation of 
benefit. On the contrary, some of the interactions illustrated an overestimated perception 
of potential risk – Mrs Banks asking if she would die (Chapter 8.3) - or burden, – Mrs 
Clarke’s family’s perception that study participation would be too much for her 
(Chapter 8.4). In contrast to the therapeutic misconception, such negative perceptions 
have been termed ‘injurious misconceptions’ (Snowdon et al., 2007), which occur when 
potential participants or their proxies take an overly cautious stance in relation to 
research risk and burden. Although evidence of this phenomenon was limited by the 
small number of research consent interactions I observed, it was also reported by several 
clinicians in my study.    
The purpose of trying to separate of clinical and research activity at the study site, 
by means of the employment of dedicated research staff, was pragmatically determined 
– the aim was to ensure the timely and proper completion of study specific activities. 
This rationale reflects the idea that distinguishing research from non-research activities 
can protect scientific or professional autonomy, by shielding researchers from political 
or outside interference (Gieryn, 1983).  Research staff pursued the goals of the ongoing 
studies, e.g. recruitment and physiological assessments such as timed blood sampling, 
without being side tracked by clinical demands, because the latter tasks were the 
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responsibility of others – the clinical team. This was evidenced by the fact that the 
research nurses did not participate in routine care or ‘dirty work’, such as bed bathing or 
giving bed pans. The research nurses’ supported this division of labour by referring to 
the time critical nature of many of their activities (as noted in Chapter 7.5).  Some of the 
clinical staff however, suggested that the research nurses’ non-participation in clinical 
activity was not task related but a deliberate choice reflecting their preferences, as noted 
by Nurse Cooper, (Chapter 6.2). Some staff in this study, from both clinical and 
research teams (Chapters 6.2, 6.3.1 and 7.7.1), suggested that research nurses and 
clinical nurses possess different characteristics and attributes, implying that one 
precluded the other, and formed the basis of the choices noted above (c.f. Hicks, 1996) . 
It can be seen therefore that whilst this separation of clinical and research roles and 
responsibilities prevented the research team being overwhelmed by clinical demands, it 
did little to promote research awareness and had implications for the development of 
working relationships between clinical and research teams. 
In addition to the issues associated with the employment of dedicated personnel, 
balancing ethical and logistical considerations means that conducting research in 
emergency situations such as stroke , is particularly difficult (Slyter, 1998). These  
difficulties may be exacerbated by the ways in which workload is distributed, and by the 
environment in which research and clinical activities are conducted (Fisher, 2006b).  
For example, facilities are often shared and activities overlap because it is more cost 
effective. As noted in Chapter 2, management of acute stroke, although improving, 
remains less than optimal in the UK (National Audit Office, 2005; National Audit 
Office, 2010) due to availability and accessibility of facilities, including imaging 
equipment, and appropriately trained personnel. Total separation of clinical and research 
activities would require the provision of separate premises, equipment and personnel. 
This may divert these scarce resources from the clinical arena and may ultimately result 
in a situation where only those eligible or willing to participate in research would have 
access to these facilities. A more integrated approach, such as that adopted at the study 
site, means that services are utilised by researchers and clinicians without the need for 
duplication of resources. However, there may be occasions where conflict arises 
between the clinical and research demands for finite resources. This was particularly 
notable in relation to CT imaging, and the ‘slotting in’ of non-urgent inpatient cases 
prior to suspected stroke patients (Chapter 7.8).  
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It has been suggested that one way to pre-empt and manage such conflicts, may be 
to employ research staff with clinical experience within the department(s) in which 
research is being undertaken, so that they will be familiar with, and can work within, the 
current systems (Kendrick et al., 2007). Although this policy was not purposively 
adopted at the study site, at least one of the research nurses had held a clinical role in 
the ASU. However, such familiarity presented its own difficulties as it fostered an 
expectation of participation on the part of some members of the clinical team, which 
some of the research nurses were not able to fulfil.  
Nevertheless, these issues notwithstanding, conducting research alongside routine 
practice has advantages. For example, the study site in this research became an early 
adopter of thrombolysis as a routine treatment for acute stroke, having trained staff and 
developed expertise in this area as a result of participating in a safety and efficacy study 
of this intervention (Hacke et al., 2004). 
Further, it has also been suggested that research could be facilitated within the 
NHS by raising the research profile so that patients using the service are aware of its 
research mission in the same way that those attending a teaching hospital are made 
aware of the likelihood that they will be involved in some way in professional education 
(Souhami, 2006). Integration or at least parallel conduct of research and clinical practice 
may contribute to raising research awareness amongst non-research personnel, patients 
and the lay public, who may be visiting or accompanying patients. Although Souhami 
(2006) was referring to research involving access to patient data, such measures could 
also promote research awareness more broadly. 
However, while the physical organisation and availability of resources may affect 
the relationship between research and care, there are other things that serve to maintain 
these distinctions, namely the staff perceptions and relationships with/to the different 
activities. 
9.3 Clinical Staff’s Engagement With Research Activity  
Throughout my study, clinical staff repeatedly claimed that they ‘know’ their 
patients and delivered holistic care (cf. May, 1992b; May, 1992a). However, just as 
research staff are able to disengage from hands-on care, clinical staff are similarly able 
to justify their own dissociation from research, a phenomenon that can be explained 
with reference to what have been termed ‘discourses of ignorance’ (Michael, 1996; 
Turner and Michael, 1996). 
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Turner and Michael’s work refers to the lay public’s ignorance of, and 
justification of their ignorance of, science and scientific expertise. They refer to three 
discourses which people draw upon to justify or excuse their ignorance: mental 
constitution; division of labour; and deliberate choice. All can be applied to my data to 
illustrate the way in which those not directly involved in clinical research activity were 
able to justify their disengagement from it.  
First, the discourse of ‘mental constitution’ holds that those who cannot, do not, or 
will not, engage with science (i.e. clinical research),  justify this on the grounds that 
they lack the mental capacity to do so, either due to lack of appropriate education or an 
inherent incapacity to engage in and with scientific matters. This perception was clearly 
illustrated by Sister Stone’s claim that some nurses think that research is ‘above them’ 
(Chapter 6.2), and was supported by further reports from clinical staff where 
participants deemed themselves lacking the capacity to grasp scientific or research 
concepts, downplaying not only their ability to understand research concepts but also 
the extent and adequacy of their training in this respect (Chapter 6.4). 
Second, ‘division of labour’ discourses, may be used to defend ignorance by 
claiming that one does not need to know about, or engage with, a concept because it is 
not a fundamental component of their role i.e. ‘it’s not my job’. This is exemplified in 
the current study by Sister Hatfield and Nurse Cooper, in Chapter 6.6. 
Finally, the discourse of ‘deliberate choice’, allows the uninterested or disengaged 
to claim that their lack of knowledge about research concepts and practice is the result 
of a conscious decision. Moreover, this discourse can be used strategically to diminish 
the importance of the research endeavour and the position of the researcher, by 
portraying both as potentially detracting from more important issues, in this case 
clinical activity. This position, in contrast to the ‘mental constitution’ discourse, in 
effect turns the tables on the researcher and suggests, like Nurse Cooper (Chapter 6.6), 
that research is not only different to, but is also less important than physical and clinical 
care, and that it is the researcher who is ignorant of these issues. 
However, whilst these discourses of ignorance have been drawn upon by my 
study population, other claims made constantly and consistently throughout the study, 
regarding poor staffing levels and skill mix, and heavy clinical workload cannot be 
ignored. Time restrictions and prohibitive workload responsibilities of clinical staff 
should not be allowed to undermine potential participants’ opportunity to contribute to 
clinical research (Bond Sutton et al., 2003). Similar operational and capacity issues are 
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also noted in work conducted outside, but equally pertinent to, the UK, where it is stated 
that crisis management inherent in healthcare means that clinical staff do not have time 
to consider the advantages of engaging with academia or research, either in terms of 
developments in nursing practice or improving patient care and outcomes (Redekopp, 
1997).   
In consideration of these issues, and as acknowledged by my study participants, it 
is clear that research integrity would be threatened if research specific tasks were 
delegated solely to the clinical team.  Alternative structures – i.e. the deployment of 
research nurses - are therefore required if research is to be successfully undertaken 
within the NHS. 
9.4 Can The Employment Of Dedicated Research Nurses Within The Clinical 
Environment Provide An Effective And Workable Means To Close The Gap 
Between Research And Clinical Practice? 
It has been suggested that the gap between research and clinical practice is 
affected by resources and knowledge, as noted above, and the perceptions and 
expectations of nurses (Albert and Siedlecki, 2008). Although Albert et al refer to the 
nurse researcher, rather than the research nurse role (for summary of differences see 
Gordon, 2008) there are some areas of commonality. For example, in my study, the 
clinical staff presented and expected a very specific version of the role of the nurse, 
which was, for the most part, the socially constructed, stereotypical image of the caring 
professional ‘tending the fevered brow’. Simultaneously, and as suggested by other 
authors, the research nurses were also stereotyped as being detached, objective, 
analytical, and driven by paperwork and protocols (Chalmers, 1983; Robson, 1993; 
Hicks, 1996; Roberts et al., 2006).   
There has been little empirical examination of the role and experiences of the 
clinical research nurse (Raja-Jones, 2002; Stephens-Lloyd, 2004; Spilsbury et al., 
2008). However, work has been undertaken focussing upon some of the other recently 
established senior nursing roles such as specialist nurses, advanced nurse practitioner 
and nurse consultants. Raja-Jones (2002), suggests that there may be some overlap 
and/or similarities between these roles and that of the clinical research nurse. Therefore, 
as it has been suggested that specialist nurses can improve patient satisfaction and can 
provide continuity of care (Hammond et al., 1995), it seems likely that research nurses 
could demonstrate similar impact. Compared with medical staff who operate a rotational 
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system, and ward or clinic based nurses who typically see the patient in only one 
bounded area, it has been noted that dedicated research staff generally have more time 
to spend with individual patients, and are encouraged to do so (Fisher, 2006a). This 
allows for discussion of patients’ and families’ fears and concerns about the research, 
and for clarification of understanding, by reiterating information given by the physician-
investigator or presented in study information documents. They are also able to spend 
time reviewing this information in the light of the patient’s personal circumstances, 
rather than solely with a view to advancing recruitment targets and meeting sponsor 
requirements. Also, as discussed in Chapter 7, not only can research nurses spend more 
time with study participants than would typically be the case in the clinical situation, but 
they can follow them up as they move between and within clinical areas, and at review 
appointments. In this respect then, because the research nurses within my study were 
not ultimately responsible for planning the clinical management of patients and did not 
(with the exception of assessment for and delivery of certain interventions e.g. 
thrombolysis) usually deliver clinical care, they were better placed to emphasise the 
delineation between research and clinical activity, and the voluntary nature of research 
participation.  
Contrary to Hicks’(1996) claim that the care-giving element of nursing has less 
prominence in the research nurse role, other work has highlighted the contribution that 
nurses make to trial coordination because of their dedication to care work and nursing 
related knowledge and skill (Mueller, 2001; Mueller and Mamo, 2002) and the fact that 
utilising the interactive skills of the nurse can benefit, rather than detract from, the 
research process (Colbourne and Sque, 2004). Although some of these studies report on 
the role of clinical trial coordinators, this title (and others) is often used interchangeably 
with that of research nurse (White-Hershey and Nevidjon, 1990; Hill and Schron, 1992), 
and both are acknowledged to play a vital role in clinical trials (Dennis and Strickland, 
1987; McKinney and Vermeulen, 2000). McKinney and Vermeulen noted that since 
employing research nurses in their Clinical Trials Unit they took on more studies, and 
increased patient recruitment and retention, whilst others have reported that the 
involvement of research nurses has also enhanced communication with clinical staff and 
participants, and has thus improved recruitment and patient compliance (Spilsbury et 
al., 2008).   
Despite these potential advantages associated with the research nurse role, there 
was evidence (Chapters 6 and 7) that the research nurses in this study were perceived, or 
195 
 
 
perceived themselves as occupying a liminal position - lying outwith the perceived 
boundaries of the taken-for-granted nursing role - and were therefore, viewed with 
apprehension and were more or less socially excluded by others in the ASU (Chapter 
6.3.2). We define ourselves in contrast and in relation to ‘the other’; therefore if we 
cannot recognise and define ‘the other’, this raises questions about our own identity. 
Those who occupy a liminal status, such as the research nurses in this study, are often 
perceived as threats to the social order and as a result become further marginalised 
(Bauman, 1991). Not only were the research nurses in this study perceived as 
functioning outside the traditional boundaries of nursing, but also they were seen as 
transgressing those of other disciplines, such as medicine and management. 
Consequently they were rendered hybrids (Bhabha, 1994), not easily recognised and not 
easily identified and thus viewed with an air of suspicion. It is possible that the clinical 
staff’s perception of the extended, or otherwise different, role of the research nurse, 
brought into sharp relief the limitations of their own role, skills, knowledge and 
attributes, and engendered an uncomfortable sense of ignorance in this regard. Such a 
realisation may be threatening or destabilising and this, rather than a rejection of, or 
animosity towards the research role and its incumbents, may account for their reticence 
to engage with research. Whatever the cause, there is a danger that such perceptions 
may generate a spiral of exclusion, resulting in the marginalisation of the research 
nurses, and the entire research endeavour, which in turn may adversely impact upon 
recruitment and retention of patients to, and in, clinical trials.  
The employment of dedicated research nurses may reduce the potential burden of 
extra work for the clinical staff but may simultaneously minimise the incentive to 
engage with research and the research team. Thus, although it was noted that integration 
of research in a clinical context can raise research awareness, there are examples within 
my study which suggest that integration may have an adverse effect by perpetuating 
poor research awareness and a sense of lack of involvement in wider decisions (c.f. 
Spilsbury et al., 2008). 
9.4.1 Professionalisation and extension of the nursing role. 
As noted above, the research nurses’ liminality (Chapter 5)  was compounded by 
their transgression of other professional boundaries, which may be related to the 
observation that part of the rationale for the uptake of research and research roles by 
nurses has been the desire to achieve professional status (Mulhall, 2002), which is itself 
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seen as a desirable and natural occupational goal (Storch and Stinson, 1988) . 
Attainment of professional status can enhance an occupation’s self-esteem and its 
development of self-regulatory mechanisms and ethical codes, whilst facilitating the 
abandonment of historically entrenched hierarchies (Meulenbergs et al., 2004) – in this 
case, for example, the subordination of nursing to the medical profession.  However, 
attempts to professionalise nursing have been criticised for mimicking other professions 
rather than developing distinct structures, ideologies and codes of practice (Rutty, 1998; 
Radcliffe, 2000). This has meant that those who choose to engage with what are 
considered to be the more professional aspects of their role, such as research, may be 
seen to be aligned to the historically dominant medical profession (Baumann et al., 
1998; Bonell, 1999), rather than the neophyte profession emerging from their own 
discipline.  
Moreover, whilst research nurses might often experience a more autonomous role 
than their clinical colleagues, they do not have the professional freedom of their 
academic counterparts - nurse researchers - who may either pursue their own academic 
interests, without medical input, or may collaborate jointly and equally with other 
disciplines (Gordon, 2008). For the most part, and certainly within my study site, most 
research nurses are involved in coordinating and managing randomised controlled trials 
under the (often remote) auspices of a senior medical colleague. Rather than being seen 
as a positive extension of their role then, this might be viewed as delegation – or cherry 
picking- on the part of the Principal Investigator so that the research nurses are left with 
the more technical and potentially less challenging aspects of the role. For example, 
Research Nurse Higgs (Chapter 7.4) expressed concern that although the research 
nurses were usually more familiar with study processes and procedures, they must still 
defer to either the research fellow or a non-research medic (in the absence of the 
research fellow) in order to obtain informed consent. Although I did not observe the 
latter practice during my fieldwork, involvement of non-research personnel in 
recruitment has raised questions about the quality and adequacy of information 
conveyed to potential study participants (Monico et al., 2008), and also raises questions 
about the perceived level of confidence and trust in the research nurse role. As 
described in Chapter 7.4 however, research nurses at the study site frequently guided 
medical staff, including the research fellow, through study procedures that they were not 
permitted to complete themselves. This gives mixed messages about the research 
nurses’ status and credibility and it is possible, that rather than enhancing professional 
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status, this particular manifestation of the research role cements nurses’ position as 
handmaidens and doctors’ helpers, thus undermining their skills and knowledge. 
Further, although remote management of research nurses allows them greater autonomy, 
lack of contact with nursing peers is likely to contribute to a similar sense of isolation to 
that reported by nurse researchers (Spilsbury et al., 2008). Thus, research nurses often 
miss the camaraderie and connections that they enjoyed in the clinical environment (Hill 
and MacArthur, 2006), as evidenced by the example of the research nurses’ exclusion 
from the Christmas tombola (Chapter 6.3.2).  
In addition to their potential isolation, research nurses are frequently treated with 
disdain by their clinical counterparts and are considered in some way to have turned 
their backs on the most fundamental principles of their profession (Hill and MacArthur, 
2006) (see Chapter 6.3.1, Nurse Cooper’s perception of the attractiveness of the 
research nurse role). It is significant that doctors who undertake research are often 
lauded, admired and respected, whilst nurses who do so, or who extend their skills 
across professional boundaries frequently find their clinical skills and motivation 
brought into question (Rutty, 1998). This may be due to the fact that senior doctors who 
undertake research usually still undertake some of the same clinical activities as their 
non-research colleagues. By integrating research with practice in this way, senior 
research doctors have avoided being seen as a separate group, or as clinically 
incompetent. Similar models exist for nurses within other units, where they can 
combine clinical and research roles without the same negative implications I witnessed. 
For example, diabetes research nursing is considered a specialist role and is usually 
embedded within that of the diabetes specialist nurse (Chester et al., 2007). However, 
this career model was not available to senior nurses within my study site, even though 
the role of ‘specialist practitioner’, as outlined in the UKCC’s Post-registration 
Education and Professional Practice (PREPP), includes a research element (United 
Kingdom Central Council for Nursing Midwifery and Health Visiting, 1995).  
It has been suggested that clinical research nurses are often perceived as being 
‘elitist and removed from clinical practice’, which may be linked to the fact that many 
work in academic units removed from the hospital environment, but in in my study it 
was simply that they were removed from their patient population due to 
organisational/operational constraints (Raja-Jones, 2002). Raja-Jones’ experience also 
differs from my own, in that she suggests that nurse specialists do not perceive research 
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to be part of their role, whereas my observations demonstrated a strong affinity between 
specialist and research staff.  
Given this affinity at the study site, it is also possible that there may be other areas 
of similarity between research and specialist nurse roles. I noted in Chapter 7 that at the 
study site, even amongst the research nurses themselves there were differing perceptions 
of their role. Similar findings were noted in a study of the relatively new role of clinical 
nurse specialist (CNS), and it is suggested that such ambiguity or confusion may lead to 
frustration when ward staff are perceived to harbour  unrealistic expectations and make 
unreasonable demands of these specialist staff (Redekopp, 1997). I suggest that similar 
disparities exist between research and clinical staff, and are not necessarily unilateral. 
Either group may make what are perceived to be unusual or unreasonable demands of 
the other, either because they do not understand each other’s roles, or do not appreciate 
the impact that requests for assistance/support (in either direction) may have. Examples 
include the request for research staff to fix a malfunctioning ECG machine (Chapter 
6.7), and requests for clinical staff to undertake blood pressure recordings more 
frequently than would usually be expected for clinical purposes (Chapter 6.6). 
Redekopp (1997) also states that there may be knock on effects on communication and 
collaboration which may develop into situations of conflict with other healthcare 
professionals when the CNS applies specialist knowledge that cuts across professional 
boundaries, as demonstrated in the interaction between the senior research nurse and 
senior radiography staff (Chapter 7.8).  
But while they may treat their research colleagues with disdain, Mulhall (2002) 
suggests that generally, nurses perceive the activity of research in a positive light. 
Similar observations could be made about the current study, which, like Mulhall, 
revealed that for some, research is perceived as a slightly mysterious and elite activity. 
Mulhall also observed that researchers are often perceived to be seeking academic rather 
than practice goals. In contrast, the clinical staff in my study, often seemed to think that 
individuals take up research roles to avoid the unpleasant aspects of clinical work 
(Chapter 6.3.1), rather than to achieve more positive outcomes either in terms of 
improved healthcare outcomes at a population level or their own personal and 
professional development.   
A criticism of research nurse roles is that although they usually offer the prospect 
of promotion and enhanced autonomy, this is often unsupported by subsequent career 
development opportunities (Johnson, 1986). It is argued that research should be 
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integrated within senior nursing roles as a clinical skill with direct practical relevance 
(Richardson, 2005b) and steps have been taken to address such issues but were not 
sufficiently advanced to allow comment in relation to this study (UKCRC 
Subcommittee for Nurses in Clinical Research (Workforce), 2007) 
So far, in this chapter, I have discussed the advantages and disadvantages of 
integrating research and clinical practice, primarily with regard to the impact upon 
research itself and upon healthcare professionals involved in these activities. However, 
the patient-participant is also drawn into the liminal space between experimentation and 
routine care, and it is this element that I now discuss below.  
9.5 Positioning The Patient 
As well as the ethical, organisational and professional issues discussed above, a 
further difficulty associated with the separation of research and clinical practice, relates 
to the positioning of the patient. Despite the theoretical distinction between research and 
clinical practice, at a pragmatic level, these activities overlap and become blurred, and 
are thus conflated by researchers, clinicians and patients alike (Hallowell et al., 2009). 
Further, as the focus of these activities, the patient cannot be compartmentalised, 
particularly in an emergency and potentially life threatening situation. Nevertheless, 
although it is not physically possible to divide an individual into ‘the part that is 
participating in research’ and ‘the part that is receiving clinical care’, in practice such 
distinctions are made everyday, usually for good reason and to good effect. 
As discussed in Chapter 5.6, in different departments and across different 
disciplines multiple configurations of the patient exist, according to the spaces they 
occupy and in relation to activities and outcomes. The research team’s interactions with 
patients were conducted in the environments that they shared (albeit as guests) with 
their clinical counterparts and their activities often relied upon the same props and 
processes. The similarities were finite however and although they might be expected to 
orientate towards their patient population in the same way, they did not. 
In my study, the clinical nurses judged the research nurses’ behaviour in 
comparison to their own - because this was their closest point of reference – and found 
them lacking. Similarly patients and families approached by the research fellow seeking 
consent for study involvement responded to him as a doctor (Chapter 8.3 and 8.4), 
because they were not familiar with the research aspect of his role. Likewise their 
reaction to ‘research’ is likely to be based on what, if anything, they already know about 
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research.  As others have similarly noted (Mueller, 1997; Edwards and Chalmers, 2002; 
Brody and Miller, 2003), the clinician-researcher must negotiate dual roles and their 
attendant conflicts; it may be less obvious however, that potential study participants are 
also faced with optional identities.  
In the context of a RCT, such as those observed in my study, when approaching a 
potential study participant the clinician-researcher has a choice of vantage points based 
on experience; the patient is always known to be a patient, but anticipated to be a 
research participant. Patients approached to consider research participation do not enter 
the encounter furnished with the same set of assumptions. Most adults are familiar with 
at least some of the assumptions about the patient role (Parsons, 1951; Makoul, 1998), 
(although the traditional, more passive role is gradually being replaced by a more active 
participatory one), and therefore know what is expected of them as a patient. They are 
less likely however, to be familiar with research, the role of the clinician-researcher, or 
their potential role as study participant.  
Patients and their proxies have certain expectations about members of the caring 
professions, as well as a considerable degree of trust concerning medical research (Kass 
et al., 1996; Sugarman et al., 1998). Based on these factors, and in the absence of any 
evidence to the contrary, they are generally willing to accept advice (McNeally and 
Martin, 2000; Bosk, 2002). This is particularly so in what are usually unfamiliar, one-
off situations, such as those of an emergency or life threatening nature. In such 
situations they may struggle with the nature, complexity and volume of information 
delivered to them when being invited to participate in a clinical trial (Featherstone and 
Donovan, 1998; Akkad et al., 2006). Thus, whilst  policy makers contend that it is 
important for patients to have the opportunity to make their own healthcare choices, it is 
also argued that others would perhaps prefer ‘to be taken care of, to have experts relieve 
them of the burden of tragic choices by deciding what is best’ (Bosk, 2002 p.V-67).  
However, although the question “what would you do?” is a familiar one for 
doctors and nurses, for the clinician-researcher, it is one that most are reluctant to 
answer. Even, or perhaps especially, where the patient lacks capacity, the clinician 
researcher can do no more than present the options and their pros and cons. The 
professionals involved in my study, whether research or clinically orientated, confirmed 
that whilst they would, or would expect to be able to, make a recommendation about 
clinical care, this would not be the case with regard to a decision about research 
participation.  The clinician-researcher’s reluctance to make a recommendation may be 
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perceived by the patient or their family as a lack of engagement and may be both 
confusing and isolating for the patient, particularly those unfamiliar with the clinician-
researcher role and inexperienced in participating in decision making about their own 
healthcare. For the patient who is used to following the clinician’s advice, lack of 
guidance in such situations, although intended to promote voluntariness and to avoid 
coercion, may be interpreted as abandonment (Ingelfinger, 1980; Burns and Troug, 
1996).  
Clearly, an individual cannot make an autonomous choice about participating in a 
clinical trial if they are not aware of, or do not understand, basic concepts of research 
methodology and ethical frameworks (Pickersgill, 2011). My research participants 
broadly echoed Pickersgill’s suggestions that work within communities, for example 
schools and local groups, and within research forums, may usefully promote public 
understanding of research and associated concepts.  
Lack of familiarity with research and the research participant role, procedural and 
therapeutic misconceptions, and the likelihood of the patient being in a dependent 
relationship with the clinician-investigator, along with its potential influence on 
voluntariness, brings us to the final issue that my study set out to address, i.e. whether 
or not one of the main problems in conducting emergency research was that of 
obtaining informed consent.  
9.6 Obtaining Informed (Or Proxy) Consent For Participation In Randomised 
Controlled Trials In Acute And Hyperacute Stroke 
Whilst I did not see sufficient research consent interactions to draw firm 
conclusions, it was evident that the issues noted above may undermine efforts to 
promote and/or maintain patient autonomy during the informed consent process. The 
impact of procedural or therapeutic misconceptions makes it difficult for the unprepared 
patient to understand that they are in a different situation and this lack of understanding 
may impact upon their understanding of, and voluntariness to, consent to study 
participation. The situation is further complicated when capacity is compromised. 
In the clinical situation where an urgent decision is required, but capacity is 
compromised, the default position, based on the common law doctrine of necessity, is 
that the clinician will act in the patient’s ‘best interests’, and the requirement for consent 
is therefore waived (Frazier et al., 1995; Johnston and Liddle, 2007). Nevertheless, 
consent is often assumed by clinicians, on the grounds that most rational patients would 
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wish to take the course of action that would save their life and/or avoid any severe or 
lasting disability (Miller, 1993). For research participation however, it is a requirement 
that consent is informed, rather than assumed (Declaration of Helsinki, 2000; EU 
Directive, 2001). Because research participants are being invited to contribute to the 
evaluation of an intervention of unknown efficacy, involvement can neither be claimed 
to be in, nor against, their best interests, and therefore, the final decision regarding study 
participation lies with the patient. The patient may consult others, such as family 
members to help them in reaching a decision, but when no decision can be reached, 
either because of time restrictions, lack of understanding or non-availability of next of 
kin (either to provide support or to act as proxy in the case of the incapacitated patient), 
the default position (prior to the changes introduced within the Medicines for Human 
Use (Clinical Trials) Amendment (No. 2) Regulations, 2006) was exclusion. Although 
these changes came into force during my data collection period, the studies ongoing 
within the study site had commenced before these changes were introduced and no such 
changes to the recruitment processes had been made or requested, hence the continued 
default position of exclusion, as demonstrated in the interactions examined in Chapter 
8.3 and 8.4. These contrast sharply with the interactions concerning clinical 
thrombolysis in Section 8.2, where decision making authority was devolved to, and 
accepted by, the consultant physician in these examples. 
It is argued that the default position of exclusion from research participation in the 
absence of prospective informed (or proxy) consent, protects vulnerable persons from 
risks associated with experimental treatment and upholds their autonomy by not 
including them in a study for which, had they been capable, they may not have given 
their informed consent (Lazar et al., 1996). However, acceptance of exclusion by 
default was mixed among my study participants, and it is argued in the literature that a 
presumption of willingness to participate is no more or less likely to contravene an 
individual’s wishes (Harris, 2005; Rhodes, 2005; Brazier, 2008).  
Further, we should not assume that patients or their proxies  are always the 
neutral, rational, decision makers upon which normative ethics grounds the concept of 
informed consent (Bosk, 2002), or that they make their decisions based only on the 
information provided to them by the clinician-researcher.  It has been suggested that 
Western thought is stifled by an ‘irrational passion for dispassionate rationality’ 
(Williams, 1998; p.747) . There are few situations where this is more obviously 
apparent than the research consent interaction, and where the tendency to attempt to 
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hold separate emotion and reason in relation to decision making (Rieff, 1979; Williams, 
1998) is pronounced.  Conversely, others suggest that we are able to make informed 
decisions because of our emotions rather than in spite of them, and that they are in fact 
an essential element of rational thought and normal social behaviour (Damasio, 1994). 
It is a limitation of this thesis that I was not able to demonstrate this more clearly in 
relation to research consent interactions. However, I believe that I have touched upon 
this with regard to decision making for clinical thrombolysis, particularly in Mrs 
Adams’ delegation of responsibility to Dr White, based upon her own perception of her 
husband’s beliefs and values and her potential burden of guilt about making the ‘wrong’ 
decision (Chapter 8.2). A patient is never only a patient; they may be husband/wife, 
parent, employer, employee and/or any number of other roles, with their attendant life 
experiences – any or all of which may have a bearing on decisions they make, or those 
that others make on their behalf (for example Clare’s refusal to sanction her 
grandmother’s study participation, Chapter 8.4).  
In the previous sections I have discussed my main findings in relation to the 
advantages and disadvantages of separating or integrating research and clinical activity, 
including the impact of employing dedicated research personnel. I have considered the 
different roles available to the patient in the research encounter, and the way in which 
their understanding of research and the research role may influence decisions regarding 
study participation. I have demonstrated that issues discussed in the literature are not the 
only, or necessarily the main, obstacles to research recruitment. I now move to some of 
the difficulties and limitations in the conduct of this study, before making 
recommendations for practice and further work.    
9.7 Limitations Of The Study    
In Chapter 2, I identified a gap in the literature, which consists predominantly of 
theoretically based work, or empirical studies exploring responses (anticipated or 
actual) to hypothetical situations. This study, by adopting an ethnographic approach, 
facilitated the accrual of empirical observational data, regarding the actual day to day 
conduct of clinical research activity in an acute clinical environment, which are not 
widely available in the current literature.  However there were also problems associated 
with employing this method in this particular clinical situation. 
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9.7.1 Unpredictable volume and erratic timing of the presentation of stroke referrals   
An ethnographic approach is useful when one wishes to observe all aspects of a 
situation or regular occurrences/behaviours. However, when the focus of study is less 
predictable, the cost-benefit trade-off between long hours of observation versus volume 
and quality of data collected is an important consideration, especially for a single 
researcher.  Predominantly as a result of the emergency nature of the topic of 
exploration, it was not possible to identify in advance how many patients (and therefore 
observations of their management) would occur during my periods of observation, or to 
predict when study eligible patients would be received at the EAS. Thus I could not 
guarantee to be in ‘the right place at the right time’ and my periods of observation 
involved long periods of ‘hanging around’. However, maintaining a presence in this 
way was essential in providing rich contextual data and in ensuring that the clinicians 
became accustomed to me being there, so that when interactions occurred that I wished 
to observe more closely, team members were not unduly perturbed or excessively 
influenced by my presence.  
Having become aware of the fact that the unit was receiving fewer stroke referrals 
than anticipated, I sought and secured the necessary permissions to extend recruitment 
to a neighbouring hospital and was able to obtain two recordings of research consent 
interactions from that site. However, because I did not collect observational and 
contextual data from this second site I decided not to incorporate these data within this 
thesis. They will however inform other academic work. 
9.7.2 Research awareness and participants’ unfamiliarity with the research method 
Despite my long periods of observation in the ASU, just as clinical research was 
not a priority for the clinical team, my observational research was not uppermost in the 
minds of the research team when receiving and assessing potential participants for acute 
or hyperacute clinical trials. In general, the paucity of consent interactions observed was 
due to a lack of eligible patients, but on two occasions I missed the opportunity to 
record consent interactions.   
On the first of these occasions I was present in one of the ward bays when the 
research team assessed a patient in EAS. They later acknowledged that they had not 
informed me because it was one of the few occasions when I had stayed in the 
department after 5pm and they had forgotten that I intended to do so. On the other 
occasion, I was outside the hospital but was able to get there quickly when contacted by 
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the research nurse. Despite this however, the research fellow forgot about my study and 
despite the fact that there was plenty of time remaining, had approached the patient for 
consent before I arrived and therefore it was not possible to record the exchange. Whilst 
it was frustrating to miss these interactions, these scenarios themselves were useful 
indicators of the way in which research is perceived, and the way in which the staff 
engaged with it. The research team’s limited engagement with my study, was similar to 
the way in which clinical staff engaged, or did not, with their own academic or 
pharmaceutical studies, and reinforced the issue of research awareness, prioritisation, 
exposure and training requirements. 
9.7.3 Scope of the study 
The study may be criticised for its single centre focus. However, as a single 
researcher, and in light of some of the issues noted above pertaining to the unpredictable 
and erratic nature of the topic under investigation, a multicentre approach was not 
logistically feasible. It may also be noted that my interactions, particularly the 
interviews but also the less formal discussions through the fieldwork, focussed 
primarily upon healthcare professionals rather than patients or their family members. I 
outlined my rationale in this regard in Chapter 4.4.5, and maintain that greater 
involvement of patients and their carers would have been more useful and more 
acceptable had there been a greater number of patients enrolled in or approached for 
enrolment in the ongoing clinical trials. 
9.8 Strengths Of The Study 
Despite the difficulties noted above, the observational aspect of this ethnographic 
study furnished a rich description of ongoing research activity in the ASU, whilst data 
collected via interviews and less formal discussions, facilitated exploration of 
participants’ perception of their own, and others’ roles in relation to research, and the 
ways in which these roles were fulfilled. I was thus able to compare observed and 
reported behaviour and rationale, and to explore the reasons why discrepancies may 
exist. I was also able to explore the extent to which actual practice reflects accounts in 
the literature. Interviews alone would not have allowed for contextualisation of 
responses, whilst isolated observations would have relied solely upon my own 
interpretation of events, rather than co-constructing an understanding in collaboration 
with study participants. 
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The ethnographic approach facilitated observation of activity in all of the clinical 
areas through which the suspected stroke patient was likely to pass, and the opportunity 
to clarify issues as and when they arose, rather than attempting to anticipate and explore 
every issue within the context of a single interview. It is unlikely that interviews alone 
would have highlighted issues beyond the consent interaction which nevertheless have 
considerable impact upon recruitment and retention of study participants. The study 
highlighted that such difficulties are not confined solely to process of obtaining 
informed consent.  
Despite the difficulties noted in the previous section, I am confident that this 
approach provided more comprehensive and robust data than interviews alone. 
Although limited to one diagnostic area, the study begins to address the absence of 
empirical work examining the conduct of emergency research within the clinical 
environment. It provides data that can be used to furnish an understanding of the actual 
difficulties encountered in the day to day conduct of acute and hyperacute RCTs of 
stroke treatments in the clinical environment. Its broader focus, extending to include the 
context in which decisions regarding study participation are made, and not just the 
decision making process itself, supports a number of recommendations which I outline 
in the following section. In addition to the provision of empirical data however, the 
study also adds to the understanding of the practicalities of ethnographic methodology 
by means of a reflexive approach which allows the reader to apprehend some of the 
difficulties encountered in conducting ethnographic work in this context.  
 
9.9 Recommendations 
The study identified a number of issues that may contribute to the development of 
research awareness and thus enhance recruitment. 
9.9.1 Integration of research within clinical practice 
The model of partial integration of clinical and research activity adopted at the 
study site is a method that ensures research processes and procedures are completed in a 
timely manner, thus maintaining study integrity and participant safety. However, this 
study identified a need for closer temporospatial integration of clinical and research 
staff, from both medical and nursing teams, in order to promote research awareness and 
a general understanding of each other’s roles, responsibilities and restrictions. Dedicated 
administrative space for the research team within the clinical area would contribute to 
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the visibility of the team and promote closer working between the two teams. Whilst the 
cost of providing an ‘on-call’ research service may be prohibitive, a two shift system 
with provision of some weekend cover would also raise the profile of the research and 
the research team within the ASU. The purported ethical benefits of total separation are 
outweighed by the practical limitations in this particular scenario. 
9.9.2 Greater integration of research in professional education and training 
Clinical and research staff alike noted deficiencies in their basic/undergraduate 
training with regard to research concepts and methodologies. Development and 
inclusion of more applied research modules within educational programmes at 
undergraduate and/or postgraduate level may demystify research and promote 
understanding and acceptance of research concepts. 
 The report of the UK Clinical Research Collaboration Subcommittee for Nurses 
In Clinical Research (Workforce) made recommendations for the development of 
clinical academic nursing roles and aimed to address issues of research capacity and 
capability (UKCRC Subcommittee for Nurses in Clinical Research (Workforce), 2007). 
My data collection was undertaken prior to the publication of this report and therefore it 
is not possible to say what effect, if any, this report has had. 
Finally, it  is a requirement that research personnel undergo training in Good 
Clinical Practice, with refresher sessions every three years ('The Medicines for Human 
Use (Clinical Trials) Regulations,'). In terms of patient safety, I suggest that this training 
should not be restricted solely to research staff, but should also be undertaken by any 
healthcare professional employed in an environment where clinical trial participants 
may be cared for. 
9.9.3 Raising public awareness 
Many of the healthcare professionals participating in this study reported a 
perception that patients and the public have little knowledge or awareness of healthcare 
research. Although limited by small numbers, my data suggest that patients are ill 
prepared for the likelihood of research participation during healthcare encounters and 
experience difficulty in orienting to a potential participant role. Wider and more easily 
accessible reporting of research activity may promote understanding and engagement, 
and could be achieved locally by displaying notification of research activity on hospital 
noticeboards, within community groups and via presentations to student groups in 
schools and colleges. Forums such as Café Scientifique would also be appropriate to 
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disseminate such information and I will consider presenting the findings of this study in 
this arena.  
9.10 Further Work 
Study data supported some of the conceptual and theoretical literature but often 
also provided some contradictory evidence. Having observed fewer research consent 
interactions than anticipated, it was difficult to support or refute the claims made in the 
literature and by healthcare participants, regarding the emotional distress, and by 
implication, impaired decision making capacity, of patients and families approached to 
consider participation in RCTs in the acute or hyperacute period following the onset of 
stroke symptoms. Further empirical work is required to explore this issue. 
The parallel study, funded by The Stroke Association (noted in Chapter 4), 
explores patients’ and families’ views about recruitment to acute and hyperacute stroke 
studies, and will provide some insight into this question. However, this sister study 
relies upon accounts of reported behaviour, which may be tainted by hindsight, 
particularly as the behaviour in question took place at a very emotionally charged time.  
Joint analysis of the data from both studies is planned and is expected to broaden and 
strengthen the findings of each. 
Further work exploring areas in which research and clinical activity are either 
wholly integrated or completely separated would provide a more comprehensive picture 
of the difficulties encountered and alternative management approaches. Logistical issues 
inherent in the method, may be less pronounced in non-emergency situations, but 
nevertheless might be better managed by nesting such ethnographic work within the 
RCT(s) under observation. 
9.11 Conclusion 
This study has confirmed that recruitment to acute and hyperacute stroke studies is 
problematic; however, the primary barriers reported and observed within this study were 
not necessarily those described in the medical and bioethical literature, and reflect more 
local, policy and organisational issues. This study has also demonstrated, that the 
differences between the activities we call research and clinical practice may be more 
apparent than real.   
It was observed that absolute separation between research and clinical activities  is 
neither: a) attainable, due to resource issues; b)  sustainable, because even though 
separately ‘identified’ by research specific personnel, individuals cannot subsequently 
209 
 
 
be compartmentalised into separate patient/participant roles, nor can research staff 
withdraw themselves entirely from every aspect of clinical or caring activity as there are 
inevitable areas of overlap;  nor c) desirable, because it potentially alienates 
professionals within and across disciplinary groups and teams, minimising incentives 
and opportunities for joint learning and collaboration . Therefore, whilst research and 
clinical practice may involve different types of activities, and have different aims and 
objectives, perhaps a more helpful way to look at these concepts is to consider them 
different, but complementary, aspects of ‘treatment’ ranging from experimental to 
routine.    
A conundrum exists in that ethical concerns recommend the separation of clinical 
practice and clinical research so that potential participants can make autonomous 
choices about research participation, without coercion, and without unrealistic 
expectation of benefit (Appelbaum et al., 1982; Brody and Miller, 2003; Fisher, 2006b),  
pragmatic considerations, such as staffing requirements, preclude this total separation 
however. In order to ensure participants’ safety and study integrity, it is essential that 
potential participants (and non-research healthcare professionals) have at least a basic 
understanding of research methodologies, processes and practice. In addition, if 
research and clinical teams cannot demonstrate confidence and trust in each other’s 
capabilities, patients may also struggle to do so; clinical staff’s lack of understanding of 
the research nurse role and the studies which they administer, will fail to engender trust 
and confidence among patients who may be invited to participate in such studies thus 
threatening recruitment rates.   
Placement of research nurses within the clinical environment may promote 
transparency and greater understanding of their role and may simultaneously demystify 
research and its associated concepts; ultimately this may promote closer working 
relationships and contribute to the enhancement of recruitment, retention and 
management of research participants. It is both a functional and an ethical requirement 
that both research input and output should be shared (Mulhall, 1997).  Research findings 
will only be applied and embedded if they are fully understood. An effective way for all 
parties to achieve this is to promote wider exposure to research in both educational and 
experiential settings, and to ensure understanding at the earliest stages, not just at the 
implementation phase. We respond to people and situations on the basis of what we 
already know and expect (Blumer, 1969b; Rock, 2001) therefore, it can be argued that 
patients, the public, and healthcare practitioners will not become familiar with research 
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activities  until they become  normalised within our everyday lives, and more 
specifically, our healthcare.  
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Chapter 10. Appendices 
10.1 APPENDIX A. 
 
 
 
 
 
Sunderland Local Research Ethics Committee 
c/o Sunderland Teaching Primary Care Trust (South Office) 
Administration Corridor 
Ryhope Hospital 
Ryhope 
Sunderland 
SR2 0LY 
 
Tel: 0191 5699515 
Fax: 0191 5699545 
 
Bill Hackett – Manager 
Shelley Rowe – Administrator 
Email: bill.hackett@suntpct.nhs.uk 
Email: shelley.rowe@suntpct.nhs.uk 
 
30 May 2006 
 
Dr Madeleine Murtagh 
Lecturer in Social Science and Public Health 
University of Newcastle upon Tyne 
School of Population & Health Sciences 
4
th
 Floor William Leech Building 
Framlington Place 
Newcastle upon Tyne 
NE2 4HH 
 
Dear Dr Murthagh, 
 
Full title of study:  Processes and practices in the enrolment of patients to RCTs of 
acute and hyperacute stroke treatment: decision making by 
patients, relatives/carers and healthcare professionals. 
REC reference no: 06/Q0904/19 
 
Thank you for  your letter date 15
th
 May 2006, responding to the Committee’s request for further 
information on the above research and submitting revised documentation. 
 
The further information has been considered on behalf of the Committee by myself as Vice-Chair. 
 
Confirmation of ethical opinion 
 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for the above 
research on the basis described in the application form, protocol and supporting documentation as 
revised. 
 
Ethical review of research sites 
 
The Committee has designated this study as exempt from site-specific assessment (SSA). There 
is no requirement for [other] Local Research Ethics Committees to be informed or for site-specific 
assessment to be carried out at each site. 
 
Conditions of approval 
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The favourable opinion is given provided that you comply with the conditions set out in the 
attached document. You are advised to study the conditions carefully. 
 
Research governance approval 
 
The study should not commence at any NHS site until the local Principal Investigator has obtained 
final research governance approval from the R&D Department for the relevant NHS care 
organisation. 
 
Statement of compliance 
 
The Committee is constituted in accordance with the Governance Arrangements for Research 
Ethics Committees (July 2001) and complies fully with the Standard operating Procedures for 
Research Ethics Committees in the UK. 
 
06/Q0904/19   Please quote this number on all correspondence 
 
With the Committee’s best wishes for the success of this project. 
 
Yours sincerely  
 
[electronic signature deleted]  
 
Reverend Caroline Worsfold 
Vice-Chair  
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10.2 APPENDIX B. 
Semi-Structured Interview Guide 
(Healthcare Professionals) 
· Interviewee consent–  
· Review participant information: purpose of the study and aim of the interview 
· Consent form 
· Check acceptability of audio recording the interview 
· Clarify any questions or concerns 
 
· Purpose of the study: to examine how medical and nursing staff approach patients or relatives 
for consent/assent to take part in acute and hyperacute RCTs of treatments for stroke.   
 
1. Could you please tell me a little about your background and how you came to be working at the 
Acute Stroke Unit? 
 
2. You are involved in the care of patients enrolled in acute and hyperacute RCTs of treatments for 
stroke. Think about a recent patient*. How was a decision made about study eligibility? Can you 
describe the consent process (including ‘pre-approach’)?  
 
Explore: 
· * Last interaction, typical interaction, atypical interaction 
· Level of involvement 
· Involvement of other healthcare professionals 
· Issues discussed before and during consent interaction   
· Assessment of capacity 
· How did the patient/relative respond to the invitation? 
· What worked well? Examples that worked better/worse? Why was this so? 
· Different approaches  
· Factors that facilitate or hinder participation in research 
· Key challenges to engaging patients/relatives in research in the acute or hyperacute situation  
· Differences/similarities to engagement in clinical situations, or less acute research studies  
 
3.  What do you understand by the term informed consent? Are you aware of any alternatives to 
prospective informed consent? Can you describe them? 
 
Explore:  
· Understanding of the legal requirements regarding consent for research purposes. 
· Assessment of patients’/relatives’ decision making capacity in the acute/hyperacute. 
· Own feelings re. consent/assent process for research purposes in the acute or hyperacute 
situation. 
 
4. Is there anything else you would like to tell us about the consent process, or about acute or 
hyperacute research in stroke? 
------------------------------------------------------------------------------------------------------- 
Thank you for taking part in this interview.  Are there any questions you would like to ask, for 
example, about the study?  
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